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Chapter 1. Introduction 
 
 
 
 
The keywords describing this work are fractionation and speciation, the elements indium 
and arsenic  and the terms body fluids, tissues and exposure. The terms fractionation and 
speciation will be discussed in the next paragraph. Indium and arsenic are two elements 
having completely different physical and chemical properties. They only touch common 
ground when incorporated as indium arsenide (InAs) in semiconductors. 
 
The two elements will be discussed in chapters two and three. In the workgroup led by Dr. 
Rita Cornelis, the field of interest has since long been chemical speciation in clinical 
samples. Clinical samples include body fluids such as urine, blood, serum, packed cells, but 
also organ tissues, hair, nails etc. The term exposure is to be interpreted in the most 
comprehensive way. In the case of indium, laboratory animals have been exposed to 
background levels of an indium compound. In the case of arsenic, healthy human 
volunteers have been exposed to arsenosugar-containing foodstuffs. As will be discussed 
later, arsenosugars are believed to cause no harm to human health. 
 
1.1. Chemical speciation 
 
[Templeton et al. , 2000] 
 
There was a lot of debate before the international community achieved unanimity about the 
nomenclature and definition of the word speciation. According to the International Union 
for Pure and Applied Chemistry (IUPAC), chemical speciation of an element is defined as 
the distribution of an element amongst defined chemical species in a system. Chemical 
species are specific forms of an element defined as to isotopic composition, electronic or 
oxidation state, and/or complex or molecular structure. Speciation analysis is at last defined 
as analytical activities of identifying and/or measuring the quantities of one or more 
individual chemical species in a sample . When elemental speciation is not feasible, the term 
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fractionation is used, i.e., the process of classification of an analyte or a group of analytes 
from a certain sample according to physical (e.g., size, solubility) or chemical (e.g., 
bonding, reactivity) properties. 
 
Speciation analysis is carried out in the field of environmental, geological, nuclear, 
biological, clinical chemistry, in food, occupational health and hygiene, medicine etc. 
 
It is noteworthy to differentiate between fractionation and speciation. The analytical 
techniques used for separation of indium containing complexes are not able to ensure that 
one single species is detected. In the case of arsenic single species can be isolated using 
high performance liquid chromatography (HPLC) techniques. 
 
In relation to the nomenclature and definitions about elemental chemical speciation, it is 
worth citing from a lecture held at the last International Conference on Biological and 
Environmental Aspects of Main-group Organometallics (ICEBAMO) in Pau, December 3-5th, 
2003: “For years, people have been doing speciation analysis without knowing, while other 
people think they are doing speciation analysis but are not”. 
 
1.2. Timeframe and scope of this work 
 
This manuscript consists of two parts: indium and arsenic. The original concept of this PhD 
was to study the metabolism of two elements, indium and gallium, in body fluids and 
tissues. Indium and gallium have numerous applications in industry, the most important 
ones being their incorporation in the so-called, III-V semiconductors. Examples are GaAs 
and InAs. The unique properties of these binary compounds make them ideal for advanced 
applications in electronics. Along with their growing use, there is an increasing interest in 
the effects of both elements on human health. During the production and processing as 
well as during maintenance procedures, workers are exposed to dust and fumes of these 
particles and their derivatives. A series of experiments have revealed various adverse 
systemic and toxic effects on laboratory animals. Most of these studies used a toxicological 
and biochemical approach. My intention was to carry out speciation analyses in order to 
find out how indium and gallium are taken up, distributed, metabolised and excreted, and 
what the chemical forms of indium and gallium are in the different body fluids and tissues. 
I chose to use radioisotopes of both elements. Radiotracers have many advantages in the 
field of in vitro and in vivo studies. From a practical point of view, indium was selected to 
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be studied first. Speciation analysis imply the use of separation techniques. Because the 
primary interest was analysis of blood and body fluids, consisting of hundreds of proteins, 
fast protein liquid chromatography methods were optimised. Afterwards three sets of in 
vivo experiments with laboratory animals were carried out, the last one dealing with the 
speciation of indium after oral administration of [114mIn]InAs to rats. 
 
At about the same time, a bilateral scientific co-operation with the Tsinghua University of 
Beijing, P.R. China, as well as the funding for an electrospray triple quadrupole mass 
spectrometer (ES-MS/MS) were approved within the research group. The area of interest of 
this bilateral co-operation was the speciation of arsenic in humans who are exposed to 
arsenosugar containing food, such as edible algae, crustaceans and molluscs. The identity 
of most of the metabolites of these arsenosugars in urine is still unknown. Electrospray 
mass spectrometry lends itself as a powerful technique to deal with structure confirmation 
and elucidation. As will be clearly mentioned in chapter three, the toxicity of arsenic is 
highly dependent on the chemical form. Inorganic arsenic is very toxic, whereas ‘seafood 
arsenicals’ are assumed to be innocuous. Measuring the total amount of arsenic in 
foodstuffs, water, etc. does therefore not give the necessary information on health hazards. 
Likewise, the analysis of the total amount of arsenic in clinical samples, such as urine and 
blood does not provide the necessary information on possible exposure to toxic substances. 
Therefore chemical speciation analysis is again the key answer to the study of the 
metabolism of arsenosugars by humans. 
 
As the results of the last in vivo experiment of indium showed that absorption of orally 
administered InAs is negligible and does not lead to accumulation of indium in the body, 
and in order to make good use of the ES-MS/MS, it was decided to leave the field of indium 
speciation and replace gallium with arsenic. Arsenic speciation in environmental and clinical 
samples implied thorough method development and optimisation. 
 
Both studies will be described in detail. The theoretical part of this script will focus on both 
elements, but from a different point of view. The starting point for the speciation of indium 
in body fluids and tissues was the toxicity of indium in compounds such as III-V 
semiconductors. Therefore the theoretical aspects dealing with toxicity of indium will be 
highlighted in chapter 2. Arsenic speciation in body fluids after ingestion of arsenosugar 
containing food focuses on the transformations of arsenic in the environment and in the 
human body. Therefore these metabolic aspects will be thoroughly described in chapter 3. 
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An overview of the applied separation and detection methods will be given in chapter 4. 
Chapters 5 and 6 deal with in vitro and in vivo experiments, respectively, of indium in body 
fluids and tissues. Chapter 7 copes with the optimisation of the techniques for the 
determination of arsenic. The measurement of arsenic metabolites from arsenosugars is 
described in chapter 8. 
 
References 
 
[Templeton et al., 2000] 
Templeton DM, Ariese F, Cornelis R, Danielsson LG, Muntau H, Van Leeuwen HP 
and Lobinski R (2000). Pure Appl. Chem., 72, 1453-1470. 
 
 
 
Chapter 2. Indium: chemistry and biology 
______________________________________________________________________________________________________ 
 5
Chapter 2. Indium: chemistry and 
biology 
 
 
 
 
2.1. Introduction 
 
2.1.1. History and occurrence 
 
[Downs, 1993] 
 
The German scientists Ferdinand Reich and Theodor Richter were the first to identify 
indium in 1863. Spectrographic examination of a crude zinc chloride liquid derived from 
samples of zinc blendes (sphalerite) disclosed a brilliant indigo blue line. Reich and Richter 
were able to isolate the oxide of the new element and reduce it to the metal by heating it 
in a stream of hydrogen or coal gas. They were responsible too for coining the name 
indium in token of the element distinctive flame colouration (Latin indicum, indigo). 
 
Table 2.1. Abundance of indium in different environmental compartments. 
 
   
environmental compartment concentration reference 
   
   
sun 45 atoms per 1012 of H [Downs, 1993] 
earth 4 ng/g [Downs, 1993] 
continental crust 50 ng/g [Downs, 1993] 
Atlantic ocean 0.1 ng/L [Matthews and Riley, 1970] 
air (England) 0.3 ng/m3 [Peirson et al., 1973] 
   
 
Indium belongs to group 13 of the periodic table. All the members of this group have odd 
atomic numbers and their nuclei are therefore less stable than those of the adjacent 
members of the carbon group. Indium does not form any minerals of its own. Instead it is 
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widely distributed in minute amounts in many zinc (sphalerite), copper, lead and tin 
minerals, usually but not exclusively being concentrated in sulphide deposits. Zinc, which it 
also resembles in size and other properties, is an important carrier, and zinc blendes are 
the principal commercial source of the metal. With a terrestrial abundance of 4 ng/g, 
indium is a rare element. It is about as rare as silver. Few minerals contain more than 
0.1%, although pegmatite dikes in western Utah (USA) are reported to contain up to 2.8% 
indium. Germanite (Cu3(Fe,Ge)S4) and cylindrite (Pb3Sn4FeSb2S4) contain relatively large 
amounts of indium (0.1 to 1% In). The abundance of indium in different environmental 
compartments is shown in table 2.1. 
 
2.1.2. Physical, chemical and nuclear properties 
 
[Downs, 1993] 
 
Indium is a soft, semiprecious non-ferrous metal with a silvery-white colour and a brilliant 
lustre. It is very malleable and ductile and can undergo almost limitless deformation. The 
atomic number is 49; it has an atomic weight of 114.82. The electronic configuration is 
[Kr]5s24d105p1. The melting point is 156.6°C, the boiling point is 2080°C, and the specific 
gravity is 7.31 (20°C). Indium metal is unaffected by air at ordinary temperatures, but at 
red heat it burns with a blue-violet flame to form the yellow oxide In2O3. The metal 
dissolves in mineral acids but is unaffected by potassium hydroxide or boiling water. When 
heated in the presence of halogens or sulphur, direct combination takes place. Though a 
few authentic indium(I) compounds have been prepared (e.g., halides), indium is 
commonly trivalent in its compounds. 
 
The solution chemistry of indium is characterised by extensive hydrolysis, described by the 
following general equation: 
 
[ ] ++-+ +¾¾ ®¬+ yH)OH(InOyHxIn )yx3(yxQ23 xy  
 
with Qxy  the stepwise stoichiometric constants, y = 1 to 4 for the 4 successive hydrolysis 
steps and x = 1 for mononuclear species. The indium cation in non-complexing aqueous 
solutions is [In(OH2)6]3+. In perchlorate solutions, hydrolysis first becomes detectable above 
pH 2 and, at ordinary concentrations, hydroxyl numbers from 0.6 to 0.8 can be reached 
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before precipitation of the hydroxide occurs. Hydrolysis leads to In(OH)2+ and In(OH)2+ 
species, as well as several polynuclear complexes Inn+1(OH)2n(n+3)+, such as In2(OH)24+ and 
In3(OH)45+. Base induced hydrolysis of trivalent indium solutions causes precipitation well 
before the OH/In ratio reaches 3.0. The outcome depends on the nature of the counter-
anion and on the particular base and is influenced by temperature and ageing of the 
precipitate. If halide ions are present, they are likely to be incorporated in the precipitate, 
but in their absence, In(OH)3 is the eventual product. In the presence of chloride, 
hydrolysis is retarded and at high concentrations of chloride does not become appreciable 
until the pH exceeds 4. In(OH)3 is in essence a basic hydroxide. A slight solubility in 
concentrated NaOH has been ascribed to four coordinate [In(OH)4]- or six-coordinate 
[In(OH)4(OH2)2]-. The successive hydrolysis steps are described by the following equations: 
 
+++ +¾¾ ®¬+ HInOHOHIn 2Q2
3 11  
( ) +++ +¾¾ ®¬+ H2OHInOH2In 2Q23 12  
( ) ++ +¾¾ ®¬+ H3OHInOH3In 3Q23 13  
( ) +-+ +¾¾ ®¬+ H4OHInOH4In 4Q23 14  
 
Table 2.2. Hydrolysis constants of indium. 
 
   
 [Martell and Smith, 1984] [Baes and Mesmer, 1976] 
   
   
-log Q11 4.3 4.4 
-log Q12 9.4 8.8 
-log Q13 13.9 12.4 
-log Q14 23.4 22.1 
   
 
Stepwise stoichiometric constants have been determined and compiled by several 
researchers. The stoichiometric constants Qxy  of these four hydroxides as described in two 
references are shown in table 2.2. 
 
Natural indium consists of two isotopes: 113In (stable, 4.33%) and 115In (half-life 4.4 x 1014 
y, 95.67%). A list of the most common radioisotopes can be found in table 2.3 [Sunderman 
and Townley, 1960]. 
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Table 2.3. Characteristics of the most common radioisotopes of indium. 
 
     
isotope production half-life mode of decay main g-rays [keV] 
     
     
111In 109Ag(a,2n)111In, 111Cd(p,n)111In 2.805 d e to 111Cd 245.4, 171.3 
113mIn 112Sn(n,g)113Sn and e to 113mIn 1.658 h IT to 113In 391.7 
114mIn 113In(n,g)114mIn, 114Cd(p,n)114mIn 49.51 d IT to 114In; e to 114Cd 190.3, 558.4, 725.2 
116mIn 115In(n,g)116mIn 54.1 min b- to 116Sn 1293.6, 1097.3 
     
n: neutron; p: proton; a: alpha decay; e: electron capture; b-: negatron decay 
g: gamma decay; IT: internal transition 
     
 
2.1.3. Production and uses 
 
Because of the widespread but low abundance of indium in minerals, commercial 
production of the element arises almost exclusively from metal residues, slags and flue 
dusts during the smelting of zinc ores. 
 
In 1982, the world year production of indium was 50 tons. This amounted to 200 tons in 
1996. In 1988, 40% of the indium was used in the electronics industry, another 40% was 
used in solders and alloys and 20% in research and others. 
 
The first reported commercial application of indium was as a minor addition to gold-based 
dental alloys in which indium served as a scavenger for oxygen. Hardness and ductility 
were also improved, as was resistance to discoloration. Indium is still added to some of 
these alloys. 
 
Major uses in 1993 were as follows [Polmear, 1993]: 
 
Semiconductors. Indium combines with Group 15 elements such as arsenic, antimony and 
phosphorus to produce compounds that exhibit semiconductor characteristics. The so-
called III-V compounds form the material systems for solid-state opto-electronic devices 
and are used extensively in high-speed, high frequency applications. Components made in 
these materials include infrared and visible light-emitting diodes and detectors, lasers and 
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high-speed and microwave integrated circuits. Developments arise along similar lines as the 
main representative of the III-V group, namely GaAs. Optical fibre telecommunications 
have driven the development of InP-based lasers and detectors for transmission in the 
optimum wavelength band. Modern telephone trunk networks rely on InP devices. The 
optical properties are a result of the electronic energy band structure. The band gap 
between conduction and valence band allows optical transitions. The high-speed 
applications are a consequence of the higher electron mobility. InP and CuInSe2 are 
relatively efficient at converting sunlight into electricity and are therefore used in solar cells. 
 
Fusible alloys. Indium is a component of a number of alloys that have very low melting 
points, e.g., Bi(22%)Pb(18%)In(11%)Sn(8.5%) melts at 48°C. These alloys are used in 
temperature overload devices such as fuses and plugs for sprinkler systems. 
 
Speciality solders. A number of solders based on indium are available with melting points as 
low as 93°C. Indium is incorporated in solders based on lead, bismuth, tin and cadmium. 
 
Speciality bearings. Indium may be applied as an electroplated or sprayer layer to lead-
based bearings and then allowed to diffuse into the surface by heating. This leads to 
improved hardness, corrosion-resistance and anti-seizure properties. These bearings are 
used in high performance engines. 
 
Nuclear control rods. Rods composed of Ag, In and Cd have high capture cross-section for 
neutrons and are therefore widely applied in the majority of pressurised water nuclear 
reactors. 
 
Conductive films. Because of the high transparency of films of the compounds In2O3 and 
(In,Sn)2O3 to visible light, they are used on glass as conductive patterns for liquid crystal 
displays and as demister strips on motorcar windscreens. 
 
Sodium vapour lamps. Indium is applied on the inside of the glass cylinder of low-pressure 
sodium vapour lamps that are commonly used for outdoor lightning. The indium coating 
reflects infrared waves emitted by the lamp while, at the same time, transmitting the visible 
light, which permits the lamp to operate at a higher temperature, thereby raising its 
efficiency. 
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Jewellery. Indium is used in alloys with gold and one composition comprising 5% In has a 
distinctive colour referred to as ‘green gold’. 
 
Radiopharmaceuticals . Because of the favourable decay characteristics of 111In and to a 
lesser degree 113mIn, both radioisotopes have numerous applications in nuclear medicine as 
radiopharmaceuticals. 111In decays by electron capture and has no ß emission. The half -life 
of 67 hours allows in vivo studies to be carried out for several days without having to 
administer excessively large quantities of radioactivity. Moreover the energy of the gamma 
photo emission of 111In (171.3 keV and 245.4 keV) is in the optimum detectable range and 
the abundance is high (89% and 94%, respectively). Radiopharmaceuticals can be grouped 
into two groups: pharmaceuticals for dynamic functional studies of certain organs and 
pharmaceuticals for localisation of abnormalities in the body (e.g., tumours, infarcts, 
abnormal organs). Reports mention the use of several indium compounds such as 113mIn-
Fe(OH)3 for lung scanning [Stern et al. , 1966; Goodwin, 1971]; 113mIn(OH)3 above pH 4 for 
liver scanning [Goodwin et al. , 1966]; 113mInCl3 for blood-pool (heart, placenta) scanning 
[Stern et al. , 1967; Olkkonen et al. , 1977]; 111In-colloid for lymphatic scintigraphy after 24 
hours [Goodwin et al. , 1969]; 111InCl3 for localisation in soft tissue tumours [Hunter and De 
Kock, 1969; Hunter and Riccobono, 1970], in tumours of head and neck [Farrer et al. , 
1972] and in abscesses [Sayle et al. , 1983]; 113mInCl3 to estimate plasma volume [Wochner 
et al. , 1970] and for labelling of red blood cells [Adatepe et al. , 1971]; 111InCl3 for 
haematopoietic bone marrow scanning after 24h [Rayudu et al. , 1973; Reske, 1991]; 
111InCl3 [Lilien et al. , 1973; Farrer et al. , 1973] and 111In-citrate [Glaubitt et al. , 1975] for 
bone marrow scanning; 111In-colloid for leucocyte labelling [Zimmer and Spies, 1983]. All 
these applications make use of the chemical properties of the indium compounds. Moreover 
111In and to a lesser degree 113mIn have been complexed with several ligands. Here indium 
isotopes are chosen because of their favourable radiochemical properties and the 
application is based on the type of ligand. Examples are 113mIn-Fe-DTPA 
(diethylenetriaminepenta acetate) for brain scanning [Stern et al. , 1967] and for renal 
imaging (Reba et al. , 1968; Farrer and Saha, 1973); 111In labelled bleomycin for tumour 
scanning and 111In-oxine for labelling of leukocytes [Thakur, 1977]; 111In-DTPA labelled to 
antibodies for localisation in inflammatory lesions and tumours [Saccavini et al. , 1984; 
Weiner and Thakur, 1995]; 111In labelled to neutrophils for accumulation in abscesses [Bitar 
et al. , 1986]; 111In-leukocytes for bone scintigraphy [Outwater et al. , 1988]; 111In-DTPA to 
determine the distribution of cerebrospinal fluid [Weiner and Thakur, 1995]; 111In-oxine 
labelled to leukocytes for imaging arthritis inflammation [Chinol et al. , 1996]. 
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2.2. Indium in the body 
 
[Fowler and Goering, 1991; Fowler, 1986; Fowler, 1988; Fowler, 1995; Hayes, 1988] 
 
2.2.1. Food, daily intake and absorption 
 
The indium content in plants and animal tissues consumed as food ranges from below 
detection to 0.01 mg/kg (beef muscle and ham). However, algae, fish and shellfish 
collected near smelter outfalls have been reported to contain concentrations ranging from 
0.4-7 mg/kg (for algae) up to 10-15 mg/kg (for fish and shellfish). The daily intake for 
humans of indium has been estimated at about 8-10 mg. 
 
Indium is poorly absorbed by inhalation. Smith et al.  [1960] have evaluated the absorption, 
distribution and excretion of 114mIn(OH)3 or 114mIn-citrate following intratracheal (i.t.) 
instillation in rats and found that most of the administered dose was taken up by the 
tracheobronchial lymph nodes. Leach et al.  [1961] reported similar findings in rats exposed 
to In2O3 via inhalation. The absorption of inhaled 114mIn sesquioxide particles by rats has 
been estimated to be between 3% and 6% of the total dose after a single one-hour 
exposure and about 18% for sequential one-hour exposures on 4 successive days. Isitman 
et al.  [1974] administered 111InCl3 or 111In-DTPA to adult humans by ultrasonic nebulisation 
and found deposition in the major airways with little (1.3% to 4.4%) alveolar deposition. 
 
Absorption of indium by ingestion is reported to be very low. The intestinal absorption of 
indium in rats has been reported to be about 0.5% of the administered dose (0.4 or 0.8 g 
In/kg body mass) given as either In(OH)3 or indium citrate. The intestinal absorption of 
indium in volunteers was less than 2% of a 200 mCi dose of 113In as a DTPA complex. 
Coates et al.  [1973] reported no detectable absorption of a 500 mCi dose of [113In]InCl3 to 
human adults. More recently, Zheng et al.  [1994] showed that InP was poorly absorbed 
from the GI tract following oral (p.o.) administration to rats in both single- and multiple-
dose studies. Only 0.67% of a single dose and 0.27% of the last dose in the multiple -dose 
study were retained in the tissues and excreted in the urine 24 hours following the 
administration. 
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2.2.2. Distribution and excretion 
 
The metabolism of indium after administration of a single i.t., subcutaneous (s.c.), 
intramuscular (i.m.) and p.o. dose to rats was investigated by Smith et al.  [1960]. Kidney, 
spleen, liver and salivary glands were target organs, but pelt, skeleton and muscle 
contained the largest absolute amounts. The transport and distribution of indium in body 
fluids and tissues is determined by the chemical form [Castronovo and Wagner, 1971a; 
Castronovo and Wagner, 1971b, Castronovo and Wagner, 1973]. Ionic indium (at pH 3.0) 
is transported in the blood bound to transferrin and was found to be cleared within 3 days 
from the blood of mice given an intravenous (i.v.) injection. On the other hand colloidal 
hydrated indium oxide (at pH 7.2) injected i.v. was immediately cleared from the blood. 
Distribution of indium is also dependent on its chemical form. The kidney extensively 
accumulates ionic indium. Three days after a single i.v. injection, about 20% of a tracer 
dose and 30% of an LD100 dose of ionic 114mInCl3 was found in the kidneys of mice. In 
contrast colloidal indium oxide is accumulated by the liver (64% of a tracer dose and 40% 
of an LD100 dose), spleen and the reticulo-endothelial system (RES). The chemical form 
administered determines the primary route of indium excretion from the body. Ionic indium 
is mainly excreted in the urine while colloidal indium complexes are primarily excreted in 
faeces. Mice have been found to excrete 52% of an administered dose of ionic indium via 
urine and 53% of a dose of colloidal indium via faeces. InAs s.c. administered to hamsters 
dissolves slowly over time and is concentrated in kidney, liver, lung and spleen [Yamauchi 
et al. , 1992]. Zheng et al.  [1994] studied the tissue distribution of InP in rats after i.t. and 
p.o. administration. Upon oral absorption indium was relatively evenly distributed among 
the major organs such as liver, kidney, lung, spleen and testes. The majority, however, was 
recovered from the GI tract. Faecal excretion served as the major route for indium 
elimination. After i.t. instillation, the lungs concentrated virtually all indium. Hoyes et al.  
[1995] intraperitoneally (i.p.) injected adult and neonatal rats with 114mIn[InCl3] and looked 
at the tissue distribution at 2 and 63 days post injection. At each time point, the highest 
accumulation of 114mIn was observed in liver, spleen and kidneys in both adult and neonatal 
rats. 
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2.2.3. Health effects and biological monitoring 
 
Human exposure to indium compounds may occur in the semiconductor industry during the 
manufacture (sawing, grinding, or polishing) of semiconductor wafers or during 
maintenance of the production equipment, and as a result of indium isotope utilisation for 
organ scanning and treatment of tumours. The impact of waste disposal of electronic 
equipment on human health has not yet been taken into account. A series of animal 
experiments has shown that indium is toxic to mammals. Liver, kidneys, blood, haem 
biosynthetic pathway, lungs, reproductive and developmental systems and the immune 
system are adversely affected by indium compounds. 
 
Liver. Castronovo and Wagner [1971b] investigated the hepatoxicity of lethal doses of InCl3 
and In(OH)3 in mice. Administration resulted in inflammation and multiple small areas of 
necrosis. The effects of InCl3 on hepatocyte structure and function were studied in male 
rats injected i.p. with doses of 10-40 mg/kg [Fowler et al. , 1983]. The primary intracellular 
target was the endoplasmic reticulum (fragmentation and degranulation, increase of 
surface density) and its associated microsomal enzymatic activities. Volume density 
increased in the lysosome compartment, but decreased in the vacuole compartment. The 
effects of indium compounds on the hepatic haem biosynthetic pathway are described 
below. 
 
Kidneys. Administration of LD50 and LD100 levels of InCl3 and In(OH)3 to mice showed 
necrosis of the cells lining the proximal portion of the convoluted tubules [Castronovo and 
Wagner, 1971b]. In a dose finding pilot study by Chapin et al.  [1995] male and female 
mice were administered InCl3 at doses of 50-350 mg In /kg/day by gavage during 22 days. 
In males, urinary N-acetyl glucosaminidase decreased, which is an indicator for proximal 
tubular damage. For both sexes there was a trend toward reduction in overall white blood 
cells and increased kidney weight. The effects on the renal haem biosynthesis are 
described below. 
 
Haem biosynthesis . Indium is capable of altering the haem biosynthetic pathway in liver, 
kidney and erythrocytes. Haem is a red pigment comprised of four subunits joined together 
as a single large tetrapyrrole (porphyrin) ring structure and at the centre a transition metal 
(e.g., Fe, Cu, Co) is chelated. In physiological systems it is bound to proteins, and these 
proteins bind oxygen at the site of the metal (e.g., haemoglobin, catalase) or they function 
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as components of membrane-bound electron transport chains (i.e., cytochromes). Cellular 
respiration, energy respiration and chemical oxidations are dependent on these haem 
proteins. The haem biosynthetic/degradative pathway is sensitive to alteration by metals. 
The inhibition of haem synthesis for example compromises the production of the 
microsomal haemoprotein cytochrome P-450, resulting in a reduced capacity to 
biotransform xenobiotics as well as endogenous compounds. The haem biosynthesis takes 
place in the mitochondrion and cytosol. The pathway starts with the formation of d-
aminolevulinic acid and the condensation of two d-aminolevulinic acid units to 
porphobilinogen. These two steps are catalysed by the enzymes d-aminolevulinic acid 
synthase (ALAS) and d-aminolevulinic acid dehydratase (ALAD), respectively. [Maines and 
Kappas, 1977] 
 
Woods et al.  [1979] administered InCl3 i.p. at doses of 5-40 mg/kg to rats and studied the 
hepatic influences. There was a dose dependent decrease of ALAS activity and a dose 
dependent increase of haem oxygenase in the liver. Both enzymes are the rate-limiting 
enzymes in the production and breakdown of haem. These changes were accompanied by 
a marked reduction in microsomal haem concentrations and a decrease in microsomal 
haem dependent oxidative functions in the liver such as cytochrome P-450. Woods et al.  
further investigated the effects of InCl3 (i.p. injection of 10-40 mg/kg InCl3) to kidney rats. 
InCl3 exerts a dose dependent inhibition of ALAD owing to selective localisation of indium 
within the cytosolic fraction of the proximal tubule cells. Zn2+, a nutritional cofactor of ALAD 
could prevent inhibition by InCl3. Conner et al.  [1995] investigated the effects of 
subcutaneously administered InCl3 (1.5 mg/kg 3 times per week for 4 weeks) and InAs 
(single injection of 1000 mg/kg) in hamsters and reported reduced ALAD activities in 
erythrocytes, but not in liver. In vitro studies showed that hepatic  ALAD activity was 
primarily influenced by the indium moiety. 
 
Pulmonary toxicity. Tanaka et al.  [1994] examined the pulmonary toxicity of i.t. instilled 
InAs (0.82 mg In, once a week for 15 weeks) in hamsters. They reported reduced body 
weight gain, histopathological findings (proteinosis-like lesions, pneumonia, alveolar or 
bronchiolar cell hyperplasia), but the incidence of tumours was not significantly higher than 
the control group. Another experiment by Tanaka et al.  [1996] included InP, administered 
in analogy to the protocol mentioned above. Although InP administration did not reduce 
the increase in body weight, it also resulted in histopathological findings that were similar 
to that in the InAs treated group. In a study by Blazka et al.  [1994a] a single i.t. dose of 
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1.3 mg/kg InCl3 was given to rats. Their study showed that InCl3 is capable of producing 
severe pulmonary responses that are present 56 days after dosing, even though most of 
the administered dose had left the lungs. These include inflammatory response, increased 
lung weight, increased number of cells in the bronchoalveolar lavage fluid (BALF), 
biochemical changes and development of fibrosis. Blazka et al.  [1994b] extended their 
research to inhalation experiments with rats exposed to varying doses (up to 20 mg 
InCl3/m3). Low doses of InCl3 in air initiated an inflammatory response. Higher doses 
induced biochemical changes on the longer term. The acute pulmonary toxicity of Copper 
Indium diselenide (CuInSe2) was studied by Morgan et al.  [1995]. Female rats were 
administered 12-100 mg/kg CuInSe2 intratracheally once. It was found to be responsible 
for increased lung weight, reduced body weight gain, and increased number of cells in the 
BALF. CuInSe2 also caused intra-alveolar inflammation and cell hyperplasia. The long-term 
health effects of CuInSe2 to rats were also examined by Morgan et al.  [1997]. Female rats 
were administered i.t. with 24 mg/kg CuInSe2 and euthanised up to 28 days after 
exposure. Relative lung weights and BALF cell numbers were increased. Inflammatory 
lesions, biochemical changes and hyperplasia were observed. Oda [1997] examined the 
toxicity of low level (1.2 - 62.0 mg/kg) InP in rats after i.t. instillation. Biochemical changes 
were observed in the BALF in all groups after 1 day. After 8 days BALF parameters were 
changed only in the highest exposure group. Uemura et al.  [1997] studied the effects of i.t. 
administered InP (1-10 mg/kg) on rats. There was a dose dependent increase in BALF 
parameters. Indium was detected in liver and spleen in a dose dependent manner with 
phagocytosis of macrophages probably being responsible for the disposal and distribution 
from the lungs to these organs. Yamazaki et al.  [2000] investigated the long-term (2 years) 
toxicity of InAs and InP (2.4 mg In /kg twice a week for 8 weeks), instilled i.t. in hamsters. 
Weight gain was suppressed in both groups. Serum indium levels were increased, more 
drastically in the case of InAs, an indication of in vivo dissociation. Severe pulmonary 
inflammation and localised lesions were present in both groups. Gottschling et al.  [2001] 
observed dose-dependent incidences of alveolar adenomas and carcinomas after two years 
in both male and female rats that were chronically exposed to an aerosol of InP (6 h/day, 5 
days/week for 21 weeks at levels of 0.1 and 0.3 mg/m3 or 105 weeks at levels of 0.03 
mg/m3). Three-month exposure resulted in severe pulmonary inflammation and alveolar 
proteinosis. Tanaka et al.  [2002] further investigated the pulmonary toxicity of indium-tin 
oxide after i.t. instillation into hamsters (4.5 mg In /kg, once a week for 16 weeks). Lung 
weight significantly increased, but there was no reduced weight gain. In general the 
inflammatory response was weaker than in the case of an equal amount of InP. The report 
Chapter 2. Indium: chemistry and biology 
______________________________________________________________________________________________________ 
 16
from Homma et al.  [2003] is the first case history describing a man with interstitial 
pneumonia consistent with the inhalation of indium-tin oxide particles. Numerous fine 
particles were scattered throughout the lungs and an extremely high indium serum level 
(290 ng/mL) was found. The high blood levels had also caused chronic adverse health 
effects in liver and spleen. 
 
Reproductive and developmental system and testicular toxicity. Ferm and Carpenter [1970] 
reported the teratogenic and embryopathic  effects of a single dose of indium nitrate i.v. 
injected in increasing amounts into pregnant hamsters on day 8 of gestation. Indium 
caused a high incidence of malformations of the digits. At doses above 1 mg/kg it was 
completely embryopathic, killing all embryos in utero. The study of Chapin et al.  [1995] is 
an extension of the previous report. The conclusion of a series of experiments was that 
doses of 50, 150 and 250 mg In kg/day InCl3 given orally by gavage during 20 days did not 
affect the ability of male mice to impregnate females or the ability of those females to 
become pregnant, but did adversely affect foetal survival. Also a decreased body weight 
gain for females and body weight loss for males was observed. An in vitro test showed that 
indium was embryotoxic at levels consistent with the amount of indium found in the 
foetuses from the indium-treated dams. Hoyes et al.  [1995] i.p. injected 37 MBq/kg 
[114mIn]InCl3 into adult and neonatal male rats. The treated rats had reduced sperm head 
counts and abnormal testicular histology, adults being more prone than neonates. Ungvary 
et al.  [2000] administered several oral doses (50-400 mg/kg) of InCl3 to rats on days 6-15 
of gestation. They also administered several doses (50-20 mg/kg) of InCl3 to rabbits on 
days 6-20 of gestation. In rats, InCl3 produced dose-dependent maternal toxic effects and 
was embryotoxic and teratogenic up to 200 mg/kg and embryolethal at the highest level. 
The teratogenic effects were highest on days 11 and 12 of gestation. The teratogenic 
effects result from indium crossing the placental barrier. In rabbits the highest dose was 
lethal for the dams and lethal and teratogenic for the embryos. Nakajima et al.  [1998, 1999 
and 2000] examined the developmental toxicity of InCl3 by i.v. and oral administration in 
rats, of InCl3 in cultured rat embryos and of InCl3 in both rats and mice. A single dose of 
0.4 mg In /kg given to rats i.v. on day 9 of gestation was teratogenic (malformation of the 
tail and digits) and embryolethal. No significant changes were observed in the group 
receiving p.o. doses up to 300 mg In /kg. Also here the in vitro test showed that indium 
was embryotoxic at levels comparable to the serum levels in the i.v. treated rats. It was 
concluded from this study that both rats and mice were susceptible to the embryotoxicity of 
indium at similar developmental stages in the early organogenetic period, but that mice 
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were less susceptible than rats in terms of malformations. Omura et al.  administered 7.7 
mg/kg InAs i.t. 14 times in 8 weeks to male hamsters [1996a] and rats [1996b]. In case of 
the hamster InAs did not show any testicular toxicity, but body weight decreased after the 
8th instillation and weight of testes and epididymes significantly increased. Epididymal 
sperm count did not decrease. Rats receiving the same doses, 16 times in total, showed a 
sperm count decrease in the epididymes, but a change in weight was not observed. 
Because of the emaciation of the hamsters and the fact that high concentrations of indium 
and arsenic were still detected in the serum of the hamsters, Omura et al.  [2000] extended 
their research on testicular toxicity of InAs and InP in hamsters during a two-year period 
after repeated i.t. instillations (twice weekly for 8 weeks) of 4 mg/kg/day InAs and 3 
mg/kg/day InP. This was half of the amount of indium compared to the previous study. 
After 88 weeks InAs caused reduced body weight and sperm count; and both materials 
decreased testes and epididymis weight. Severe histopathological changes were observed 
in the testes for both InAs and InP. InAs is more toxic than InP; this could be explained by 
the difference in internal exposure to indium (higher serum levels at all times). Omura et 
al. [2002] further examined the testicular toxicity of indium-tin oxide and InP after 
repeated (once weekly for 16 weeks) i.t. instillation of 6 mg/kg indium-tin oxide and InP. 
Similar results as in their study were observed for InP. In the indium-tin oxide group body, 
testes and epididymis weight did not alter. Sperm count did not change and only few 
histopathological changes were observed in the indium-tin oxide group. 
 
Immunotoxicity. InCl3 induces a dose dependent apoptosis in rat thymocytes at low doses 
(1 mM) and causes necrosis at higher doses (1 mM) in vitro [Bustamente et al. , 1997]. 
 
Conner et al.  [1995] suggest, on the basis of in vivo studies on hamster, that the altered 
urinary excretion patterns and erythrocyte ALAD activity may be appropriate biological 
markers for evaluating exposure to InAs. Miyaki et al.  [2003] analysed blood and urine of 
occupationally exposed workers and reported that blood, serum and creatinine adjusted 
urinary indium concentrations are useful indices of indium exposure. 
 
In summary, indium compounds cause adverse effects on the haem biosynthetic pathway 
in liver, kidney and erythrocytes. The enzymatic activity of ALAD and ALAS is altered. At 
higher doses InCl3 and In(OH)3 are nephrotoxic (necrosis of cells lining the proximal portion 
of the convoluted tubes) and hepatoxic (damage to endoplasmic reticulum and associated 
enzymatic activities). The pulmonary toxicity of several indium-containing III-V 
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semiconductor compounds as well as InCl3 has been recognised. Inflammatory response, 
increased lung weight, reduced body weight gain and several histopathological findings 
were reported. Indium compounds are embryotoxic, but do not affect the ability of males 
to impregnate females and of females to become pregnant. InCl3, InAs and InP cause 
decreased sperm count and reduced testes and epididymis weight. 
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Chapter 3. Arsenic: chemistry and 
biology 
 
 
 
 
3.1. Introduction 
 
3.1.1. History 
 
Arsenic is named after the yellow coloured ore orpiment (As2S3) in which arsenic is found 
[Nriagu, 2002]. The Greek name arsenikon means bold, valiant or masculine and it refers 
to the reactivity of the sulphide ores with other metals. Although many an alchemist claims 
to be the real discoverer of the metalloid arsenic, the discovery of elemental arsenic is 
generally credited to the German chemist Albertus Magnus (1193-1280). 
 
3.1.2. Physical, chemical and nuclear properties 
 
[Ishinishi et al., 1986; Adriano, 1986] 
 
Arsenic belongs to group 15 in the periodic table. The atomic number is 33 and it has an 
atomic weight of 74.92. Several allotropic forms of arsenic are known, but at 20°C only the 
grey form is stable. The metastable yellow form rapidly changes to the grey, semi-metallic 
form at low temperatures, and instantaneously in sunlight at room temperature. Brown and 
black amorphous forms are also known. The grey form is a crystalline solid with a brilliant 
cluster. It is a good conductor of heat but a poor electrical conductor. Arsenic melts in the 
absence of oxygen at 814°C (36 atm) and sublimes at 615°C. Naturally occurring arsenic 
consists of one isotope 75As, which is stable. The principle oxidation states of arsenic are 
+V (in arsenates) or +III (in arsenites), and to a lesser extent +II (in realgar) and -III (in 
arsenides). The oxidation state of arsenic in arsines is not fully understood. The 
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electronegativity of As and H are 2.18 and 2.20, respectively, on the Pauling scale, and 
2.20 each according to the Allred-Rochow scale. In some books, the oxidation state of As in 
arsines is denoted as -III, although +III can be found in other references. In this work the 
arsenic will be assumed to be +III. Other important properties are compiled in table 3.1. A 
list of the arsenic species, mentioned throughout this script, is given in table 3.2. 
 
Table 3.1. Physical, chemical and nuclear properties of arsenic. 
 
    
first ionisation energy [kJ/mol] 947 
redox potential AsV ®  AsIII [V] H3AsO4 + 3H
+ + 2e- ® H3AsO3 + H2O E° = 0.559 
electronic configuration [Ar]3d104s24p3 
electronegativity (Pauling scale) 
As H C O S 
2.18 2.20 2.55 3.44 2.55 
bond enthalpies in gaseous diatomic species [kJ/mol] 
As-As As-H As-C As-O As-S 
348 245 200 477 379 
isotope production half-life mode of decay main g-rays [keV] 
74As 74Ge(p,n)74As 17.78 d e and b+ to 74Ge 595.9 
   b- to 74Se 634.8 
76As 75As(n,g)76As 26.3 h b- to 76Se 559.1 
p: proton; n: neutron; e: electron capture; b-: negatron decay; b+: positron decay; g: gamma decay 
     
 
Table 3.2. Name, chemical formula and structure and pKa of arsenic species. 
 
 name & formula chemical structure pKa 
    
AsIII 
arsenous acid 
H3AsO3 
As OH
OH
HO
 
pKa1: 9.2 
pKa2: 13.5 
pKa3: 14.0 
 
arsine 
AsH3 
AsH
H
H
 
none 
MAIII 
methylarsonous acid 
CH3As(OH)2 
AsHO
OH
CH3
 
*~9 
DMAIII 
dimethylarsinous acid 
(CH3)2AsOH 
AsHO
CH3
CH3
 
*? 
TMA 
trimethylarsine 
(CH3)3As 
AsH3C
CH3
CH3
 
none 
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AsV  
arsenic acid 
H3AsO4 
As
O
HO
OH
OH
 
pKa1: 2.3 
pKa2: 6.7 
pKa3: 11.6 
MA 
methylarsonic acid 
CH3AsO(OH)2 
As CH3
OH
HO
O
 
pKa1: 3.6 
pKa2: 8.2 
DMA 
dimethylarsinic acid 
(CH3)2AsO(OH) 
As CH3
CH3
HO
O
 
**pKa1: 1.3 
pKa2: 6.2 
TMAO 
trimethylarsine oxide 
(CH3)3AsO 
As CH3
CH3
H3C
O
 
***pKa1: 3.6 
TETRA 
tetramethylarsonium ion 
(CH3)4As
+ 
+AsH3C
CH3
CH3
CH3
 
none 
DMAE 
dimethylarsinoyl ethanol 
(CH3)2AsOCH2CH2OH 
AsH3C
CH3
O
OH
 
? 
DMAA 
dimethylarsinoyl acetic acid 
(CH3)2AsOCH2COOH 
AsH3C
CH3
O
OH
O  
? 
AB 
arsenobetaine 
(CH3)3As
+CH2COOH 
As+H3C
CH3
CH3
OH
O  
pKa1: 2.2 
AC 
arsenocholine 
(CH3)3As
+CH2CH2OH 
As+H3C
CH3
CH3
OH
 
none 
    
 
* estimate for MAIII and unknown for DMAIII [Gailer et al. , 1999] 
** pKa1: 1.3 for the reaction: (CH3)2As+(OH)2 « (CH3)2AsO(OH) + H+ 
*** pKa: 3.6 for the reaction (CH3)3As+OH « (CH3)3AsO + H+ 
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3.1.3. Production and uses 
 
[Azcue and Nriagu, 1994; Ishinishi et al. , 1986; Adriano, 1986] 
 
Arsenic is produced commercially by reduction of As2O3 with charcoal. As2O3 is produced as 
a by-product of metal-smelting operations. It is present in flue dust from the roasting of 
ores, especially those produced in copper smelting. The world year production of As2O3 in 
recent years has lowered to 20000 tons, but amounted up to 47000 tons in 1973. 
 
Historical uses. Arsenic has a rich history of uses and abuses. Throughout the ages arsenic 
has been used in metallurgy (bronze), as a pigment, to produce a silvery shine on mirrors 
and statues, and as a homicidal poison. Fowler’s solution (1% potassium arsenite solution) 
was used as a medication. Over 8000 arsenic based compounds were used to treat asthma, 
malaria, tuberculosis, diabetes, and skin diseases. Also, it is stated that arsenic based 
compounds were used until the mid 1980s for treating sleeping sickness. During these 
centuries arsenic has killed millions of people, be it by occupational exposure, by iatrogenic 
effects, or in cases of homicide and suicide. 
 
Agriculture. One of the main uses of arsenic is in agriculture, namely as different kinds of 
pesticides. In 1983, arsenical insecticides were one of the largest classes of biocontrol 
agents in the USA. From the 1970s there has been a shift from inorganic compounds 
(including lead and calcium arsenate and copper acetoarsenite) to inorganic and organic 
compounds (arsenic acid, sodium arsenate, mono- and disodium methanearsonate, and 
DMA). Both inorganic arsenicals, primarily, sodium arsenite and organic arsenicals, are 
widely used since about 1890 as weed killers, particularly as non-selective soil sterilants. 
Arsenic acid is used extensively as a cotton desiccant to facilitate harvesting. Complexes of 
arsenic, such as fluor-chrome-arsenic-phenol, chromated copper arsenate, ammonical 
copper arsenate are used as wood preservatives. 
 
Feed additives. Many arsenic compounds are used as feed additives. In 1946 it was shown 
that 3-nitro-4-hydroxyphenylarsonic acid (roxarsone, 3-NHPAA) was capable of controlling 
coccidiosis in poultry. While investigating the therapeutic performance of this compound, it 
was also discovered that it acted as a growth promoter, improved feed conversion, 
provided better feathering, increased egg production and pigmentation. Other arsenic 
compounds were shown to have similar properties: p-arsanilic acid (p-ASA), 4-nitro-
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 29
phenylarsonic acid (4-NPAA) and p-ureidophenylarsonic acid (p-UPAA). Nowadays 3-NHPAA 
and p-ASA are approved as animal feed additives for both poultry and swine, whereas 4-
NPAA and p-UPAA are approved only for controlling blackhead disease in turkey. 
 
Industrial. Arsenic pentoxide and As2O3 are used as additives in alloys, particularly with lead 
and copper; arsenic and As2O3 are used in the manufacturing of low-melting glasses. 
Arsenic trioxide is used in decolourising and fining agent (reduction in bubbles) in the 
production of glass. Manufacturing of ceramics utilizes arsenic. High-purity arsenic metal, 
gallium arsenide and indium arsenide are also used in semiconductor products. 
 
3.2. Arsenic in the environment 
 
3.2.1. Arsenic compounds in the marine environment 
 
3.2.1.1. Arsenic in seawater and marine sediments 
 
Arsenic concentrations in seawater are quite uniform at around 2 mg/L with slightly higher 
values in deep-water compared to surface water. HAsO42- is the predominant form in 
seawater (pH 7.5-8.3). AsV/AsIII ratios of 1015-1026 have been calculated for seawater, 
depending on the choice of pE (8.0 or 12.5, respectively). However, arsenite occurs at 
concentrations greater than those expected from purely thermodynamic considerations. 
The reason for this is that arsenate is partly reduced by marine bacteria and marine 
phytoplankton. Seawater also contains small amounts of MA and DMA. The concentrations 
of AsIII, MA and DMA are higher in the photic zone of marine waters, suggesting that algae 
play an important role in the production of these species from AsV . Other organisms were 
also shown to transform arsenate into arsenite, MA and DMA. 
 
The average level of arsenic in marine sediments of the world oceans is about 40 mg/kg. 
Information on the chemical form of the arsenicals in marine sediments is difficult to 
obtain, because extraction procedures are needed to gain knowledge of the way arsenic is 
bound within the sediments. These chemical extraction techniques may change the form of 
arsenic originally present. Sediments from coastal regions and estuaries contain rather 
lower concentrations of arsenic than deep-sea sediments. Alternatively sediment pore 
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waters (interstitial water) can be examined, because they provide information about the 
bio-available arsenic. According to a study of Andreae [1979] both forms of inorganic 
arsenic are present, but contrary to thermodynamic considerations, arsenate is the major 
form. MA, DMA and TMAO were also found in interstitual water. 
 
3.2.1.2. Arsenic in marine algae 
 
Algae are very simple chlorophyll-containing organisms. Members of this group are pond 
scums, terrestrial algae, snow algae, seaweeds, and freshwater and marine phytoplankton. 
Algae are simple organisms composed of one cell, or grouped together in colonies, or as 
multicellular organisms, sometimes collaborating together as simple tissues. Algae are 
found in seas, rivers and lakes, on soils and walls, in animals and plants (as symbionts - 
partners collaborating together). Algae can differ greatly in size: from unicellular (3-10 mm) 
to giant kelps up to 70 meters long and growing at up to 50 cm per day. Algae are found in 
the fossil record dating back to approximately 3 billion years in the Precambrian. They 
exhibit a wide range of reproductive strategies, from simple, asexual cell division to 
complex forms of sexual reproduction. A detailed classification is beyond the scope of this 
work. In general algae are divided in bacillariophyta (diatoms), charophyta (stoneworts), 
dinophyta (dinoflagellates), chlorophyta (green algae), chrysophyta (golden algae), 
cyanobacteria  (blue-green algae), phaeophyta (brown algae)  and rhodophyta (red algae) 
[http 1; http 2; http 3]. 
 
Most reports on arsenic in algae deal with macroalgae, commonly called seaweeds. The 
most important macroalgae are the rhodophyta such as Phorphyra, phaeophyta such as 
Laminaria , Sargassum, Fucus and Undaria , and the chlorophyta such as Codium. Seaweeds 
do not have roots and shoots like higher plants but they generally have root-like 
attachment structures and leaf-like fronds that act like shoots. Most seaweeds are made up 
of cells that are relatively unspecialised but there are seaweeds that transport material 
internally (kelps). Seaweeds grow mostly on rocky areas or on coral reefs. Seaweeds are 
used as a source of food, for industrial applications and as a fertiliser. Industrial utilisation 
is at present largely confined to extraction for gums and chemicals. The major utilisation of 
these plants as food is in Asia, where seaweed cultivation has become a major industry. 
Most important food species are Porphyra (nori in Japanese, zicai in Chinese), Laminaria 
(kombu in Japanese, haidai in Chinese) and Undaria Pinnatifida (wakame in Japanese, 
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 31
qundaicai in Chinese). In most western countries food and animal consumption is 
restricted. 
 
 
Figure 3.1. Chemical structure of 17 naturally occurring arsenosugars. 
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Algae contain high levels of arsenic (up to 230 mg/kg dry mass). Reports of arsenic in the 
sea and in its organisms first appeared at the beginning of the 20th century but it was not 
until the 1920 that the application of improved analytical techniques led to the acceptance 
that marine organisms naturally contain high levels of arsenic. Jones [1922] was one of the 
first to give concentration levels of arsenic in different algae. It soon became apparent that 
the form of arsenicals present in algae was different from those in marine animals. A report 
by Lunde [1973] showed that marine unicellular algae incorporated radiolabeled (74As) 
arsenite and arsenate into various water-soluble and lipid-soluble fractions, the latter being 
relatively unstable and easily convertible into a water-soluble compound already present in 
the algae. Other researchers confirmed these findings [Irgolic et al. , 1977; Cooney et al. , 
1978]. Edmonds and Francesconi [1981] analysed the brown alga Ecklonia radiata and 
were the first to report the presence of what now is commonly denoted as arsenosugars. 
During the following years these two, among other authors, frequently reported new 
arsenosugars found in several biological species such as the giant clam Tridacna maxima 
[Edmonds et al. , 1982a] and the brown algae Ecklonia radiata [Edmonds and Francesconi, 
1983], Hizikia fusiforme [Edmonds et al. , 1987] and Sargassum lacerifolium [Francesconi et 
al., 1991a]. X-ray crystal structure analysis and NMR were used for identification. 
 
Arsenosugars comprise a dimethylarsinoyl or a trialkylarsonium derivative bound to a 
ribofuranoside sugar. A total of 17 different arsenosugars have been isolated from natural 
sources so far: 13 species are dimethylarsinoyl derivatives, 4 species are quaternary 
arsonio analogues. Compounds 1-12 and 14-17 are water-soluble, whereas compound 13 
is lipid-soluble. A complete list of all naturally occurring arsenosugars is shown in figure 3.1. 
Next to the naturally occurring arsenosugars, other analogues have been synthesised. 
Although the diversity of arsenosugars is outspoken, four arsenosugars predominate. The 
four readily available arsenosugars, shown in figure 3.2, received several denotations so 
far, which are often misleading. The full names of these arsenosugars are 3-[5’-deoxy-
5’(dimethylarsinoyl)-ß-D-ribofuranosyloxy]-propylene glycol (arsenosugar OH), 3-[5’-deoxy-
5’-(dimethylarsinoyl)-ß-D-ribofuranosyloxy]-2-hydroxypropyl 2,3 dihydroxypropyl phosphate 
(arsenosugar PO4), 3-[5’-deoxy-5’(dimethylarsinoyl)-ß-D-ribofuranosyloxy]-2-hydroxy-
propanesulphonic acid (arsenosugar SO3) and 3-[5’-deoxy-5’-(dimethylarsinoyl)-ß-D-
ribofuranosyloxy]-2-hydroxypropyl hydrogen sulphate (arsenosugar SO4 ) The notation for 
the sugars in figure 3.2 refers to a part of the functional group of the side chain. In some 
cases in the text, and also in the tables and chromatograms shown later, the abbreviations 
AsSug-OH, AsSug-PO4, AsSug-SO3 and AsSug-SO4 will be used. 
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Figure 3.2. Structure and denotation of the four most common arsenosugars. 
 
Arsenosugar OH and arsenosugar PO4 are common arsenicals in green and red macroalgae. 
Arsenosugar SO3 is the dominant form in brown macroalgae of the class Laminariales. In 
brown seaweed of the class Fucales all four common arsenosugars are found. In general 
the concentrations of arsenosugars in brown algae (<1-230 mg/kg dry mass) are higher 
than those found in red (0.4-45 mg/kg dry mass) and green (0.1-23 mg/kg dry mass) 
species. A minor though commonly found constituent in macroalgae is DMA. AsIII, AsV  and 
MA appear at trace level but are often not detected at all. A notable exception is the brown 
alga Hizikia fusiforme, which contains approximately half of its arsenic content as inorganic 
arsenate. Studies on the lipid-soluble fraction of the brown alga Undaria pinnatifida, carried 
out using NMR and GC mass spectrometric analysis, revealed the presence of a 
phosphatidylarsenosugar (compund 13 in figure 3.1). This compound comprises up to 25% 
of the total content. The identification of lipid-type arsenicals is, however, hampered by 
their instability and ease towards hydrolysis [Morita and Shibata, 1988]. 
 
The arsenic pattern in unicellular algae became clear after the analysis of the kidney of the 
giant clam Tridacna maxima [Edmonds et al. , 1982a]. Clams host the unicellular algae in 
their mantle edges. The algae serve as food to the clam. They remain intact in the mantle 
before being carried to the visceral mass for digestion. The compounds found in unicellular 
algae are essentially the same as those formed by macroalgae. 
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Figure 3.3. Pathway for the formation of arsenosugars from arsenate. 
 
Marine algae are exposed to arsenate originating from the ambient seawater. They absorb 
this arsenate, possibly because of an inability to distinguish it from phosphate. Although 
the exact mechanism of this uptake is not yet clear, once within the cell the arsenate is  
transformed into the range of arsenic compounds discussed above. With the exception of 
DMA, MA, AsV , AsIII and a taurine derivative [(CH3)2As(O)CH2CH2CH2C(O)NHCH2CH2SO3H], 
all these compounds contain a riboside moiety. One fundamentally supported mechanism 
was proposed by Edmonds et al.  [1982] and Edmonds and Francesconi [1987b]. It is based 
on the work of Challenger [1945] and Cantoni [1952 and 1953]. Arsenate is transformed 
into DMA by sequential reduction and oxidative methylation, followed by adenosylation, 
with SAM being both the methyl and adenosine donor. Considerable support for this 
pathway was provided by isolation of the key intermediate dimethylarsinoyladenosine 
[Francesconi et al. , 1991b; Francesconi et al. , 1992a]. This intermediate, upon 
glycosidation with available algal metabolites, yields the range of arsenosugars that have 
been identified from algal sources. A schematic overview of the pathway is given in figure 
3.3. This pathway may also form trimethylarsonioribosides, although the stage at which the 
third methyl group is transferred to arsenic is more speculative. 
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3.2.1.3. Arsenic in marine animals  
 
Marine animals can be divided into three main groups: fish (such as mackerel, cod, plaice, 
tuna), crustaceans (e.g., lobster, shrimp, crab, krill, prawn, amphipod) and molluscs (e.g., 
mussel, oyster, scallop, cockle, clam, whelk). 
 
One of the first reports on arsenic in marine organisms was published by Chapman [1926]. 
He found that molluscs and crustaceans contained much higher concentrations of arsenic 
than did fish. Although he was not able to reveal the chemical form of the arsenicals, he 
already saw the importance of speciation and stated that the arsenicals in marine 
organisms could not be present as arsenic trioxide or in any form having a similar toxicity. 
He postulated that the main arsenic compound present in lobster is a more or less complex 
organic substance, soluble in both water and alcohol and sufficiently stable to resist the 
action of hot dilute HCl or 5% NaOH. Further research showed that the level of arsenic in a 
particular organism did not appear to be related to its position in the food chain and to the 
size of the animal. First Edmonds and Francesconi [1977a] postulated that the 
trimethylated arsenic compound found in the rock lobster Panulirus Cygnus was most likely 
TMAO, but soon afterwards this compound was identified as AB. The identity was 
confirmed with X-ray analysis [Edmonds and Francesconi, 1977b]. In the following years, 
AB was found to be the major arsenical in many more marine animals [Edmonds and 
Francesconi, 1981b; Edmonds and Francesconi, 1981c; Francesconi and Edmonds, 1987a]. 
AB is now generally accepted as non-toxic. AC was the second arsenical to be identified in 
marine animals. However it appears only at trace amounts [Norin and Christakopoulos, 
1982]. The discovery of TETRA was important as it appeared in many crustacean and 
mollusc species at considerable concentrations [Shiomi et al. , 1987; Morita and Shibata, 
1987]. TMAO was found as a minor natural component in marine animals [Edmonds and 
Francesconi, 1987a]. TMAO and AC are considered as a breakdown product and a 
precursor of AB, respectively. Also arsenosugars have been identified in marine animals, 
more exactly in tissues of the giant clam Tridacna maxima [Edmonds et al. , 1982a; 
Francesconi et al. , 1992a;] and in species of gastropod [Francesconi et al. , 1998]. Marine 
algae are the source of arsenosugars in these animals. Next to arsenosugars, lipid-soluble 
arsenic compounds were found in the yelloweye mullet Aldrichetta forsteri following oral 
administration of AC. It was seen that AC was incorporated in phosphatidylarsenocholine 
and glycerylphosphorylarsenocholine, the latter being found as a minor water-soluble 
compound and as an alkaline hydrolysis product of the lipid-soluble phosphatidyl-
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arsenocholine [Francesconi et al. , 1990]. Later Edmonds et al.  [1992] found 
phosphatidylarsenocholine and a lipid-soluble arsenosugar (compound 13 in figure 3.1) in 
the digestive gland of the Western rock lobster Panulirius cygnus. 
 
Although marine animals contain many arsenic compounds, most animals contain AB as the 
major arsenical. Fish tend to have a simple pattern of arsenic compounds dominated by AB. 
Crustaceans also generally contain AB as a high percentage of their total arsenic. 
Gastropods often contain very high arsenic concentrations (up to 340 mg/kg wet mass), 
most of which is usually AB. Bivalve molluscs, in addition to AB, can contain large quantities 
of TETRA. High arsenosugar levels have been reported in some scallop species. Marine 
mammals contain only low levels of arsenic. In all cases AB predominates. Lipid arsenic 
compounds also occur in marine animals. MA, DMA, inorganic As and some unknown 
species appear at trace or minor levels in marine animals as well. The origin of AB in 
marine animals remains a matter of debate. Possible sources are water and food. 
 
It seems that marine animals are unable to convert inorganic arsenic from the ambient 
seawater into AB. Lunde [1972] showed that fish absorb inorganic arsenic, but that no 
organo arsenicals are formed. Klumpp and Peterson [1981] exposed fish to 74As-arsenate 
but were not able to detect neither a radioactive AB nor any precursor of AB. In another 
study it was shown that the mussel Mytilus edulis  did not accumulate appreciable amounts 
of arsenite and arsenate [Gailer et al. , 1995]. The same type of mussels was maintained in 
seawater containing different levels of AB. The mussels accumulated the AB readily, in a 
dose and time dependent way. The mussels were unable to regulate their rate of uptake. 
The AB was not further metabolised (Francesconi and Edmonds, 1987b). Similar 
experiments were carried out with the lobster Panulirus Cygnus. The lobsters accumulated 
the AB less efficiently and during a depuration period the levels decreased more rapidly 
compared to the mussels. From both experiments, however, it could be concluded that AB 
in seawater was not a significant contributor to the body burden of AB. Moreover, AB has 
by now not been found at detectable levels in seawater. A reason for the apparent absence 
of AB from seawater is that this compound is rapidly degraded into DMAA and DMA, 
obviously by microbial demethylation [Khokiattiwong et al. , 2001]. Hunter et al.  [1998] 
examined the uptake of AsV , TMAO and AB by the shrimp Crangon crangon. These arsenic 
species do not significantly contribute to the high AB levels. By now, it can be concluded 
that AB is not synthesized de novo by marine animals from ingested arsenic. 
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Likewise marine animals seem unable to convert AB directly from arsenic containing food. 
Several experiments have been carried out in which different arsenicals were administered 
through food. Edmonds and Francesconi [1987a] showed that the catfish Cnidoglanis 
macrocephalus and the school whiting Sillago bassensis  accumulated less than 1% of 
arsenate as TMAO. The methylation was probably achieved by the gut microflora. These 
authors also conducted a similar experiment [Francesconi et al. , 1989]. Of a set of organo-
arsenicals, only AB and AC were accumulated by the yelloweye mullet Aldrichetta forsteri. 
Dimethylarsinoyl ethanol (DMAE), dimethylarsinoyl acetate (DMAA) and dimethyl-
arsinothioyl ethanol were not retained by the fish, suggesting that no methylation occurred. 
An important finding was that the AC was rapidly and quantitatively transformed into AB 
(see below). Experiments on radiolabeled arsenosugars, originating from algae exposed to 
74As-arsenate in seawater, fed to the lobster Homarus americanus, revealed no new 
radioactive compounds and 74As-arsenobetaine was not detected [Cooney and Benson, 
1980]. In a recent study by Francesconi et al.  [1999a] the shrimp Crangon crangon was fed 
a synthetic dimethylated and a trimethylated arsenosugar. The dimethylated compound 
was poorly absorbed and found mostly unchanged. The trimethylated sugar was slightly 
absorbed and half of this was transformed into AB. Goessler et al.  [1997] found large 
amounts of AB in the herbivorous gastropod Austrocochlea constricta, which fed on the 
seaweed Hormosira banksii but they were unable to prove whether the AB was originating 
from the arsenosugar present in the alga rather than from other sources. The arsenic 
profile in the next step of the food chain, the carnivorous gastropod Morula marginalba, 
was not much different. Edmonds et al.  [1997] studied another five food chains but were 
unable to conclude whether AB is originating from the ambient water, food or through 
direct conversion from arsenosugars. The identification of TMAO, which might be a 
precursor of AB, might reveal new insights. As in the case of seawater, marine animals 
seem unable to biotransform AB from food. 
 
However, marine animals, directly or indirectly, feed on algae. Despite the apparent lack of 
AB in algae, the arsenosugars - because of their high levels in algae - remain the most 
plausible precursors of AB. When considering the chemical structure of arsenosugars, it can 
easily be seen that conversion of dimethylarsinoyl ribosides to AB requires cleavage of the 
C3-C4 bond of the sugar ring with subsequent oxidation at C4, and reduction and further 
methylation on arsenic. These changes could be microbially mediated and may take place 
in sediments. This hypothesis was supported by experimental evidence. When the brown 
alga Ecklonia radiata was allowed to decompose with marine sediment and associated 
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microflora under controlled anaerobic conditions, the dimethylated arsenosugars were 
quantitatively transformed into DMAE [Edmonds et al. , 1982b]. Only a limited number of 
experiments have been carried out, on benthic-feeding organisms. TMAO in estuary catfish 
is believed to originate from methylation of arsenate in surface sediments [Edmonds and 
Francesconi, 1987a]. In another experiment the polychaete Tharyx marioni was found to 
contain extremely high amounts of arsenic and radiotracer experiments showed that 
sediments were the source of this. However, the chemical identity of this arsenic remained 
unknown [Gibbs et al. , 1983]. The formation of DMAE from arsenosugars might also occur 
in the gut tract of the marine animals. 
 
DMAE requires only methylation and oxidation (or vice versa) via arsenocholine or DMAA, 
respectively, for conversion to AB. Unfortunately this hypothesis could not yet be confirmed 
by experimental evidence. As already described, Francesconi et al.  [1989] carried out 
feeding experiments with yelloweye mullet (Aldrichetta forsteri) but found that fish 
receiving DMAE or DMAA showed no increase in arsenic concentration compared to the 
control group. It is yet to be established at what stage in the food chain (bacteria < 
detritovores < AB-containing animals of higher trophic levels) the final conversion of DMAE 
to AB occurs. 
 
In analogy, anaerobic microbial degradation of a trimethylarsonioriboside leads to AC 
[Francesconi et al., 1992b]. No further methylation outside the algae is required in this 
case. It can easily be shown that AC is a precursor of AB. AC fed to fish is immediately 
transformed into AB [Francesconi et al. , 1989]. 
 
Both proposed pathways are illustrated in figure 3.4. The two steps in the transformation of 
trimethyl derivatives into AB occur readily under laboratory conditions. The proposed 
pathway based on dimethyl derivatives, however, requires an extra methylation step, which 
has yet to be achieved from laboratory experiments. Still the large amounts of 
dimethylarsinoyl sugars seem to be the only source of AB. The biogenesis of AB is still 
under investigation. Recently a new arsenobetaine has been isolated from marine 
organisms [Francesconi et al. , 2000] and new findings about the uptake of several arsenic -
betaines [Francesconi et al. , 1999b] have been published. Moreover an alternative 
mechanism for the formation of AB, based on the chemical structure of a 
trialkylarsonioriboside has been suggested [Edmonds, 2000]. 
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Figure 3.4. Pathway for the formation of arsenobetaine from dimethylarsinoylribosides 
and trimethylarsonioribosides. 
 
3.2.2. Arsenic compounds in the atmospheric and terrestrial environment 
 
[Cullen and Reimer, 1989; Mandal and Suzuki, 2002] 
 
3.2.2.1. Arsenic  in the earth’s crust 
 
The terrestrial abundance of arsenic is around 1.5-3 mg/kg, being the 20th most abundant 
element in the earth’s crust. There is, however, a large variability depending on rock type, 
with sedimentary rock generally containing higher levels than igneous rock. It has been 
estimated that of the total arsenic contained in the various reservoirs (rocks, oceans, soils, 
biota, atmosphere), more than 99% is associated with rocks and minerals. Arsenic naturally 
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occurs in over 200 different mineral forms, of which 60% are arsenates, 20% sulphides 
and sulphosalts and the remaining 20% include arsenides, arsenites, oxides, silicates and 
elemental arsenic. Arsenopyrite (FeAsS) is the most abundant arsenic -containing mineral. 
Pure arsenic ores are realgar (As4S4), orpiment (As2S3) and arsenolite (As2O3). Other 
important minerals are olivenite (Cu2OHAsO4), cobaltite (CoAsS) and proustite (Ag3AsS3). 
 
3.2.2.2. Arsenic in soils and terrestrial sediments 
 
Arsenic concentration in soil and shales is considerably higher than in earth’s crust, because 
of its accumulation during weathering and translocation in colloid fractions. Background 
concentrations of arsenic in soil range from 0.1-50 mg/kg with a mean of about 6 mg/kg. 
Many factors may influence the arsenic content in soils. The natural sources of arsenic in 
soil are mainly the parent (or rock) materials from which it is derived. Arsenic may also 
accumulate in soil through anthropogenic sources such as pesticides, herbicides, fungicides, 
fertilisers, irrigation water from mines, dust from fossil fuel combustion and disposal of 
industrial and animal wastes. Arsenic occurs mainly as inorganic species, with depending on 
the pH and the redox conditions of the soil, arsenates and arsenites being the stable 
arsenic species. Inorganic arsenic compounds can be methylated to MA, DMA and TMAO by 
microorganisms. Further reduction can lead to volatile trivalent methylarsines. 
 
The natural level of arsenic in sediments is usually below 10 mg/kg (dry mass). AsV , AsIII, 
MA and DMA are the predominant species. 
3.2.2.3. Arsenic in the atmosphere 
 
Arsenic enters the atmosphere from natural sources that include volcanic activity, wind 
erosion, sea spray, forest fires, microbial reduction and low temperature volatilisation 
(mainly biological formation of volatile arsenicals). Smelting operations and fossil fuel 
combustion contribute to anthropogenic sources of arsenic. The ratio of natural to 
anthropogenic sources is 60:40. Particulate arsenic trioxide is the main form of arsenic 
released by these processes. Arsine and methylated arsines (MeAsH2, Me2AsH, Me3As) have 
been reported over sites where biological activity is high. These species then partly oxidate 
to the pentavalent state. Typical background levels for arsenic are 0.2-1.5 ng/m3 for rural 
areas, 0.5-3 ng/m3 for urban areas and < 50 ng/m3 for industrial sites. 
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3.2.2.4. Arsenic in freshwater and groundwater 
 
Arsenic is found at low concentration in natural surface water. The concentration of arsenic 
in unpolluted fresh waters ranges from 1-10 mg/L. In 2001, the US Environmental 
Protection Agency adopted a new standard for arsenic in drinking water at 10 mg/L, 
replacing the old standard of 50 mg/L. The date by which systems must comply with the 
new 10 mg/L standard is January, 2006 [http 4]. The World Health Organisation has 
established a provisional guideline value of 10 mg/L [http 5]. 
 
Arsenic levels in groundwater average about 1-2 mg/L, except in areas with volcanic rock 
and sulphide mineral deposits where arsenic levels can range up to 3.4 mg/L. 
 
3.2.2.5. Arsenic in terrestrial and freshwater plants 
 
Arsenic levels in terrestrial plants are generally lower than those found in marine plants. 
The concentrations seldom exceed levels higher than 1 mg/kg dry mass. Inorganic arsenic 
predominates (arsenite, or more usually arsenate) and MA and DMA can be found as well. 
TMAO, TETRA, AB and presumably also AC have been detected as well. AsSug-OH and 
AsSug-SO3 have been detected in some plant species. Plants that serve as foodstuff for 
humans do not cause a substantial increase in the arsenic burden. Values for total arsenic 
in lettuce, beans, carrots etc. range between 0.1 and 10 mg/kg (wet mass). Notable 
exceptions are mushrooms. Although not classified as plants they will be described here. 
Arsenic levels in fungi vary between <1-2000 mg/kg (dry mass). DMA predominates in 
fungi although the amount of MA can be up to 50%. Inorganic arsenate is also a common 
constituent. AB can be the major arsenical and TETRA and/or AC can be found as well. 
TMAO and arsenosugars have been detected in some species. 
 
In freshwater plants arsenite and arsenate predominate and low levels of MA and DMA are 
also detectable. Arsenosugars are only occasionally detected. TETRA and an appreciable 
amount of lipid-soluble arsenic can be seen as well.  
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3.2.2.6. Arsenic in terrestrial animals  
 
Arsenic levels in terrestrial animals are low. Arsenite and arsenate predominate. Median 
levels in pork, poultry and beef are around 5 mg/kg (wet mass). Also here animals served 
as food for humans do not give rise to high uptake of arsenic. 
 
3.3. Arsenic in the human body 
 
3.3.1. Arsenic in humans after intake of inorganic arsenic 
 
3.3.1.1. Exposure, uptake, storage and excretion 
 
[Ishinishi et al. , 1986] 
 
Because of its widespread use and occurrence, humans may be exposed to various arsenic 
species from many different sources, both natural and anthropogenic. Anthropogenic 
sources are more important than natural sources. The main routes of exposure are 
inhalation (dust and fumes) and ingestion (water, beverages, soil and food), although skin 
absorption of trivalent arsenic has been reported. Inhalation of airborne arsenic is 
commonly associated with smelting and mining activities and from coal fly ash due to the 
burning of high arsenic containing coals. Exposure by the general population occurs mainly 
through ingestion of arsenic in drinking water (high arsenic levels in groundwater in regions 
of India, Bangladesh, Mongolia...) and food (contaminated with arsenic pesticides, grown 
on arsenic rich soils or with arsenic contaminated water). Short or long-time exposure to 
inorganic arsenic leads to different adverse health effects. Exposure to arsenicals present in 
food such as fish, crustaceans, molluscs and algae was not shown to cause any danger for 
human health. The metabolism and kinetics of excretion is, however, highly dependent on 
the chemical form of the ingested arsenical. Because this aspect is of prime interest for the 
scope of this work, it will be discussed in a separate paragraph. This paragraph will focus 
mainly on inorganic arsenic. 
 
Once ingested, the gastrointestinal tract easily takes up (over 90%) dissolved inorganic 
arsenic. In blood arsenic is preferentially found in the packed cell fraction. Whole blood 
levels for unexposed people vary between 2-7 mg/L. Serum and packed cell levels amount 
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around 0.1-5.5 mg/L and 0.4-20 mg/L As, respectively [Versieck and Vanballenberghe, 
1985]. Absorbed arsenite and arsenate are initially bound to haemoglobin, yet they leave 
the intravascular space within 24 hours and are concentrated in the liver, kidneys, spleen, 
lungs and gastrointestinal tract. Within a day, residual arsenic is found in nails, hair and 
skin and this due to the high thiol content of keratin. Inorganic arsenic  is mainly excreted 
through urine. 
3.3.1.2. Metabolism and mechanisms of toxicity of inorganic arsenic  
 
 
Figure 3.5. Biomethylation of inorganic arsenic. 
 
Several studies have shown that mammals metabolise inorganic arsenic to MA and DMA 
[Crecelius, 1977; Buchet et al. , 1981]. These methylated species are a result of 
biomethylation, which involves a stepwise reduction of pentavalent arsenical to a trivalent 
arsenical followed by oxidative addition of a methyl group. In humans DMA is the end 
metabolite. Gluthathione (GSH) [Buchet and Lauwerys, 1987] and S-adenosylmethionine 
(SAM) [Marafante and Vahter, 1984; Buchet and Lauwerys, 1985] serve as the reducing 
agent and methyl donor, respectively. The liver is the main site for this methylation. The 
methylating capability is, however, very much dependent on the biological species. 
Marmoset monkeys, e.g., have a very poor methylating efficiency [Vahter et al. , 1982]. The 
process of (bio)methylation was first described by Challenger [1945]. A schematic overview 
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is given in figure 3.5. Challenger developed his findings in analogy with other methyl-
forming metals such as selenium and tellurium. The identification of Gosio gas as 
trimethylarsine (TMA), a gas having a garlic odour and formed by interaction of moulds 
with arsenicals present as pigments in wallpaper, led Challenger to put forward this 
mechanism, which is now generally accepted. According to Challenger, arsenate is 
transformed to TMA by the mould Scopulariopsis brevicaulis  by sequential reduction and 
oxidative methylation through several intermediates such as arsenite, MA, DMA and TMAO. 
Although he could not isolate these intermediates at that time, addition of MA, DMA and 
TMAO to a culture of S. brevicaulis  always yielded TMA. He also postulated that SAM was 
the likely source of Me+. This has been confirmed later on. Methylation of inorganic occurs 
in bacteria, fungi, yeasts, anaerobic microorganisms and mammals… The methylation 
pathway in these organisms is identical, but reducing agents and methyl donors might be 
different. 
 
It has long been assumed that this methylation is a detoxification process. Indeed the 
methylated species have much higher LD50 values compared to inorganic species (see table 
3.3). However, during the last years work has focussed on the trivalent methylated 
intermediates MAIII and DMAIII. Animal experiments and in vitro studies have shown that 
these species are at least as toxic as the inorganic arsenicals and maybe even more. 
Because these reduced species have been reported to be very unstable [Gong et al. , 2001], 
their toxicity is still a matter of debate. 
 
When highlighting the mechanism by which arsenic poses a threat for human health, it is 
important to distinguish between arsenite and arsenate. It is generally thought that the 
overall toxicity of arsenite is due to the inhibition of critical sulphhydryl-containing enzymes 
by trivalent arsenic. Many enzymes are susceptible to deactivation by arsenic. The 
deactivation is believed to be reversible because adding an excess of a monothiol such as 
GSH restores the enzymatic activity. Moreover GSH depletion has been shown to be more 
susceptible to arsenic intoxication. Some pentavalent compounds are partly reduced in vivo 
to the more toxic trivalent forms, but the redox equilibrium in vivo favours the pentavalent 
state. Pentavalent arsenic does not appear to lead to enzyme inhibition. It is, however, 
capable of uncoupling the oxidative phosphorylation in the mitochondria by a process called 
arsenolysis. The oxidative phosphorylation is the process in which adenosine triphosphate 
(ATP) is formed. The mechanism of toxicity for arsenate is thought to be related to the 
competitive substitution of arsenate for phosphate, with which it is isoelectric and isosteric, 
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and to the subsequent formation of an unstable arsenate ester of ADP, which is rapidly 
hydrolysed. In this regard, it can be concluded that arsenic has a doubled toxic impact on 
the cellular respiration: the trivalent arsenic inhibits the reduction of nicotinamide adenine 
dinucleotide (NADPH) by deactivating critical enzymes, and the pentavalent arsenic 
uncouples the oxidative phosphorylation. 
 
Table 3.3. LD50  values of different arsenic species in mammals. 
 
  
LD50 in humans (mg/kg)  
As2O3 1.4 oral [Fairchild et al., 1977] 
MA 50 oral [Fairchild et al., 1977] 
DMA 500 oral [Fairchild et al., 1977] 
    
LD50 values in animals (mg/kg)  
As2O3 34.5 mouse, oral [Kaise et al., 1985] 
arsenite 4.5 rat, ip [Frank and Moxon, 1936] 
arsenate 14-18 rat, ip [Frank and Moxon, 1936] 
MA 1800 mouse, oral [Kaise et al., 1989] 
DMA 1200 mouse, oral [Kaise et al., 1989] 
TMAO 10600 mouse, oral [Kaise et al., 1989] 
AB >10000 mouse, oral [Kaise et al., 1985] 
    
 
The toxicity of arsenic is highly dependent on its chemical form. Inorganic arsenicals 
(arsine, arsenite and arsenate) are highly toxic, whereas MA and DMA are much less toxic. 
Trimethyl and tetra-alkylarsonium compounds (TMAO, TETRA, AC, AB, and arsenosugars) 
are considered innocuous. MAIII and DMAIII are at least as toxic as inorganic arsenic. In 
general, soluble inorganic arsenicals are more toxic than the organic ones, and AsIII is more 
toxic than AsV . A table with LD50 values of some arsenic species is given in table 3.3. 
 
Biomarkers of inorganic arsenic exposure are to be found in urine in short-term (up to one 
week) and in hair or in nails for long-term (several weeks to several months) exposure. 
Blood levels are generally low, because of the fast clearance into tissues. Only in the case 
of continued arsenic exposure is the blood arsenic level likely to be a useful indicator. 
 
3.3.2. Arsenic in humans after intake of marine food 
 
Arsenic is present in seafood at concentration as high as several 100 mg/kg. Speciation 
studies show that AB is the major component in fish and crustaceans, with arsenosugars, 
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AC, TMAO, TETRA, MA, DMA and inorganic arsenic present as minor species. Both AB and 
arsenosugars are present in molluscs. Arsenosugars are the primary arsenic constituents of 
algae, the residual arsenicals being DMA and inorganic arsenic. 
 
3.3.2.1. Arsenic in humans after exposure to arsenobetaine 
 
Cox [1925] reported high values of arsenic found in patients, often leading to the 
conclusion that they were chronically poisoned by arsenic. As he was aware of the fact that 
fish contains high amounts of arsenic, he made a link between the arsenic in fish and in 
urine. Chapman [1926] found that when two people ate lobster, the arsenic levels in the 
urine drastically increased and only a small proportion of this could be directly detected, 
i.e., without mineralisation of the organic matter by nitric and sulphuric acids. Although it 
was impossible to conclude whether the compound found in the urine was identical to the 
one in the lobster, he concluded that after passage of this compound through the body it 
had not changed into a compound that could directly be analysed by reduction with 
hydrogen. Coulson et al.  [1935] carried out experiments with both humans and rats to 
compare the rate and completeness of excretion of shrimp-arsenic. They found that this  
arsenic compound was excreted rapidly and unchanged by the kidneys. Crecelius [1977] 
found no marked increase in urinary levels of AsIII, AsV , DMA and MA after a volunteer had 
ingested crab. However, after hot basic digestion with 2 M NaOH, high levels of DMA were 
detected in the samples. Measurements were carried out with a hydride generation (HG) 
technique. Using HG, only directly hydride-forming elements are detected, whereas organo-
arsenicals are insensitive towards this technique (see paragraph 4.4). This shows again that 
the arsenical present in the urine after ingestion of crab-arsenic was organic. Crecelius also 
reported that the crab-arsenical was excreted within 1-2 days after ingestion. In 1977 
Edmonds and Francesconi [1977b] identified this compounds as AB. Buchet et al.  [1980] 
reported a mean arsenic biological half -life of 18 hours after 4 volunteers ate crab. This 
half-life was significantly shorter than that reported for inorganic arsenic (30 hours). A 
mass balance was determined and it was found that 56% of the ingested arsenic was 
recovered from the urine within 4 days. Cannon et al.  [1981] found that AB was excreted 
unchanged in the urine of a volunteer who had a meal of the Western Rock lobster 
Panulirus Cygnus, which contains AB as the sole constituent. They therefore concluded that 
AB represents no toxic hazard for humans. Kaise et al.  [1985] determined an LD50 value of 
AB in male mice. No deaths were observed with oral administration of 10 g/kg, so the LD50 
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value was set to this amount (see table 3.3). They recovered the arsenical in urine in the 
non-metabolised form. Yamauchi et al.  [1992] determined the content of inorganic and 
mono-, di- and trimethylated species in several diets as well as in blood and urine of a 
Japanese population. The mean total arsenic intake was 195 mg per day, composed of 76% 
trimethylated arsenic. An average of 64.6% of a total mean of 129 mg/L arsenic in urine 
was also trimethylated. The mean blood total arsenic level was 7.3 mg/ L arsenic of which 
73% was trimethylated. The trimethylated levels in urine correlated well with the 
trimethylated levels in blood. After the ingestion of 500 g crab, a 10-fold increase of total 
urinary arsenic was observed, with a maximum recovered between 4 and 17 hours after 
intake. The ingestion of crab, shrimp and salmon showed no effect on the urinary excretion 
of MA and DMA [Le et al. , 1993]. Later Le et al.  [1994] conducted a study in which several 
volunteers ingested a portion of crab and shrimp. The AB was excreted unchanged and for 
two volunteers 66% and 73% of the ingested arsenic was recovered within 37 hours after 
ingestion. A maximum amount was recovered from urine 8 hours after intake. 
 
In general it can be concluded that AB is excreted fast and unchanged in the urine and 
therefore is not believed to pose any threat on human health. Regarding this latter remark, 
Buchet et al.  [1994; 1996] followed the assessment of inorganic arsenic after seafood 
consumption. They found that consumption of ray, cod or plaice did not result in an 
increase of urinary arsenite, but that consumption of mussels led to an amount of DMA 
excreted in urine, which is significantly higher than that expected on the basis of the 
amount of inorganic arsenic and its methylated derivatives already present in the shellfish. 
This is due to the arsenosugar content in the mussels. 
3.3.2.2. Arsenic in humans after exposure to arsenosugars 
 
The ingestion of arsenosugar containing food shows a totally different urinary excretion 
pattern. 
 
Le et al.  [1994] carried out several experiments on different kinds of algae samples. In one 
study two male volunteers consumed a portion of kelp. The total arsenic and hydride-
forming arsenic was followed in function of time relative to the ingestion of kelp. Both 
results show the same time dependent response and only small amounts of arsenic are 
non-hydride forming arsenicals. A considerable concentration of arsenic is found between 
17 and 37 hours after ingestion. Speciation analysis shows that the kelp consists of 
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arsenosugars OH and PO4 and an unidentified species comprising about 40% of the total 
extractable arsenic. On the other hand speciation analysis of selected urine samples before 
and after ingestion led to the conclusion that in the first case only DMA and arsenate were 
found, whereas 23 hours after eating, 3 unknown species were detected besides increased 
amounts of DMA and AsV . In the urine of the other volunteer two identical and one 
different unidentified arsenic species were found. Because of these findings they suggested 
that the metabolism of arsenosugars is dependent on the individual and they extended 
their study to 9 people ingesting a portion of nori, an algae containing only one 
arsenosugar. Urinary arsenic levels peaked between 10 and 60 hours after ingestion for 7 
volunteers. Two volunteers showed no response. Selected urine samples were again 
subjected to speciation analysis with HPLC-ICP-MS. Up to 6 unknown arsenicals in addition 
to increased amounts of DMA and AsV  were present in the urine samples. Because of the 
mutual differences between the nine subjects, they concluded again that the metabolism of 
arsenosugars differs from individual to individual. Finally they suggested that arsenosugars 
were not simply decomposed by the acid present in the stomach as an extraction of nori in 
water and in 10 mM HCl showed no significant difference. Ma and Le [1998] subsequently 
reported similar findings. Again they showed the presence of unknown metabolites and an 
increased amount of DMA. Spiking of the urine samples with the algae extract moreover 
showed that the unknown peaks could not be attributed to the arsenosugars originally 
present in the consumed seaweed. Time dependent plots of urinary excretion were similar 
to those presented earlier. 
 
Francesconi et al. [2002] carried out a thorough study. A male volunteer ingested a 
synthetic arsenosugar (1.22 mg in As). Determination of total arsenic versus time showed 
that 81% is excreted within 94 hours after ingestion. The highest amount was found 27 
hours after eating. Both anion and cation exchange HPLC-ICP-MS was used to elucidate the 
identity of the different metabolites present in the urine. Four major peaks were present in 
the urine after separation on the anion exchange column. One of them was assigned to as 
DMA. Another eluted in the void volume and is a mixture of neutral and cationic 
compounds. Cation exchange chromatography revealed two major peaks, eluting closely 
together. The largest peak was assigned to as DMAE, by matching retention times and by 
recording the molecular ion with electrospray mass spectrometry (ES-MS). It was 
postulated that the DMAE was formed by microbial breakdown of the arsenosugar by the 
gut microflora. The small peak was postulated to be TMAO. Evidence was found by spiking 
the urine sample with a calibrant. More evidence for the presence of DMAE and TMAO was 
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found by eluting the urine sample under different chromatographic conditions. For both 
species, the change in retention time matched that of a pure standard. The authors also 
found that the different arsenic species were excreted at different rates. The two unknown 
compounds from the anion exchange chromatogram peaked at 22 h, whereas DMA and 
DMAE reached a maximum after 27 hours. Finally they postulated that one significant 
metabolite was possibly dimethylarsinous acid (DMAIII). 
 
Three more studies conducted by Feldmann et al.  [2000] and Hansen et al.  [2003a; 2003b] 
are worth mentioning. Instead of humans they carried out experiments on sheep from 
Northern Scotland. These sheep feed on seaweed and ingest enormous amounts (3-5 kg 
per day). Besides urine, also tissue, wool, faeces and blood were analysed. Urine, blood 
and wool levels of arsenic were significantly higher than those of control sheep that fed on 
grass. Especially the arsenic concentration in wool was astounding as it reached a 100-fold 
increase compared to the control sheep. Arsenic in wool was measured because it is one of 
the primary sites for long-term storage of arsenic. Speciation experiments of urine showed 
that almost all arsenic was found as DMA. Minor metabolites were MA, TETRA and 
arsenosugar OH. In a similar second study, sheep were again submitted to a feeding 
experiment [Hansen et al. , 2003a]. 13% of the ingested arsenic was excreted in the 
faeces, with the remainder estimated to be excreted in the urine. DMA (60%) and MA, 
TETRA, AsV  and DMAE were recovered from the urine of the sheep. The excretion rate 
peaked between 4 and 28 hours after seaweed intake. In Hansen et al.  [2003b] no mention 
of MA is made, but DMAA was identified as the second most abundant metabolite. 
 
There are no reports on the acute toxicity of arsenosugars. Sakurai et al.  [1997] 
investigated the in vitro cytotoxicity of arsenosugar OH and reported that it was not 
cytotoxic to both peritoneal macrophages and to alveolar macrophages at the mM 
concentration level, although it was able to induce several cellular responses in both 
macrophages at high concentrations (1-10 mM). In a review written by Sakurai [2002], an 
experiment is mentioned in which the in vivo acute toxicity was tested (unpublished 
results). An indicative LD50 value of > 6 g/kg was given for oral administration to mice. He 
concluded that one-time consumption is not very toxic to the human health. However, the 
fact that arsenosugars are partly transformed into DMA raises questions about the possible 
toxicity of arsenosugars. DMA has been said to be a potent co-carcinogen. 
 
 
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 50
References 
 
[Adriano, 1986] 
Adriano DC (1986). In Trace Elements in the Terrestrial Environment, Springer, New 
York, pp 47-72. 
[Andreae, 1979] 
Andreae MO (1994). Limnol. Oceanogr., 24, 440-452. 
[Azcue and Nriagu, 1994] 
Azcue JM and Nriagu JO (1994). In Arsenic in the environment, part I: cycling and 
characterization (ed. Nriagu JO), John Wiley & Sons, New York, pp 1-15. 
[Buchet and Lauwerys, 1985] 
Buchet JP and Lauwerys R (1985). Arch. Toxicol. , 57, 125-129. 
[Buchet and Lauwerys, 1987] 
Buchet JP and Lauwerys R (1987). Toxicol. Appl. Pharmacol. , 91, 65-74. 
[Buchet et al., 1980] 
Buchet JP, Lauwerys R and Roels H (1980). Int. Arch. Occup. Environm. Health, 46, 
11-29. 
[Buchet et al., 1981] 
Buchet JP, Lauwerys R and Roels H (1981). Int. Arch. Occup. Environ. Health, 48, 
71-79. 
[Buchet et al., 1994] 
Buchet JP, Pauwels J and Lauwerys R (1994). Environ. Res., 66, 44-51. 
[Buchet et al., 1996] 
Buchet JP, Lison D, Ruggeri M, Foa V and Elia G (1996). Arch Toxicol. , 70, 773-778. 
[Cannon et al., 1981] 
Cannon JR, Edmonds JS, Francesconi KA, Raston CL, Saunders JB, Skelton BW and 
White AH (1981). Aust. J. Chem., 34, 787-798. 
[Cantoni, 1952] 
Cantoni GL (1952). J. Am. Chem. Soc., 74, 2942-2943. 
[Cantoni, 1953] 
Cantoni GL (1953). J. Biol. Chem., 204, 403-416. 
[Challenger, 1945] 
Challenger F (1945). Chem. Rev., 36, 315-361. 
[Chapman, 1926] 
Chapman AC (1926). Analyst, 51, 548-563. 
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 51
[Cooney and Benson, 1980] 
Cooney RV and Benson AA (1980). Chemosphere, 9, 335-341. 
[Cooney et al., 1978] 
Cooney RV, Mumma RO and Benson AA (1978). Proc. Natl. Acad. Sci. USA, 75, 
4262-4264. 
[Coulson et al., 1935] 
Coulson EJ, Remington RE and Lynch KM (1935). J. Nutr., 10, 255-270. 
[Cox, 1925] 
Cox HE (1925). Analyst, 50, 3-13. 
[Crecelius, 1977] 
Crecelius EA (1977). Environ. Health Persp., 19, 147-150. 
[Cullen and Reimer, 1989] 
Cullen WR and Reimer KJ (1989). Chem. Rev., 89, 713-764. 
[Edmonds and Francesconi, 1977a] 
Edmonds JS and Francesconi KA (1977). Tetrah. Letters, 18, 1543-1546. 
[Edmonds and Francesconi, 1977b] 
Edmonds JS and Francesconi KA (1977). Nature, 265, 436. 
[Edmonds and Francesconi, 1981a] 
Edmonds JS and Francesconi KA (1981). Nature, 289, 602-604. 
[Edmonds and Francesconi, 1981b] 
Edmonds JS and Francesconi KA (1981). Mar. Poll. Bull. , 12, 92-96. 
[Edmonds and Francesconi, 1981c] 
Edmonds JS and Francesconi KA (1981). Chemosphere, 10, 1041-1044. 
[Edmonds and Francesconi, 1983] 
Edmonds JS and Francesconi KA (1983). J. Chem. Soc. Perkin Trans. I, 2375-2382. 
[Edmonds and Francesconi, 1987a] 
Edmonds JS and Francesconi KA (1987). Sci. Tot. Environ., 64, 317-323. 
[Edmonds and Francesconi, 1987b] 
Edmonds JS and Francesconi KA (1987). Experientia , 43, 553-557. 
[Edmonds et al., 1982a] 
Edmonds JS, Francesconi KA, Healy PC and White AH (1982). J. Chem. Soc. Perkin 
Trans. I, 2989-2993. 
[Edmonds et al., 1982b] 
Edmonds JS, Francesconi KA and Hansen JA (1982). Experientia , 38, 643-644. 
 
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 52
[Edmonds et al., 1987] 
Edmonds JS, Morita M and Shibata Y (1987). J. Chem. Soc. Perkin Trans. I, 577-
580. 
[Edmonds et al., 1992] 
Edmonds JS, Shibata Y, Francesconi KA, Yoshinaga J and Morita M (1992). Sci. Tot. 
Environ., 122, 321-335. 
[Edmonds et al., 1997] 
Edmonds JS, Shibata Y, Francesconi KA Rippingale RJ and Morita M (1997). Appl. 
Organomet. Chem., 11, 281-287. 
[Edmonds, 2000] 
Edmonds JS (2000). Bioorg. Med. Chem. Lett., 10, 1105-1108. 
[Fairchild et al., 1977] 
Fairchild EJ, Lewis RJ and Tatken RL (1977). Registry of toxic effects of chemical 
substances, US Department of Health, Education, and Welfare. National Institute for 
Occupational Safety and Health, Cincinnati.  
[Feldmann et al., 2000] 
Feldmann J, John K and Pengprecha P (2000). Fres. J. Anal. Chem., 368, 116-121. 
[Francesconi and Edmonds, 1987a] 
Francesconi KA and Edmonds JS (1987). Comp. Biochem. Physiol. , 87C, 345-347. 
[Francesconi and Edmonds, 1987b] 
Francesconi KA and Edmonds JS (1987). In Heavy metals in the environment, 
volume 2 (ed. Lindberg SE and Hutchinson TC), CEP consultants, Edinburgh, pp 71-
73. 
[Francesconi et al., 1989] 
Francesconi KA, Edmonds JS and Stick RV (1989). Sci. Tot. Environ., 79, 59-67. 
[Francesconi et al., 1990] 
Francesconi KA, Stick RV and Edmonds JS (1990). Experientia , 46, 464-466. 
[Francesconi et al., 1991a] 
Francesconi KA, Edmonds JS, Stick RV, Skelton BW and White AH (1991). J. Chem. 
Soc. Perkin Trans. I, 2707-2716. 
[Francesconi et al., 1991b] 
Francesconi KA, Stick RV and Edmonds JS (1991). J. Chem. Soc. Chem. Commun., 
928-929. 
 
 
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 53
[Francesconi et al., 1992a] 
Francesconi KA, Edmonds JS and Stick RV (1992). J. Chem. Soc. Perkin Trans. I, 
1349-1357. 
[Francesconi et al., 1992b] 
Francesconi KA, Edmonds JS and Stick RV (1992). Appl. Organomet. Chem., 6, 247-
249. 
[Francesconi et al., 1998] 
Francesconi KA, Goessler W, Panutrakul S and Irgolic KJ (1998). Sci. Tot. Environ., 
221, 139-148. 
[Francesconi et al., 1999a] 
Francesconi KA, Hunter DA, Bachmann B, Raber G and Goessler W (1999). Appl. 
Organomet. Chem., 13, 669-679. 
[Francesconi et al., 1999b] 
Francesconi KA, Gailer J, Edmonds JS, Goessler W and Irgolic KJ (1999). Comp. 
Biochem. Physiol. C, 122, 131-137. 
[Francesconi et al., 2000] 
Francesconi KA, Khokiattiwong S, Goessler W, Pedersen SN and Pavkov M (2000). 
Chem. Comm., 1083-1084. 
[Francesconi et al., 2002a] 
Francesconi KA, Tanggaard R, McKenzie CJ and Goessler W (2002). Clin. Chem., 
48, 92-101. 
[Franke and Moxon, 1936] 
Franke KW and Moxon AL (1936). J. Pharmacol. Exp. Ther., 58, 454-459. 
[Gailer et al., 1995] 
Gailer J, Francesconi KA, Edmonds JS and Irgolic KJ (1995). Appl. Organomet. 
Chem., 9, 341-355. 
[Gailer et al., 1999] 
Gailer J, Madden S, Cullen WR and Denton MB (1999). Appl. Organomet. Chem., 
13, 837-843. 
[Gibbs et al., 1983] 
Gibbs PE, Langston WJ, Burt GR and Pascoe PL (1983). J. Mar. Biol. Assoc. U.K., 
63, 313-325. 
[Goessler et al., 1997] 
Goessler W, Maher W, Irgolic KJ, Kuehnelt D, Schlagenhaufen C and Kaise T (1997). 
Fres. J. Anal. Chem., 359, 434-437. 
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 54
[Gong et al., 2001] 
Gong Z, Lu, X, Cullen WR and Le XC (2001). J. Anal. At. Spectrom., 16, 1409-1413. 
[Hansen et al., 2003a] 
Hansen HR, Raab A, Francesconi KA and Feldmann J (2003). Environ. Sci. Technol. , 
37, 845-851. 
[Hansen et al., 2003b] 
Hansen HR, Raab A and Feldmann J (2003). J. Anal. At. Spectrom., 18, 474-479. 
[http 1] 
http://seaweed.ucg.ie. 
[http 2] 
http://botany.ubc.ca/algae. 
[http 3] 
http://www.nmnh.si.edu/botany/projects/algae/AlgIntro.htm 
[http 4] 
http://www.epa.gov/safewater/ars/implement.html 
[http 5] 
http://www.who.int/mediacentre/factsheets/fs210/en 
[Hunter et al., 1998] 
Hunter DA, Goessler W and Francesconi KA (1998). Mar. Biol. , 131, 543-552. 
[Irgolic et al., 1977] 
Irgolic KJ, Woolson EA, Stockton RA, Newman RD, Bottino NR, Zingaro RA, Kearney 
PC, Pyles RA, Maeda S, Mcshane WJ and Cox ER (1977). Environ. Health Persp., 19, 
61-66. 
[Ishinishi et al., 1986] 
Ishinishi N, Tsuchiya K, Vahter M and Fowler BA (1986). In Handbook on the 
Toxicology of Metals, volume II: Specific Metals  (ed. Friberg L, Nordberg GF and 
Vouk VB), Elsevier, Amsterdam, pp 43-83. 
[Jones, 1922] 
Jones AJ (1922). Year book of Pharmacy, J&A Churchill, London, pp 388-395. 
[Kaise et al., 1985] 
Kaise T, Watanabe S and Itoh K (1985). Chemosphere, 14, 1327-1332. 
[Kaise et al., 1989] 
Kaise T, Yamauchi H, Horiguchi Y, Tani T, Watanabe S, Hirayama T and Fukui S 
(1989). Appl. Organomet. Chem., 3, 237-277. 
 
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 55
[Khokiattiwong et al., 2001] 
Khokiattiwong S, Goessler W, Pedersen SN, Cox R and Francesconi KA (2001). Appl. 
Organomet. Chem., 15, 481-489. 
[Klumpp and Peterson, 1981] 
Klumpp DW and Peterson PJ (1981). Mar. Biol. (Berlin), 62, 297-305. 
[Le et al., 1993] 
Le XC, Cullen WR and Reimer KJ (1993). Talanta, 40, 185-193. 
[Le et al., 1994] 
Le XC, Cullen WR and Reimer KJ (1994). Clin. Chem., 40, 617-624. 
[Lunde, 1972] 
Lunde G (1972). Fiskeridir. Skr., Ser. Teknol. Unders., 5, 1-16. 
[Lunde, 1973] 
Lunde G (1973). Acta Chem. Scand., 27, 1586-1594. 
[Ma and Le, 1998] 
Ma M and Le XC (1998). Clin. Chem., 44, 539-550. 
[Mandal and Suzuki, 2002] 
Mandal BK and Suzuki KT (2002). Talanta, 58, 201-235. 
[Marafante and Vahter, 1984] 
Marafante E and Vahter M (1984). Chem. Biol. Interact., 50, 49-57. 
[Morita and Shibata, 1987] 
Morita M and Shibata Y (1987). Anal. Sci. , 3, 575-577. 
[Morita and Shibata, 1988] 
Morita M and Shibata Y (1988). Chemosphere, 17, 1147-1152. 
[Morton and Dunnette, 1994] 
Morton WE and Dunnette DA (1994). In Arsenic in the Environment, part II: Human 
Health and Ecosystem Effects (ed. Nriagu JO), John Wiley, New York, pp 17-34. 
[Norin and Christakopoulos, 1982] 
Norin H and Christakopoulos A (1982). Chemosphere, 11, 287-298. 
[Nriagu, 2002] 
Nriagu JO (2002). In Environmental Chemistry of Arsenic  (ed. Frankenberger WT 
Jr.), Marcel Dekker, New York, pp 1-26. 
[Sakurai et al., 1997] 
Sakurai T, Kaise T, Ochi T, Saitoh T and Matsubaru C (1997). Toxicology, 122, 205-
212. 
 
Chapter 3. Arsenic: chemistry and biology 
______________________________________________________________________________________________________ 
 56
[Sakurai, 2002] 
Sakurai T (2002). Appl. Organomet. Chem., 15, 401-405. 
[Shiomi et al., 1987] 
Shiomi K, Kakehashi Y, Yamanaka H and Kikuchi T (1987). Appl. Organomet. 
Chem., 1, 177-183. 
[Vahter et al., 1982] 
Vahter M, Marafante E, Lindgren A and Dencker L (1982). Arch. Toxicol. , 51, 65-77. 
[Versieck and Vanballenberghe, 1985] 
Versieck J and Vanballenberghe (1985). In Trace elements in Man and Animals, 
Volume 5 (ed. Mills CF, Bremner I and Chesters JK), Farnham, Commonwealth 
Agricultural Bureau UK, pp 650-655. 
[Yamauchi et al., 1992] 
Yamauchi H, Takahashi K, Mashiko M, Saitoh J and Yamamura Y (1992). Appl. 
Organomet. Chem., 6, 383-388. 
 
 
Chapter 4. Analytical techniques 
______________________________________________________________________________________________________ 
 57
Chapter 4. Analytical techniques 
 
 
 
 
4.1. Production and measurement of radiotracers 
 
4.1.1. Choice and production of a suitable radiotracer for indium 
 
Although a radioisotope exists for almost every element in the periodic table, only a few are 
suitable for in vitro and in vivo studies. Firstly, the half -life (t½) of the isotope must be 
adequate for the duration of the experiment. Half -lives of the order of days are preferable. 
The second prerequisite is that the radiation should be measurable under the experimental 
conditions. Gamma-emitters are the most suitable because the self -absorption of the 
radiation is negligible and the samples are easy to prepare. Any liquid or solid form is 
convenient for measurement with a scintillation or semiconductor detector. The use of 
carrier-free radioisotopes is very important. Preferably no stable indium isotopes are added 
as toxic levels can easily be reached. Low-level exposure is more representative for in vivo 
studies [Cornelis, 1992]. In the case of indium, four isotopes have the potential for being 
used in further research [Firestone, 1996]. They are shown in table 4.1. 
 
Table 4.1. Characteristics of indium radioisotopes. 
 
    
isotope t½ main g-rays [keV] & decay probability production 
    
    
    
111In 2.80 d 245.4 (94.5%), 171.3 (90.7%) 111Cd(p,n)111In 
113mIn 1.658 h 391.7 (100.0%) 112Sn(n,g)113Sn and e to 113mIn 
114mIn 49.51 d 190.3 (15.4%), 558.4 (4.4%), 725.2 (4.4%) 113In(n,g)114mIn; 114Cd(p,n)114mIn 
116mIn 54.2 min 1293.6 (84.4%), 1097.3 (56.2%) 115In(n,g)116mIn 
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Because of the long term in vivo experiments that were planned, 114mIn with a half-life of 
49.51 days was selected. 116mIn was used for the optimisation of the 114mIn tracer 
purification procedure. 
 
Using charged particle activation, the production of carrier free radioisotopes is guaranteed. 
In charged particle activation a nucleus is bombarded with charged particles, thereby 
inducing a nuclear reaction. Nuclear reactions with charged particles can vary from simple 
(p,n) reactions to complex (p, 3He2n) reactions, depending on the identity and energy of 
the charged particles and target nucleus [Vandecasteele, 1988]. 
 
The Q-value of a nuclear reaction A(a,b)B is the energy associated with each reaction 
event. When Q is positive, the reaction is exoergic and energy is released. When Q is 
negative, the reaction is endoergic and the charged particle must exceed a given energy, 
called the threshold energy ET. This threshold energy is the minimum energy needed by a 
projectile to make the reaction energetically possible. When a positively charged particle 
approaches a nucleus, it is repelled by the electrostatic field. At a ‘short’ distance (i.e., the 
sum of the radius of projectile and target nucleus) the strong attractive nuclear forces are 
more important. At a certain distance both effects will compensate. The loss in kinetic 
energy caused by this barrier is called the Coulomb energy. If a nuclear reaction is  
energetically possible, it can take place only if the energy of the incident particle exceeds 
the Coulomb energy. The loss in kinetic energy necessary to overcome the Coulomb barrier 
is released again after the nuclear reaction took place. 
 
The probability of a nuclear reaction is expressed by means of the cross section s(E), which 
has the dimensions of a surface. The barn (10-24 cm2) is often used. The cross section is 
dependent on the energy of the incident particle; their relation is given in an excitation 
function. s(E) changes with depth in the sample, as the energy of the projectile changes 
with depth. The total cross section is the sum of the cross sections of several reactions: 
(p,n), (p,2n), (p,pn)… The cross section is zero for an energy lower than the threshold 
energy, very low for an energy lower than the Coulomb barrier, increases with increasing 
particle energy because the probability for penetration of the Coulomb barrier increases. At 
increasing energy, the excitation energy is sufficient to allow the emission of 2 neutrons 
and competition between the (p,n) and (p,2n) occurs, resulting in a decreasing cross 
section for the (p,n) reaction. The excitation function therefore shows a maximum. The 
total amount of activity induced by the nuclear reaction is called thick target yield. 
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On their path through matter, charged particles lose energy mainly by interaction with 
electrons. This eventually leads to excitation or ionisation of atoms and molecules or to 
dissociation of molecules. Charged particles have a range: when a mono-energetic beam of 
charged particles loses energy on its path through matter, the number of particles in the 
beam does not change, and eventually all the particles are stopped after roughly the same 
path length. The range R is the mean path length for a large number of particles. Because 
of the large mass of the projectile relative to the electron mass, the fractional loss per 
collision is small. The stopping power S(E) of a material for a particle with energy E is a 
measure of the ability of materials to absorb all the energy of the projectile. The stopping 
power is inversely proportional to the particle energy. 
 
4.1.2. Neutron activation analysis 
 
[Ehmann and Vance, 1991] 
 
Neutron activation analysis (NAA) is a radiometric method for the determination of trace 
amounts of elements. By irradiation of stable nuclei with thermal neutrons, i.e., neutrons 
having an energy of ± 0.0025 eV, (n,g) reactions are induced, giving rise to an excited 
intermediate, also called compound nucleus. This nucleus emits prompt gamma rays. The 
neutrons are provided by a nuclear reactor. Further decay by a, b and/or g-rays of the 
induced radioisotope offers a suitable means of radiometric detection. 
 
The rate at which radioactive nuclei are formed by neutron bombardment is given by: 
 
*
*
×-××= NN
dt
dN lfs  
 
with N* the number of radioactive nuclei, N the number of stable nuclei, s the absorption 
cross-section for thermal neutrons [barn = 10-24cm2], f the neutron flux [neutrons.cm-2.s-1] 
and l the decay constant (0.693 / t½) [s-1]. The total amount of activity produced within 
the irradiation time ti is therefore: 
 
( )i
i
t
t e1NNA
×-* -×××=×= lfsl  
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The term between brackets is called the saturation factor S. S becomes 1 when the 
irradiation time ti®¥. The activity at a waiting period tw after irradiation is described by: 
 
( ) wiw
iw
ttt
tt ee1NeAA
×-×-×- ×-×××=×= lll fs  
 
Accurate quantification can be done by relative calibration. The relation between N and m 
can be described as follows: 
A
M
N
AN
m
×
×=
q
 
 
with m the mass [g], AM the atom mass [g.mol-1], NA  the Avogadro constant [mol-1] and q 
the isotopic abundance (100% = 1). When a standard (s) and a sample (x) are irradiated 
and measured simultaneously, the equation 
 
sxsx AAmm =  
 
holds true. Ax and As are the activity of the radioisotope in sample and standard at the start 
of the measurement [Bq] and mx and ms the mass of sample and standard [g]. To 
eliminate errors due to a different geometrical position of standards and samples, so called 
flux monitors, i.e., discs of Fe, Al or Au are also irradiated. Relative changes in the induced 
activity during irradiation in the different discs is a measure of the change in neutron flux 
and thus for the fluctuations in induced activity of the radioisotope in the different samples 
and standards (differences among samples in space or time). Most detectors measure only 
a part of the absolute activity. The detection efficiency is the ratio of the measured activity 
[counts per seconds] and the absolute activity [Bq]. The measured activity A will not be 
recorded, but rather an amount of counts C is registered during a measuring time tm: 
 
dtAC
mt
0
×= ò  
 
The measured activity Atw at the beginning of the measurement can thus be calculated as: 
 
( )mw tt e1
C
A
×--
×=
l
l  
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From the above mentioned equations it can be stated that: 
 
( ) ( )
( ) ( ) xttts
s
ttt
x
sx
xmxwxi
smswsi
e1ee1C
e1ee1C
mm
f
f
lll
lll
×-××-×
×-××-×
×=
×-×-×-
×-×-×-
 
 
with fs/fx the neutron flux ratio for standard to sample, that can be gauged form the 
measurement of the induced radioactivity in de flux monitors. 
 
4.1.3. Gamma-ray spectrometry 
 
[Ehmann and Vance, 1991] 
 
The activity can be measured with different instruments depending on the type of 
irradiation emitted. Gamma-ray detection depends on the transfer of the g-ray energy to 
electrons within the detector material. Depending on the energy loss, the interaction is 
attributed to photoelectric absorption (PE), Compton scattering (CS) or pair production 
(PP). Depending on the size and geometry of the detector, a characteristic spectrum can be 
obtained for each radioactive nuclide. The bigger the detector the more efficient is the 
interaction of the gamma rays and the more gamma ray energy is recovered within the full 
energy peak. For a small detector the contribution of Compton scattering is more 
outspoken and single and double escape peaks (in case of pair production) can be seen. 
Both a NaI(Tl) scintillation detector and a Ge(Li) semiconductor detector were used. 
 
Scintillation detectors are based on the emission of light induced by incoming radiation. The 
incoming radiation interacts with the scintillation material by PE, CS and PP, producing 
ionisation and excitation. The excited electrons undergo de-excitation by emission of light 
photons. This light is directed towards a photomultiplier tube (PMT), which converts the 
light into an electrical signal.  The scintillation material should be optically transparent at the 
wavelength of light generated and light emission should be fast. The most widely used 
gamma-ray detectors are alkali halide crystal such as NaI. These crystals have a structure 
of valence and conduction bands. Absorption of energy from incident radiation can excite 
an electron from the valence band into the conduction band. As the excited electrons 
return to their ground state, they emit photons. In a pure NaI crystal the energy gap 
between valence and conduction band is very large, so that electron transitions are not 
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highly probable. If electron transitions do occur, the emitted photons have an energy that 
is too high for efficient amplification in a PMT. By doping the crystal with an impurity (e.g., 
Tl) new energy levels are created within the band gap. Electron transitions to these new 
levels do not require as much energy, so that they are more likely to occur and the emitted 
light will be primarily in the UV or visible region where the PMT has a higher efficiency. 
 
Semiconductor detectors are usually made of Ge or Si. A similar band structure as in a NaI 
crystal exists here too. However, the band gap is much smaller so that the passage of 
radiation may inject enough energy to raise an electron from the valence band to the 
conduction band, creating an electron-hole pair. Under normal circumstances the excited 
electrons in the conduction band might be expected to eventually de-excite and return to 
the valence band. In the presence of an applied electric field they will instead migrate and 
can produce an electric signal. The number of electron-hole pairs is directly proportional to 
the gamma-ray energy absorbed. Impurities in the crystal such as B or Ga produce p-type 
or acceptor-type Ge. As and P will cause an n-type or donor-type semiconductor. When a 
p-type and n-type semiconductor are brought into contact, forming a p-n junction, the 
semiconductor can be used as a radiation detector. In the immediate vicinity of the p-n 
junction electrons will migrate toward the p-zone and holes toward the n-zone. This will 
create an area where there are neither excess holes nor excess electrons. This depletion 
region resists the passage of electric current. When a reverse bias is applied to the p-n 
junction, the depletion region is increased because of the movement of electrons and holes 
away from the junction in the n-type and p-type semiconductor, respectively. In practice all 
Ge and Si detectors turn out to be p-type. When the purity of Ge is questioned, it is often 
doped with lithium. The lithium atoms act as n-type and cancel the p-type acceptor 
impurities, which are found in excess in Ge. A compensated region is formed which acts 
identical to a depletion region. Because of the high mobility of Li in the crystal, the detector 
must be cooled at all times. Nowadays Ge(Li) detectors are largely replaced by intrinsic Ge 
detectors. These Ge detectors without Li are sufficiently pure to approach the properties of 
the theoretical true intrinsic semiconductor material. Intrinsic Ge detectors are similar to 
Ge(Li) detectors in their efficiency and resolution characteristics, but are in some case even 
better. Another advantage is that no cooling is required when they are not in use. The 
intrinsic Ge detector has not been used throughout this work. 
 
The biggest disadvantage of NaI(Tl) crystals is their poor energy resolution in comparison 
to Ge(Li) detectors (NaI(Tl): 6% for the 662 keV g-ray of 137Cs, Ge(Li): 0.1% for the 1332 
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keV g-ray of 60Co). On the other hand scintillation detectors offer a superior detection 
efficiency. When a mixture of different isotopes (e.g., after NAA) is measured or in case of 
a high dose rate, a Ge(Li) detector was used. In the case of in vitro and in vivo incubation 
experiments with pure tracer, detection was mostly realised with a NaI(Tl) detector. 
 
4.2. Liquid chromatography 
 
4.2.1. Principle 
 
[Meyer, 1998] 
 
Liquid chromatography involves a sample being dissolved in a liquid mobile phase. The 
mobile phase is then forced through an immobile, immiscible stationary phase. The phases 
are chosen such that components of the sample have different selectivity for each phase. A 
component, which shows a higher affinity for the stationary phase, will take longer to travel 
through it than a component that does not. As a result of these differences in mobility, 
sample components will become separated from each other as they travel through the 
stationary phase. The sample is transported through the column by continuous addition of 
mobile phase. 
 
The distribution of analytes between phases can often be described quite simply. An 
analyte is in equilibrium between the two phases. An equilibrium constant KD termed the 
distribution coefficient, is defined as the molar concentration of analyte in the stationary 
phase divided by the molar concentration of the analyte in the mobile phase. Phase 
preference can also be expressed by the retention factor k. 
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with cS and nS the molar concentration and number of moles of an analyte in the stationary 
phase, respectively, VS the volume of the stationary phase, cM and nM the molar 
concentration and number of moles of an analyte in the mobile phase, respectively, and VM 
the volume of the mobile phase. 
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The time between sample injection and an analyte peak reaching a detector at the end of 
the column is called the retention time (tR ). Each analyte in a sample will have a different 
retention time. The linear velocity of the mobile phase uM flowing through a column of 
length L can be calculated as 
M
M t
L
u =  
 
with tM the time taken for the mobile phase or a non-retained compound to pass through 
the column. The retention time is function of mobile phase flow velocity and column length. 
If the mobile phase is moving slowly or if the column is long, then tM and tR are both large. 
Therefore retention time is not suitable for characterising a compound. Instead the 
retention factor k is preferred, which is also defined as 
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k is independent of the column length and mobile phase flow rate and represents the molar 
ratio of the compound in the stationary and the mobile phase, as mentioned earlier. Two 
components A and B in a mixture cannot be separated unless they have different k values, 
the means of assessment being provided by the selectivity factor, a. a is the ratio of the k 
values of two compounds. 
 
To obtain optimal separations, sharp, narrow, symmetrical chromatographic peaks must be 
obtained. This means that band broadening must be limited. Band broadening is defined by 
the column efficiency. A theoretical model is therefore proposed. The plate model supposes 
that the chromatographic column contains a large number of separate layers (theoretical 
plates). Separate equilibrations of the sample between the stationary and mobile phase 
occur in these plates. The analyte moves down the column by transfer of equilibrated 
mobile phase from one plate to the next. The efficiency of a certain column can then be 
described by either the number of theoretical plates N in a column, or by stating the plate 
height or the Height Equivalent to a Theoretical Plate (HETP). 
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with L the length of the column. Because of the Gaussian character of a chromatographic 
peak, it is possible to express the column efficiency in terms of the variance s2 per unit of 
column length. The variance is the sum of all peak-broadening factors, originating from the 
column and extra column contributions. The number of theoretical plates that a real column 
possesses can be found experimentally by examining a chromatographic peak after elution: 
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where w1/2 is the peak width at half-height (see figure 4.1). A non-gaussian peak can show 
tailing or fronting. The tailing factor is defined as the ratio of b to a in figure 4.1. Fronting 
is the opposite. The factors a and b are measured at 10% of the peak height. 
 
 
 
Figure 4.1. Characteristic features of a chromatographic peak. 
 
There are many reasons for band broadening during a chromatographic elution. Different 
processes contribute to the overall column variance s2. 
 
A-term. The mobile phase moves through the column that is packed with stationary phase. 
Solute molecules will take different paths through the stationary phase at random. This will 
cause broadening of the solute band, because different paths are of different lengths. The 
mobile phase passes in a laminar flow between the stationary phase particles. The flow is 
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faster in the centre than it is near a particle. This leads to band broadening as well. Packing 
the column with evenly sized particles may reduce Eddy diffusion and flow distribution. The 
broadening due to Eddy diffusion and flow distribution is little affected, if at all, by the 
mobile phase flow velocity. 
 
B-term. Sample molecules spread out in the solvent without any external influence. This 
longitudinal diffusion has a disadvantageous effect on column efficiency. If the velocity of 
the mobile phase is high then the analyte spends less time on the column, which decreases 
the effects of longitudinal diffusion. 
 
C-term. The analyte takes a certain amount of time to equilibrate between the stationary 
and mobile phase. If the velocity of the mobile phase is high, and the analyte has a strong 
affinity for the stationary phase, then the analyte in the mobile phase will move ahead of 
the analyte in the stationary phase. Slow interactions at the surface will hold back the 
molecules more than expected from the distribution constant. Non-uniform stationary 
phase particles cause the analytes to traverse different distances before they reach the 
contact surface. The deeper the pores of the particles (size exclusion chromatography), or 
the thickness of the stationary phase (ion exchange, reversed phase) the longer the 
migration time and the greater the spreading will be. The higher the velocity of the mobile 
phase, the worse the broadening becomes. 
 
The contribution of these factors leads to the overall column variance. This column 
efficiency is described by the Van Deemter equation: 
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with l and w packing factors, dp the particle size, DM and DS the diffusion coefficient of the 
analyte in the mobile and stationary phase respectively and df is the diffusion distance in 
the stationary phase. A plot of plate height versus linear velocity of mobile phase, which is 
called a Van Deemter plot, is of considerable use in determining the optimum mobile phase 
flow rate. 
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A measure of how well species have been separated is provided by measurement of the 
resolution. The resolution of two species, A and B, is defined as 
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Baseline resolution is achieved when R = 1.5 It is useful to relate the resolution to the 
number of plates in the column, the selectivity factor and the retention factors of the two 
solutes 
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with k  the average retention factor of compounds A and B. 
 
To obtain high resolution, the three terms must be maximised. An increase in N by 
lengthening the column leads to an increase in retention time and increased band 
broadening - which may not be desirable. Instead, to increase the number of plates, the 
HETP can be reduced by reducing the size of the stationary phase particles. It is often 
found that by controlling the capacity factor, separations can be greatly improved. This can 
be achieved by changing the composition of the mobile phase. Gradient elution is an 
efficient way of doing so. The selectivity factor a can also be manipulated to improve 
separations. When a is close to unity, optimising k and increasing N is not sufficient to give 
good separation in a reasonable time. In these cases, k and a are increased by changing 
mobile or stationary phase composition or the column temperature. 
 
4.2.2. Chromatography in practice 
 
[Amersham Pharmacia, 1987; 1998; 1999; 2001] 
 
Different kinds of chromatographic separation modes have been used throughout this 
work. Size exclusion chromatography (SEC) was applied for the separation of indium bound 
to proteins and low molecular mass compounds in serum, packed cell lysate, urine and the 
cytosolic fraction of liver, kidney and spleen cells. Reverse phase chromatography (RPC) 
was utilised for the separation of creatinine in urine. Anion (AEC) and cation (CEC) 
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exchange chromatography were used extensively for the separation of indium compounds 
in serum and for the separation of arsenic species in marine sample extracts, serum, urine 
and other kinds of samples. Affinity chromatography (AC) has been used to study the 
binding of indium to albumin. AEC, CEC, RPC and AC are based on the adsorption of 
analytes on the stationary phase according to a chemical interaction. In SEC a simple 
molecule size classification process forms the basis of the separation. 
 
Reverse phase chromatography is the term used to describe the state in which the 
stationary phase is less polar than the mobile phase. Chemically bonded octadecylsilane 
(ODS), an n-alkane with 18 carbon atoms, is the most frequently used stationary phase. 
The less water-soluble the sample compounds are, the better they are retained by the 
stationary phase. Also the retention time increases as the number of carbon atoms 
increases. The mobile phase generally consists of mixtures of water or aqueous buffer 
solution with various water-miscible solvents such as methanol and acetonitrile . Separation 
in RPC is due to the different binding properties of the solutes present in the sample as a 
result of the differences in their hydrophobic properties. 
 
In ion exchange chromatography, the stationary phase has electric charges on its surface. 
Ionic groups such as HSO3-, COO-, NH3+, NR3+ are incorporated in the resin or gel of the 
stationary phase. These charges are neutralised by mobile counter ions. The ions in the 
mobile phase and ionic sample molecules compete for a place on the surface on the 
stationary phase. Strong anion and cation exchange refer to the fact that the functional 
group is charged over the whole pH range. Sulphonic and quaternary amine groups are 
strong cation and anion exchangers respectively. Carboxy and tertiary amine groups can be 
categorised as weak. Type, pH and concentration of the mobile phase determine the 
elution behaviour of analytes. 
 
Affinity chromatography is the most specific chromatographic method. The interaction is 
biochemical in nature, e.g., antigen « antibody, enzyme « inhibitor or hormone « 
carrier. The highly specific nature of these interactions is due to the fact that the two 
participating compounds are ideally suited to each other spatially and electrostatically. One 
component (ligand) is bound to a support and the other (sample) is adsorbed from 
solution, the process being reversible. 
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Size exclusion chromatography is based on the sieving effect of the stationary phase, which 
consists of inert porous particles of a well-defined size. The pores of the gel are comparable 
in size to the molecules that are to be separated. In theory the elution will be in the order 
of large to small molecular masses. Molecules larger than the largest pores are completely 
excluded from the stationary phase and will have a retention volume VR that is identical to 
the void volume V0 (i.e., the volume of the mobile phase outside the particles). Small 
molecules are delayed in their passage through the column compared with the large 
molecules. Molecules smaller than the smallest pores on the other hand are completely 
accessible for the stationary phase 
0SR VVV +=  
 
With VS the volume of the stationary phase particles. The diffusion of intermediary sized 
molecules can be described by the distribution coefficient KD 
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Residual charges on the particles can lead to ionic interactions with the analytes in solution 
and hence a non-ideal elution is obtained. As a consequence some molecules have a 
retention time, which is different from that obtained from the distribution coefficient. 
Because VS  is difficult to calculate, the equilibrium can be described by KSEC  
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with Vt the sum of the volume of stationary phase and stagnant mobile phase, i.e., the 
mobile phase within the pores of the particles. 
 
Depending on the type of samples analysed we can distinguish between High Performance 
Liquid Chromatography (HPLC) and Fast Protein Liquid Chromatography (FPLC). FPLC is a 
commercial name, which involves the separation of biological macromolecules such as 
proteins. Special stationary phases have been developed to allow the separation of these 
biomolecules with good resolution, recovery and selectivity. 
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Different HPLC systems were used throughout this work. In combination with ICP-MS an 
Alltech Model 526 (Alltech, Deerfield, USA) metal free isocratic HPLC pump fitted with a 6-
port valve and injection loop (Rheodyne, Cotata, USA) was used. For ES-MS/MS and/or UV-
HG-AFS measurements an Alliance 2690 HPLC system (Waters, Milford, USA) with 
quaternary pump, built-in on-line vacuum degassing unit, cooled autosampler and 
thermostated column compartment was used. For FPLC separations an Äkta Purifier 10 
(Amersham Biosciences, Uppsala, Sweden) integrated system with binary pump, pH and 
conductivity monitor, variable wavelength UV monitor and fraction collector was used. This 
unit was also used for the preparative HPLC separations of the urine samples (see chapter 
8). Urinary creatinine was determined by reversed phase HPLC with UV detection on a 
Waters 600 pump and a Waters 486 UV detector (Waters, Milford, USA). 
 
4.3. Mass spectrometry 
 
Mass spectrometry is an instrumental approach that allows the mass measurement of 
atoms and molecules. The basic parts of any mass spectrometer are a sample introduction 
device, an ionisation source, a mass analyser, a vacuum system and an ion detector. A 
mass spectrometer determines the atomic or molecular mass by ionising, separating, and 
measuring atomic or molecular ions according to their mass-to-charge ratio (m/z). Positive 
ions are generated in the ionisation source by inducing either a loss of an electron, or 
addition of a proton or an ionic adduct. Negative ions can be generated by loss of a proton. 
Once the ions are formed in the gas phase they can be electrostatically directed into a 
mass analyser, separated according to m/z and finally detected. Two techniques with a 
different ionisation source that allow detection of either atoms or molecules have been 
used: inductively coupled plasma for elemental analysis and electrospray for molecular 
analysis. 
4.3.1. Electrospray mass spectrometry 
 
[Blades et al. , 1991; Kebarle and Tang, 1993; Kebarle and Ho, 1997; Kebarle and Peschke, 
2000; Gaskell, 1997; Watson, 1997] 
 
Electrospray mass spectrometry (ES-MS) provides molecular and structural information 
about an analyte. By applying a strong electrical charge to the eluent as it emerges from a 
nebuliser, an aerosol of charged droplets is produced. Solvent evaporation reduces the size 
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of the droplets until a sufficient charge density makes the ejection of sample ions from the 
surface of the droplets possible. Characteristically, ions are singly or multiply charged and 
the mass analyser sorts them by mass-to-charge (m/z) ratio. ES-MS allows rapid, accurate 
and sensitive analysis of a wide range of analytes from low molecular mass (less than 200 
Da) polar compounds to biopolymers larger than 100 kDa. Generally, compounds less than 
1 kDa produce singly charged positive or negative ions. High mass biopolymers, for 
example peptides, proteins and oligonucleotides, produce a series of multiply charged ions. 
The acquired data can be transformed by the data system to give a molecular mass profile 
of the biopolymer. 
 
 
Figure 4.2. Schematic representation of the major processes occurring in the source. 
 
Liquid containing the analyte of interest is pumped through a metal capillary, which is 
surrounded by a nitrogen flow. The tip of this capillary is connected to a voltage supply 
(around 3 kV). The end of the tip faces a counter-electrode plate held at 0 V. The electric 
field, when turned on, will penetrate the solution at the capillary tip and the positive and 
negative electrolyte ions in the solution will move under the influence of the field until a 
charge distribution results which counteracts the imposed field and leads to essentially field 
free conditions inside the solution. When the capillary is the positive electrode (in positive 
ion mode), positive ions will have drifted downfield in the solution, i.e., towards the 
meniscus of the liquid. Negative ions will have drifted away from the surface. The repulsion 
between the positive ions on the surface overcomes the surface tension of the liquid and 
the surface begins to expand allowing the positive charges and liquid to move downfield. A 
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cone forms, the Taylor cone, and if the applied field is sufficiently high, a fine jet emerges 
from the cone tip which breaks up into small charged droplets (figure 4.2). 
 
The droplets are positively charged due to the excess of positive electrolyte ions on the 
surface of the liquid cone and the cone jet. The charged droplets drift downfield through 
the air towards the counter electrode. Solvent evaporation at constant charge leads to 
droplet shrinkage and an increase in the electric field normal to the surface of the droplets. 
This solvent evaporation is controlled by a gas flow, by heating or a combination of both. 
At some given radius R and charge q, the force due to the repulsion of the surface charges 
becomes equal to the surface tension force of the liquid. This condition is expressed by 
Rayleigh’s stability limit qRy: 
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where e0 is the permitivity of vacuum and g is the surface tension of the solvent. Further 
evaporation leading to a decrease in the radius below the Rayleigh value results in droplet 
fission. A schematic representation of the development of the droplet fission and 
evaporation is shown in figure 4.3. 
 
A sequence of repeated droplet fission and evaporation leads ultimately to gas phase ions. 
Two alternative models have been described: the Charged Residue Model (CRM) and the 
Ion Evaporation Model (IEM). Both theories assume that gas phase ions are formed only 
from very small droplets. The CRM proposes that gas phase ions result from the 
evaporation of solvent from very small droplets, which contain only one analyte molecule 
and one ion. Such droplets are assumed to have been formed by a succession of Rayleigh 
desintegrations. The type of droplets needed, can be found in the second generation of 
offspring droplets, leading to sizes with R < 3 nm (see bottom right in figure 4.3). The IEM 
theory assumes that gas phase ions solvated by several solvent molecules can be emitted 
into the gas phase from charged droplets which are much larger (R = 10 nm) and which 
carry some hundreds of charges. Such droplets can be found in the first offspring droplets. 
Ion evaporation from such droplets is predicted to be faster than the Rayleigh fission of the 
droplet. 
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Figure 4.3. Schematic representation of droplet fission and evaporation. N is the number 
of elementary charges on the droplet, R is the radius (mm). 
 
Most of the ions produced by electrospray tend to be very similar to those formed by 
straightforward chemical ionisation with a lot of protonated ([M+H]+) or cationated 
([M+Na]+, [M+NH4]+) positive ions, or negative ions lacking a hydrogen ([M-H]-). Briefly, 
chemical ionisation works by collision between sample molecules and specially produced 
reagent gas ions such that ions are formed from sample molecules by various processes, 
one of the most important of which is the transfer of a proton. 
 
It is assumed that the charging of the unipolar droplet spray is due to electrophoretic 
charging, i.e., the separation of positive from negative electrolyte ions present in the 
solution. Thus at a steady operation of the ES, positive droplet emission will continuously 
carry off positive ions (in positive ion mode). The requirement for charge balance in such a 
continuous-electric-current device, together with the fact that only electrons can flow 
through the metal wire supplying the electric potential to the electrodes, leads to the 
supposition that the ES process must include an electrochemical conversion of ions to 
electrons. In this sense the electrospray source can be regarded as a special type of 
electrolytic cell. It is special because the ion transport does not solely occur through an 
uninterrupted solution, but also through the gas phase, where unipolar charged droplets 
and gas-phase ions are the charge carriers. A conventional electrochemical oxidation 
reaction should be occurring at the positive electrode, which either converts atoms from 
the capillary metal M to positive ions in solution (1) or which removes negative ions present 
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in the solution (2, 3). The net effect of the oxidation reaction at the capillary tip is the 
creation of an excess of positive ions over negative ions in the solution. In this regard, 
reaction 4 could also be a process producing positive ions. All reactions result in the 
formation of electrons that will be used for the reduction reactions at the counter electrode. 
 
M (s) ® Mn+ (aq) + ne-   E°red = -0.76 (Zn2+/Zn) (1) 
4OH- (aq) ® O2 (g) +2H2O + 4e- E°red = 0.40   (2) 
2Cl- (aq) ® Cl2 (g) +2e-   E°red = 1.36   (3) 
2H2O ® O2 (g) +4H+ (aq)+ 4e-  E°red = 0.68   (4) 
 
When a Zn or stainless steel capillary tip was used, release of Zn2+ and Fe2+, respectively to 
the solution could be detected. Furthermore, the amount of Zn2+ and Fe2+ released to the 
solution per unit time when converted to coulombs per second was found to be equal to 
the measured electrospray current. 
 
The ES interface consists of a Z-spray source fitted with an electrospray probe [Micromass 
1; Micromass 2]. Mobile phase from an HPLC column or infusion pump enters through the 
probe and is pneumatically converted to an electrostatically charged aerosol spray. At very 
low flow rate (a few mL/min), the difference in potential is sufficient to create the spray. At 
higher flow rate, a nebuliser gas (nitrogen) is necessary to maintain a stable spray. Efficient 
solvent evaporation is provided by a heated nitrogen flow close to the probe (desolvation 
gas) and by the cone (cone gas). The source block is also heated, for final desolvation. The 
resulting analyte and solvent ions are drawn through the sample cone aperture into the ion 
block, from where they are then extracted into the analyser. A schematic representation is 
shown in figure 4.4. In the first stage the Z-spray source the spray is directed 
perpendicularly past the sampling cone, which is displaced from the central axis of the 
instrument. Ions are extracted orthogonally from the spray into the sampling cone aperture 
leaving large droplets, involatile materials, particulates and other unwanted components 
behind. The second orthogonal step enables the volume of gas (and ions) sampled from 
the atmosphere to be increased. Gas at atmospheric pressure sampled through an aperture 
into a partial vacuum forms a freely expanding jet, which represents a region of high 
pressure compared to the surrounding vacuum. If this jet is directed on-axis into the 
second aperture of the interface it increases the flow of gas through the second aperture. 
Maintaining a suitable vacuum in the MS analyser therefore places a restriction on the 
maximum diameter of the aperture. However, if the jet passes orthogonal to the second 
Chapter 4. Analytical techniques 
______________________________________________________________________________________________________ 
 75
aperture the flow into it is significantly decreased. Consequently in the Z-spray interface 
the diameter of the sampling cone aperture may be increased to allow more gas (and ions) 
to be sampled from the atmospheric spray without degrading the analyser vacuum or 
increasing the pumping speed of the system. Ions in the partial vacuum of the ion block 
are extracted electrostatically into the hexapole ion bridge, which efficiently transports ions 
to the analyser. Additionally background or ‘neutral’ noise is significantly reduced by 
orthogonal sampling. 
 
 
 
 
Figure 4.4. Schematic representation of electrospray probe and ion source block. 
 
A 50:50 mixture of acetonitrile or methanol and water is a suitable mobile phase for the 
syringe pump system. This is appropriate for positive and negative ion operation. Positive 
ion operation may be enhanced by 0.1 to 1% formic acid in the sample solution. Negative 
ion operation may be enhanced by 0.1 to 1% ammonia in the sample solution. Although 
the electrospray can accommodate flow rates up to 1 mL/min, it is recommended that the 
flow is split post-column to approximately 200 mL/min. Also even at lower flow rates, a split 
may be required for saving valuable samples. The post-column split consists of a zero 
dead-volume tee piece. The mass spectrometer in itself is a mass-flow sensitive detector, 
which means that the response is directly proportional to the mass-flow (change of mass 
per unit of time). However, when an electrospray source is coupled to the MS, it often 
behaves more like a concentration sensitive detection technique due to the opposing 
effects of increased mass-flow and reduced droplet charging at higher flow rates. Once the 
ions have been produced, they need to be separated according to the masses to be 
determined. For this purpose electrospray can be coupled to a wide range of mass 
analysers including quadrupole, time-of-flight, quadrupole ion-trap, Fourier transform ion 
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cyclotron resonance and magnetic -sector or a combination of the above mentioned 
instruments. The instrument used throughout this study consists of a triple quadrupole 
mass spectrometer (figure 4.5). 
 
 
 
Figure 4.5. Schematic representation of a triple quadrupole mass spectrometer. 
 
The triple quadrupole mass spectrometer is a tandem arrangement, in which the first (Q1) 
and third (Q2) quadrupoles are mass selective, whereas the second quadrupole (q) 
operating in RF-only mode serves as an ion guide in a collision cell. The collision cell, which 
in fact is a hexapole, is a small chamber mounted in the ion path of the mass spectrometer. 
It has two small openings, one to let the precursor ion i.e., any ion selected for analysis by 
collision activated dissociation (CAD) in and the second to let the product ions out. The 
chamber can be pressurised with a collision gas that collides with the precursor ions, 
thereby activating their decomposition or fragmentation into product ions. Triple 
quadrupole mass spectrometry allows the use of several single MS and MS/MS scan and 
static analysing modes. In the full scan mode, in which Q1 is used as the mass filter, the 
instrument detects signals over a mass range during a short period of time. In single ion 
recording mode (SIR), the first quadrupole is set to only monitor a few known m/z ratios. 
As a result the quadrupole is able to spend more time sampling each of the m/z values, 
with a concomitant and large increase in sensitivity. The product ion scan is the most used 
MS/MS scan mode. Precursor ions are selected in Q1 for CAD in the collision cell. The 
resulting fragments can be scanned using Q2. It is used for structural elucidation and for 
method development studies. Precursor ion scanning is the reverse of product ion 
scanning. Q1 scans the precursor ions of the CAD products ions that are selected by Q2. 
Precursor ion scanning provides complementary or confirmatory information for production 
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ion scan data. Neutral loss scanning is interesting when the mass of a certain CAD is known 
(e.g., in sugar analysis). The scans of Q1 and Q2 are synchronised, i.e., both quadrupoles 
scan at a certain m/z difference. Multiple reaction monitoring (MRM) is the MS/MS 
equivalent of SIR. Q1 and Q2 are fixed on a precursor and product ion respectively. As both 
quadrupoles are static, this allows a greater dwell time on the ions of interest and therefore 
a better sensitivity (~100x) compared to scanning MS/MS. Moreover as only one m/z ratio 
is allowed to pass each quadrupole, the noise is very low, resulting in a better signal to 
noise. An overview of all MS and MS/MS modes is given in table 4.2. A Quattro Micro triple 
quadrupole mass spectrometer (Micromass, Manchester, UK) with Z-spray dual orthogonal 
electrospray source and hexapole collision cell was used in this work. 
 
Table 4.2. Overview of MS and MS/MS modes. 
 
    
analysis mode Q1  q Q2  
    
   
full scanning scanning RF only (pass all masses) 
selected ion recording static RF only (pass all masses) 
    
    
product ion scanning 
static 
(precursor mass selection) 
scanning 
precursor ion scanning scanning 
static 
(product mass selection) 
multiple reaction monitoring 
static 
(precursor mass selection) 
static 
(product mass selection) 
constant neutral loss scanning 
scanning 
(synchronised with Q2) 
scanning 
(synchronised with Q1) 
  
RF 
only 
(pass 
all 
masses) 
 
 
4.3.2. Inductively coupled plasma mass spectrometry 
 
[Ebdon et al. , 1998a; Montaser et al. , 1998; Vandecasteele and Block, 1993a] 
 
Inductively coupled plasma mass spectrometry (ICP-MS) allows elemental analysis with 
excellent sensitivity and high sample throughput. The ICP-MS instrument employs a plasma 
as the ionisation source and a mass spectrometer analyser to detect the ions. It can 
measure most elements in the periodic table within the same run and determine analyte 
concentration down to the sub ng/L level.  
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Liquid supplied via a peristaltic pump (total analysis) or via a column effluent (speciation 
analysis) is introduced into a pneumatic nebuliser where it is converted into the sample 
aerosol. A spray chamber ensures that only the smallest droplets (diameter <10 mm) are 
introduced into the plasma. The plasma is formed in a stream of argon gas flowing through 
an assembly of three concentric quartz tubes, known as the plasma torch. The torch is 
encircled at the top by a water-cooled induction coil, connected to an RF generator. The 
magnetic field generated by the RF current through the coil induces a current in the argon 
gas stream. A plasma is formed almost instantaneously when the argon gas is seeded with 
electrons. These electrons are produced by a high voltage Tesla discharge. Once in the 
ICP, the aerosol droplets are desolvated, the molecules are atomised and the atoms thus 
formed are ionised by the high temperature of the plasma (6000-10000 K). If an electron 
acquires sufficient energy, equal to the first ionisation energy of the element, it escapes 
from the influence of the attraction of the atomic nucleus and an ion is formed. The major 
mechanism by which this ionisation occurs are electron impact (M + e- ® M+ + 2e-) and 
Penning ionisation (M + Ar* ® M+ + Ar + e-). The degree of ionisation of an element can 
be estimated from the Saha equation (for a system in thermal equilibrium): 
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where ni and ne are the number densities of the ions and free electrons, respectively, na is 
the number density of the atoms, Zi and Za are the ionic and atomic partition functions, 
respectively, m the electron mass, k the Boltzmann constant, T the temperature, h Planck’s 
constant and Ei is the first ionisation energy. The degree of ionisation is dependent on the 
electron number density, the temperature and the ionisation energy of the element in 
question. Taking the average electron number for an argon ICP to be 1015 cm-3 and the 
ionisation temperature to be 7500 K, then the degree of ionisation for arsenic is about 52% 
[Houk, 1986]. This is much lower than the >90% efficiency, which is obtained for most 
metals in the periodic table. The reason for the low ionisation efficiency is the high first 
ionisation energy of arsenic: 947 kJ/mol. However, addition of carbon in the plasma 
enhances the signal intensity for arsenic, because of an alternative chemical ionisation 
mechanism: 
CAs  As C * +®+ ++  
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It is suggested that the introduction of carbon-containing components into the central part 
of the plasma via the sample aerosol leads to a strongly increased population of C+ (1st Ei = 
1086 kJ/mol) and/or carbon-containing polyatomic ions. In order for the proposed reaction 
to take place, the first ionisation energy of carbon must be close to the energy of excited 
arsenic ions. The energy to generate excited As+ ions, which corresponds to an electron 
shift between the ground state of 4p2 3P and 4p2 1D, requires an energy of 1062 kJ/mol. 
This is very close to the 1st Ei of carbon [Abou-Shakra et al. , 1997]. Larsen and Stürup 
[1994] found that the combined use of a high RF power and the addition of 3% methanol 
to the analyte solution (total analysis) or the elution buffer (speciation analysis) gives rise 
to a more than two-fold increase of the arsenic signal intensity. 
Figure 4.6. Schematic representation of an ICP-MS instrument. 
 
Since the ICP operates at atmospheric pressure and since for its operation the mass 
spectrometer generally requires a vacuum better the 10-5 mbar, the ions must be extracted 
into a vacuum system. This is accomplished by making use of a series of differentially 
pumped vacuum chambers held at consecutively lower pressures. The ICP is aligned so 
that the central channel is on-axis with the tip of a water-cooled sampling cone, which has 
an orifice of approximately 1 mm in diameter. The pressure behind the sampling cone is 
about 1 mbar. As a result the plasma gases containing the analyte ions are extracted into 
the first chamber and expand. This supersonic expansion takes the form of a cone with a 
shock-wave structure at its base, called a Mach disc. The region within the expansion cone 
is called the ‘zone of silence’. The 0.7 mm orifice of a second cone (skimmer cone) is 
 
detector 
quadrupole filter skimmer cone 
ion lenses 
sampler 
cone 
torch 
ICP 
spray chamber 
nebuliser 
 
vacuum pumps 
data system 
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placed within this zone. The ions pass through the skimmer cone orifice into a second 
intermediate vacuum chamber held at <10-4 mbar. The analyte ions are then focused by a 
series of ion lenses into a quadrupole mass analyser, which separates the ions according to 
their m/z ratio. Finally, the ions are detected using an electron multiplier. A schematic 
overview of an ICP-MS instrument is shown in figure 4.6. The ICP-MS instruments used in 
this work were an Elan 5000 (Ghent) or an Elan 6000 (Beijing, China) from Perkin-Elmer 
Sciex (Concord, Canada). For both systems, the sample introduction system consists of a 
cross flow nebuliser and a Ryton Scott-type double-pass spray chamber. 
 
4.3.3. Quadrupole mass spectrometry 
 
[De Hoffmann et al. , 1996; Watson, 1997] 
 
In inductively coupled plasma mass spectrometry and electrospray mass spectrometry, the 
mass analyser consists of one and three quadrupoles, respectively. The quadrupole is a 
device, which uses the stability of the trajectories to separate ions according to their m/z 
ratio. It employs a combination of direct-current (DC) and radiofrequent (RF) fields as a 
mass filter. As illustrated in figure 4.7a, quadrupole analysers are made up of four rods 
with a hyperbolic cross section. Diagonally opposed rods are connected together electrically 
and to RF and DC voltage sources. They form electrode pairs exerting the same magnitude, 
but opposite potential. Ions entering the mass analyser and travelling along the z-axis are 
subjected to the influence of an electric field made up of the RF field superposed on the DC 
field. The potential F  at each point in the quadrupole filter at any time will be described by: 
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where U is the magnitude of the DC potential, Vcos(wt) represents a radiofrequent field of 
amplitude V and angular frequency w, x and y are the distances along both axes and r0 is 
the distance from the z-axis to either of the quadrupole rod surfaces. Along the central axis 
(x and y = 0) and when x = y (dashed lines in figure 4.7a), the potential is zero. Assume 
an ion has a zero velocity component along the y-axis: its trajectory will be in the x-z plane 
(positive U). Heavy ions with a high inertia will not substantially respond to the variation of 
the field: on average, they will sense the positive potential U and are focused on the 
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central axis. However, ions with lower mass, having a lower inertia, will oscillate with the 
change in voltage and as they gain amplitude will be discharged and thus lost on one of the 
electrodes. Thus the two positive electrodes constitute a high-mass filter. Consider now an 
ion that has a zero velocity component along the x-axis: it will remain in the y-z plane 
(negative U). Under these circumstances, heavy ions with a high inertia will eventually be 
attracted by the negative electrodes. Lighter ions that can rapidly react to the influence of 
the RF field will be transmitted. Thus the z-y plane constitutes a low-mass filter. In order 
for a certain ion to exhibit a stable path through the quadrupole filter, its trajectory should 
be stable in both planes. Only ions having an m/z above (x-z plane) and below (y-z plane) 
a critical mass will pass through the quadrupole. As a result, only ions within a small 
window will be transmitted. The width of the window is dependent on the ratio U/V, while 
the m/z ratio is given by the magnitude of both the DC and the RF voltage. An a and q 
term have been defined allowing to simplify the Mathieu equations, which give a 
quantitative description of the equation of motion for an ion within the quadrupole: 
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with z the valence of the ion, e the electronic charge and m the mass of the ion. In an au-
qu diagram, the stability areas can be represented. In these areas, the values of U and V 
are such that x and y do not reach values above or equal to r0. Figure 4.7b represents one 
of these stability areas. Although a whole series of stability regions exist, each 
corresponding to stable solutions to the Mathieu equations, only the regions near the origin 
in the au-qu diagram are chosen for the operation of the quadrupole mass filter in 
commercial instrumentation. A line representing the ratio a/q = 2U/V can be drawn on the 
stability diagram. This line represents the situation where the ratio of the amplitudes of the 
RF and DC components is held constant while their absolute values are increased. Such a 
line is known as a scan line. The line passes from the origin through a region of x stability 
and y instability before crossing into a region of both x and y stability. As a and q further 
increase, the scan line passes into a region of x instability and y stability before finally 
reaching an area where both x and y are unstable. If q lies in the range q1 to q2, ion 
trajectories exist that will allow particles to pass the full length of the mass filter. By 
scanning the values of U and V while holding their ratio constant, it is possible to bring ions 
of different masses successively into the stability region for transmission. This is illustrated 
in figure 4.7c. As long as the scan line keeps going through stability areas, the higher the 
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slope of the scan line (slope of scan line 2 is higher than of scan line 1), the better will be 
the resolution. 
 
Figure 4.7. Schematic representation of the cross section of a quadrupole (a), of a 
stability area for an ion with certain m/z (b) and of a scan of three ions with mass m1 , 
m2  and m3  (c). 
 
In RF-only mode (e.g., in the collision cell of the triple quadrupole mass spectrometer), 
there is no DC voltage; thus a equals zero. Therefore the operating line lies horizontally 
along the abscissa, indicating theoretically that ions of all m/z values have stable 
trajectories and are transmitted through the quadrupole. 
 
4.4. Hydride generation atomic fluorescence spectrometry 
 
[Ebdon et al. , 1998b; Howard, 1997; Vandecasteele and Block, 1993b] 
 
Atomic fluorescence spectrometry (AFS) uses radiation from a line source to excite atoms 
to a higher electronic state. The fluorescence emitted as the excited atoms return to the 
ground state is measured. The instrument used throughout this work utilises resonance 
fluorescence [Corns et al. , 1993; PS Analytical]. In this type, the fluorescence radiation is of 
the same wavelength as the absorbed radiation. For arsenic the fluorescence signal is 
obtained at the three resonance lines 189.04, 193.76, 197.26 nm. A set of lenses will 
collect and focus the useful radiation and a multi-reflectance filter is inserted to achieve 
wavelength isolation and reduce flame emissions. Illumination from the excitation source is 
at right angles to the detection axis to suppress detection of radiation from the excitation 
source. The intensity of AFS is proportional to the intensity of the absorbed radiation and to 
the concentration of the analyte atoms. Detection limits can thus be improved if an intense 
excitation source is used. A boosted discharge hollow cathode lamp (BDHCL), providing a 
more intense line spectrum compared to conventional hollow cathode lamps is therefore 
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used. A BDHCL uses a secondary discharge between the cathode and a high efficiency 
electron emitter, which passes through the atom cloud generated by the normal discharge. 
 
Arsenic, among other elements of groups 14, 15 and 16 of the periodic table, forms 
hydrides with nascent hydrogen. A suitable reagent for reduction and hydride formation is 
sodium borohydride (NaBH4). In the case of arsenic NaBH4 can be thought of as acting as 
both a reductant and as a hydride generation (HG) source. In its reaction with pentavalent 
arsenicals, the first step is a reduction of the arsenic to the +III state: 
 
RnAs(O)(OH)3-n + H+ + BH4- ® RnAs(OH)3-n + H2O + BH3 
 
where R is mostly a methyl group and n ranges from 0 to 3. Subsequent reaction with 
NaBH4 takes the arsenic compound through to the corresponding arsine. The borane 
generated by these reactions hydrolyses giving boric acid and hydrogen. 
 
RnAs(OH)3-n + (3-n)BH4- + (3-n)H+ ® RnAsH3-n + (3-n)BH3 + (3-n)H2O 
BH3 + 3H2O ® H3BO3 + 3H2 
 
Arsenite, arsenate, MA, DMA and TMAO can be converted into AsH3, AsH3, MeAsH2, Me2AsH 
and Me3As, respectively. For AsV , it was found that the reaction was much slower than for 
AsIII and that this species continued to be reduced in the reaction loop. This is explained by 
the fact that NaBH4 is not converted directly into H3BO3 but into an intermediate product 
that is still able to produce AsH3 from AsV . The difference between the trivalent and 
pentavalent oxidation states depends strongly on the system used and the experimental 
conditions. In batch systems and at pH <1 arsine is formed more slowly from AsV  than from 
AsIII, but the peak areas are more or less the same. In flow systems, the situation is 
significantly different. The slower reduction of the pentavalent oxidation state leads to 
greater differences in sensitivity due to kinetic discrimination. Pre-reduction of AsV  to AsIII, 
which is usually done in batch experiments using a solution of KI, KI + ascorbic acid or L-
cysteine, is not advised for flow injection systems. The low kinetics and high temperatures 
needed prevent the technique of being used routinely without the loss of sensitivity. It is 
therefore better to use a longer reaction coil. An advantage of HG-AFS is that the element 
can be separated from almost all other accompanying materials, avoiding a lot of 
interference. 
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Organic arsenicals such as TETRA, AB and AC are insensitive towards hydride formation. In 
order to overcome this drawback, the organic arsenicals can be mixed with an oxidising 
solution of potassium persulphate (K2S2O8) in combination with UV irradiation [Howard and 
Hunt, 1993; Rubio et al. , 1993 and 1995; Zhang et al. , 1996; van Elteren and Slejkovec, 
1997, Slejkovec et al. , 1997 and 1999; Gomez-Ariza et al. , 1998; Dagnac et al. , 1999; Sur 
et al. , 1999; He et al. , 2000; Tsalev et al. ,  1998 and 2000; Vilano and Rubio, 2001; 
Sanchez-Rodas et al. , 2002), microwave irradiation [Le et al. , 1993; Welz et al. , 1993; 
Lopez-Gonzalez et al. , 1995; Lamble and Hill, 1996; Sur et al. , 1999) or with heating [Suner 
et al. , 2001]. This process transforms the organoarsenicals into simpler arsenic forms. 
Attalah and Kalman [1991] have identified inorganic arsenic, MA, DMA and TETRA as 
photo-oxidation products of AB. In the ideal case, all organic arsenicals are transformed 
into arsenate. The persulphate ion is one of the strongest oxidising agents in aqueous 
solution [Golimowski and Golimowska, 1996]. The standard redox potential for the 
reduction of persulphate to sulphate equals 1.96 V. The first stage of the decomposition of 
S2O82- is the formation of radicals: 
·-- ® 4
2
82 SO2OS  
In the second stage the sulphate radicals react with water to form hydroxyl radicals: 
·-·- +®+ OHHSOOHSO 424  
The next stages of chain reaction of the S2O82- decomposition are: 
244
2
82 O21SOHSOOHOS ++®+
·--·-  
244 O21HSOOHSO +®+
-··-  
The hydroxyl radicals are capable of disrupting the arsenic-carbon bond. The best photo-
oxidation of AB is obtained in neutral or basic solutions [Attalah and Kalman, 1991]. Photo-
oxidation should occur on-line in order to do speciation analysis. The arsenicals in the 
mobile phase are mixed with a solution of S2O82- in NaOH and directed to a reaction coil 
wrapped around a low-pressure mercury lamp. If a suitable reaction time is respected, the 
organoarsenicals will be transformed completely into arsenate. To prevent band 
broadening, which is inevitable when a photo-oxidation pretreatment is involved, the 
mobile phase can first be segmented with a flow of ambient air [Zhang et al. , 1996]. The 
air bubbles prevent the mobile phase of diffusing and thus the peak broadening is kept 
minimal. After conversion into arsenate, the flow is first mixed with HCl and then with a 
solution of NaBH4 for production of the hydrides. This NaBH4 is dissolved in alkaline media 
for stability reasons. The hydrides and the excess hydrogen are swept out of the liquid in a 
gas-liquid separator (GLS) using a stream of argon. The gaseous flow passes a drying 
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cassette, consisting of a set of coaxial membranes [Branch et al. , 1991; Corns et al. , 1992]. 
As the wet gas passes through the inner membrane, the moisture is removed and 
transferred to the outer tube, where a dryer gas in counter flow removes the moisture. 
Finally the hydrides are sent to an argon-hydrogen diffusion flame for atomisation. 
Atomisation is probably realised via a free radical mechanism within the flame. The 
resulting atoms are detected by AFS. The configuration is shown in figure 4.8. Only very 
recently, Schmeisser et al.  [2004] have reported the hydride-forming capabilities of 
arsenosugars without prior decomposition. The HG efficiency depends on the type of GLS 
and is influenced by the concentration of NaBH4 and HCl. 
 
HG-AFS has also been used for the analysis of total arsenic in clinical samples. Prior to 
analysis with HG-AFS the samples need to be digested. Urine, serum, packed blood cells 
and blood were mineralised in open vessels with a mixture of HNO3/HClO4/H2SO4 in a ratio 
of 7:2:1 under the influence of a temperature-controlled programme [Zhang et al.  1995, 
Cornelis et al.  1998]. For total element analysis, the instrumental set-up is slightly different 
from that needed to carry out speciation analysis. In a flow injection mode, the sample is 
dissolved in HCl to which potassium iodide (1%) and ascorbic acid (0.2%) is added. This 
solution is then mixed with the hydride-forming reagent and sent immediately to the GLS. 
The remainder of the process is identical to the one described above. Potassium iodide and 
ascorbic acid is added to all blank solutions, samples and standards to ensure that all 
arsenic is in the trivalent form. 
Figure 4.8. Schematic overview of the HPLC-UV-HG-AFS instrument. 
 
The HG-AFS equipment was purchased from PS Analytical (Orpington, UK). The PSA 10.055 
Millennium Excalibur system uses a boosted discharge hollow cathode lamp (Photron, Narre 
Warren, Australia) and can be employed in flow injection mode for measurement of total 
arsenic and for speciation analysis. 
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4.5. Nephelometry 
 
[Behring] 
 
Nephelometry is a technique used for the measurement of proteins. Quantification is based 
on the specific reaction of proteins with antisera. Proteins present in the sample react with 
the specific antiserum to form insoluble complexes. When light passes through this 
suspension, a portion of the light is scattered forward by the complexes and focused onto a 
photodiode by an optical lens system. An infrared light emitting diode (840 nm) serves as 
the light source. Because the particle diameter of the complexes is generally much larger 
than the incident IR light wavelength, Mie-scattering dominates over Rayleigh-scattering. 
The scattered light is collected on a photodiode from an angle ranging between 13° and 
24°. Nephelometry has been used for semi-quantitative purposes. Fractions obtained after 
chromatographic separation of serum were analysed for the presence of transferrin, 
albumin and IgG in order to assess the retention behaviour of the proteins. Nephelometry 
is a more reliable and specific detection method compared with UV detection. The 
instrument was obtained from Behring (Hoechst, Charleroi, Belgium). 
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Chapter 5. Indium: in vitro 
experiments 
 
 
 
 
5.1. Preparation of [114mIn]InCl3 radiotracer 
 
114mIn can be produced from various nuclei. The most convenient way, however, is by 
irradiation of a cadmium target with protons, according to the following nuclear reaction: 
 
114Cd (p,n) 114mIn 
 
114Cd is the most abundant cadmium isotope (28.73%) and bombardment with protons of 
suitable energy could easily be done in the cyclotron of the institute. Naturally occurring 
cadmium consists of 8 stable isotopes, which will all undergo a (p,n) reaction. Moreover 
(p,2n) reactions are common interfering reactions. Table 5.1 lists the possible (p,n) and 
(p,2n) reactions. 
 
Table 5.1. List of indium radioisotopes produced by proton bombardment of a Cd target. 
 
   
isotope and 
abundance 
(p,n) and t½ (p,2n) and t½ 
   
   
106Cd (1.25%) 106mIn (5.3 min), 106In (6.2 min) 105mIn (43 s), 105In (5.1 min) 
108Cd (0.89%) 108mIn (40 min), 108In (57 min) 107mIn (51 s), 107In (32.4 min) 
110Cd (12.49%) 110mIn (1.15 h), 110In (4.9 h) 109mIn (1.3 min), 109In (4.2 h) 
111Cd (12.80%) 111mIn (7.7 min), 111In (2.8049 d) 110mIn (1.15 h), 110In (4.9 h) 
112Cd (24.13) 112mIn (20.8 min), 112In (14.4 min) 111mIn (7.7 min), 111In (2.8049 d) 
113Cd (12.22%) 113mIn (1.658 h), 113In (stable) 112mIn (20.8 min), 112In (14.4 min) 
114Cd (28.73%) 114mIn (49.51 d), 114In (1.198 min) 113mIn (1.658 h), 113In (stable) 
116Cd (7.49%) 116nIn (2.16 s), 116mIn (54.2 min), 116In (14.1 s) 115mIn (4.486 h), 115In (stable) 
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Only 111In has a half -life, which is sufficiently long to interfere with 114mIn. All other isotopes 
have half -lives in the order of seconds to a few hours and will decay within minutes to 4 
days. The characteristics of both isotopes are listed in table 5.2. The measured induced 
activity of the nuclear reaction is proportional to eg x  Ig x ? / t½, with eg the detection 
efficiency of the detector for a gamma ray, Ig the decay probability and ? the isotopic 
abundance. From the last column in table 5.2 it can be seen that a gamma-ray spectrum 
taken immediately after production of the indium tracer would be dominated by the 111In g-
rays. The measured radioactivity of the 171.28 keV g-ray of 111In is 50 times higher than 
the 190.27 keV g-ray of 114mIn. After a cooling period of 36.5 or 46.4 days, the activity of 
111In is reduced to 1% and 0.1% of the 114mIn activity, respectively. At this time the 
remaining 114mIn is still 61% and 53% of the original activity, respectively. 
 
Table 5.2. Characteristics of 111In and 114mIn radioisotopes. 
 
       
isotope main g-energy [keV] Ig  [%] rel. eg  ? Cd [%] t½ [d] rel. act. 
       
       
111In 171.28 90.7 2.8 12.80 2.80 50.0 
 245.35 94.5 2.3   42.8 
       
114mIn 190.27 15.4 2.6 28.73 49.51 1.0 
 558.43 4.4 1.2   0.1 
 725.24 4.4 1   0.1 
       
 
The optimum parameters for proton bombardment of the Cd target were derived from 
literature values. The threshold energy is 2.2 MeV and the Coulomb energy is 8.5 MeV. 
Therefore the proton energy must exceed 8.5 MeV [Skakun et al. , 1975]. A proton energy 
of 18 MeV was chosen. At higher energies, interfering (p,2n) reactions are more likely to 
occur. Higher values do not significantly increase the total yield. For 18 MeV protons the 
stopping power is 14.82 MeV/g/cm2. This corresponds to a range of 0.7206 g/cm2 or 0.833 
mm, taking into account a density of 8.65 g/cm3 Cd. As only foils of 0.5, 0.75 and 1 mm 
are commercially available, the 1 mm thick foil was chosen. The advantage is that the 
protons are completely stopped by the foil. A disadvantage might be that more Cd has to 
be separated from the indium afterwards. The total amount of 114mIn activity depends on 
the irradiation time and the intensity of the proton current. A current of 1 mA was chosen in 
order not to overheat the sample. The Cd foil was placed in a double cooled sampler. A 
double cooled sampler was preferred because of the low melting temperature of cadmium 
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(320.9 °C). In theory interfering (p,a) reactions might produce Ag isotopes. However, these 
were not observed in the final product. 
 
Afterwards a suitable separation procedure was developed to isolate the indium from the 
cadmium matrix (purity 99.999%). Notice in table 5.1 the formation of stable 113In and 
115In isotopes. Together with the ultra-low levels of indium impurity present in the cadmium 
foil and in the reagents needed for the separation of indium from the foil, this will 
contribute to the total amount of indium carrier in the tracer. The separation method was 
done using solvent extraction [Lawson and Kahn, 1957; Schweitzer and Coe, 1961; Stary, 
1963] and liquid chromatography [Chattopadhyay et al. , 1997]. Indium forms a stable 
complex with 8-hydroxyquinoline (oxine). The log K for InOx3 is 0.89, while for CdOx2.2HOx 
this value amounts to –5.29. Moreover, the extraction into oxine is dependent on the initial 
pH of the aqueous solution. At pH 2.13 half of the indium is extracted with 0.01 M oxine 
while for Cd this value is reached at a pH of 6.65. A quantitative extraction of indium is 
realised from a solution having a pH between 3.4 and 6.4. At this pH Cd cannot yet be 
extracted with a solution of oxine. The indium can be back extracted with an acid solution. 
The whole method was optimised using reactor-produced radioisotopes of indium (116mIn) 
and cadmium (115Cd). The following steps were carried out: 
 
ü dissolve the cadmium foil in a minimum amount of 14 M HNO3. 
ü buffer the solution at pH 3.4 with NH4OAc. 
ü extract twice with an equal volume of 10 mM oxine in chloroform. 
ü wash the organic phase twice with NH4OAc. 
ü extract the organic phase back into the aqueous phase twice with 1 M HBr. 
 
The yield proved to be nearly quantitative. An additional ion exchange purification step was 
necessary to remove remaining trace amounts of Cd. After extraction it could be calculated 
that about 360 mg Cd (0.07% of the original mass) was still present. Therefore the solution 
was evaporated to nearly dry, dissolved in concentrated HBr and brought onto a Dowex 
50Wx4 ion exchange column (diameter: 7 mm, length: 70 mm). Rinsing with 9 M HBr leads 
to the elution of the remaining cadmium, while washing with 12 M HCl results in the 
selective elution of indium. Again the indium yield reached nearly 100%. The final product 
was radiochemically pure (only 114mIn). The ion exchange method is based on the formation 
of [InBr4]- and [CdBr4]2- in concentrated HBr and can be explained by the Donnan potential 
[Diamond and Whitney, 1966]. The origin of the Donnan potential will be outlined in the 
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case of a cation exchange resin composed of fixed SO3- groups, H+ counter ions and a 
mobile phase containing HCl. The resin phase is usually more concentrated than the mobile 
phase, so the resin counter ions of the cation exchanger (e.g., H+) tend to diffuse into the 
mobile phase. Similarly, the aqueous-phase co-ions (co-ions are mobile phase ions in the 
resin phase carrying the same sign as that of the resin-fixed ions, e.g., Cl-) tend to diffuse 
into the resin phase. This distribution leads to a violation of the electro neutrality and as 
such a potential difference is established at the interface. In practice the cation exchange 
resin becomes negative with respect to the external solution. This potential prevents the 
uptake of non-exchangeable electrolyte such as [InBr4]-. The higher the valence of the non-
exchangeable electrolyte, the more efficiently it is excluded from the resin phase. The 
importance of the phenomenon of Donnan exclusion for the present work, however, is the 
feature that the exclusion becomes poorer as the external solution concentration is 
increased. As a result, resins in contact with concentrated electrolyte solutions no longer 
only show equivalent exchange but also non-exchangeable electrolyte absorption or resin 
invasion, and the latter can become an important process. Using concentrated HBr, the 
indium [InBr4]- is absorbed by the resin phase whereas cadmium [CdBr4]2- is efficiently 
excluded. When changing the mobile phase composition into concentrated HCl, indium will 
form complexes with chlorine with a charge more negative than -1. As a result the indium 
can be eluted from the column. 
 
5.2. Ultrafiltration experiments of indium species 
 
The suitability of a chromatographic buffer is of major importance, especially in the case of 
weakly bound and kinetically not inert species, such as electrostatically bound metal-ligand 
complexes [Sanz-Medel, 1995]. The composition of this buffer should be chosen such that 
it does not disrupt the binding between the metal and the ligand. This metal ligand bond 
can be broken by changing the chemical properties of the medium, such as pH, ionic 
strength, temperature, addition of chemicals, etc. Ionic strength and pH of the buffer were 
always adapted to the type of sample to be analysed: serum, packed cell lysate, urine, 
homogenised tissue. Therefore only the type of buffer had to be tested for its suitability as 
a chromatographic eluent. Ultrafiltration is a convenient means of studying the behaviour of 
trace elements in clinical samples and the influence of different parameters on this 
behaviour. Ultrafiltration experiments were conducted in which serum, packed cells and 
solutions of transferrin, albumin and haemoglobin were incubated with [114mIn]InCl3 and 
ultrafiltered on a 10 kDa cut-off filter. The activity in the ultrafiltrate was measured and 
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compared with a reference sample of the same incubated mix ture. Thus a value of the 
amount of radio indium bound to the high molecular mass (HMM) and low molecular mass 
(LMM) fraction could be determined. 
 
5.2.1. Ultrafiltration of indium species in serum 
 
In a first stage 6 solutions were incubated with ionic [114mIn]InCl3 for 2 h at 37°C: 
ü undiluted serum (A) 
ü serum 1+9 diluted in 25 mM NaHCO3 + 0.15 M NaCl, pH 7.4 (B) 
ü serum 1+9 diluted in 20 mM tris:HCl + 10 mM NaHCO3, pH 7.4 (C) 
ü serum 1+9 diluted in 20 mM tris:HCl + 10 mM NaHCO3 + 0.32 M NaCl, pH 7.4 (D) 
ü serum 1+9 diluted in 10 mM hepes + 5 mM NaHCO3 +0.15 M NaCl, pH 7.4 (E) 
ü serum 1+9 diluted in 10 mM hepes + 5 mM NaHCO3 + 1 M NaCl, pH 7.4 (F) 
Then 3 x 250 mL was transferred into an ultrafiltration cup and centrifuged during 20 min at 
3000 rpm and 4°C in order to separate the LMM fraction from the HMM fraction. The 
activity in the filtrate was measured with a NaI(Tl) scintillation detector. The percentage 
protein bound indium was measured through comparison with a reference (a non-
ultrafiltered solution of equal volume of the same mixture). Weighing the vessels before 
and after ultrafiltration allowed correction for the differences in sample throughput by the 
filter membranes. This was necessary since the sample was never centrifuged till dry. The 
results in table 5.3 indicate that 93% of the indium is associated with the protein fraction. 
This result is in good agreement with that of Kulprathipanja and Hnatowich [1978], who 
found that 96% of a [113mIn]InCl3 activity was found in the protein fraction after both in 
vitro and in vivo incubation of dog serum with 113mIn. Their results were obtained with gel 
filtration. Hosain et al.  [1969] found that 113mIn is bound to the protein transferrin. Their 
findings were based on experiments with starch gel electrophoresis and gel filtration. In a 
study on 113mIn for blood pool and brain scanning Stern et al.  [1967] were the first to 
predict that indium is presumably bound to transferrin in serum. However, their hypothesis 
was not confirmed by experimental evidence. Hultkvist et al. [1987] demonstrated that the 
binding between indium and transferrin is dependent on the pH of the medium. They 
chromatographed rat blood plasma that was in vivo incubated with [113mIn]InCl3 by gel 
filtration using buffers at different pH values and found that at pH values below 6, the 
indium was no longer found in the protein fraction. This clearly illustrates the carefulness 
one should take when doing chromatographic analyses on metal-protein complexes. 
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Table 5.3. Distribution of 114mIn in serum. 
 
  
amount of 114mIn3+ in HMM fraction (n = 3) [%] amount of 114mIn3+ in LMM fraction (n = 3) [%] 
  
  
A: undiluted serum/114mIn3+ 93 G: 114mIn3+ in HCl 96 
B: serum/114mIn3+ in NaHCO3 94 H: 
114mIn3+ in physiological buffer 95 
C: serum/114mIn3+ in tris:HCl + NaHCO3 98 I: 
114mIn3+ + In3+ carrier in physiological 98 
D: serum/114mIn3+ in tris:HCl + NaHCO3 + NaCl 95     buffer  
E: serum/114mIn3+ in hepes + NaHCO3 95   
F: serum/114mIn3+ in hepes + NaHCO3 + NaCl 95   
  
 
Compared to the amount of In3+ bound to the HMM fraction of the undiluted serum sample 
(93%), dilution in the different buffer systems does not drastically alter the binding 
characteristics of indium. Tris:HCl and hepes are two widely used biological buffers with 
low metal content and pKa values of 7.77 and 7.31, respectively. Buffers B and E can be 
used for gel filtration chromatography, whereas buffers C, D and F are used in anion 
exchange and affinity chromatography. Depending on the pH of the solution, indium 
undergoes hydrolysis, resulting in In3+ being present as [In(OH)n(H2O)6-n]3-n (n = 0 to 4). At 
pH 7.4 indium forms insoluble In[(OH)3(H2O)3]. To be sure that the high activity of 114mIn in 
the HMM fraction was a result of the protein binding affinity of In3+ and not due to 
precipitation of In3+ at physiological pH three more solution were also ultrafiltered: 
ü a solution of [114mIn]InCl3 in 0.01 M HCl (G) 
ü a solution of [114mIn]InCl3 in 25 mM NaHCO3 + 1.6 mM phosphate + 0.1 mM citric acid 
+ 0.15 M NaCl, pH 7.4 (H) 
ü a solution of [114mIn]InCl3 and 150 mM InCl3 carrier in 25 mM NaHCO3 + 1.6 mM 
phosphate + 0.1 mM citric acid + 0.15 M NaCl, pH 7.4 (I) 
In all three cases more than 95% of the 114mIn3+ activity was found in the ultrafiltrate, 
indicating that hydrolysis is not responsible for the high amount of indium in the HMM 
fraction. 
 
Transferrin is the protein responsible for the transport of iron in serum. Since transferrin is 
only 30% saturated with Fe3+, the protein is capable of complexing other metals, preferably 
trivalent metals such as In3+. Albumin is the most abundant protein in serum, its primary 
function being the non-specific binding and transport of small molecules, metals, drugs and 
hormones in blood. In order to study the binding of In3+ with transferrin and albumin, a 
physiological solution of 
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ü 2 g/L transferrin in 25 mM NaHCO3 + 0.15 M NaCl, pH 7.4 
ü 2 g/L transferrin in 25 mM KH2PO4 + Na2HPO4 + 0.15 M NaCl, pH 7.4 
ü 2 g/L transferrin in 10 mM hepes + 0.15 M NaCl, pH 7.4. 
ü 40 g/L albumin in 25 mM NaHCO3 + 1.6 mM phosphate + 0.1 mM citric  acid + 0.15 M 
NaCl, pH 7.4 
ü 10 g/L albumin in 15 mM tris:HCl + 0.15 M NaCl, pH 7.3 
ü 10 g/L albumin in 25 mM NaHCO3 + 0.15 M NaCl, pH 7.3 
ü 10 g/L albumin in 15 mM hepes + 0.15 M NaCl; pH 7.3 
were incubated with [114mIn]InCl3 at 37°C. After several time intervals an aliquot of 1 mL 
was taken from the reaction mixture. Ultrafiltration was done as described above. The 
binding of In3+ with transferrin is complete in case of the bicarbonate buffer but only 
moderate in case of the hepes buffer (maximum 16%) and in case of the phosphate buffer 
(maximum 23%). In case of the bicarbonate buffer, the binding shows no time dependency 
within the time interval of 1-8 h. Binding of In3+ with albumin is also rapidly established 
(within one hour). The percentage of 114mIn bound to albumin amounts to 91% when 
albumin is dissolved in the physiological buffer of bicarbonate, phosphate and citrate. Also 
the binding of In3+ to albumin seems to be influenced by the reaction medium. The 
percentage of In3+ bound to albumin amounted to maximum 65%, 70% and 67% in the 
case of tris:HCl, NaHCO3 and hepes, respectively. These values are lower than the 91% 
found in the case of the physiological buffer of bicarbonate, phosphate and citrate. 
 
These findings indicate that In3+ is capable of forming a metal-protein complex with both 
transferrin and albumin in vitro. A buffer containing HCO3- was chosen for the preparation 
of the transferrin solution because it is the main buffering substance in serum. Moreover, a 
synergistic carbonate anion is necessary for the binding of metals to transferrin. The low 
binding affinity of In3+ for transferrin in case of the hepes and phosphate buffer is in 
agreement with the findings of Harris et al. [1998], who postulated that the binding of non-
synergistic anions to apotransferrin interferes with metal binding by competing directly with 
the binding of the synergistic bicarbonate anion. The strongest interfering non-synergistic 
anion is HPO42-. In the above mentioned report it is also stated that previous studies had 
suggested that the sulphonic acid moiety in hepes may also act as a competitor to the 
synergistic bicarbonate anion. The binding constants for phosphate, bicarbonate and hepes 
to the two binding sites of transferrin are given in table 5.4. 
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Table 5.4. Binding constants for different ligands to transferrin. 
 
    
 hepes bicarbonate phosphate 
    
    
log K1 1.36 3.06 4.34 
log K2 0.76 2.44 3.54 
    
 
5.2.2. Ultrafiltration of indium species in packed cells 
 
Similar ultrafiltration experiments have been carried out on the packed cell fraction. In 
order to do this, the cell content has to be lysed. Packed cells were washed with ice-cold 
phosphate buffered saline (PBS) and 1 mL of cells was lysed in a Potter-Elvehjem type 
homogeniser with 10 mL water and 0.1 mL toluene. The cell membranes were removed by 
centrifugation at 10000 rpm during 30 min. This solution was incubated with [114mIn]InCl3 
at 37°C.  After 1, 2, 4, 8, 12 and 24 hours 3 x 300 mL was transferred into an ultrafiltration 
cup and centrifuged during 20 min at 3000 rpm and 4°C in order to separate the LMM 
fraction from the HMM fraction. The activity in the filtrate was measured with the NaI(Tl) 
scintillation detector. The percentage protein bound In3+ was measured by comparing with 
a reference (3 x 50 mL of a non-ultrafiltered solution). Weighing the vessels before and 
after ultrafiltration allowed correction for the differences in sample throughput by the filter 
membranes. Binding to the HMM fraction was realised within 1 hour and nearly complete 
(between 93% and 95%). Afterwards a more convenient lysis method was chosen in which 
1 mL washed packed cells was lysed with 1 mL 200 g/L glucose and 3 mL water in a 
Potter-Elvehjem type homogeniser. An identical ultrafiltration experiment was done and 
93% of the 114mIn activity was found in the HMM fraction. 
 
Similar to serum, the effect of different buffers on the binding between [114mIn]InCl3 and 
packed cell proteins was tested. Yet another lysis technique was chosen: packed cells were 
alternately thawed and frozen 4 times. Although less quantitative, this method does not 
require chemicals. Afterwards undiluted cell lysate and cell lysate 1:10 diluted in: 
ü 0.15 M NaCl 
ü 50 mM NH4HCO3 
ü 15 mM tris:HCl + 0.15 M NaCl 
ü 15 mM hepes + 0.15 M NaCl 
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(pH of all media was between 7.1 and 7.2) were incubated with [114mIn]InCl3 for 2 hours at 
37°C. All samples were filtered through a 0.22 mm PVDF syringe filter to remove residual 
intact cells. The undiluted fraction could not be filtered and had to be discarded. Therefore 
the 0.15 M NaCl was chosen as the reference value as it is expected that dilution in a 
physiological solution with identical ionic strength and pH as the media will not alter the 
binding behaviour of indium. Ultrafiltration was carried out as described above. There is no 
difference in % HMM bound 114mIn in case of 0.15 M NaCl, tris:HCl and hepes buffer. 
NH4NO3, selected because it is used for speciation of lead compounds in packed cell lysate 
[Bergdahl et al. , 1996], leads to a decrease in the % HMM amount and will not be used. 
 
A solution of 10 g/L haemoglobin in 15 mM hepes + 0.15 M NaCl (pH 7.1) was also 
incubated with [114mIn]InCl3 and ultrafiltered. However, only 40% was found in the 
haemoglobin fraction. It can thus be expected that other ligands of the erythrocytes are 
capable of forming a complex with In3+. 
 
5.3. Chromatography experiments of indium species 
 
Different chromatographic columns were tested for their suitability for indium speciation. Of 
utmost importance is the chromatographic recovery of 114mIn. Therefore a mass balance 
was made: an equal amount of sample to be chromatographed, was diluted to the same 
extent and measured for its 114mIn content. The suitability of the chromatographic 
procedure was tested with in vitro experiments. In vitro incubation experiments were 
carried out with human serum and packed cells, which were incubated with [114mIn]InCl3. 
5.3.1. Chromatography of indium species in serum 
 
Figure 5.1 shows the chromatogram of human serum incubated with [114mIn]InCl3 and 
separated using size exclusion on Asahipak GS 520 7G. The Asahipak column separates 
molecules on the basis of their molecular mass (exclusion limit 300 kDa), but shows also an 
affinity for albumin. As a result albumin is separated from the high molecular mass fraction. 
The Asahipak column has been successfully applied for metal speciation in serum [Raab 
and Brätter, 1998]. Serum, 1+2 diluted in starting buffer was incubated with [114mIn]InCl3 
for 2 h. 100 mL was brought onto the column. Elution was done with 10 mM hepes + 5 mM 
NaHCO3 + 0.15 M NaCl, pH 7.4. Fractions of 1 mL were collected and the activity was 
measured by means of NaI(Tl) scintillation counting. It can be seen that most of the 
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activity is found within the elution volume of 12-14 mL. This fraction also contains 
transferrin. Some activity is spread out over the fraction containing albumin and a third 
peak containing 9.3% of all 114mIn is found within the elution volume of 16-17 mL. Recovery 
for 114mIn was 100%, measured by comparison with the reference. The results of the 
chromatographic separations of serum incubated with indium tracer were similar to those 
of the ultrafiltration experiments. 
 
 
Figure 5.1. Chromatogram of serum + 114mIn separated on Asahipak GS 520 7G size 
exclusion column (left). Same chromatogram with enlarged scale for the 114mIn activity 
(right). 
 
 
Figure 5.2. Chromatogram of serum + 114mIn separated on Mini Q anion exchange 
column (left). Same chromatogram with enlarged scale for the 114mIn activity (right). 
 
The results of the anion exchange chromatography experiment are shown in Fig. 5.2. 1+10 
diluted (in starting buffer) serum was incubated with [114mIn]InCl3 for 2 h. 100 mL was 
brought onto a Mini Q PE anion exchange column. The starting buffer was 10 mM hepes + 
5 mM NaHCO3, pH 7.4. Gradient elution was performed with 10 mM hepes + 5 mM NaHCO3 
+ 1 M NaCl, pH 7.4. Fractions of 500 mL were collected and the activity was measured by 
means of NaI(Tl) scintillation counting. The recovery of the 114mIn was 100%. Via 
0
50
100
150
200
250
300
350
400
450
500
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
retention volume [mL]
a
b
so
rb
a
n
ce
 2
8
0
 n
m
 [
m
A
U
]
0
40000
80000
120000
160000
200000
240000
a
ct
iv
it
y 
1
1
4
m
-I
n
 [
co
u
n
ts
]
absorbance 280 nm
activity 114m-In
0
20
40
60
80
100
120
140
160
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
retention volume [mL]
a
b
so
rb
a
n
ce
 2
8
0
 n
m
 [
m
A
U
]
0
2000
4000
6000
8000
10000
a
ct
iv
it
y 
1
1
4
m
-I
n
 [
co
u
n
ts
]
absorbance 280 nm
activity 114m-In
0
20
40
60
80
100
120
140
160
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
retention volume [mL]
a
b
so
rb
a
n
ce
 2
8
0
 n
m
 [
m
A
U
]
0
10000
20000
30000
40000
50000
60000
70000
80000
a
ct
iv
it
y 
1
1
4
m
-I
n
 [
co
u
n
ts
]
absorbance 280 nm
activity 114m-In
0
50
100
150
200
250
300
350
400
450
500
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
retention volume [mL]
a
b
so
rb
a
n
ce
 2
8
0
 n
m
 [
m
A
U
]
0
5000
10000
15000
20000
25000
30000
35000
40000
a
ct
iv
it
y 
1
1
4
m
-I
n
 [
co
u
n
ts
]
absorbance 280 nm
activity 114m-In
Chapter 5. Indium: in vitro experiments 
______________________________________________________________________________________________________ 
 101
nephelometry, one could deduce that transferrin is found within mL-fraction 7.5-9, albumin 
within mL-fraction 9-14 and IgG within mL-fraction 0.5-1.5 and 5.5-7. It is clearly shown 
that In3+ is associated with transferrin, and to a lesser degree with albumin. A considerable 
amount (7.9%) of 114mIn is found around 6-7 mL. 
 
The distribution of In3+ over transferrin and the LMM fraction, however, depends upon the 
pH of the indium tracer. The In3+ tracer incubated in serum in the latter example had a pH 
of 2. At pH 1, indium appears as the trivalent cation In3+, whereas at pH 3 hydrolysis to 
InOH2+ occurs. Serum was incubated with In3+ and InOH2+ and analysed using gel filtration 
and anion exchange chromatography. The results are shown in figures 5.3 and 5.4. 
 
 
Figure 5.3 Chromatogram of serum + [114mIn]InCl3  with tracer at pH 1 (left) and at pH 3 
(right) separated on Asahipak GS 520 7G size exclusion column. 
 
 
Figure 5.4 Chromatogram of serum + [114mIn]InCl3  with tracer at pH 1 (left) and at pH 3 
(right) separated on Hi Trap Q anion exchange column. 
 
In the gel filtration experiment the procedure was identical to the one described above. For 
the anion exchange chromatography, undiluted serum was incubated with indium tracer for 
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2 hours and 500 mL was separated on a Hi Trap Q column. This column has a higher 
loading capacity compared to Mini Q, but the functional groups are identical. Fractions of 2 
mL were taken and analysed for their 114mIn content using a NaI(Tl) detector. As can be 
seen from the chromatograms, at pH 1 of the tracer virtually all 114mIn appears in the 
transferrin region. When the pH of 114mIn[InCl3] is increased to 3, 62.3% (gel filtration) and 
60.2% of the indium tracer (anion exchange) is located with the transferrin fraction. 
Nephelometry has been used for semi quantification of transferrin in case of the anion 
exchange chromatography experiment. Between 28 and 30 mL where a first peak 
maximum of 114mIn can be seen, transferrin appears just above detection limits. Transferrin 
reaches a maximum in the range 32-36 mL. This matches perfectly well with the second 
peak in the chromatogram. 
 
 
Figure 5.5. Chromatogram of serum + 114mIn separated on Hi Trap Blue affinity column. 
 
Affinity chromatography has been tested to unambiguously prove the association between 
In3+ and albumin. 1+1 diluted serum in starting buffer was incubated with [114mIn]InCl3 for 
2 h and filtered through a 0.22 mm filter. 500 mL was brought onto a Hi Trap Blue affinity 
column. This cross-linked agarose column, substituted with Cibacron Blue F3G-A has an 
affinity for albumin, NAD+, NADP+, coagulation factors and interferons. The starting buffer 
was 20 mM tris:HCl + 10 mM NaHCO3, pH 7.4. Albumin was eluted with 20 mM tris:HCl + 
10 mM NaHCO3 + 1.5 M NaCl, pH 7.4. Fractions of 2 mL were collected and the activity 
was measured with a NaI(Tl) scintillation detector. The chromatogram is shown in figure 
5.5. It can be deduced that the fraction in which albumin is eluted, contains 8% of the 
114mIn activity. Also here, recovery reached 100%. This amount seems to be much more 
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than the value obtained using gel filtration and anion exchange chromatography. Possibly 
flushing the column with the starting buffer did not elute all In3+ (bound to transferrin and 
a LMM compound) from the column. Changing the buffer ionic strength from 0 to 1.5 M 
NaCl could then result in the elution of the residual fraction. Consequently both the residual 
114mIn and the albumin-bound 114mIn co-elute. Another possibility might be that indium is 
bound to NAD+, NADP+, coagulation factors and interferons, although this seems unlikely. 
Part of the 114mIn detected in the range 25-30 mL is probably the result of incomplete 
removal by buffer A. The 114mIn activity does not return to zero during flushing of the 
column, although a long flushing time (3 column volumes) was respected. Two albumin 
solutions (one in buffer A, one in buffer B) have been incubated with [114mIn]InCl3 and 
ultrafiltered as described in section 5.2.1. An equal amount of 114mIn was found in he HMM 
fraction for both media, indicating that buffer B does not disrupt In3+ from albumin. 
 
5.3.2. Chromatography of indium species in the LMM fraction in serum 
 
 
Figure 5.6. Chromatogram of ultrafiltrate of serum + 114mIn separated on Bio-Gel P2 size 
exclusion column (left) and on Mono Q anion exchange column (right). 
 
Efforts were made to find out the identity of the LMM compound(s) that are able to 
complex indium in vitro. In order to obtain a substantial amount of the indium bound to the 
LMM fraction, serum was incubated with [114mIn]InCl3 during 2 hours and ultrafiltered on a 
preparative 30 kDa filter. The ultrafiltrate was chromatographed on a Bio-Gel P2 size 
exclusion column (range 0.1-1.8 kDa). The result is shown in figure 5.6. The major share of 
the 114mIn appears in the range 13-15 mL. A small portion of indium is recovered from the 
void volume, indicating that some transferrin might have been ultrafiltered as well. The 
same sample was also separated using anion exchange chromatography on a Mono Q 
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column. Two major peaks appear now accompanied with a small peak around 11-12 mL 
which is due to residual transferrin present in the ultrafiltrate. Therefore it can be 
concluded that indium exists as at least two LMM compounds in serum in vitro. 
 
 
Figure 5.7. Chromatogram of citrate + 114mIn (left) and serum supplemented with citrate 
+ 114mIn (right) separated on Bio-Gel P2 size exclusion column. 
 
Citrate is known to complex Al3+ in serum [Bantan and Milacic, 1998]. Therefore it was 
checked whether citrate also binds to In3+. A pure citrate solution (17 g/L) and a 1+1 
mixture of serum + citrate (17 g/L) were incubated with [114mIn]InCl3 and separated on a 
Bio-Gel P2 size exclusion chromatography column (figure 5.7). 29% of the 114mIn is found in 
the citrate fraction in case of the pure citrate solution, whereas in serum supplemented 
with citrate only 3% is associated with citrate. 
 
 
Figure 5.8. Chromatogram of plasma + 114mIn separated on Bio-Gel P2 size exclusion 
column after collection of blood in EDTA vacuum tubes. 
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The choice for a suitable medium in which to collect the blood is very important. To 
demonstrate this, blood was collected in an EDTA, a heparin containing tube and in an 
empty tube. Afterwards this blood was incubated with [114mIn]InCl3 for 1 to 12 hours and 
centrifuged to obtain plasma and packed cells. An amount of 0.8 mL plasma, 0.2 mL 
packed cells and 1 mL original whole blood were measured for their 114mIn content by 
Ge(Li) detection. The results were normalised to 1 mL volumes. For both EDTA and heparin 
tubes, between 93.7% - 95.5% and 95.7% - 96.8%, respectively, of 114mIn was found in 
the plasma fraction. As can be seen in figure 5.8, the indium activity in the plasma that is 
obtained from EDTA tubes and separated on a Bio-Gel P2 size exclusion column, is 
completely eluted in the LMM fraction and is not bound to transferrin. In fact, each 4 mL 
collection tube contains 3.67 mM H2EDTA2-. The serum Tf concentration is around 25 mM. 
Given the fact that log K for EDTA-indium is 24.95 [Nitsch et al. , 1990] and log K for both 
Tf-indium binding sites are 18.52 and 16.64 [Harris et al. , 1994], respectively, it seems 
logical that an excess of EDTA will disrupt the binding between indium and transferrin. 
114mIn elutes at another retention time than the H2EDTA2-. In3+ forms a complex with 
H2EDTA2- according to: 
In3+ + H2EDTA2- « InEDTA- + 2H+ 
 
 
Figure 5.9. Chromatograms of EDTA + varying concentrations of [114mIn]InCl3-In(NO3)3  
separated on Bio-Gel P2 size exclusion column. The 114mIn activity was found as a single 
peak in all cases (A to E). 
 
This indium-EDTA complex elutes separately from the non-complexed EDTA. Different 
amounts of In(NO3)3 (A: 0, B: 3.35 mmol, C: 6.7 mmol, D: 13.4 mmol and E: 26.8 mmol) 
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were mixed with equal amounts of [114mIn]InCl3 and incubated with a solution of 26.1 mmol 
EDTA in 0.9% NaCl in order to obtain solutions with different concentrations of In3+ (equal 
amounts of radiolabeled indium but different amounts of ‘carrier’ indium) in equal 
concentrations of EDTA. All samples were chromatographed on the Bio-Gel P2 size 
exclusion column with 0.9% NaCl. The results are shown in figure 5.9. Non-complexed 
H2EDTA2- elutes at 8.4 mL. This peak decreases in function of an increasing indium (A ® E) 
concentration and reaches zero when equimolar amounts of indium are reached (E). 
Correspondingly the peak at retention volume 13.9 mL increases, identified as the 
radiolabeled indium-EDTA complex. 
 
150 200 250 300 350 400
m/z0
100
%
0
100
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0
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%
291147
403
363
145
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158
201 313 335
EDTA
indium
EDTA + indium
 
 
Figure 5.10. ES-MS spectra of H2EDTA
2- + In(NO3)3  (top), In(NO3)3  (middle) and 
H2EDTA
2- (bottom) using infusion full scan MS in negative ion mode. Sample cone 
voltage was set to 20 V. Intensity axes are linked. 
 
The InEDTA- complex was further studied by infusion electrospray mass spectrometry. 
Individual solutions of 3.67 mM H2EDTA2-, 1 mM In(NO3)3 and 1 M In(NO3)3 + 3.67 mM 
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H2EDTA2- were analysed in positive and negative full scan mode. Mass scans between m/z 
100 and 800 were recorded during 1 minute with a scan speed of 2 seconds. The indium 
stock solution initially contained 10.09 g/L indium in 2-5% HNO3. To obtain a 1 mM indium 
solution, the stock solution was diluted 94 times, creating a pH between 2.1 and 2.5.Figure 
5.10 shows the ES-MS of the three solutions, recorded in negative ion mode. In the EDTA 
spectrum, the following peaks can be observed (MM Na2H2EDTA = 336 Da): 
145 [H2EDTA]
2- 291 [H3EDTA]
- 
158 ? 313 [NaH2EDTA]
- 
201 ? 335 [Na2HEDTA]
- 
 
In the In(NO3)3 spectrum a single peak at m/z 363 appears, because of the presence of 
In(NO3)4-. The top chromatogram shows that binding of In(NO3)3 to H2EDTA2- leads to a 
decrease of excess EDTA and formation of a peak at m/z 403, corresponding to the 
molecular ion [InEDTA]-. 
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Figure 5.11. ES-MS spectra of In(NO3)3  using infusion full scan MS in positive ion mode. 
Sample cone voltage was set to 50 V (top) and 20 V (bottom). Intensity axes are linked. 
 
Figure 5.11 shows two spectra of In(NO3)3 recorded in positive ion mode at different 
sample cone values. At the pH of 2.1-2.5, a wide range of indium complexes can be seen: 
115 [In]+ 194 [In(OH)(NO3)]
+ 257 [In(H2O)(NO3)2]
+ 
132 [In(OH)]+ 212 [In(OH)(H2O)(NO3)]
+ 275 [In(H2O)2(NO3)2]
+ 
149 [In(OH)2]
+ 230 [In(OH)(H2O)2(NO3)]
+   
167 [In(OH)2(H2O)]
+ 239 [In(NO3)2]
+   
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The relative abundance of these complexes is dependent on the sample cone voltage. A 
higher sample cone voltage leads to more in source fragmentation of the labile indium 
complexes and results in a higher relative abundance of the smaller indium complexes. It 
can thus not be stated that the spectra in figure 5.11 give a real image of the complexes in 
the solution. 
 
Figure 5.12 shows the spectra of H2EDTA2- and H2EDTA2- + In(NO3)3 in positive ion mode 
using a sample cone voltage of 20 V. In the spectrum of EDTA, peaks at m/z 315 and 359 
predominate, due to the presence of [NaH4EDTA]+ and [Na3H2EDTA]+, respectively. In 
between these peaks, a small peak at m/z 337 can be seen, owing to the presence of 
[Na2H3EDTA]+. In the spectrum of EDTA + indium, the peaks due to the presence of EDTA 
decrease and peaks at m/z 449 ([InNa2EDTA]+) and m/z 427 ([InNaHEDTA]+) appear. The 
fact that no more peaks can be observed in the range m/z 110 to 280 (see figure 5.11) 
indicates that the indium is completely complexed by EDTA. 
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Figure 5.12. ES-MS spectra of H2EDTA
2- + In(NO3)3  (top) and H2EDTA
2- (bottom) using 
infusion full scan MS in positive ion mode. Sample cone voltage was set to 20 V. 
Intensity axes are linked. The area between m/z 400 and 500 is enhanced 10-fold. 
 
The behaviour of pure [114mIn]InCl3 tracer on Bio-Gel P2 (figure 5.13) and Mono Q (figure 
5.14) was studied. When pure tracer is chromatographed with hepes buffer it elutes as a 
single peak at the same retention volume as in figure 5.6 (left) and 5.7. However, when 
the same tracer is separated in the presence of 0.9% NaCl, it elutes in the total volume 
(indicated by the increase in conductivity) of the column. Recovery is quantitative in case of 
a hepes elution, but only 42% in 0.9% NaCl.  
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Figure 5.13. Chromatograms of pure [114mIn]InCl3  separated on Bio-Gel P2 size exclusion 
column and eluted with hepes (left) and 0.9% NaCl (right). 
 
The same conclusion can be drawn when indium tracer is eluted with tris:HCl buffer (figure 
not shown). The 114mIn activity appears at the same retention time as in the case of hepes. 
It is thought that indium is bound to the buffer and elutes as an In-hepes complex. This 
kind of behaviour has been reported in the past for soluble Fe3+ solutions complexed to 
tris:HCl buffer [Taillefert et al. , 2000]. When pure tracer is chromatographed with hepes on 
a Mono Q anion exchange column, again the same peaks appear as in figure 5.6 (right), 
indicating that there seems to be no difference between a pure solution of [114mIn]InCl3 
tracer and [114mIn]InCl3 tracer in the LMM fraction of serum. 
 
 
Figure 5.14. Chromatogram of pure [114mIn]InCl3  separated on Mono Q anion exchange 
column and eluted with hepes. 
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Electrospray mass spectrometry was used to confirm the hypothesis that In3+ is complexed 
by the buffer. A low sample cone voltage was used since the experiments with EDTA 
showed that at moderate sample cone voltage, considerable in source fragmentation 
already occurred (for in source fragmentation, see 7.1.1). The sample cone voltage was set 
to 2 V. Solutions of 15 mM hepes, 1 mM In(NO3)3 and 15 mM hepes + 1 mM In(NO3)3 were 
analysed by infusion full scan MS in negative ion mode (figure 5.15). The spectrum for 
indium is identical to the one in figure 5.10 (a single peak at m/z 363 [In(NO3)4-]) and is 
therefore not shown. Hepes (MM = 238 Da) is observed as the [M-H]- molecular ion (m/z 
237) and [2M-H]- (m/z 475). The peak at m/z 283 is a result of a formic acid adduct [hepes 
+ HCOO]-. Formic acid was used just before to clean sample cone and syringe. Adding 
indium to a solution of hepes results in the formation of a complex with m/z 300, identified 
as [hepes+indium]2-. Again the peak at m/z 346 is due to the formic acid adduct. 
240 260 280 300 320 340 360 380 400 420 440 460 480
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283238
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Figure 5.15. ES-MS spectra of In(NO3)3  + hepes (top) and hepes (bottom) using infusion 
full scan MS in negative ion mode. Cone voltage was set to 2 V. 
 
5.3.3. Chromatography of indium species in packed cell lysate 
 
Different columns were checked for their suitability in terms of 114mIn recovery. Superose 12 
HR, Asahipak GS 520 7G, Bio-Gel P2, Bio-Gel P100 and Mono S were examined. Four in 
vitro incubation experiments of packed cell lysate with [114mIn]InCl3 and separated on 
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Asahipak GS 520 7G each time resulted in a mean recovery of 53%. Bio-Gel P2 and P100 
yielded quantitative results, but the self -packed Bio-Gel P100 did not give a satisfactory 
resolution. Figure 5.16 shows the chromatograms of packed cell lysate incubated with 
[114mIn]InCl3 at different pH (2 and 7), separated on Superose 12 HR. Fractions of 0.5 and 
1 mL, respectively, were taken and measured for their 114mIn content with a NaI(Tl) 
detector. As in the case of serum, also here the pH of the tracer determines the amount of 
LMM bound 114mIn. Surprisingly the 114mIn does not co-elute with haemoglobin. 
Haemoglobin represents 95% of the total erythrocyte protein content. The 114mIn elutes in 
the transferrin fraction. Transferrin is slightly heavier than haemoglobin (76 kDa versus 
64.5 Da). 
 
 
Figure 5.16 Chromatograms of packed cell lysate + [114mIn]InCl3  with tracer at pH 2 
(left) and at pH 7 (right) separated on Superose 12 HR size exclusion column. 
 
Figure 5.17 Chromatogram of packed cell lysate + 114mIn separated on Mono S cation 
exchange column. 
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This observation can also be seen when the packed cell lysate + [114mIn]InCl3 mixture is 
eluted on the Bio-Gel P100 column (figure not shown). The fact that indium is not 
associated with haemoglobin, can be further illustrated by cation exchange 
chromatography on a Mono S column (figure 5.17). A packed cell lysate + [114mIn]InCl3 
mixture was chromtographed using 15 mM hepes (buffer A) and 15 mM hepes + 1 M LiCl 
(buffer B), both at pH 7.0. Recovery of 144mIn, however, was only 44%. No further effort 
was made to improve the quality of the chromatographic separation. It is known that the 
major share of the indium is associated with the serum fraction rather than with the packed 
cell fraction. 
 
A list of all columns used throughout this work is given in table 5.5. 
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Chapter 6. Indium: in vivo 
experiments 
 
 
 
 
Three series of in vivo experiments with Wistar rats were carried out in the course of this 
work. Each time five male Wistar rats were used. In a first experiment they were given an 
intraperitoneal injection of [114mIn]InCl3. In a second and third experiment they got 
[114mIn]InAs either subcutaneously or orally. The purpose of the first experiment was to 
learn the organ distribution and chemical speciation of the indium tracer that is injected 
directly in the blood stream. InAs was chosen in the other two experiments because it is a 
frequently used semiconductor material. First the particles were parenterally injected, 
namely under the skin. The organ distribution and chemical speciation in the body fluids 
and target organs were examined. Secondly the rats were orally exposed to small particles 
of InAs. The bioavailability and toxic impact of the orally absorbed InAs particles were 
checked. The experimental conditions and results of each experiment will be discussed 
separately. 
 
6.1. In vivo distribution and fractionation of indium in Wistar 
rats after intraperitoneal administration of [114mIn]InCl3 
 
6.1.1. Treatment of animals 
 
Five male Wistar rats weighing between 200 and 250 g were maintained in individual 
polycarbonate cages in an environmentally controlled facility on a 12 h light/dark cycle. 
Handling of the animals (cleaning of the cages, injections) was done during the active dark 
period. The animals were allowed to acclimatise for 5 days. Food and water was supplied 
ad libitum. Each rat was given a daily intraperitoneal injection of 500 mL carrier-free 17.5 
mCi [114mIn]InCl3 on four consecutive days. Consecutive injections were preferred in order to 
mimic steady state conditions. The indium tracer, which was prepared according to the 
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procedure described in 5.1, was dissolved in a physiological hepes buffered saline solution. 
One hour after the last injection the animals were sacrificed. Blood was taken from the 
arteria carotis. Urine was collected only on the second day. Kidney, liver, spleen, hart, lung, 
testes, bone, skin, thyroid glands, bladder, stomach and small intestine were removed and 
washed with 0.9% NaCl solution. All samples were stored at -20°C prior to analysis. 
 
6.1.2. Distribution of indium in the body compartments and in the blood 
 
Depending on the amount of 114mIn radio activity and mass of the organ, the total organ or 
a portion were transferred into counting vials and their radioactivity measured with NaI(Tl) 
scintillation detection. The results, shown in table 6.1, are listed as % per gram organ (wet 
mass) and as % per organ (wet mass). 
 
Table 6.1. In vivo organ distribution of 114mIn in rats (mean and SD of five rats) 
expressed as % per gram organ of total activity in all measured organs and as % per 
organ of total activity in all measured organs. 
 
   
organ % per g organ % per organ 
   
   
liver 16.5 (4.5) 69.2 (7.3) 
kidney 17.1 (2.8) 10.8 (2.8) 
hart 2.7 (0.5) 0.7 (0.3) 
testes 2.8 (0.6) 2.3 (0.6) 
thyroid gland 3.7 (0.5) 0.5 (0.1) 
lung 4.4 (1.1) 2.0 (0.9) 
spleen 21.8 (2.1) 4.2 (0.6) 
stomach 6.6 (2.1) 3.0 (1.1) 
bladder 13.4 (5.6) 0.9 (0.3) 
small intestine 6.1 (2.9) 6.4 (3.1) 
bone 4.9 (1.0) a 
atotal bone mass not measured 
   
 
In both cases the values are denoted as percentage of the total amount of 114mIn activity 
found in all measured organs. The high amount of 114mIn in kidney, liver and spleen is 
consistent with the findings of other studies done by Castronovo and Wagner [1973]. In 
that study it is stated that the chemical form of the metal largely determines the 
distribution of indium in body tissues. The kidney extensively accumulates ionic indium 
while the liver, spleen and the reticulo-endothelial system accumulate colloidal indium 
oxide. The experiments were done with mice. In the present study 114mIn, originally 
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dissolved in concentrated hydrochloric acid, was adjusted to physiological pH with NaOH 
and then dissolved in a hepes buffered saline solution. Base induced hydrolysis of In3+ 
solutions causes precipitation at physiological pH. The outcome depends on the nature of 
the counter-anion and on the particular base and is influenced by temperature and by 
ageing of the precipitate. If halide ions are present, they are likely  to be incorporated in the 
precipitate (In2(OH)3Cl3), but in their absence In(OH)3 (hydrated indium oxide) is formed 
[Taylor and Brothers, 1993]. Considering that both kidney on the one hand and liver and 
spleen on the other hand account for a high amount of 114mIn activity, it might be supposed 
that the injected compound has mixed ionic and colloidal properties. Goodwin et al.  [1966] 
developed a method for liver scanning using a 113mIn colloid. They found that 80% of the 
injected dose was localised in the liver. I found a value of 69.2 ± 7.3 %. 
 
Table 6.2. Differential centrifugation schedule. 
 
   
step centrifugation parameters outcome 
   
   
1 300 x g, 10 min, 4°C removal of intact cells and plasma membrane 
2 1000 x g, 10 min, 4°C precipitation of nuclei, cytoskeleton (A) 
3 10000 x g, 20 min, 4°C precipitation of mitochondria (B) 
4 30000 x g, 30 min, 4°C precipitation of lysosomes, peroxisomes (C) 
5 100000 x g, 75 min, 4°C precipitation of ribosomes and small vesicles (D) 
   
 
Blood collected in anti-coagulant free vacuum tubes was centrifuged twice at 2000 x g and 
4°C for 20 min. The packed cells were washed twice with 0.9% NaCl solution. Both the 
serum fraction and the packed cell fraction were diluted to the same volume and measured 
for their 114mIn activity with a Ge(Li) detector. The measurement time was set to keep the 
relative standard deviation below 1%. Serum carries the major share of the 114mIn activity 
in blood. About 90.2 ± 1.8% (mean ± sd, n=4) of total blood 114mIn could be found in 
serum. One rat did not absorb the last injection dose. In that case the amount of 114mIn in 
serum was only 75.0%. This is possibly due to the fact that the clearance of indium from 
blood cells is slower than the clearance of indium from serum. 
 
Target organs (liver, kidney and spleen) were minced and a 1 + 4 suspension in 0.25 M 
sucrose solution containing 15 mM hepes at pH 7.4 was lysed in a borosilicate Potter-
Elvehjem type homogeniser fitted with a Teflon pestle. For the intracellular fractionation of 
Chapter 6. Indium: in vivo experiments 
______________________________________________________________________________________________________ 
 118
114mIn in the target organs a five-step differential centrifugation program was used (see 
table 6.2). By differentially increasing the centrifugal speed, smaller intracellular organelles 
will be precipitated. After each step, the homogenate and pellet are separated and a next 
step is carried out on the liquid fraction. The filtrate after step 5 consists of the cytosolic 
fraction (E) [Chen et al. , 1999]. After centrifugation all pellets and homogenates were 
diluted to the same volume and the 114mIn activity was measured with a Ge(Li) detector. 
The counting time was set variable in order to keep the relative standard deviation below 
2%. Table 6.3 shows the results of the in vivo intracellular distribution of 114mIn in kidney, 
liver and spleen. In all cases the cytosolic fraction accounts for the highest activity of 
114mIn, followed by the mitochondrial fraction. Fowler et al.  found that rats, given a single 
intraperitoneal injection of InCl3 in doses up to 40 mg/kg, showed an increased number of 
In-containing autophagic lysosomes [Fowler et al. , 1983]. This finding could not be 
confirmed. However, the difference might be due to the fact that in our study non-toxic 
tracer doses of In3+ were administered. 
 
Table 6.3. In vivo intracellular distribution (mean and SD of 5 rats) of 114mIn in kidney, 
liver and spleen. A: pellet of nucleus, B: pellet of mitochondria, C: pellet of lysosomes 
and peroxisomes, D: pellet of ribosomes and small vesicles, E: homogenate containing 
cytosol. Results denoted as percentage of total activity within each tissue homogenate. 
 
   
kidney liver spleen 
  
    
% in A 9.7 (4.10 6.3 (0.3) 3.4 (1.4) 
% in B 22.5 (1.0) 14.1 (2.2) 18.7 (2.9) 
% in C 5.7 (2.6) 1.7 (0.5) 7.7 (1.6) 
% in D 15.3 (1.0) 4.6 (0.4) 11.8 (1.5) 
% in E 46.8 (3.6) 73.3 (3.3) 58.4 (5.3) 
    
 
6.1.3. Fractionation of indium in body fluids 
 
The chromatographic separations were done with the Äkta Purifier 10 fast protein liquid 
chromatography system. Before injection into the system, all samples were filtered through 
0.22 mm syringe filters. All buffers were also filtered through a 0.22 mm filter and vacuum 
degassed. Proteins were detected by means of UV/VIS absorption spectrometry at 254, 280 
and 410 nm. The detection and quantification of albumin, transferrin, immunoglobulines 
was done by means of nephelometry. 
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Figure 6.1. Chromatogram of [114mIn]InCl3/rat serum separated on Superose 12 HR size 
exclusion column. 
 
 
Figure 6.2. Chromatogram of [114mIn]InCl3/rat serum separated on Asahipak 520-GS 7G 
size exclusion column. Same chromatogram with enlarged scale for the 114mIn activity 
(right). 
 
200 mL of 1+2 diluted rat serum was separated on a Superose 12 HR size exclusion (range 
5 - 300 kDa) column and also on an Asahipak 520 GS 7G multi-mode (exclusion limit 300 
kDa) column. A 10 mM hepes + 5 mM NaHCO3 + 0.15 M NaCl, pH 7.4 elution buffer was 
used. Fractions of 0.5 or 1 mL were collected and the 114mIn activity was measured by 
means of NaI(Tl) scintillation counting. The results of the chromatographic separation of rat 
serum are shown in figures 6.1 (Superose) and 6.2 (Asahipak). One peak at the retention 
time of transferrin can be observed in the chromatogram of serum separated on the 
Superose column. A slight increase in the 114mIn activity over the albumin fraction can be 
seen in the case of separation on the Asahipak column. In vitro, there is - depending on 
the pH of InCl3 - a varying amount of indium bound to transferrin and a low molecular 
0
200
400
600
800
1000
1200
1400
1600
1800
2000
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
retention volume [mL]
a
b
so
rb
a
n
ce
 2
8
0
 n
m
 [
m
A
U
]
0
50000
100000
150000
200000
250000
300000
a
ct
iv
it
y 
1
1
4
m
-I
n
 [
co
u
n
ts
]
absorbance 280 nm
activity 114m-In
0
200
400
600
800
1000
1200
1400
1600
1800
2000
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
retention volume [mL]
a
b
so
rb
a
n
ce
 2
8
0
 n
m
 [
m
A
U
]
0
1000
2000
3000
4000
5000
a
ct
iv
it
y 
1
1
4
m
-I
n
 [
co
u
n
ts
]
absorbance 280 nm
activity 114m-In
0
300
600
900
1200
1500
1800
2100
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
retention volume [mL]
ab
so
rb
an
ce
 2
8
0
 n
m
 [
m
A
U
]
0
10000
20000
30000
40000
50000
60000
70000
ac
ti
vi
ty
 1
1
4
m
-I
n
 [
co
u
n
ts
]
absorbance 280 nm
activity 114m-In
Chapter 6. Indium: in vivo experiments 
______________________________________________________________________________________________________ 
 120
mass compound and a negligible amount of indium is bound to albumin. Also in vivo a 
small amount seems to be bound to albumin. On the other hand in vivo indium is not 
bound to LMM compounds. 
 
500 mL undiluted rat serum was also separated using anion exchange chromatography on a 
Hi Trap Q anion exchange column. The result can be seen in figure 6.3. The majority of the 
indium activity is associated with the transferrin fraction although a small fraction can be 
observed in the albumin fraction and also in the void volume. The amount of 114mIn 
associated with albumin varies between 0.5 and 0.8% (4 sera of 2 rats). 
 
 
Figure 6.3. Chromatogram of [114mIn]InCl3/rat serum separated on Hi Trap Q anion 
exchange column. Same chromatogram with detailed activity axis (right). 
 
Prior to chromatographic separation, packed cells were lysed by successive thawing and 
freezing. Afterwards the partially lysed cells were diluted 1 + 5 in elution buffer and further 
disrupted in a Potter-Elvehjem homogeniser. Afterwards the homogenate was centrifuged 
at 13000 x g and 4°C during 40 min to remove remaining cell membranes. No separation 
was made between red (>99%) and white (<1%) blood cells. A volume of 200 mL was 
injected on a Superose 12 HR; 1 mL was brought onto a self -packed Sephacryl S-200 HR 
size exclusion (range 5-250 kDa) column. Fractions of 1 and 2 mL, respectively were 
measured for their 114mIn activity with a NaI(Tl) scintillation detector. Elution was done with 
a 15 mM hepes + 0.15 M NaCl, pH 7.2 buffer. The chromatogram of the in vivo speciation 
of 114mIn in blood cell lysate separated on the Superose 12 HR column is shown in figure 
6.4. As was also noted during the in vitro experiments 114mIn comes slightly ahead of the 
haemoglobin. In3+ is said to influence the haem biosynthesis in red blood cells by inhibiting 
the enzymatic activity of d-aminolevulinic acid dehydratase (ALAD) [Conner et al. , 1995]. 
ALAD catalyses the second step of the pathway, i.e., the condensation of aminolevulinic 
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acid to form the monopyrole, porphobilinogen [Goering et al. , 1987]. From the 
chromatogram it can be seen that there is no major association between indium and the 
enzyme (MM 290 kDa), which elutes at the retention volume 7-9 mL. It could be postulated 
that the influence of indium on the haem biosynthetic pathway is caused by an indirect 
interaction, rather than to be due to a direct binding to the enzyme, as has been stated for 
lead e.g., [Bergdahl and Schütz, 1996]. In the latter case, lead displaces zinc from its SH-
mediated binding site, thereby producing an inhibitory effect. In order to confirm the 
finding about no association between ALAD and indium, the experiments were repeated on 
a Sephacryl S-200 HR column. The results were the same. 
 
 
Figure 6.4. Chromatogram of [114mIn]InCl3/rat blood cell lysate separated on Superose 
12 HR size exclusion column. 
 
200 mL of undiluted urine was injected on a Superdex Peptide HR size exclusion column. 
The working range of this column covers the low molecular mass fraction (100 - 7000 Da). 
Fractions of 1 ml were taken and the activity was measured with a NaI(Tl) scintillation 
detector. Elution was done with a 15 mM hepes + 0.15 M NaCl, pH 6.5 buffer. The 
separation of rat urine on size exclusion chromatography is shown in figure 6.5. In urine, 
indium is mostly bound to the low molecular mass fraction, with a maximum at the 
retention volume 16.5 - 17.5 mL, corresponding to a molecular mass of 300 - 1000 Da; 
only a small amount of 114mIn can be found in the void volume (> 7000 Da). In chapter 5 
where the binding of In3+ to the low molecular mass fraction in serum was discussed, we 
have postulated that indium occurs as In(OH)3, though is possibly complexed by the buffer 
(hepes and tris:HCl). Taillefert et al.  [2000] have reported a similar behaviour for soluble 
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Fe3+ solutions complexed to tris:HCl buffer. In urine similar complexation between free In3+ 
and elution buffer might occur. 
 
 
Figure 6.5. Chromatogram of [114mIn]InCl3/rat urine separated on Superdex Peptide size 
exclusion column. 
 
6.1.4. Fractionation of indium in organs 
 
Liver, kidney, spleen and lung were minced and homogenised as described above and the 
soluble fraction was obtained after centrifugation at 100000 x g and 4°C for 100 min. A 
volume of 200 mL 1+1 diluted or undiluted solution was injected on a Superose 12 HR 
column. Fractions of 0.5 or 1 mL were taken and the activity was measured with a NaI(Tl) 
scintillation detector. Elution was done with a 15 mM hepes + 0.15 M NaCl, pH 7.2 buffer. 
The results of the separation of liver, kidney, spleen and lung cytosol with size exclusion 
chromatography are shown in figure 6.6. In all cases, it appears that indium preferentially 
binds to the high molecular mass fraction. Small amounts appear in he void and in the total 
volume of the column in the case of spleen, liver and lung. A considerable amount of 114mIn 
appears in the total volume of the column in case of the kidney. This high amount of 114mIn 
in the HMM fraction might be partly due to serum transferrin still present in the organs 
after homogenisation. However, the activity peak in both cases is much broader than in the 
case of rat serum whereas the concentration of the residual transferrin in the organs 
should be much lower than in serum. Thus, it is expected that another high molecular mass 
compound is capable of binding indium, leading to an unresolved 114mIn activity peak. This 
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is illustrated in figure 6.7. For serum, and the homogenates of kidney, liver and spleen, an 
identical chromatographic separation was carried out, but fractions of 500 mL were 
collected instead of 1 mL. Details of the chromatograms are shown in the figures. It can 
clearly be seen that the elution profile of 114mIn shows a much broader peak shape in case 
of the organ tissue homogenates compared to that in serum. The fact that In3+ binds to 
more than one HMM compound can also be derived from the anion exchange experiments 
on the Hi Trap Q column. This is illustrated in figure 6.8. 
 
 
Figure 6.6. Chromatograms of [114mIn]InCl3/rat liver cytosol (top left), [
114mIn]InCl3/rat 
kidney cytosol (top right), [114mIn]InCl3/rat spleen cytosol (bottom left) and 
[114mIn]InCl3/rat lung cytosol (bottom right) separated on Superose 12 HR size 
exclusion column. 
 
The activity can be found over different fractions. The 114mIn activity found at the retention 
time around 30 minutes is most probably due to transferrin. In the case of lung cytosol this 
is clearly illustrated. Removal of blood from this organ was difficult to achieve and this 
possibly explains the high amount of indium activity recovered from this fraction. All 
cytosolic fractions show an analogous distribution pattern of 114mIn. 
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Figure 6.7. Detailed part of chromatogram of [114mIn]InCl3/rat liver cytosol (top left), 
[114mIn]InCl3/rat kidney cytosol (top right), [
114mIn]InCl3/rat serum (middle), 
[114mIn]InCl3/rat spleen cytosol (bottom left) and [
114mIn]InCl3/rat lung cytosol (bottom 
right) separated on Superose 12 HR size exclusion column. 
 
Only in the case of kidney cytosol does a considerable amount of indium appear in the low 
molecular mass fraction. In3+ influences hepatic and renal ALAD activity in vitro; however, 
In3+ inhibits only renal ALAD in vivo. [Woods and Fowler, 1982]. These authors postulated 
that this tissue-specific effect is due to the preferential accumulation of indium by the 
kidney proximal-tubule cells with selective localisation in the cytosol. Zinc reverses the 
indium-induced inhibition of renal ALAD in vitro and in vivo, suggesting that indium acts by 
binding groups on the enzyme. Although we also found that indium preferentially 
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accumulated in the cytosolic fraction, the chromatogram shows no direct binding of indium 
with ALAD and thus replacement of zinc. Therefore the inhibition may be rather due to 
some other indirect interaction. Again the fact that background levels, far below toxic doses 
have been used throughout these experiments may be a plausible explanation for the 
differences between both findings. 
 
 
Figure 6.8. Chromatogram of [114mIn]InCl3/rat liver cytosol (top left), [
114mIn]InCl3/rat 
kidney cytosol (top right), [114mIn]InCl3/rat spleen cytosol (bottom left) and 
[114mIn]InCl3/rat lung cytosol (bottom right) separated on Hi Trap Q anion exchange 
column. 
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6.2. In vivo distribution and fractionation of indium in Wistar 
rats after subcutaneous administration of [114mIn]InAs 
 
6.2.1. Production of [114mIn]InAs 
 
The production of [114mIn]InAs can be obtained via two possible routes. In-house produced 
114mIn (as a hydroxide or a salt) could be used for the manufacturing of InAs by epitaxial 
layer growth techniques. Alternatively InAs could be irradiated in a nuclear reactor. The 
first approach could not be considered due to practical limitations. The disadvantage of the 
second approach would be the extremely long irradiation time. 114mIn can be obtained by 
neutron bombardment of 113In. However, the natural abundance of this isotope is only 
4.33%. Given the fact that the thermal neutron flux of the Thetis reactor of our institute is 
only 1 x 1012 n.s-1.cm-2, obtaining a substantial amount of 114mIn would take several 
months. Therefore it was decided to use the facilities of the Study Centre for Nuclear 
Energy (SCK, Mol Belgium). Commercially available InAs was grinded in an agate mortar in 
order that the main particle size was below 10 mm, as controlled with a microscope. The 
powder was irradiated for 1 week in the BR-II reactor at the SCK with a neutron flux of 
1.5x1014 n.s-1.cm-2. This was 100 times as high as in our institute. [114mIn]InAs is formed by 
the nuclear reaction 113In (n,g) 114mIn (t½ 49.5 d). A cooling period of several weeks was 
respected for radioactive decay of the short living 116mIn (t½ 54.2 min) and 76As (t½ 26.3 h). 
 
6.2.2. Treatment of animals 
 
Five male Wistar rats weighing between 200 and 250 g were maintained in individual 
polycarbonate cages in an environmentally controlled facility on a 12 h light/dark cycle. The 
animals were allowed to acclimatise for at least 7 days. Food and water was supplied ad 
libitum. Handling of the animals (cleaning of the cages, injections) was done during the 
active dark period. Every rat was given two subcutaneous injections of 200 mL containing a 
suspension of 450 mCi [114mIn]InAs each on day 1 and 2. The total amount was equivalent 
to a dose of 50 mg InAs per kg body mass. The indium tracer was suspended in a 
physiological hepes buffered saline solution. Two rats were housed in a metabolic cage in 
order to collect urine and faeces. 15 days after the first injection the animals were 
sacrificed. Blood was taken from the arteria carotis. Kidney, liver, spleen, hart, lung, testes, 
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bone, skin and fur, bladder, stomach, small and large intestine were removed and washed 
with 0.9% NaCl solution. Blood, urine and organs were stored at -20°C prior to analysis. 
 
6.2.3. Distribution of indium in the body compartments 
 
Figure 6.9 shows the clearance of indium by faecal excretion after subcutaneous 
administration of [114mIn]InAs. The highest amount of activity was found at the first 
collection, two days after the first injection. After 8 days, no further decrease in faecal 
114mIn activity was noticed. A given amount of 114mIn found in the faeces after two days 
means that in vivo dissociation and uptake by the blood must have occurred within this 
time span. Most of this indium is, however, not stored in the organs and excreted through 
the faeces. Probably more and more indium is taken up by the organs within the next days 
to reach an equilibrium between absorbed and unabsorbed indium after 8 days. Only on 
the second day after the first injection, a detectable amount of 114mIn was found in the 
urine. The major route of excretion is thus faecal.  
 
 
Figure 6.9. Faecal excretion of 114mIn in function of time. 
 
Depending on the amount of 114mIn and mass of the organ, the total organ or a portion was 
transferred into polyethylene counting vials and its radioactivity was measured with a 
NaI(Tl) scintillation detector for 5 min. The in vivo distribution of indium over the different 
organs after sc injection of [114mIn]InAs is listed in table 6.4. The results are shown as 
percentage per gram organ (wet mass) and percentage per organ (wet mass). In both 
100
1000
10000
100000
1000000
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
time [days]
sp
ec
if
ic
 a
ct
iv
it
y 
[c
o
u
n
ts
 /
 g
 f
a
ec
es
] rat 1
rat 2
Chapter 6. Indium: in vivo experiments 
______________________________________________________________________________________________________ 
 128
cases the values are expressed as the percentage of the total amount of 114mIn activity 
found in all measured organs. On a percentage per gram organ base, spleen, kidney and 
liver account for the majority of the indium activity. On a percentage per organ base, liver 
is the major target organ. The results are also in close agreement with those obtained after 
intraperitoneal administration of [114mIn]InCl3 (see 6.1.2). This could indicate that InAs 
behaves similarly to InCl3 in vivo. Yamauchi et al.  [1992] have postulated that InAs is 
partially dissociated in vivo to form inorganic arsenic and indium. Experiments were done 
with hamsters that were given a single s.c. injection of InAs at a dose of 100 mg/kg body 
mass. They concluded that InAs dissolves slowly over time with deposits at the site of 
injection. They also measured the concentrations of indium in liver, kidney, lung and spleen 
up to 30 days after the administration. The highest concentrations were found in kidney 
followed by liver. Lower amounts appeared in spleen and lung. For all organs a maximum 
value was obtained after 30 days. Also in our case a major amount of 114mIn activity was 
deposited at the site of injection and dissolved slowly over time. In this study 15 days was 
respected between the time of administration and sacrificing. 
 
Table 6.4. In vivo organ distribution of 114mIn (mean and SD of 5 rats) in rats expressed 
as % per gram organ (wet mass) and as % per organ of total activity in all measured 
organs. a total bone, skin & fur and tissue mass not measured. 
 
    
organ mass [g] % per g organ % per organ 
    
    
large intestine 2.5 (0.5) 2.3 (0.3) 1.6 (0.1) 
small intestine 4.2 (0.7) 2.4 (0.5) 2.9 (0.3) 
stomach 1.6 (0.2) 2.7 (0.3) 1.3 (0.2) 
testes 3.3 (0.3) 3.8 (0.2) 3.7 (0.4) 
hart 1.1 (0.1) 3.3 (0.5) 1.0 (0.1) 
lung 2.1 (0.3) 3.6 (0.7) 2.2 (0.5) 
spleen 0.8 (0.1) 26.8 (4.3) 6.2 (1.5) 
kidney 2.6 (0.2) 26.3 (2.6) 20.5 (2.6) 
liver 17.2 (1.6) 12.0 (0.8) 60.5 (2.6) 
bone a 7.1 (0.5) a 
skin & fur a 7.0 (4.7) a 
tissue a 2.1 (0.6) a 
a total mass not measured 
    
 
Organs were minced and a 1 + 4 suspension in 0.25 M sucrose solution containing 15 mM 
hepes, pH 7.4 and lysed in a mechanical homogeniser. For the intracellular fractionation of 
114mIn in liver, kidney and spleen the same five-step centrifugation program as described 
above was used. After centrifugation all pellets and homogenates were diluted to the same 
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volume and the 114mIn activity was measured with a Ge(Li) detector. The counting time was 
set variable in order to keep the relative standard deviation below 2%. 
 
Table 6.5 shows the results of the in vivo intracellular distribution of 114mIn in kidney, liver 
and spleen after sc administration of [114mIn]InAs. In all cases the cytosolic fractions 
account for the highest activity of 114mIn. Lower amounts of indium can be found in the 
mitochondrial fraction of kidney, liver and spleen and in the nuclear fraction of spleen. 
These results are again in close agreement with those obtained in a previous study, except 
for the rather high amount of 114mIn in the nuclear fraction of spleen found in this 
experiment. Moreover it was not possible to show an increased amount of indium-
containing autophagic lysosomes, as was postulated by Fowler et al.  [1983]. 
 
Table 6.5. In vivo intracellular distribution of 114mIn (mean and SD of 5 rats) in kidney, 
liver and spleen. A: pellet of nucleus, B: pellet of mitochondria, C: pellet of lysosomes 
and peroxisomes, D: pellet of ribosomes and small vesicles, E: homogenate containing 
cytosol. Results denoted as percentage of total activity within each tissue homogenate. 
 
 liver spleen kidney 
    
    
% in A 2.4 (1.7) 20.1 (9.1) 10.2 (1.1) 
% in B 14.2 (5.6) 16.4 (3.7) 19.2 (0.7) 
% in C 4.1 (1.4) 12.7 (2.1) 6.2 (1.4) 
% in D 8.1 (2.2) 10.6 (0.5) 7.4 (2.0) 
% in E 71.2 (5.3) 40.1 (6.7) 57.0 (1.4) 
    
 
6.2.4. Fractionation of indium in body fluids and organs 
 
Blood was centrifuged twice at 2000 x g and 4°C for 20 min. The packed cells were washed 
twice with 0.9% NaCl solution. Both the serum fraction and the packed cell fraction were 
diluted to the same volume and measured for their 114mIn activity with a Ge(Li) detector. 
The measurement time was set to keep the relative standard deviation below 1%. At the 
end of the experiment 77% of all blood activity was found in serum. This is due to the high 
affinity for the serum protein transferrin, which transfers many metals, especially trivalent 
metals, to the target organs. 
 
The chromatographic separations were done in analogy with the experiments described 
above. A semi-preparative Sephacryl S-200 HR size exclusion (range 5-250 kDa) column 
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and a self -packed Bio-Gel P2 (range 0.1-1.8 kDa) size exclusion column were used. The low 
activity present in the samples did not allow the use of analytical columns. Instead semi-
preparative columns with a higher sample load capacity, but lower resolution, had to be 
chosen. 500 mL undiluted rat serum was injected on both columns and eluted with a 10 mM 
hepes + 5 mM NaHCO3 + 0.15 M NaCl, pH 7.4 elution buffer. Fractions of 1 or 2 mL were 
collected and the 114mIn activity was measured by means of NaI(Tl) scintillation counting. 
Figures 6.10a shows the chromatogram of the separation of rat serum on the Sephacryl S-
200 size exclusion chromatography column. The chromatogram shows that indium is 
almost exclusively bound to the high molecular mass, namely with a compound eluting at 
around 57 mL. This is also the retention volume of transferrin. The same conclusion can be 
drawn from the separation on the Bio-Gel P2 column (figure not shown): the 114mIn activity 
appears in the dead volume of the Bio-Gel P2 column, indicating that indium is associated 
with the mass fraction above 1.8 kDa. In paragraph 6.1.3 it was shown that in rat serum, 
after i.p. injection of [114mIn]InCl3, indium is associated with transferrin. It seems that 
indium shows a similar behaviour in serum after injections of InAs or InCl3. The route of 
exposure appears to be of minor importance. With these columns it is impossible to 
separate albumin from transferrin. Therefore rat serum was also chromatographed with 
anion exchange on a Hi Trap Q column with 10 mM hepes + 5 mM NaHCO3 , pH 7.4 (buffer 
A) and 10 mM hepes + 5 mM NaHCO3 , pH 7.4 + 1 M NaCl, pH 7.4 (buffer B). The result is 
shown in figure 6.10b. Except for a small (6.6%) amount of 114mIn recovered from the void 
volume, only one peak eluting at the retention time of transferrin can be seen. No 
radioactivity is found in the albumin fraction. 
 
 
Figure 6.10a. Chromatogram of [114mIn]InAs/rat serum separated on Sephacryl S-200 
HR size exclusion column (left). 
 
Figure 6.10b. Chromatogram of [114mIn]InAs/rat serum separated on Hi Trap Q anion 
exchange column (right). 
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Liver, kidney and spleen were minced and homogenised as described above and the 
soluble fraction was obtained after centrifugation at 100000 x g and 4°C for 100 min. 1 mL 
was injected on a Sephacryl S-200 HR column. Fractions of 2 mL were taken and the 
activity was measured with a NaI(Tl) scintillation detector. Elution was done with a 15 mM 
hepes + 0.15 M NaCl, pH 7.2 buffer. 
 
 
Figure 6.11. Chromatograms of [114mIn]InAs/rat liver cytosol (top left), [114mIn]InAs/rat 
kidney cytosol (top right) and [114mIn]InAs/rat spleen cytosol (bottom) separated on 
Sephacryl S-200 HR size exclusion column. 
 
Figure 6.11 shows the chromatograms of the cytosolic fraction of liver, kidney and spleen 
on the Sephacryl S-200 HR SEC column. Also in this case it is demonstrated that indium is 
mostly bound to the high molecular mass fraction. The small fraction that elutes in the 
dead volume of the column might be due to binding of In3+ to the haem regulating enzyme 
d-aminolevulinic acid (ALAD). Several studies postulate that indium is capable of regulating 
the haem biosynthesis in kidney, liver and erythrocytes by altering the activity of ALAD 
[Woods et al. , 1979; Woods and Fowler, 1982; Fowler et al. , 1983; Goering et al. , 1987; 
Aoki et al., 1990; Conner et al. , 1995]. ALAD is the enzyme that catalyses the second step 
in the biosynthetic pathway, namely the condensation of aminolevulinic acid to form 
porphobilinogen. The enzyme has a molecular mass of 290 kDa and thus appears in the 
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dead volume of the column (>250 kDa). In any case ALAD is not the major complexing 
agent of indium in these matrices. The presence of 114mIn in the high molecular mass 
fraction might be partly due to binding with transferrin. Transferrin is a normal constituent 
of cells and may also be present as a result of the incomplete removal of blood from the 
organs. The major share of 114mIn elutes, however, at a retention time that is slightly 
smaller than that of transferrin. So it is expected that other compound(s) are also able to 
complex indium. Both the results of the in vivo distribution among the different organs and 
of the intracellular distribution in the three target organs are very similar to those obtained 
after intraperitoneal administration of [114mIn]InCl3. Moreover, the chromatograms of 
serum, and homogenate of spleen, kidneys and liver look very similar to those obtained in 
the first study. Thus it can be concluded that both InCl3 and InAs act similarly, the route of 
exposure playing a minor role. The close agreement also suggests that InAs is dissociated 
in vivo after it is dissolved and will have a chemical form which is partly ionic and colloidal.  
 
6.3. In vivo distribution and fractionation of indium in Wistar 
rats after oral administration of [114mIn]InAs 
 
6.3.1. In vitro solubility of InAs 
 
Prior to this in vivo experiment, the in vitro solubility of cold InAs in simulated gastric fluid 
(SGF) and simulated intestinal fluid (SIF) as a function of time was investigated. The 
purpose of this experiment was to found out more about the degree of solubility, the 
kinetic aspect by which this happens and thus get an idea about the bioavailability of 
indium and arsenic. Two solutions containing 36 mg InAs were prepared in 80 mL SGF and 
SIF, respectively. The final concentration of indium was 272.3 mg/L. SGF and SIF were 
prepared according to the USP regulations [US Pharmacopeia, 2000]. For the preparation 
of SGF, 2.0 g NaCl and 3.2 g pepsin (from porcine stomach mucosa, with an activity of 800 
to 2500 units per mg of protein) were dissolved in 7 mL HCl and sufficient water to make 1 
L. This test solution has a pH of about 1.2. For the preparation of SIF, 6.8 g of KH2PO4 was 
dissolved in 250 mL water, and 77 mL 0.2 M NaOH and 500 mL water was added. After 
addition of 10.0 g pancreatin (from porcine pancreas, activity at least equivalent to USP 
specifications), the pH was adjusted to 6.8 with either NaOH or HCl. The solution was 
finally diluted with water to 1 L. Both solutions were incubated at 37°C in a mechanical 
shaker during 48 hours. After 0, 15, 30 min, 1, 2, 4, 8, 12, 24, 36 and 48 hours, a 1 mL 
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sample was pipetted from the solution, filtered through a 0.22 mm filter to remove particles 
of InAs and diluted 100 times. For the determination of indium in SGF and SIF, graphite 
furnace atomic absorption spectrometry (GF-AAS) was used. All samples were diluted with 
0.2% HNO3. Two sets of standard series were prepared in both SGF and SIF and diluted to 
the same extent as the samples. InAs was only slightly soluble in SGF: 3.5 mg/L or 1.3% 
was dissolved after 48 hours. InAs was not soluble in SIF. InAs shows a solubility behaviour 
that is different from that of GaAs. The in vitro solubility studies of GaAs in physiological 
buffers and in a hydrochloric acid solution showed that it dissolved to a high extent after 48 
hours [Webb et al. , 1984]. 
6.3.2. Treatment of animals 
 
Five male Wistar rats weighing between 200 and 250 g were maintained in individual 
polycarbonate cages in an environmentally controlled facility on a 12 h light/dark cycle. The 
experiment started on day 1. The animals were allowed to acclimatise for 19 days. Food 
and water were supplied ad libitum. Handling of the animals (cleaning of the cages, 
injections) was done during the active dark period. The last three days of this period the 
animals were transferred to a metabolic cage. Urine and faeces were collected daily. The 
animals were weighted each day and the food and water consumption was calculated. On 
day 20, 23, 26 and 30, the rats were supplied with an equal oral dose of [114mIn]InAs. In 
total the rats were given a dose of 9 mCi. This corresponds to a dose of 40 mg InAs per kg 
body mass. The production of the radiolabeled indium was identical as in paragraph 6.2.1. 
However, irradiation time was 3 weeks instead of 1. This explains the higher specific 
activity and consequently the lower dose per kg body mass. The [114mIn]InAs was put on 
top of the food. Four days after the last administration the animals were sacrificed. Kidney, 
liver, spleen, hart, lung, testes, pancreas, thyroid gland, thymus, bone, fat, muscle, skin 
and fur, stomach, small and large intestine were removed and washed with 0.9% NaCl 
solution. Blood, urine and organs were stored at -20°C prior to analysis. 
 
6.3.3. Excretion of indium 
 
During this experiment four doses were given p.o. to the rats. Virtually all indium activity 
was each time found in the faeces within the next 72 hours. This is in agreement with the 
low extent of in vitro solubility of InAs in SGF. Only very small amounts of 114mIn were 
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recovered from urine. Figure 6.12 shows the time dependent plot of the amount of 114mIn 
found in the faeces. It is clearly shown that all rats show almost identical behaviour. A 
maximum amount of activity in the faeces is found between 24 and 48 hours after each 
oral administration. The slight discrepancies between the rats might be partly due to 
different eating times. No straightforward conclusion about the kinetics of urinary excretion 
can be drawn from the results of urinary 114mIn versus time (figure not shown). The 114mIn 
activity was multiplied by the volume of the urine to compensate for the differences in 
urinary behaviour. A maximum 114mIn signal was noticed at around 72 hours after each oral 
administration. A wide variation is seen, partly caused by the different time of eating. The 
oral administration was not forced. The InAs particles were simply put on top of the food. 
It seems that urinary excretion is slower and much less important in comparison with faecal 
excretion. This is due to the very low solubility of InAs in the stomach. 
 
Figure 6.12. Faecal excretion in function of time. The vertical bars indicate the time 
when the rats were administered an oral dose. Time = 0 at day 20. 
 
Due to the presence of residual 114mIn in the organs of the gastrointestinal tract, it was 
impossible to accurately calculate the in vivo distribution of 114mIn. Some trends can, 
however be seen. In contrast to the in vivo distribution of 114mIn after i.p. and s.c. 
administration of [114mIn]InCl3 and [114mIn]InAs respectively, the spleen is not a major 
target organ. Kidney and liver show only moderate affinity for InAs. Even on a percentage 
per organ base, kidney is more affected than liver. The lungs seem to be the most 
important target organ. A reason for the high amount of indium activity found in the lungs 
of the rats might be that part of the InAs particles that were put on top of the food, was 
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inhaled. Indeed the InAs particles are very small (<10 mm) and black spots were seen on 
the nose of the animals. Moreover animals have the habit to sniff at their food before 
eating. Bone, thymus, thyroid gland, testes, fat, muscle and heart contain only very low 
amounts of 114mIn or none. The organs of the gastrointestinal tract (stomach, small 
intestine, large intestine) and related organs (pancreas) have the highest amounts of 
114mIn. A considerable amount of 114mIn is found in the fur/skin. These data indicate that 
uptake of indium is very low. Indium present in liver, kidney and spleen indicates that 
indium has been taken up by the body. After i.p. injection of a physiological solution of 
[114mIn]InCl3 the indium enters the bloodstream within a few minutes. Kidneys and liver 
excrete this indium, but it is also taken up by these organs. In case of the subcutaneous 
administration, InAs slowly dissolves and will be taken up by the blood that flows through 
the muscles of the site of injection. Excretion occurs in the kidneys and the liver and indium 
is slowly absorbed and distributed among the different organs. In case of oral 
administration, however, in vivo solubility is too slow compared to the process of ingestion, 
digestion and excretion. The majority of the InAs particles leave the body unchanged. It 
can thus be concluded that p.o. administered InAs will not accumulate in the body. 
 
Many of these findings are in agreement with those of Zheng et al. [1994]. In that study 
InP was administered p.o. and i.t. to rats. As a conclusion of their experiments they stated 
that it seems unlikely that indium will accumulate in the body following InP exposure. As is 
also described in that study, the moderate amount of 114mIn found in skin/fur might be due 
to contamination and/or skin excretion. In this experiment the rats were housed in 
metabolic cages and although the cages were regularly cleaned, the animals came 
continuously into contact with the InAs. To my knowledge this is the first study in which 
InAs was given orally to test animals. Previous studies dealing with InAs or other indium 
containing semiconductor compounds were carried out by Omura et al.  [1996a, 1996b], 
Conner et al.  [1995], Tanaka et al.  [1994, 1996], Morgan et al.  [1995], Yamauchi et al.  
[1992] and Zheng et al.  [1994]. All these experiments were done with either i.t. or s.c. 
instillations to rats or hamsters, except for Zheng et al.  [1994] who fed rats orally with InP. 
Not only is the route of administration very important in terms of bioavailability, also very 
high amounts of InAs were administered in some cases. Subcutaneous, intraperitoneal or 
intratracheal administration is very useful to find out more about the distribution into the 
organism, the toxic effects of a compound or binding of the compound to biological 
components in blood or tissue. These methods of administration give, however, no data 
about the uptake in the body and thus the degree of toxicity of the compound. Moreover, 
Chapter 6. Indium: in vivo experiments 
______________________________________________________________________________________________________ 
 136
the very high amounts of InAs given to the test animals in some studies do not reflect 
reality. Administered doses of 1 g/kg would be equal to 80 grams of InAs for a person 
weighing 80 kg. Giving these high amounts of InAs will eventually always lead to toxic 
effects. In the last study, rats were fed with InAs at a dose of 40 mg per kg body mass, an 
amount that would be equal to 3.2 grams of InAs for a worker weighing 80 kg. Even in the 
latter case it is unlikely that a person, working in a workshop where InAs is manufactured 
or processed, will ingest this amount. It was clear from these studies that s.c. 
administration is a much more efficient route of exposure compared to p.o. administration. 
Much higher doses (in terms of specific activity of 114mIn) were given in the oral study, but 
much higher amounts of 114mIn were recovered from the body organs and the body fluids in 
our subcutaneous study. 
 
6.4 Conclusion 
 
After repeated intraperitoneal administration (4 doses in 4 days) of [114mIn]InCl3 to male 
Wistar rats, 114mIn is primarily found in liver, kidney and spleen. Within the cells of these 
organs 114mIn is recovered mainly from the cytosolic fraction followed by the mitochondria. 
In blood 114mIn localises mainly in serum. Fractionation analysis shows that in serum In3+ is 
exclusively bound to the HMM fraction. Transferrine is the main complexor. The amount of 
In3+ bound to albumin is less than 1%. In3+ elutes slightly ahead of the haemoglobin 
fraction. Residual transferrin may be responsible for this binding. Fractionation analysis of 
the cytosolic fraction of liver, kidney, spleen and lung shows that In3+ is mainly found in the 
HMM fraction, but anion exchange chromatographic analysis shows that transferrin is not 
the sole complexor. 
 
After duplicate subcutaneous administration of [114mIn]InAs to male Wistar rats, major 
amounts of 114mIn were again found in liver, kidney and spleen. Also the intracellular 
distribution was in good agreement with the one obtained in the first study. In serum, 
114mIn was found in the transferrine fraction and in the cytosolic fraction of liver, kidney and 
spleen, 114mIn was recovered mainly from the HMM fraction. The similarities between both 
experiments indicate that InAs dissociates slowly over time and behaves like InCl3. 
 
After oral administration (4 doses in 10 days) of [114mIn]InAs to male Wistar rats, more than 
99% of the administered InAs was found in the faeces. 114mIn was mainly recovered from 
Chapter 6. Indium: in vivo experiments 
______________________________________________________________________________________________________ 
 137
the organs of the GI tract. Oral administration does not lead to accumulation of InAs in the 
body. 
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Chapter 7. Arsenic: optimisation 
of ES-MS/MS and UV-HG-AFS 
 
 
 
 
Hydride generation atomic fluorescence spectrometry (HG-AFS) and electrospray mass 
spectrometry (ES-MS/MS) were primarily considered for elemental and molecular detection, 
respectively, of the arsenic species in extracts of algae, urine and serum. HG-AFS was 
chosen because of its low cost and high sensitivity. Moreover, its small size was 
advantageous in view of the on-line dual detection. Using this instrumental set-up, 
elemental and molecular/structural information can be gained at the same time, within the 
same HPLC run. This may be an interesting feature when searching for unknown arsenic 
species. Information about an unknown species by ES-MS/MS is gathered at exactly the 
same time HG-AFS registers a signal for elemental arsenic. 
 
At first the instrumental parameters of both instruments were optimised in order to obtain 
a good sensitivity for both systems. For evaluation of the sensitivity, the signal intensity is 
not always a reliable parameter. An increase in signal intensity does not necessarily result 
in a lower detection limit. Instead a signal to noise (S/N) calculation is preferred. For the 
determination of the S/N, peak-to-peak was selected, i.e., the greatest height of the peak 
above the mean noise value is divided by the variance of the selected noise range. Those 
scans in the noise range whose deviation is greater than one standard deviation are 
rejected. In case of HPLC-ES-MS/MS and HPLC-HG-AFS, a S/N measurement was preferred. 
In case of direct infusion ES-MS/MS signal intensities were compared. 
 
Next it was checked whether UV-HG-AFS allowed quantitative on-line photo-oxidation of 
arsenic species in real-life samples. Furthermore, optimal conditions to perform dual 
detection were investigated and the capabilities of HPLC-ES-MS/MS were explored using 
algae samples. 
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7.1. Optimisation of ES-MS/MS 
 
A Quattro Micro electrospray tandem mass spectrometer (ES-MS/MS) was installed in the 
laboratory in August 2001. Although ES-MS/MS has been used previously by other 
researchers in the field of arsenic speciation analysis, the use of this type of mass 
spectrometer was novel. As it is well known that the sensitivity of ES-MS/MS is species 
dependent and strongly influenced by the sample matrix (salts, organic solvents, acids, 
bases…) a thorough optimisation had to be done. 
 
The following instrument parameters were first optimised: capillary voltage, cone voltage, 
collision energy, desolvation temperature, desolvation gas flow rate, cone gas flow rate, 
sample flow rate, methanol content in the elution buffer (HPLC) and formic acid content in 
the sample (infusion). The influence of the type of buffer on the signal intensity of the 
different arsenic species will be discussed in paragraph 7.4. 
 
7.1.1. Optimisation of voltages and collision energy 
 
In a first stage, instrument parameters such as capillary voltage, sample cone voltage, 
extraction cone voltage, hexapole RF lens voltage and collision energy were investigated. 
These parameters are species dependent. The capillary voltage is applied to the stainless 
steel capillary and supplies an excess of charge to the droplets. In positive ion mode, it 
optimises at 3.0 kV, although some samples may tune at values above or below this, within 
the range 2.5 to 4.0 kV. For negative ion operation, a lower capillary voltage is necessary, 
typically between 2.0 and 3.0 kV. The sample cone voltage assists in drawing the ions into 
the first vacuum region (first orthogonal spray). A sample cone voltage setting between 25 
and 70 V will produce ions for most samples, although solvent ions prefer the lower end 
and proteins the higher end of this range. The sample cone voltage has the biggest 
influence on the sensitivity. Increasing the cone voltage will result in ion fragmentation 
within the source. The extraction cone voltage focuses ions towards the hexapole RF lens 
and the hexapole RF lens voltage focuses the ions into the centre of the quadrupole. A 
schematic representation of the electrospray ions source and ion transmission, including 
the position of the gas flows and voltage positions, is shown in figure 4.4. 
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Aqueous standards (~1 mg/L As) of the different arsenic species were analysed by infusion 
ES-MS for optimisation of capillary voltage and sample cone voltage and by infusion ES-
MS/MS for optimisation of collision energy. The two most abundant product ions were 
selected. A list of the optimal parameters and identity of the product ions is shown in table 
7.1. 
 
Table 7.1. Instrument settings and identity of product ions for different arsenic species. 
 
       
 [M+H]+ cap. volt. cone volt. coll. energy transition product ion 
  [kV] [V] [eV]   
   
   
AsV  143 2.7 35 25 143 > 109 AsO(H2O)
+ 
    40 143 > 91 AsO+ 
MA 141 3.2 30 25 141 > 91 AsO+ 
    25 141 > 93 AsH2O
+ 
DMA 139 3.1 30 25 139 > 91 AsO+ 
    20 139 > 109 AsO(H2O)
+ 
TMAO 137 3.5 35 30 137 > 122 As(O)(CH3)2
+ 
    25 137 > 107 As(O)CH3
+ 
TETRA 135 3.3 35 20 135 > 120 As(CH3)3
+ 
    25 135 > 105 As(CH3)2
+ 
AB 179 3.2 30 25 179 > 120 As(CH3)3
+ 
    35 179 > 105 As(CH3)2
+ 
AC 165 3.0 30 20 165 > 121 As(CH3)3H
+ 
    30 165 > 105 As(CH3)2
+ 
DMAE 167 3.3 30 25 167 > 105 As(CH3)2
+ 
    20 167 > 123 As(CH3)2H2O
+ 
AsSug-OH 329 3.0 30 20 329 > 97 
    15 329 > 237 
AsSug-PO4 483 3.2 45 35 483 > 97 
    25 483 > 237 
AsSug-SO3 393 3.2 30 30 393 > 97 
    25 393 > 237 
AsSug-SO4 409 3.2 30 25 409 > 97 
     409 > 237 
       
 
The capillary voltage for all species is within the range 2.7 to 3.5 kV. For speciation analysis 
a mean value of 3.0 was used. The sample cone voltages are within the range 30 to 45 V. 
The extraction cone voltage and the hexapole RF lens voltage did not differ much and were 
set to values of 2.0 and 0.2 V, respectively. Product ions with loss of a water molecule were 
not selected in MRM analysis because they are not selective. Virtually all molecules lose a 
H2O unit upon collision with argon. 
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When the sample cone voltage is increased, in source fragmentation of the analytes occurs. 
The identity of the fragments is largely the same as those obtained by conventional 
collision activated dissociation via ES-MS/MS. The disadvantage of in source fragmentation 
is its non-selective character. All analytes and solvent molecules entering the source can 
undergo fragmentation. For metal speciation analysis, the advantages are twofold. The 
isotopic pattern is preserved as long as the fragment in which the element of interest 
remains is charged. Unfortunately, arsenic is mono-isotopic. Second, it has been observed 
that a more drastic fragmentation can be induced, often leading to the naked metal ion. 
Francesconi and co-workers used this approach for the identification of unknown arsenic 
species in marine samples [Madsen et al. , 2000; Francesconi et al. , 2000; Francesconi, 
2002]. Registration of a signal at m/z 75 is, however, no certainty of the presence of 
arsenic. Other ions can undergo in source fragmentation leading to a fragment with m/z 
75. The influence of the cone voltage on the signal of the arsenic ion was therefore 
investigated. For a series of arsenic species it was checked whether an increasing cone 
voltage resulted in the complete fragmentation to As+ and at what value of sample cone 
voltage this happened. Pure standard solutions were infused an analysed in the full scan 
mode. The result is shown in figure 7.1a and 7.1b. 
 
For complete fragmentation to As+, a sample cone voltage of minimum 120-130 V is 
needed for the cationic tetra-alkylated compounds (AC, AB, TETRA). A higher voltage (130-
150 V) is needed for the compounds containing an arsenic-oxygen double bond (MA, DMA, 
TMAO, AsSug-PO4). This indicates that cleavage of an As-C bond is more readily achieved 
than cleavage of an As=O bond. The identity of the fragments is given in table 7.2. 
 
 
Figure 7.1a. Formation of in source fragments in function of sample cone voltage for MA 
(left) and DMA (right). 
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Figure 7.1b. Formation of in source fragments in function of sample cone voltage for AB 
(top left), AC (top right), TMAO (middle left) and TETRA (middle right) and arsenosugar 
PO4  (bottom). 
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Table 7.2. Mass (m/z) and chemical formula of fragments. 
 
    
m/z chemical formula m/z chemical formula 
    
    
75 As+ 107 AsO2
+, (CH3)AsOH
+ 
89 As(CH2)
+ 120 (CH3)3As
+ 
91 AsO+, (CH3)AsH
+ 121 (CH3)2AsOH
+ 
92 AsOH+ 122 (CH3)2AsOH
+ 
93 As(H2O)
+ 123 (CH3)As(O)OH
+ 
101 As(CH)2
+ 135 (CH3)4As
+ 
103 (CH3)AsCH
+ 149 (CH3)3AsCH2
+ 
105 (CH3)2As
+ 97, 237, 329 see figure 7.1 
    
 
7.1.2. Optimisation of gas and sample flow rates and of desolvation temperature 
 
Optimum nebulisation for electrospray performance is achieved with a nitrogen flow coaxial 
to the capillary. A default flow rate of 80 L/h is used. The desolvation gas, also nitrogen, is 
heated and delivered as a coaxial sheath to the nebulised spray. The optimum desolvation 
temperature and flow rate is dependent on the mobile phase composition and flow rate. 
When infusion ES-MS was done a value of 500 L/h was used. Increasing this value up to 
700 L/h resulted in a slight increase in signal intensity, but this increase in sensitivity was 
insufficient to compensate for the higher cost of gas consumption. Only in the case of 
HPLC-ES-MS/MS this value was increased to 650 L/h to compensate for the increased 
amount of solvent entering the probe. The cone gas is a reverse flow of nitrogen delivered 
around the sample cone. The optimum cone gas flow rate is again dependent on the 
mobile phase composition and flow rate. However, it did not seem to have much influence 
on the signal intensity within the range 0-100 L/h. The primary use of the cone gas is to 
prevent contamination of the sample cone. A default value of 50 L/h was used in both 
infusion and HPLC mode.  
 
The optimal sample flow rate for conventional HPLC columns with a diameter of 4.6 mm is 
around 1 mL/min. Although the electrospray can accommodate sample flow rates up to 1 
mL/min, it is recommended that the sample flow is split post-column to approximately 200 
mL/min by means of a T-piece. Higher sample flow rates lead to incomplete ion evaporation 
in the source and thus a decrease in signal intensity. The split rate is dependent on the 
inner diameter (i.d.) of the tubing and to a lesser extent on the length. Using two red PEEK 
tubing of 0.005’’ i.d. the flow is split with 60% going to the waste. When the waste tubing 
Chapter 7. Arsenic: optimisation of ES-MS/MS and UV-HG-AFS 
______________________________________________________________________________________________________ 
 145
is replaced by a yellow PEEK tubing of 0.007’’ i.d., 75% is directed to the waste. A blue 
PEEK tubing of 0.01’’ i.d. leads 85% to the waste. When a sample flow rate of 1 mL/min is 
used, a flow rate of 400, 250 and 150 mL/min towards the ES source is realised for the red, 
yellow and blue waste tubing, respectively. It was checked which of these split 
configurations was best. AB, DMA and MA were chromatographed on a PRP-X100 column 
with 3 mM ammonium oxalate (pH 6) at different sample flow rates corresponding to the 
flow rate that would be resulting from a split of a 1 mL/min flow rate by the three different 
split configurations (i.e., 150, 250 and 400 mL/min). As a consequence, the whole sample 
was directed to the ES. The results are shown in table 7.3. Increasing the sample flow rate 
leads to lower signal intensities of the three compounds. This is in correlation with the 
higher amount of liquid present in the source and thus less efficient ion evaporation. 
However, when the respective split rates are taken into account, the outcome is totally 
different (right side of table 7.3). The signal intensities of the three compounds for the 
three flow rates were multiplied with their respective split ratios (source/total). A split of 
85% to the waste implies that only 15% of the original sample is sent to the ES source. 
Although the lower sample flow rate results in higher signal intensity, the smaller sample 
amount drastically reduces the overall sensitivity. Thus when a conventional 4.6 mm HPLC 
column is used, it is advised to use a split ratio that directs more sample to the ion source 
(i.e., 40% or 400 mL/min to the source). 
 
Table 7.3. Signal intensities for AB, DMA and MA at different sample flow rates. 
 
       
 signal intensity [counts] signal intensity [counts] 
 100% injection with split 
total sample flow rate [mL/min] 150 250 400 150 250 400 
to waste [%] 0 0 0 85 75 60 
to ES source [%] 100 100 100 15 25 40 
       
       
AB 71122 58683 45579 10668 14671 18232 
DMA 145781 101056 67133 21867 25264 26853 
MA 24304 17271 12384 3646 4318 4954 
       
 
Within the same experiment the desolvation temperature was also varied. The desolvation 
temperature is the temperature of the desolvation gas aiding the solvent evaporation. The 
optimum temperature is dependent on the mobile phase composition and flow rate, with 
water-containing mobile phases and high flow rates requiring more heat. Moreover, solvent 
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cluster ions may form if the temperature is too low. In infusion mode, where flow rates are 
limited to 10-20 mL/min, a desolvation temperature of 150-200°C is sufficient for drying and 
desolvation of the aerosol. When doing HPLC-ES-MS(/MS), higher flow rates and 
consequently higher desolvation temperatures are required. At each flow rate (150, 250 
and 400 mL/min), the desolvation temperature was set at 200, 250 and 300°C. For all flow 
rates the maximum sensitivity was obtained with the highest desolvation temperature (see 
figure 7.2). The highest relative increase (between 200°C and 300°C) is found for the 
highest flow rate. All three compounds exhibit almost the same relative increase at each 
flow rate. 
 
Figure 7.2. Signal intensities for AB, DMA and MA at different sample flow rates and 
different desolvation temperatures. The relative increases mentioned in the figure are 
those between a desolvation temperature of 200°C and 300°C. 
 
When a microbore column of 2.1 mm i.d. is used, there is no need for splitting. However, it 
was again checked at which sample flow rate an optimum ionisation in the ES source was 
achieved. A more extended experiment was carried out on a standard mixture of AB, AC, 
TETRA, DMA and MA. This mixture was injected on a PRP-X100 guard column using sample 
flow rates between 50 and 1000 mL/min. The results are shown in figure 7.3. The 
maximum sensitivity is reached using a sample flow rate of 100 mL/min. However, a sample 
flow rate of 200 mL/min (optimal sample flow rate for 2.1 mm microbore columns) does not 
drastically decrease the signal intensities for the different arsenic species (>85%). The 
trend is identical to that shown in figure 7.2. 
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Figure 7.3. Relative signal intensities for DMA, AB, MA, TETRA and AC at different sample 
flow rates. 
 
7.1.3. Optimisation of MeOH content in the mobile phase and HCOOH content in 
the sample 
 
In positive ion mode it is advised to add formic acid to the sample. In infusion MS a 50:50 
mixture of acetonitrile or methanol and water is a suitable mobile phase for the syringe 
pump system. Positive ion operation may be enhanced by 0.1 to 1% formic acid in the 
sample solution. Using a standard mixture of AB, AC, TETRA, MA, DMA and AsV  (~1 mg/L 
in As, except AsV : 10 mg/L) in water and increasing amounts of formic acid, the influence 
of the acid on the signal intensity of all compounds was tested. The result is shown in 
figure 7.4. Increasing the HCOOH content to 1%, leads to a 2.5-3-fold increase in signal 
intensity in case of the cations AB, AC and TETRA, a 3.5-fold increase in case of DMA, a 10-
fold increase in case of MA, and a 100-fold increase for AsV . As can be expected the biggest 
improvement is found for the anions. Surprisingly, further increase of the formic acid 
content up to 50% drastically improves the signal intensities. The total relative increase is 
shown in the figure. The cationic species TETRA and AC show an 8-fold increase in signal 
intensity upon addition of 50% HCOOH. This amounts up to a factor 11 and 13 for AB and 
DMA, respectively. MA and AsV  are 40 times and 310 times more when 50% HCOOH is 
used. 
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Figure 7.4. Signal intensities for TETRA, AC, AB, DMA, MA and AsV at different formic acid 
contents. The relative increases mentioned in the figure are those between a HCOOH 
content of 0% and 50%. 
 
To my knowledge, no reports have yet been published in which a thorough investigation 
was done of all parameters, which have a profound effect on the signal intensity of arsenic 
species in HPLC-ESMS/MS analysis. The reason is probably that many of these parameters 
mutually influence each other and that the influence of these parameters will not be 
identical for the different arsenic species. Moreover, a different influence is expected 
between aqueous samples and real-life samples. Add to this that these parameters are 
probably not easily copied from one instrument to another. A good example is definitely the 
influence of organic solvents on the sensitivity of the arsenic species in HPLC-ES-MS/MS 
analysis. It is known that volatile solvents have a positive influence on the signal intensities 
in ES-MS. Methanol or acetonitrile are more easily evaporated and therefore more analytes 
will enter the mass spectrometer. In case of infusion ES-MS this is always observed. A 
sample dissolved in water will have a lower degree of ionisation in the ES source compared 
to a sample dissolved in 50:50 water/methanol or 50:50 water/acetonitrile. However, in 
combination with HPLC, the outcome is not that straightforward. The degree of ionisation 
in the source for a given analyte is dependent on the total amount of molecules in the 
source. If pyridine is used as a buffer instead of acetate, the sensitivity by which e.g., MA 
can be detected will be much lower, because of the good ionisation of pyridine in the ES 
source compared to acetate. In case of HPLC, a compound eluting at a certain retention 
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time is accompanied by many other analytes, which might influence the degree of 
ionisation of the compound of interest. Addition of methanol to the mobile phase results in 
a shift of the retention times. Thus the compound of interest might be accompanied by 
other analytes, which have another influence on the degree of ionisation. The influence of 
the varying amounts of methanol on the signal intensities of different arsenic species was 
investigated with a real-life sample. Both anion exchange and cation exchange buffers were 
evaluated. An extract of kelp powder was spiked with MA, DMA, TETRA, AB and AC. This 
mixture was separated on a PRP-X100 anion exchange column with 3 mM ammonium 
oxalate (pH 6) and on a CS10 cation exchange column with 10 mM pyridine (pH 2.8). To 
the buffer 0%, 5%, 10% and 20% of MeOH was added. The results are shown in figure 
7.5. In anion exchange chromatography, the influence of MeOH on the signal to noise of 
the different arsenic species is not straightforward. MA and arsenosugar OH are negatively 
influenced by addition of MeOH. The other arsenosugars are detected more sensitively in 
the presence of 5% MeOH. AB seems to be not influenced. On the other hand, in cation 
exchange chromatography, addition of MeOH drastically improves the sensitivity for AC and 
TETRA. For DMA, arsenosugar OH and AB, the improvement is not that outspoken. There 
seems to be a correlation between the rate of improvement and the charge of the arsenic 
species. In the case of cation exchange chromatography, the amount of MeOH has no 
profound influence on the retention time of the arsenic species, whereas in anion exchange 
chromatography, the retention times are drastically reduced by addition of MeOH. 
 
 
Figure 7.5. Signal intensities for different arsenic species at different methanol contents 
in anion exchange eluent (left) or cation exchange eluent (right). 
 
The optimised instrumental parameters for infusion and HPLC ES-MS/MS are listed in table 
7.4. 
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Table 7.4. Instrument settings for infusion and HPLC mode ES-MS/MS analysis. 
 
   
parameter infusion HPLC 
   
   
capillary voltage [kV] 2.8-3.2 3.0 
sample cone voltage [V] 30-45 30-45 
extraction cone voltage [V] 2 2 
hexapole RF lens voltage [V] 0.2 0.2 
source temperature [°C] 120 120 
desolvation temperature [°C] 200 300 
desolvation gas flow [L/h] 500 650 
sample cone gas flow [L/h] 50 50 
   
 
7.2. Optimisation of UV-HG-AFS 
 
In case of conventional hydride generation without UV decomposition step, the 
experimental conditions prescribed by the manufacturer were used. These are listed in 
table 7.5. When HG-AFS was preceded by UV decomposition, the following parameters 
were optimised: K2S2O8 and NaOH concentrations, HCl concentration, UV coil type, length 
and diameter, flow segmentation and reaction coil length. 
 
Table 7.5. Instrument settings for conventional HPLC-HG-AFS analysis. 
 
  
mobile phase speed 1 mL/min 
acid carrier 1.5 M HCl, 1.5 mL/min 
reducing agent 1.4% (m/v) NaBH4 in 0.4% (m/v) M NaOH, 1.5 mL/min 
carrier gas argon, 250 mL/min 
dryer gas argon, 2.5 L/min 
lamp current 27.5 mA (primary current) and 35.0 mA (boost current) 
  
 
First a UV decomposition unit supplied by the manufacturer (PSA 10.570) was compared 
with an old unit that has been previously used in our laboratory, namely a 5 m 0.8 mm i.d. 
PTFE tube wrapped around a 6 W Philips UV lamp [Zhang et al. , 1995 and 1996]. The 
performance characteristics of the two units were tested with a standard mixture of AsIII, 
DMA, MA and AsV , using the experimental conditions optimised by Gomez-Ariza et al.  
[1998]. They evaluated HG-AFS with and without photo-oxidation for the measurement of 
arsenic species and used the following parameters for the UV decomposition: 2% (m/v) 
K2S2O8 in 2% (m/v) NaOH, 8 M HCl and 1.5% (m/v) NaBH4 in 1% (m/v) NaOH. Our unit 
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provided sharper peaks and consequently better signal to noise ratios. The signal intensities 
of the peaks for our unit were also higher, indicating a better rate of decomposition. 
Moreover the signal for DMA proved to be very poor in case of the PSA 10.570 unit. 
Therefore it was decided not to use the commercial unit. The old Philips unit was 
afterwards replaced with a 15 W Heraeus TNN 15/35 low pressure Hg lamp (254 nm). A 
teflon tube was wrapped around it and the lamp was covered with aluminium foil for better 
light reflection and eye protection. 
 
Next the UV decomposition parameters were further optimised. First it was checked 
whether decreasing the acidity had a negative influence on the performance characteristics 
of a measurement of AB in triplicate by flow injection (no column added). In a first step the 
HCl molarity was decreased from 8 M to 6 and 4 M and in a second step to 6, 5.5 and 5 M. 
A hydrochloric acid concentration of 5.5 M (decrease of 31.25% of HCl) did not significantly 
lower the sensitivity. According to Tsalev et al.  [1998], the concentrations of K2S2O8 and 
NaOH are not critical within the ranges 0.5-4% (m/v) and 1.6-8% (m/v), respectively. 
Keeping the amount of NaOH constant at 2% (m/v), the influence of varying amounts of 
K2S2O8 on the sensitivity of AB detection was tested. The concentration of persulphate 
could be lowered to 1.5% (m/v) (decrease of 25% of K2S2O8) without a loss in sensitivity. 
Finally the sodium hydroxide concentration was varied at constant K2S2O8 (1.5% m/v) and 
2.5% (m/v) NaOH was chosen as an optimal value. The instrumental set-up of HPLC-UV-
HG-AFS, shown in figure 4.8 consists of a lot of tubing between the outlet of the column 
and the detector. This will inevitably result in peak broadening. The HETP due to an open 
tube is decribed by the Golay equation 
 
M
2
M
D24
ur
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with DM the diffusion coefficient of the solute in the mobile phase, u the linear flow rate and 
r the radius of the tube. If u >> Dm/r (which will be true for most practical 
chromatographic systems, then the peak variance (in volume units) is  
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with Q the flow rate [ml/min] through the tube (pr2u) and L the length of the tube [http 6]. 
Chapter 7. Arsenic: optimisation of ES-MS/MS and UV-HG-AFS 
______________________________________________________________________________________________________ 
 152
However, when the flow can be segmented post column with a stream of gas, diffusion will 
be efficiently reduced. This is proven by the following examples. An equal amount of MA 
was injected into the system (no column inserted) and analysed in triplicate with and 
without segmentation. Signal intensity, S/N and FWHM were registered (table 7.6). 
 
Table 7.6. Performance characteristics for AB with and without flow segmentation. 
 
    
 intensity S/N FWHM [min] 
 mean & SD (n = 3) mean & SD (n = 3) mean & SD (n = 3) 
    
    
without 21908 (1746) 45.66 (3.3) 0.62 (0.4) 
with 21824 (567) 129.98 (4.6) 0.17 (0.2) 
        
 
Whereas the signal intensity of the peak remains the same, the FWHM drastically decreases 
(factor 3.6). As a consequence, S/N increases (factor 2.8). Similarly a mixture of AsIII, DMA 
and MA was separated on a Hamilton PRP-X100 column with and without flow 
segmentation (figure 7.6). Again better S/N and FWHM values are obtained for all species. 
The improvement is less outspoken compared to the example of MA analysed without 
column. By aspirating air through a tube via the same peristaltic pump as the one used for 
injection of the K2S2O8 solution, flow segmentation is realised. 
 
 
Figure 7.6. Chromatograms of AsIII, DMA and MA separated on anion exchange column 
with and without flow segmentation. Detection with HG-AFS. 
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The type, length and diameter of the teflon tubing were optimised. From the above-
mentioned equation it can be derived that peak broadening is proportional to the inner 
radius of the tube. From this point of view a tube as thin as possible should be used. On 
the other hand the permeability of teflon for UV light is dependent on the thickness of the 
walls. Commercially available teflon tubing has a fixed outer diameter of 1.59 mm (1/16 
inch). Tubes with smaller inner diameter consequently have a larger wall thickness. 
Therefore tubing with a larger inner diameter should yield more UV light absorption. 
Moreover the permeability of teflon for UV light is dependent on the type of teflon material. 
Conventional PTFE (polytetrafluoroethylene) shows poor permeability for UV light. Other 
teflon materials such as PFA (perfluoroalkoxy) and FEP (fluorinated ethylene propylene) are 
less opaque and thus more transparent towards UV light. The transmission for radiation of 
250 nm light through a 0.2 mm foil is 86% for PFA and 84% for FEP. PTFE is 20% less 
transparent [http 7, http 8]. These three types were compared. At first different types of 
teflon tubing with 0.8 mm internal diameter were tested. Afterwards it was checked 
whether decreasing the inner radius resulted in an improved peak shape. For each inner 
diameter, the length was chosen such that it provides an irradiation time long enough for 
complete conversion of AB into AsV . An irradiation time of 70 seconds was selected from 
literature values [Tsalev et al. , 1998]. An equal amount of AB was injected into the UV coil, 
made of different teflon materials with equal diameter and length. Each time at least 6 
replicates were taken. Mean values of signal intensity and signal to noise are reported in 
table 7.7. The type of teflon and the different transmittance for UV light seems to have no 
influence on the conversion of AB to AsV . When the signal intensities of AB are compared to 
those of equal amounts of arsenate a conversion of AB to arsenate of more than 94% is 
achieved for all three materials. 
 
Table 7.7. Performance characteristics for AB using different types of teflon tubing in 
the UV-coil. 
 
   
 intensity S/N 
 mean & SD (n > 6) mean & SD (n > 6) 
   
   
FEP 30037 (1024) 48.0 (5.5) 
PTFE 27946 (1605) 49.7 (10.2) 
PFA 30217 (2355) 51.9 (7.3) 
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A comparison between a UV coil of two different internal diameters of equal volume shows 
no better FWHM and consequently smaller peak broadening for a 0.5 mm i.d. (7.2 seconds) 
compared to a 0.8 mm i.d. (7.8 seconds) tubing. It seems that the influence of the inner 
diameter of the UV coil tubing has no significant influence on the overall peak broadening 
caused by the column and post column processes. The fact that flow segmentation by 
argon efficiently reduces peak broadening may be a plausible explanation. 
 
The following conditions for measurement of arsenic by UV-HG-AFS were used (table 7.8): 
 
Table 7.8. Instrument setting for UV-HPLC-HG-AFS analysis. 
 
  
mobile phase speed 1 mL/min 
flow segmentation air, 0.5 mL/min 
oxidant 1.5% (m/v) K2S2O8 in 2.5% (m/v) NaOH, 0.5 mL/min 
UV unit 15 W Heraeus TNN 15/35 low pressure Hg lamp 
 0.8 mm i.d. PFA, 3.9 m (volume 2.0 mL) 
acid carrier 5.5 M HCl, 1.5 mL/min 
reducing agent 1.4% (m/v) NaBH4 in 0.4% (m/v) M NaOH, 1.5 mL/min 
carrier gas argon, 250 mL/min 
dryer gas argon, 2.5 L/min 
lamp current 27.5 mA (primary current) and 35.0 mA (boost current) 
  
 
7.3. Flow injection UV-HG-AFS for analysis of total arsenic 
 
If the UV coil yields quantitative conversion of organoarsenicals to arsenate, it could be 
tested whether it is possible to directly determine the total arsenic concentration in real-life 
samples. Individual stock solutions of 1 µg/mL of AsV , MA, DMA, AB, AC, DMAE and 
arsenosugar PO4 were prepared. Each of these solutions was diluted (1 + 9) in water, in 
urine and in 1 + 9 diluted urine. The urine was taken from a volunteer who had not eaten 
seafood during 3 days. In this urine sample arsenic was detected at a level, which was 
much lower than the concentration level during this experiment (100 ng/mL As). A volume 
of 50 µL (water) or 100 µL (urine) was injected in the system. The experimental conditions 
were as follows: 1.5% (m/v) K2S2O8 in 2.5% (m/v) NaOH, 5.5 M HCl, 1.4% (m/v) NaBH4 in 
0.4% (m/v) NaOH. The results are shown in table 7.9. The values for the different 
arsenicals are shown relative to the value obtained for AsV . It can be seen that in water, all 
arsenicals are completely transformed into AsV . The undiluted urine matrix, on the other 
hand, exerts a significant influence on the breakdown of arsenic compounds into arsenate. 
All arsenicals show a lower relative signal intensity than AsV , exception made of MA. Photo-
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oxidation converts organo arsenic compounds such as AB and AC to AsV  via TETRA, TMAO, 
DMA and MA. Incomplete breakdown of AB would thus result in a mixture of AB and 
TETRA, TMAO, DMA, MA and AsV  leaving the UV-coil. Some of these compounds have no 
(AB, TETRA), lower (TMAO, DMA) or higher (MA) sensitivity for hydride formation 
compared to arsenate. Therefore the incomplete break-down of AB, AC, DMA, DMAE and 
arsenosugar PO4 leads to a lower signal compared to AsV , whereas incomplete break-down 
of MA will result in a higher signal, compared to that of AsV . 
 
Table 7.9. Signal intensities (relative to AsV) for different arsenic species dissolved in 
water, undiluted urine and 1+9 diluted urine. 
 
        
 water undiluted urine 1 + 9 diluted urine 
        
    
AB 101.6% 56.9% 47.8% 
AC 99.8% 53.9% 47.1% 
DMA 102.9% 94.3% 76.5% 
MA 101.6% 159.6% 104.9% 
DMAE 98.0% 59.0% n.r. 
AsSug-PO4 100.1% 58.3% n.r. 
        
 
These findings are in agreement with those described by Tsalev et al.  [2000]. They also 
reported that MA yields a higher signal compared to AsV . 1 + 4 diluted urine spiked with 
different arsenic species revealed lower signals for DMA, AB and AC and higher signals for 
MA, a pattern that is consistent with the results obtained in this work. Further dilution to 1 
+ 9 led to an increase in signal intensity of DMA, AB and AC to a level higher than AsV . This 
probably implies incomplete breakdown of these species to MA. Even at a dilution factor of 
1 + 20, the signals of DMA, MA, AB and AC were higher than for arsenate. 
 
In this work, lower values for DMA, AB and AC and higher values for MA were obtained for 
1+9 diluted urine. This illustrates again that AB, AC and DMA are not completely broken 
down and that not much MA was formed yet. The different experimental configurations 
between this work and that from Tsalev et al.  [2000] might account for the different 
outcomes. At the end, it can be concluded that online FI-UV-HG-AFS cannot be used for 
direct analysis of the total arsenic concentration in urine. Instead a digestion programme 
with mineral acids (HClO 4, H2SO4 and HNO3) and pre-reduction (KI, ascorbic acid) will be 
used in the continuous flow mode of HG-AFS. 
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7.4. Selection of suitable buffer for ES-MS and UV-HG-AFS 
 
The sensitivity of both ES-MS and UV-HG-AFS is highly dependent on the type of buffer 
selected. Whereas volatile buffers and solvents enhance the sensitivity of ES-MS detection, 
non-volatile buffers should be used with HG-AFS and organic solvents should be avoided. 
In a study by Le et al.  [1998] it was shown that the maximal amount of MeOH to be added 
to the buffer in case of HPLC-HG-AFS was 5%. It has been the intention to simultaneously 
couple both detectors to the HPLC unit in order to attain both elemental and 
molecular/structural information at the same time. In order to do so, a buffer had to be 
found which allows a good separation and detection on both instruments. As both detectors 
have completely different optimal experimental conditions, a compromise had to be found. 
The following mobile phases were evaluated: ammonium acetate (20 mM), ammonium 
formiate (20 mM), ammonium bicarbonate (30 mM), ammonium tartrate (2, 5 and 10 mM), 
ammonium malonate (2, 5 and 10 mM), ammonium oxalate (2, 5 and 10 mM), sodium 
phosphate (20 mM) and water. All buffers were adjusted to pH 6 with NH3 or HCOOH. In a 
first stage the suitability towards a good separation of arsenite, DMA, MA and arsenate was 
evaluated using HG-AFS and ES-MS/MS. Concentrations of 5 and 10 mM of the tartrate, 
malonate and oxalate buffers were too high to allow base-line separation of arsenite, DMA 
and MA. The concentration of the three buffers was later adjusted from 2 mM to 3 mM. 
Acetate, bicarbonate and phosphate at this pH and concentration have been used widely 
and have proved to allow good separation of AsIII, DMA, MA and AsV . Repeated 
chromatographic separation of the four arsenicals on the Hamilton PRP-X100 column with 
20 mM ammonium formiate, however, resulted in gradual degradation of the peak shape 
and shift of the retention times. 
 
Next individual solutions of AsV , MA, DMA, AB and TETRA were eluted with different 
buffers. No column was used because changing from one buffer to another needs a long 
equilibration time. Signal to noise ratio (S/N) was used for evaluating the sensitivity. The 
results are shown in figures 7.7 and 7.8. In the case of UV-HG-AFS water, phosphate, 
tartrate and oxalate seem to be the best eluents, followed by malonate. Acetate, formiate 
and bicarbonate gave poor results. It can be seen that the sensitivity is inversely 
proportional to the buffer volatility. A very high noise level accompanied the poor sensitivity 
of bicarbonate. This is most probably due to the formation of CO2 in the UV reaction coil. 
When UV-HG-AFS is used alone, sodium phosphate is the ideal eluent. 
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Figure 7.7. Sensitivity of HPLC-UV-HG-AFS for different arsenic species using different 
mobile phases. 
 
The results for ES-MS are quite different. Note that, because the ionisation efficiency is 
highly dependent on the identity of the arsenic species, relative signal to noise values were 
used. Despite the non-volatile character of oxalate, its low concentration allows good 
detection of all arsenicals. No clogging of the cones is observed with this buffer. 
Bicarbonate gives good results as well, followed by acetate. Formiate is worse than acetate 
except for AB. Malonate should be avoided. When both UV-HG-AFS and ES-MS/MS are 
used, ammonium oxalate is the best compromise between the two detectors. 
 
 
Figure 7.8. Sensitivity of HPLC-ES-MS/MS for different arsenic species using different 
mobile phases. 
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7.5. Arsenic speciation in algae 
 
Extracts of algae samples were selected for optimisation of the detection techniques. A 
commercially available powdered kelp specimen was chosen. Other researchers had 
analysed it and it contains the four major arsenosugars and DMA. ICP-MS, UV-HG-AFS and 
ES-MS/MS were used as detectors. A portion of 0.1 g kelp was transferred into a centrifuge 
tube, extracted with 6 mL 1:1 H2O/MeOH in an ultrasonic bath for 15 minutes and 
afterwards centrifuged at 9000 rpm for 15 minutes. The extraction procedure was repeated 
another 5 times. All filtrates were combined and left to dry overnight at 40°C. The dried 
residue was dissolved in a minimal amount of water, centrifuged, diluted and filtered 
through 0.22 mm PVDF filters before analysis. The extracts were separated on a Hamilton 
PRP-X100 column using different mobile phases. Each of these mobile phases allows a 
good separation of the four arsenosugars and DMA. It was not the intention to fully 
examine the quantitative aspects of the arsenic species in the algae samples. This part 
rather served as an exploration of the capabilities of ES-MS/MS for qualitative research of 
arsenic species in real-life samples, and a check whether UV-HG-AFS and ICP-MS allowed a 
good detection of the arsenic species. 
 
7.5.1. Detection via ICP-MS and UV-HG-AFS 
 
 
Figure 7.9. Chromatograms of kelp extract separated on PRP-X100 anion exchange 
column. Detection with ICP-MS (left) and UV-HG-AFS (right). 
 
Two chromatograms of an extract of kelp powder, analysed with HPLC-ICP-MS and HPLC-
UV-HG-AFS, respectively, are shown in figure 7.9. The mobile phase was 20 mM 
(NH4)2HPO4 (pH 7) and 3 mM ammonium oxalate (pH 6) for ICP-MS and UV-HG-AFS 
respectively. The relative abundance of the arsenic peaks was determined and compared 
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with those obtained by other researchers. The results are given in table 7.10. The results 
obtained via UV-HGAFS and ICP-MS correlate well, not only mutually, but also with those 
obtained by other researchers [Wangkarn and Pergantis, 2000; Lai et al. , 1997]. The 
sensitivity of ICP-MS is much better than for UV-HG-AFS, but for marine samples with high 
amounts of arsenic, UV-HG-AFS proves to be a good and cheap alternative. The good 
similarity between the measurements with UV-HG-AFS and ICP-MS indicates that the UV 
cell is capable of completely breaking down the organic arsenicals to arsenate, leading to 
relative abundances which do not significantly differ from those obtained via ICP-MS. This 
is in contrast to the analysis of total arsenic in urine samples (paragraph 7.3). 
 
Table 7.10. Relative abundance of arsenic species in kelp powder extract. 
 
       
reference detector AsSug-OH DMA AsSug-PO4 AsSug-SO3 AsSug-SO4 
              
       
[Wangkarn and Pergantis, 2000] ICP-MS 31.0% 2.6% 4.9% 12.5% 49.0% 
[Lai et al., 1997] ICP-MS 35.2% n.d. 3.0% 16.4% 45.4% 
this work ICP-MS 29.9% 3.5% 5.0% 12.1% 49.5% 
this work UV-HG-AFS 30.8% 3.2% 6.3% 13.1% 46.6% 
              
 
7.5.2. Detection via ES-MS(/MS) 
 
The capabilities of HPLC-ES-MS/MS were explored using an extract of kelp powder. The 
extract was separated on a PRP-X100 anion exchange column with 20 mM NH4HCO3 in 
20% MeOH (pH 7.7). In paragraph 7.4 it was found that bicarbonate is not the ideal mobile 
phase for ES-MS/MS, but that experiment was done afterwards. The kelp extract was 
analysed via different analysis modes: selected ion recording (SIR), multiple reaction 
monitoring (MRM) and product ion scan. The choice of the product ions was based on 
infusion experiments. Pure standards of arsenic species were directly introduced in the MS 
and analysed via a product ion scan. The most abundant product ions were selected. 
 
In SIR mode, the molecular ion m/z is selected. As can be seen from figure 7.10, more 
than one peak appears in each chromatogram, indicating that other compounds in the kelp 
extract also have the same mass as the compound of interest. In the chromatogram of 
arsenosugar OH (bottom), a peak at retention time 10.6 minutes co-elutes with a peak in 
the chromatogram of arsenosugar SO4 (top). As will be discussed later, arsenosugar SO4 
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undergoes in-source fragmentation with loss of the SO3 group, leading to arsenosugar OH. 
Because of the high abundance of arsenosugar SO4 in kelp, this peak also dominates the 
chromatogram of arsenosugar OH. 
 
2 4 6 8 10 12 14 16 
Time 0 
100 
% 
1 
100 
% 
4 
100 
% 
1 
100 
% 
2 
100 
% 
10.6 
8.8 
2.4 
7.4 
1.8 
5.8 
2.3  
5.1 
2.1 
8.1 
10.6 
2.3 
arsenosugar SO4 
arsenosugar SO3 
DMA 
arsenosugar PO4 
arsenosugar OH 
 
 
Figure 7.10. Chromatogram of kelp extract separated on a PRP-X100 anion exchange 
column. Detection with ES-MS (SIR mode): signals (from top to bottom) at m/z 409, 
393, 139, 483, 329 were monitored. Time is displayed in minutes. 
 
Figure 7.11a shows a series of chromatograms of the same kelp extract analysed in MRM 
mode. In MRM, Q1 and Q2 are set to the molecular ion and a product ion, respectively and 
the collision cell is filled with argon. Now it can be seen that only one peak appears, except 
for the arsenosugars that undergo in source fragmentation. In figure 7.11b, the 
chromatograms of the MRM of AsSug-PO4 and AsSug-SO4 are shown again, with a 10 times 
enhanced y-axis for the retention window 0-8 minutes in the chromatogram of arsenosugar 
SO4. It can be seen that in both chromatograms a peak elutes at the same retention time. 
In fact arsenosugar PO4 also undergoes in source fragmentation with cleavage of the 
carbon-phosphodiester bond, as is shown in figure 7.12. 
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Figure 7.11a (left). Chromatogram of kelp extract separated on a PRP-X100 anion 
exchange column. Detection with ES-MS/MS (MRM mode): transitions (from top to 
bottom) at m/z 409>97, 393>97, 139>121, 483>97 and 329>97 were monitored. Time 
is displayed in minutes. 
 
Figure 7.11b (right). Same chromatogram of kelp extract separated on a PRP-X100 
anion exchange column. Detection with ES-MS/MS (MRM mode): transitions at m/z 
409>97 (top) and 483>97 (bottom) were monitored. An enhanced y-axis in a part of the 
chromatograms of arsenosugar SO4  indicates in source fragmentation of arsenosugar 
PO4 . Time is displayed in minutes. 
 
 
 
Figure 7.12. In source fragmentation of arsenosugar PO4 . 
 
Figure 7.13 shows a series of HPLC-ES-MS/MS chromatograms analysed in product ion scan 
mode. Q1 selects the molecular ion [M+H]+, the collision cell is filled with argon and Q2 
scans the product ions in a given m/z range. Figures 7.14 and 7.15 show the product ion 
spectra of DMA and the 4 arsenosugars from that product ion scan, respectively. The 
product ion spectra of the pure standards of DMA and the four arsenosugars are found in 
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figures 7.14 and 7.16, respectively. In figures 7.15 and 7.16, the region between m/z 100 
and 300 is enlarged five times. The product ion spectra of the 5 arsenic species in the kelp 
extract are in good agreement with those of the pure standards. 
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Figure 7.13. Chromatogram of kelp extract separated on a PRP-X100 anion exchange 
column. Detection with ES-MS/MS (product ion scan mode): product ions of (from top to 
bottom) m/z 409, 393, 139, 483 and 329 were monitored. Time is displayed in minutes. 
 
The type of analysis mode (product ion scan, precursor ion scan, MRM, SIR, neutral loss 
scan, full scan) has implications for the ion energies in the mass spectrometer region (see 
also table 4.2). Quadrupoles that perform a scan (Q2 in product ion scan mode, Q1 in 
precursor ion scan mode, Q1 and Q2 in neutral loss scan mode, Q1 in full scan MS1 mode) 
are set at a lower ion energy than quadrupoles that perform a static analysis (Q1 and Q2 in 
MRM, Q1 in SIR, Q1 in product ion scanning and Q2 in precursor ion scanning), because ions 
should pass sufficiently slowly to allow a complete scan over a wide m/z range (e.g., 500 
Da) within a short time span (1-2 seconds). 
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Figure 7.14. Product ion spectra of DMA in kelp (top) and a DMA standard (bottom). 
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Figure 7.15. Product ion spectra of the 4 arsenosugars in kelp. From top to bottom: 
AsSug-SO4 , AsSug-SO3 , AsSug-PO4  and AsSug-OH. 
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Figure 7.16. Product ion spectra of the 4 arsenosugar standards. From top to bottom: 
AsSug-SO4 , AsSug-SO3 , AsSug-PO4  and AsSug-OH. 
 
More details about the identity of the different product ions formed from arsenic species 
have been compiled in a review of McSheehy and Mester [2003]. 
7.5.3. Dual detection with UV-HG-AFS and ES-MS/MS. 
 
Figure 7.17 gives an example of the capabilities of dual detection with UV-HG-AFS and ES-
MS/MS (MRM mode). An extract of kelp was analysed via anion exchange chromatography 
with 3 mM ammonium oxalate (pH 6). The fact that both elemental and 
molecular/structural information is obtained within one run is especially advantageous 
when searching for unknown arsenic species. When UV-HG-AFS is combined with full scan 
ES-MS, each signal of elemental arsenic is accompanied by a signal obtained from the full 
scan spectrum at exactly the same retention time. 
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Figure 7.17. Chromatogram of kelp extract separated on PRP-X100 column. Detection 
with UV-HG-AFS (top) and ES-MS/MS (below) in MRM mode: transitions (from top to 
bottom) 409 > 97, 393 > 97, 483 > 97, 139 > 91 and 329 > 97. Time is displayed in 
minutes. 
 
It can, however, be questioned whether UV-HG-AFS is sensitive enough to detect the low 
amounts of unknown arsenic metabolites in urine. At least for the identification of unknown 
arsenicals in marine samples, this approach is very promising. 
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7.5.4. Elemental detection via ES-MS 
 
Madsen et al.  [2000] have analysed an extract of the alga Fucus serratus with HPLC-ICP-
MS and HPLC-ES-MS on a single quadrupole MS. They used the approach of in source 
fragmentation to identify the arsenosugars. Using variable cone voltage values in source 
fragmentation allows the detection of the molecular ion (low cone voltage), a fragment of 
the arsenosugars (moderate cone voltage) and at very high voltage the naked 75As+ ion. 
 
Figure 7.18 shows a series of chromatograms of an extract of Fucus. The top 
chromatogram is an overlay of 4 MRM transitions (329>97, 483>97, 393>97 and 409>97). 
The small peaks at the retention time of AsSug-PO4 and AsSug-SO4 are the result of in 
source fragmentation of AsSug-PO4 to AsSug-SO4 and AsSug-SO4 to AsSug-OH, 
respectively. Below a SIR chromatogram is given in which the signal at m/z 75 is recorded 
using a cone voltage of 150 V. As described in paragraph 7.1.1., a cone voltage of 150 V 
results in complete fragmentation of the arsenic -oxygen bond. Although the base line 
severely fluctuates, 4 peaks corresponding to the retention time of the 4 arsenosugars 
dominate. The bottom chromatogram again clearly proves the high matrix dependence of 
ES-MS/MS. The drop in baseline in the void volume is a result of the co-elution of many 
neutral molecules and cations. 
 
When searching for unknown arsenic species, this approach is a good alternative to the 
dual detection approach. An additional advantage is that no compromise of the 
experimental conditions for the HPLC separations is needed to fit as well elemental as ES-
MS/MS detection. It should, however, be reported that a signal at m/z 75 is no proof for 
the presence of arsenic. Other compounds can also undergo in source fragmentation and 
lead to a compound with the same mass. It can again be questioned whether this approach 
will allow the detection of the low amounts of arsenic metabolites in urine. On the other 
hand, if each peak at m/z 75 (As+) is accompanied by a signal at m/z 90, (MeAs+), 91 
(AsO+), 105 (Me2As+)… there is convincing proof of the presence of an arsenic containing 
compound. 
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Figure 7.18. Chromatogram of Fucus extract separate onPRP-X100 anion exchange 
column. Detection via MRM (top) of 4 arsenosugars and via SIR of m/z 75 (bottom) at 
high cone voltage. Time is displayed in minutes. 
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Chapter 8. Arsenic: measurement 
of arsenic metabolites from 
arsenosugars 
 
 
 
 
The main part of the work on arsenic speciation deals with the metabolism of arsenosugars 
in humans. Arsenosugars appear in marine plants and animals. Algae were chosen as the 
food source of arsenosugars, because the concentration of the arsenosugars in algae is 
normally higher than in marine animals and because arsenosugars are, except for some 
DMA, the main organic arsenicals present in algae. Urine and blood samples were analysed 
for their total arsenic content and speciation of arsenic compounds. Because low levels of 
arsenic were expected in urine and blood, ICP-MS was chosen besides UV-HG-AFS, as the 
element specific detector. The ICP-MS measurements were optimised to obtain a high 
sensitivity. During the past years, a series of experiments have been carried out in which 
several volunteers ingested the edible seaweed Laminaria japonica. These experiments will 
be described chronologically. 
 
8.1. Optimisation of ICP-MS 
 
RF power and methanol content are considered the most relevant factors to exert an 
influence on the sensitivity of the arsenic detection [Larsen and Stürup, 1994]. These were 
checked, as well as the other instrumental parameters that were optimised daily. 
Furthermore it was checked whether simple sample dilution would yield quantitative 
recovery of arsenic notwithstanding the high carbon and salt content in urine. 
 
A solution of DMA (20 ng/mL As) in 1% HNO3 was measured using RF power settings 
between 1100 and 1350 W. Signals at m/z 75 (75As+), 77 (40Ar37Cl+) and 51 (35Cl16O+) were 
detected. The signals at m/z 77 and 51 served as a measure for the chloride interference. 
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The results are shown in table 8.1. There is a significant increase in signal intensity for 
arsenic, which is likely to further increase above 1350 W. In order not to damage the 
instrument, it was chosen to use a value of 1300 W. At this value different degrees of 
methanol were added to either a solution of DMA (20 ng/mL As) in 1% HNO3 or DMA (20 
ng/mL As) in 1:50 diluted urine. A urine sample was taken from a volunteer who had not 
recently eaten arsenic-rich food (table 8.2). In both cases, the highest signal intensity was 
obtained at a methanol degree of 3%. Changing the RF power from 1100 W to 1300 W and 
adding 3% MeOH to the solution thus resulted in a six-fold increase in signal intensity. The 
influence of an increasing amount of MeOH on the signal intensity of As at a normal RF 
value of 1100 W was less outspoken (data not shown). 
 
Table 8.1. Influence of RF power on signal intensities of 75As+, 77[ArCl]+ and 51[ClO]+ in 
solution of DMA (20 ng/mL As) in 1% HNO3 . 
 
    
RF power 75As+ [counts] 77[ArCl]+ [counts] 51[ClO]+ [counts] 
[W] mean & SD of 10 replicates mean & SD of 10 replicates mean & SD of 10 replicates 
        
    
1100 35465 (1535) 445 (50) 942 (66) 
1150 58131 (1496) 712 (31) 1792 (115) 
1200 70603 (1196) 896 (44) 2271 (68) 
1250 80243 (712) 1057 (37) 2831 (86) 
1300 86457 (645) 1151 (49) 3213 (100) 
1350 90029 (969) 1273 (81) 3516 (77) 
     
 
Table 8.2. Influence of MeOH on signal intensity of 75As+ in solution of DMA (20 ng/mL 
As) in 1% HNO3  and of DMA (20 ng/mL As) in 1:50 diluted urine. 
 
      
% MeOH 1% HNO3  1:50 urine 
 75As+ [counts] 75As+ [counts] 
 mean & SD of 20 replicates mean & SD of 20 replicates 
      
   
0% 84717 (2272) 83774 (1230) 
1% 155319 (6433) 145727 (9359) 
3% 207011 (8194) 209827 (5580) 
5% 107083 (12512) 136813 (8112) 
10% 21816 (3384) 26425 (4101) 
      
 
The influence of NaCl on the signal intensity of As was investigated in order to derive which 
dilution factor had to be used in order to overcome a significant polyatomic interference 
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from 75ArCl+. The average urinary chloride concentration is 135 mmol/day with extreme 
ranges of 80-270 mmol/day. This is equivalent to a maximum of 7.04 g/L chloride, taking 
into account a mean daily urinary volume of 1.36 L (33 men). These values were obtained 
from literature data [Geigy, 1981]. First a blank urine and then spiked (DMA, 20 ng/mL As) 
solutions of 1% HNO3 and diluted urine (1:50 and 1:100) were analysed. The results are 
shown in table 8.3. The signal intensity of 51ClO+ in the blank and spiked samples increases 
in the series 1% HNO3 < 100x diluted urine < 50x diluted urine. This indicates that the 
amount of NaCl increases in the series 1% HNO3 < 100x diluted urine < 50x diluted urine. 
On the other hand, there is no apparent difference between the signal intensities of 75As+ 
for 20 ng/mL As in nitric acid, in 50x diluted urine and in 100x diluted urine, indicating that 
at these dilution factors, the NaCl does not give rise to a significant spectral interference of 
75[ArCl]+. Notice that a 1 mg/L NaCl solution does not significantly contribute to a signal at 
m/z 75As+ either. It causes an apparent arsenic concentration of 0.7 ng/mL. Notice that the 
signal for 75As+ and 77[ArCl]+ in the urine samples is lower than in the 1% HNO3 solution. 
This is most probably due to the presence of easy ionisable elements in the urine sample 
that cause a decrease in the ionisation efficiency of 75As+ and 77[ArCl]+. 
 
Table 8.3. Influence of salt content on signal intensities of 75As+, 77[ArCl]+ and 51[ClO]+ 
in blank and spiked solutions of 1% HNO3 , 1:100 diluted urine and 1:50 diluted urine. 
 
    
sample 75As+ [counts] 77[ArCl]+ [counts] 51[ClO]+ [counts] 
 mean & SD of 
30 replicates 
mean & SD of 
30 replicates 
mean & SD of 
30 replicates 
    
    
blank 1% HNO3 4435 (150) 1406 (53) 2662 (85) 
20 ng/mL As as DMA in 1% HNO3 83232 (699) 1126 (38) 3020 (116) 
    
blank 100x diluted urine 3707 (148) 1201 (50) 5058 (125) 
20 ng/mL As as DMA in 100x diluted urine 82364 (561) 1107 (50) 5130 (126) 
    
blank 50x diluted urine 3943 (108) 1227 (55) 6902 (305) 
20 ng/mL As as DMA in 50x diluted urine 82730 (697) 1179 (51) 6907 (232) 
    
1 mg/L NaCl in 1% HNO3 2719 (136) 1200 (55) 2911 (117) 
    
 
No methanol was added to these solutions, so the question can be asked whether or not 
the carbon present in urine influences the signal intensity of arsenic. The total carbon 
content of urine is around 3.6 g/L, estimated from mean urinary levels of urea (CH4N2O, 
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20.0% (m/m) C, 20.6 g/d), creatine (C4H9N3O2, 36.6% (m/m) C, 85 mg/d), creatinine 
(C4H7N3O, 42.5% (m/m) C, 1.4 g/d) and uric acid (C5H4N4O3, 35.7% (m/m) C, 528 mg/d) 
and a mean urinary volume of 1.36 L/d [Geigy, 1981]. In 50x diluted urine the total carbon 
content would be 0.073 C g/L or 0.0073% (m/v) C. This is equivalent to 0.0194% MeOH. 
Although the influence of a solution of 0.0194% MeOH on the signal intensity of 75As+ was 
not tested, it is unlikely that this low amount of carbon would significantly contribute to an 
increased signal at m/z 75. Moreover when the urine samples will be analysed the amount 
of carbon in the diluted samples will be negligible compared to the amount of MeOH added. 
 
Table 8.4. Influence of urine matrix on signal intensities of 75As+, 77[ArCl]+ and 51[ClO]+. 
 
    
sample 75As+ [counts] 77[ArCl]+ [counts] 51[ClO]+ [counts] 
 
mean & SD of 
10 replicates 
mean & SD of 
10 replicates 
mean & SD of 
10 replicates 
    
    
20 ng/mL As in 1% HNO3 59506 (875) 939 (42) **3002 (39) 
20 ng/mL As in 1:100 urine 59608 (569) 947 (31) **5504 (137) 
20 ng/mL As in 1:50 urine 60489 (628) 846 (25) **7853 (215) 
20 ng/mL As in 1:30 urine 59195 (748) 935 (54) **11004 (386) 
20 ng/mL As in 1:10 urine 61340 (802) *1395 (43) **25696 (1570) 
    
* significantly different from other 77[ArCl]+ values (P = 0.05) 
** correlation coefficient R2 = 0.9994 
    
 
The influence of the urine matrix was further checked. Solutions of DMA (20 ng/mL As) in 
1% HNO3 and in 1:100, 1:50, 1:30 and 1:10 urine were prepared. The results are shown in 
table 8.4. There is no significant increase in signal intensity for m/z 75 and 77 up to 1:30 
diluted urine. The good correlation (R2 0.9994) of the signal intensity at m/z 51 shows the 
increasing amount of chlorine in the samples. The signal intensity for m/z 77 in the 1:10 
urine is significantly (P = 0.05) different from the other four values. The increase for the 
signal at m/z 77 for the 1:10 diluted urine sample amounts to 478 counts compared to the 
other four urine samples. An increase of 478 counts for m/z 77 corresponds to an increase 
of 1495 counts at m/z 75, taking into account the isotopic ratio of 35Cl/37Cl. This increase of 
1495 counts is almost identical to the increase noted between the 1:10 diluted urine and 
the mean of the other samples at m/z 75 (difference of 1640). Vanhoe et al.  [1994] 
investigated the spectral interferences encountered in the analysis of biological samples by 
ICP-MS. They calculated that chlorine concentrations of 100 and 500 mg/L (4 and 20 g/L, 
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respectively, before dilution) gave rise to an apparent arsenic concentration of 1.6 and 7.6 
ng/mL, respectively. A linear relationship between chloride concentration and apparent 
arsenic concentration was found in the interval 1-1000 mg/L chloride. A maximum of 7.04 
g/L chloride (176 mg/L after dilution) results in an apparent arsenic level of 2.78 ng/mL. 
This is well below the expected elevated arsenic levels in urine (up to 100 ng/mL As) found 
after ingestion of arsenosugar containing food. 
 
8.2. Arsenic speciation in urine and blood 
 
In order to study the metabolites of the arsenosugars after ingestion of the seaweed 
Laminaria , seven trials were designed whereby Belgian and Chinese volunteers ate a given 
portion of seaweed. In the consecutive trials, new findings of previous trials and new 
findings of other researchers were checked, and other separation and detection methods 
were used. Prior to each trial,  Laminaria was thoroughly cleaned with tap water and rinsed 
with deionised water. The volunteers ingested a portion of 20-30 g (dry mass) algae, either 
dried, wetted or boiled within a time span of 30 minutes. The total arsenic content in the 
Laminaria is 43.2 ± 0.4 mg kg-1. A chromatogram of an extract of the Laminaria , as 
ingested, is shown in figure 8.1. It contains AsSug-OH, AsSug-PO4, AsSug-SO3 and a small 
amount of DMA. The volunteers refrained from eating arsenic -rich food (fish, crustaceans, 
molluscs, mushrooms…) 3 days prior to and during the experiment. 
 
 
Figure 8.1. Chromatogram of Laminaria extract separated on PRP-X100 anion exchange 
column. Detection with ICP-MS. 
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8.2.1. First trial 
 
A first experiment was conducted at the Tsinghua University in Beijing, P.R. China in April 
2001. Four male Chinese volunteers (aged 21, 24, 28 and 45 y) and myself (age 25 y) 
ingested a portion of 20 g raw Laminaria . Volunteer 1 mixed the seaweed in his soup. 
Volunteer 2 ate fish two days after ingestion of the seaweed and repeated the experiment 
two weeks later. Therefore small differences in retention times can be seen between the 
peaks in the chromatograms of volunteer 2 compared to the others. Urine was collected 
before and up to 120 hours after uptake. Each of the volunteers was asked to collect as 
much urine samples as possible. A minimum of four urine samples was collected each day. 
The urine samples were collected in acid washed polyethylene (PE) beakers and transferred 
into acid washed PE bottles, or collected directly in the PE bottles. The bottles were stored 
at 4°C. All urine samples were analysed for their total arsenic (ICP-MS) and creatinine 
(HPLC-UV) content and selected urine samples of all volunteers were chromatographed 
(anion exchange HPLC-ICP-MS) for speciation analysis. The objective of this first trial was 
to get a general idea about the concentration of arsenic in the urine samples and about the 
amount of urinary arsenic metabolites in a small population who is used to ingest algal 
food. 
 
For the analysis of the total amount of arsenic in urine, the samples were diluted 40x in 1% 
HNO3 to which 3% MeOH was added. Standards were also diluted in 1% HNO3 to which 
3% MeOH was added. All samples and standards were measured by means of ICP-MS on 
an Elan 6000 (PE Sciex, Toronto, Canada). External calibration using an arsenic standard 
solution (AsV) was applied. The ICP-MS measurement conditions were optimised on a daily 
basis. Average values for nebuliser gas flow (1 L/min), RF power (1300 W) and lens voltage 
(9 V) were obtained. The ion intensities at m/z 75 (As+) and 77 (Se+, ArCl+) were 
monitored. Urinary creatinine was determined in order to normalise the different urine 
samples of each volunteer. The method is based on that of Archari et al.  [1983]. Reversed 
phase HPLC with UV detection on a Waters 600 pump and a Waters 486 UV detector 
(Waters, Milford, USA) was used. A volume of 50 ml of a 50x diluted urine was 
chromatographed with 50 mM sodium acetate (pH 6.5) in 98+2 water/acetonitrile on a 
Waters C18 column using a flow rate of 1 mL/min. A plot showing the creatinine adjusted 
urinary arsenic concentration versus time after ingestion for all volunteers is given in figure 
8.2. It can be seen that for the Chinese volunteers a maximum arsenic/creatinine ratio is  
obtained within 15 to 25 hours after ingestion. Only low concentrations were to be noted 
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for volunteer 5; a small maximum can be seen at 38 hours. From the figure, it might be 
concluded that the arsenic metabolism of volunteer 5 differs from that of the other 
volunteers. However, in terms of non-normalised amounts, the maximum urinary arsenic 
levels of volunteer 5 are not significantly below the others. The highest value was found in 
the urine of volunteer 4 (228 ng/mL), followed by volunteer 2 (158 ng/mL), volunteer 3 
(141 ng/mL), volunteer 1 (72 ng/mL) and volunteer 5 (70 ng/mL). On the other hand, the 
mean urinary creatinine value of volunteer 5 was higher than for volunteers 1, 2 and 3. 
Volunteer 4 showed the highest mean creatinine value. Creatinine is  a waste product from 
meat protein in the diet and from the muscles. The diet and the physical 
condition/behaviour therefore play an important role. In fact none of the 5 volunteers had 
problems in digesting the seaweed or felt uncomfortable during the course of the 
experiment. All concentration levels return to background levels after about 80 h. The 
different ethnic origin and food culture might explain the different background level of 
arsenic in urine. 
 
 
Figure 8.2. Urinary creatinine-normalised arsenic concentrations of five volunteers 
before and after ingestion of Laminaria. Detection with ICP-MS. 
 
The results correlate well with those obtained by Le et al.  [1994], Ma and Le [1998] and 
Francesconi et al.  [2002]. Le et al.  found that 9 volunteers who ingested 9.5 g of nori 
showed maximum concentrations 10-60 hours after ingestion. Their values, however, were 
not normalised versus creatinine. Using non-normalised data we also obtained a broader 
time span. According to Ma and Le [1998], the highest concentrations in the urine of the 4 
volunteers who ingested 9.5 g of nori were found between 22 and 38 hours after ingestion. 
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In the study by Francesconi et al.  [2002] one volunteer obtained the maximum normalised 
arsenic value 27 hours after ingestion of a pure arsenosugar. 
 
Table 8.5. Chromatographic conditions of anion and cation exchange for separation of 
arsenicals in algal extracts and urine. 
 
   
technique anion exchange cation exchange 
   
   
column Hamilton PRP-X100 Dionex Ionpac CS10 
dimensions & particle size guard column 25 x 2.3 mm id, 12-20 µm 50 x 4 mm id, 10 µm 
dimensions & particle size anal. column 250 x 4.1 mm id, 10 µm 250 x 4 mm id, 10 µm 
flow rate [mL/min] 1 1 
buffer 20 mM (NH4)2HPO4 (pH 7) 
in 3% MeOH 
20 mM pyridine (pH 3) 
in 3% MeOH 
   
 
Speciation analysis using anion exchange and cation exchange was done. The experimental 
conditions for HPLC are listed in table 8.5. For the anion exchange buffer a pH of 7 was 
chosen on the basis of the separation of the Laminaria extract. At pH 6 no base-line 
separation of arsenosugar OH from DMA can be achieved. Only later it was realised that at 
pH 7, DMA and MA are not well separated from one another. Figures 8.3 to 8.7 show the 
anion exchange HPLC-ICP-MS chromatograms of urine samples from all volunteers. In the 
figures 8.3a to 8.7a the chromatogram of the urine sample containing the highest amount 
of arsenic is shown for each volunteer. In the insert of each of these chromatograms a 
detailed area (the retention window 0-5 minutes) of four urine samples obtained at 
different points of time relative to seaweed intake is shown. In the figures 8.3b to 8.7b a 
more detailed insert of the urine sample containing the maximum amount of arsenic is 
shown, also for each of the volunteers. A total of 11 arsenic containing peaks can be 
observed. Peak identification was done using a blank urine sample spiked with AB, AsIII, 
DMA, MA and AsV . Peak 1 is unknown. Peaks 2 and 3 co-elute with AB and AsIII, 
respectively. Peak 4 is DMA, while peak 5, in the right shoulder of the DMA peak, is MA. 
Peaks 7 to 11 are unknown. A small peak sometimes appears which co-elutes with the 
signal of 51ClO+, indicating the presence of a 75ArCl+ interference. This peak is denoted as X 
throughout all chromatograms. 
Chapter 8. Arsenic: measurement of arsenic metabolites from arsenosugars 
______________________________________________________________________________________________________ 
 177
 
 
 
Figure 8.3a (top). Chromatogram of urine sample from volunteer 1. In insert a detailed 
area of different urine sample. Separation on PRP-X100 anion exchange column, 
detection with ICP-MS. 
 
Figure 8.3b (bottom). Same chromatogram as in figure 8.3a with enhanced y-axis. 
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Figure 8.4a (top). Chromatogram of urine sample from volunteer 2. In insert a detailed 
area of different urine sample. Separation on PRP-X100 anion exchange column, 
detection with ICP-MS. 
 
Figure 8.4b (bottom). Same chromatogram as in figure 8.4a with enhanced y-axis. 
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Figure 8.5a (top). Chromatogram of urine sample from volunteer 3. In insert a detailed 
area of different urine sample. Separation on PRP-X100 anion exchange column, 
detection with ICP-MS. 
 
Figure 8.5b (bottom). Same chromatogram as in figure 8.5a with enhanced y-axis. 
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Figure 8.6a (top). Chromatogram of urine sample from volunteer 4. In insert a detailed 
area of different urine sample. Separation on PRP-X100 anion exchange column, 
detection with ICP-MS. 
 
Figure 8.6b (bottom). Same chromatogram as in figure 8.6a with enhanced y-axis. 
 
 
0
10000
20000
30000
40000
50000
60000
0 2 4 6 8 10 12 14 16 18 20 22
retention time [minutes]
in
te
n
si
ty
 7
5
A
s 
[c
o
u
n
ts
]
0 1 2 3 4 5
- 0.5 h + 24 h + 49 h + 87.5 h
1 2 3
5
4
1
2
3
4
5      X                                        7                             8   
3000
3500
4000
4500
5000
5500
6000
6500
7000
7500
8000
0 2 4 6 8 10 12 14 16 18 20 22
retention time [minutes]
in
te
n
si
ty
 7
5
A
s 
[c
o
u
n
ts
]
1
2
3
4
5
X
6
10
7
8
11
Chapter 8. Arsenic: measurement of arsenic metabolites from arsenosugars 
______________________________________________________________________________________________________ 
 181
 
 
 
Figure 8.7a (top). Chromatogram of urine sample from volunteer 5. In insert a detailed 
area of different urine sample. Separation on PRP-X100 anion exchange column, 
detection with ICP-MS. 
 
Figure 8.7b (bottom). Same chromatogram as in figure 8.7a with enhanced y-axis. 
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urine of volunteers 1 and 2, respectively, whereas peak 11 is only present in the urine of 
volunteers 4 and 5. Peak 6 is only absent in the urine of volunteer 2. Only volunteer 5 does 
not show a significant increase of peak 2 (see inserts in figures 7.3a to 7.8a). Except for 
these small discrepancies the chromatograms of the 5 volunteers look very simila r. Le et al.  
[1994] and Ma and Le [1998] mentioned that individuals metabolise arsenosugars in 
different ways. Our findings do not fully confirm this statement. Furthermore the fact that 
there is no difference between the Chinese volunteer 1 (boiled in soup) and the others 
(eaten raw) might indicate that mixing the seaweed with soup does not change the 
chemical composition of the arsenicals. However, to be sure, a more thorough study would 
be needed. Looking at the five chromatograms, it seems strange that the time-dependent 
urinary arsenic profile of volunteer 5 is so much different from the others. During 
conservation of the urine samples at 4°C, a pink precipitation was frequently observed for 
this volunteer. Pink precipitation was much less often seen for the other volunteers. The 
presence of this precipitation might have influenced the measurement of total urinary 
arsenic with ICP-MS. Complete microwave digestion with mineral acids ought to be 
preferred. Because this equipment was not available on the spot, it could not be 
considered. On the other hand, it was not the intention to determine very accurately the 
exact arsenic concentration in all urine samples. The extra work to be spent on sample 
digestion would not have given us relevant additional information. There is a difference 
between the two ethnic groups in the increase of peak 2 (AB) for the Chinese volunteers. 
There is, however, a presumption that the algae were not the only source of arsenicals in 
the diet of the Chinese volunteers. Although hypothetical, it makes sense to assume that 
the Chinese people unknowingly to them ingested arsenic-rich food, which may not be the 
case for the Belgian volunteer. The Chinese cuisine is dominated by rice, food from marine 
origin, mushrooms, stock prepared from fish… It is therefore more likely to conclude that 
the presence of AB originates from AB-containing food, rather than from decomposition of 
arsenosugars. Moreover, AB is absent from algae or at least no reports on the presence of 
AB in algae are available. 
 
The speciation analysis results correlate well with those obtained by Francesconi et al.  
[2002]. They noted 4 major and 4 minor peaks in the urine of a 47 year old male 
volunteer, 27 hours after the ingestion of a pure arsenosugar. Differences in the mobile 
phase composition make a direct comparison difficult, but most probably, at least 3 of the 
major peaks found in their study match peaks 2, 4 and 8 in our chromatograms. It is 
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difficult to compare these results with those of Le et al.  [1994] and Ma and Le [1998] 
because they used ion pair RPC. 
 
 
Figure 8.8. Chromatograms of standards and urine samples from 3 volunteers separated 
on CS10 cation exchange column. Detection with ICP-MS. 
 
None of the peaks in the anion exchange chromatogram of the urine samples, except for 
those in the void volume, match the original arsenosugars in the seaweed extract. Because 
arsenosugar OH shows no retention in anion exchange mode, cation exchange 
chromatography was applied. The chromatograms showing selected standards (MA, DMA 
and AB: black line; arsenosugars: dotted black line) and urine samples is given in figure 
8.8. In none of the urine samples, a peak was found that matched the retention time of 
arsenosugar OH. On the other hand it can be seen that the increase of the peak in the void 
volume of a urine sample from a Chinese volunteer is most likely due to AB (grey line). The 
AB peak in the chromatogram from the urine comes a few seconds ahead of that of a 
standard mixture. The high salt content in the urine matrix always results in a shorter 
retention time. Likewise it can be seen that the increase of the peak in the void volume of a 
urine sample from volunteer 5 is not due to AB (thick black line). From the same figure it 
can also be seen that in a urine sample from volunteer 1, taken 25 hours after ingestion, a 
peak at the retention time of 320 seconds appears, but no increase at the retention time of 
AB is seen (thick grey line). The peak at 320 s might be DMAE. At that time, however, I 
was not aware of the possible presence of that compound in urine and consequently had 
no standard available. From the first experiment it can thus be concluded that the 
arsenosugars are completely transformed into DMA, MA and a series of unknown 
metabolites. All five volunteers show a fairly similar urinary arsenic pattern. Although three 
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peaks can be distinguished in the void volume, it is difficult to unambiguously identify 
them. On the basis of the cation exchange chromatograms, it is tempting to state that the 
second and third peak in the void volume of the anion exchange chromatograms are AB 
and AsIII, respectively. Most probably other neutral and/or cationic species are also present. 
The presence of arsenite remains an open question. 
 
8.2.2. Second trial 
 
A second experiment was carried out in Ghent in June 2002. A portion of 20 g (dry mass) 
Laminaria was boiled for three minutes and ingested by a Belgian (age 26 y) and a Chinese 
volunteer (age 28 y), both male. Only selected urine samples (within the first 36 hours) 
were collected. The urine samples were collected in acid washed PE bottles. The bottles 
were stored at 4°C. It was the intention to test the possibilities of HPLC-UV-HG-AFS for the 
detection of arsenic species in the urine samples. It was also checked whether boiling of 
the algae had an influence on the stability of the arsenosugars. 
 
 
Figure 8.9. Chromatograms of boiled and raw Laminaria extract separated on PRP-X100 
anion exchange column. Detection with UV-HG-AFS. 
 
A raw and a boiled portion of Laminaria were extracted with 50:50 water/methanol as 
described before (section 7.5). Both portions were extracted under exactly the same 
conditions. These algae extracts, together with the urine samples were analysed using 
HPLC-UV-HG-AFS with 20 mM Na2HPO4 (pH 6) on a Hamilton PRP-X100 anion exchange 
column. Figure 8.9 shows the chromatograms of both algae extracts. It can be seen that 
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boiling of the Laminaria efficiently extracts nearly all DMA and a significant amount of 
arsenosugar OH. The signal intensities for the peaks of arsenosugars PO4 and SO3 remain 
stable. Because of these small changes, it was decided to ingest only raw Laminaria in all 
other experiments. 
 
 
Figure 8.10. Chromatogram of urine separated on PRP-X100 anion exchange column. 
Detection with UV-HG-AFS. 
 
An example of a urine sample, analysed with HPLC-UV-HG-AFS, is given in figure 8.10. It 
can be seen that the sensitivity of the AFS detector is much lower compared to that of ICP-
MS (figures 8.3 to 8.7). No further efforts were made to improve the sensitivity of UV-HG-
AFS. Instead, ICP-MS will be used in all further experiments. 
 
8.2.3. Third trial 
 
A third experiment was conducted in October 2002 in Ghent as well as in Beijing. Two 
Belgian male volunteers (aged 26 and 22 y) ingested a portion of 20 g raw Laminaria. 
Blood was collected before and within a short time-span after ingestion. The blood was 
collected in heparin free vacuum tubes. Afterwards serum and packed cells were separated 
by centrifugation (two times at 3000 rpm, 20 min, 4°C) and both fractions were stored at 
4°C. Urine was sampled only between 15 to 48 hours after ingestion. The urine samples 
were collected in acid washed PE bottles. The bottles were stored at 4°C. Portions of the 
urine and serum samples were freeze dried and analysed in Beijing by HPLC-ICP-MS. 
Speciation analysis was carried out on the same ICP-MS instrument as described in section 
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8.2.1. Samples were chromatographed on a Hamilton PRP-X100 anion exchange column 
with 30 mM NH4Oac in 3% (v/v) MeOH (pH 6). The objective of this experiment was to 
confirm the presence of MA in urine and to check whether DMAE and TMAO were present 
in urine, as was found by Francesconi et al.  [2002]. Furthermore a first idea about 
speciation in serum should hopefully be obtained. Finally the capabilities of HPLC-ES-MS/MS 
for arsenic speciation analysis were explored. 
 
 
Figure 8.11. Chromatogram of urine (left) separated on PRP-X100 anion exchange 
column. Same chromatogram with 12x enhanced y-axis (right). Detection with ICP-MS. 
 
Figure 8.11 shows an anion exchange HPLC-ICP-MS chromatogram of urine from volunteer 
1 collected 17 hours after ingestion of Laminaria . A total of 8 arsenic species can be 
detected. In contrast to the first experiment, only one peak elutes in the void volume. 
However, most probably different neutral and positively charged arsenic species may 
account for this. The peak denoted as X is due to the presence of a 75ArCl+ interference. 
Peak identification by spike addition was done on another urine sample. A urine sample 
was spiked with a standard mixture of AsIII, DMA, MA and AsV . The chromatograms are 
shown in figure 8.12. Peaks 2 and 3 are DMA and MA, respectively. Peak 6 is most probably 
arsenate. 
 
Although no information is given about the mechanism of formation of DMA from 
arsenosugars, DMA is generally accepted as one of the main metabolites of arsenosugars. 
[Le et al. , 1994; Ma and Le, 1998, Feldmann et al. , 2000; Francesconi et al. , 2002]. It 
makes sense to state that DMA is formed by cleavage of the arsinoyl moiety in the 
arsenosugars. 
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Figure 8.12. Chromatograms of urine and urine supplemented with standards of AsIII, 
DMA, MA and AsV, separated on PRP-X100 anion exchange column. Detection with ICP-
MS. 
 
To my knowledge this is the first report on the presence of MA in urine of people who 
ingested arsenosugar-containing food. It is unlikely that MA is an intermediate in the 
formation of DMA, as it is in the metabolism of inorganic arsenic. Therefore the presence of 
MA indicates a demethylation process. At present, I can give no explanation for the 
presence of MA. However, arsenosugars seem to be unstable when stored for a long time. 
A composite chromatogram of an old extract of kelp powder that was stored for more than 
one year at 4°C, and a standard mixture of AsIII, DMA, MA and AsV  is shown in figure 8.13. 
In comparison with figure 7.9 (left), in which a fresh extract of kelp powder is shown, the 
percent abundance of DMA increases, and a peak of MA appears, whereas all arsenosugars 
show a lower relative abundance (see table 8.6). Also old extracts of Laminaria give rise to 
formation of MA (chromatogram not shown). Francesconi et al.  [2002] could not find MA in 
the urine of a volunteer who had ingested a pure arsenosugar. On the other hand 
Feldmann et al.  [2000] reported on MA as a urinary metabolite in sheep that fed on algae. 
According to them, the occurrence of MA is assumed to be a precursor of the exposure to 
inorganic arsenic, since demethylation of dimethylated or trimethylated organoarsenic 
compounds is not known. In a more recent paper from that research group [Hansen et al. , 
2003b], however, they make report of DMAA as a metabolite instead of MA. Both 
compounds elute closely together using anion exchange chromatography. 
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Figure 8.13. Chromatograms of old extract of kelp powder and standards of AsIII, DMA, 
MA and AsV, separated on PRP-X100 anion exchange column. Detection with ICP-MS. 
 
The similarity with the urine samples of the five volunteers from the first experiment is 
good. The retention times of the arsenicals are, however, longer because the elution 
strength of 30 mM NH4OAc (pH 6) is lower than that of 30 mM (NH4)2HPO4 (pH 7). 
 
Table 8.6. Relative abundances of arsenicals in old and fresh extract of kelp powder. 
 
       
 AsSug-OH DMA AsSug-PO4 MA AsSug-SO3 AsSug-SO4 
       
       
fresh extract 29.9% 3.5% 5.0% 0.0% 12.1% 49.5% 
old extract 28.6% 12.0% 3.2% 7.7% 9.0% 39.5% 
       
 
The urine samples were also subjected to HPLC-ES-MS/MS using a 30 mM NH4Oac in 20% 
(v/v) MeOH (pH 6) buffer. Figure 8.14 shows an HPLC-ES-MS/MS chromatogram with two 
MRM transitions for DMA. The detection of the molecular ion signal as well as two product 
ions unambiguously proves the presence of this compound. The peak containing DMA was 
also collected off-line, freeze-dried and reconstituted in 50:50 water/methanol to which 
0.2% HCOOH was added. A product ion scan was done. The resulting mass spectrum is 
shown in figure 8.15. The presence of fragments with m/z 91, 93, 106, 109 and 121 is in 
close agreement with a standard solution of DMA. ES-MS/MS shows a poor sensitivity for 
MA and it could thus not be detected. 
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Figure 8.14. Chromatograms of urine, separated on PRP-X100 anion exchange column. 
Detection of 2 MRM transitions of DMA with ES-MS/MS. Time is displayed in minutes. 
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Figure 8.15. Product ion scan spectra of DMA standard (top) and urine HPLC fraction 
containing DMA (bottom). Detection with ES-MS/MS. 
 
Cation exchange chromatography was also applied on selected urine samples. At that time 
Francesconi et al.  [2002] reported on the presence of DMAE in urine. Using both HPLC-ICP-
MS as well as HPLC-ES-MS/MS the presence of DMAE could be confirmed. Figure 8.16 
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shows a detailed area of the chromatograms of a urine sample and a urine sample 
supplemented with DMAE, separated on a Dionex CS10 cation exchange column with 20 
mM pyridine buffer in 3% (v/v) MeOH (pH 2.8). 
 
 
Figure 8.16. Detail of the chromatograms of urine and urine supplemented with DMAE 
separated on CS10 cation exchange column. Detection with ICP-MS. 
 
In figure 8.17, two MRM transitions of DMAE in a urine sample and one MRM transition of 
DMAE in that same extract spiked with DMAE are shown. The experimental conditions were 
identical to those used with ICP-MS except that 10 mM buffer was used instead of 20 mM. 
This logically results in longer retention times. Francesconi et al.  [2002] were first to report 
on the presence of DMAE in urine after ingestion of arsenosugars by means of HPLC-ICP-
MS and HPLC-ES-MS on a single quadrupole instrument. In their paper, they postulate that 
DMAE is likely to be originating from the degradation of the arsenosugars in the gut micro 
flora, rather than from the addition of the CH2CH2OH moiety to DMA. Their hypothesis is 
supported by experimental evidence [Edmonds et al. , 1982]. 
 
The peak containing DMAE was also collected off-line, freeze-dried and reconstituted in 
50:50 water/methanol to which 0.2% HCOOH was added. A product ion scan was done. 
The resulting mass spectrum is shown in figure 8.18. The spectrum of the urine fraction 
shows more peaks than the DMAE standard. The presence of fragments with m/z 103, 105, 
121 and 149, however, is a good match. 
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Figure 8.17. Chromatograms of urine and urine supplemented with DMAE, separated on 
CS10 cation exchange column. Detection of 2 MRM transitions of DMAE (bottom and 
middle) in urine sample and 1 MRM transition of DMAE (bottom) in supplemented urine 
sample with ES-MS/MS. Time is displayed in minutes. 
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Figure 8.18. Product ion scan spectra of DMAE standard (top) and urine HPLC fraction 
containing DMAE (bottom). Detection with ES-MS/MS. 
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Figure 8.19. Chromatograms of four serum samples from 1 volunteer separated on PRP-
X100 anion exchange column. Detection with ICP-MS. 
 
Serum samples of both volunteers were also subjected to speciation analysis. Blood 
samples were collected before and 2, 4 and 7 hours after ingestion in heparin free vacuum 
tubes. The blood was centrifuged (20 min, 3000 rpm, 4°C) twice to obtain serum and 
packed cells. The packed cell fraction was discarded and the serum was freeze-dried. After 
freeze-drying, all serum samples were reconstituted to their original volume and analysed 
similarly as the urine samples. Figure 8.19 shows the HPLC-ICP-MS chromatograms of the 
4 serum samples from volunteer 2. Surprisingly no change in the arsenic profile can be 
seen, although the residence time of food in the stomach and small intestines is shorter 
than 7 hours. Moreover, uptake of dissolved arsenic species in the gastro intestinal tract by 
blood is believed to be fast and its elimination efficient in case of normal renal function. It 
is worth mentioning that the peak in the void volume is not due to arsenite, because 
spiking one of the serum samples with a mixture of AsIII, DMA and MA shows two closely 
eluting peaks in the void volume (figure 8.20). Arsenite is the second peak in the void 
volume. 
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Figure 8.20. Chromatogram of serum sample supplemented with standards of AsIII, DMA 
and MA, separated on PRP-X100 anion exchange column. Detection with ICP-MS. 
 
8.2.4. Fourth trial 
 
A fourth experiment was conducted in March 2003 and focussed only on the analysis of 
total arsenic in blood samples by HG-AFS. To find out whether or not arsenic was taken up 
by the packed cell fraction, whole blood, serum and packed cells were analysed for their 
total arsenic content. In this experiment, blood samples were collected from two volunteers 
(A Belgian aged 27 y and a Chinese aged 25 y) before and 4 and 7 hours after ingestion of 
20 g Laminaria . The blood was collected in heparin free vacuum tubes. Afterwards serum 
and packed cells were separated by centrifugation (two times at 3000 rpm, 20 min, 4°C) 
and both fractions were stored at 4°C. The arsenic content in blood, serum and packed 
cells was analysed by HG-AFS. All samples were digested in open vessels using a mixture of 
HNO3, H2SO4 and HClO4 (7:2:1) and a 3-step temperature programme. First the sample 
was heated at 85°C for 2 hours, followed by a heating step at 130°C (3 hours) and 230°C 
(3 hours). The length of the digestion programme was also dependent on the amount of 
sample added to the vessel. On average, 3 mL serum, 2 mL blood and 1 mL packed cells 
were digested with 10 mL of the acid mixture. The final solution was diluted to 25 mL with 
3 M HCl to which 0.1 g L-1 KI and 0.02 g L-1 ascorbic acid was added in order to reduce all 
arsenic to its trivalent state. Hydride generation was realised by mixing a flow of the 
sample at a speed of 9 mL min-1 with a stream of 0.7% (m/v) NaBH4 in 0.4% (m/v) NaOH 
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at 4.5 mL min-1. The accuracy of the measurement was tested by the analysis of a certified 
reference material, freeze-dried human serum, with a certified value of 19.6 ± 4 ng g-1 As 
[Versieck et al. , 1988]. The value obtained with our method was 24.0 ± 1.8 ng g-1 As for 3 
sub samples, each measured in triplicate. There is no siginificant difference (P = 0.05) 
between the experimental results and the certified value. The results are shown in table 
8.7. In whole blood as well as in serum and packed cells, the concentration of arsenic does 
not significantly change. Only one sub-sample was available. It was measured in threefold. 
Volunteer 1 shows higher background levels of arsenic. This might be due to the fact that 
he is Chinese. Higher urinary background levels for Chinese people were also noticed in 
experiment one. 
 
Table 8.7. Arsenic concentration in the different blood compartments of two volunteers. 
Detection with HG-AFS. 
 
     
  concentration & SD (n = 3) [ng/g] 
  before after 4 h after 7 h 
          
     
volunteer 1 blood 4.4 (0.5) 4.1 (0.5) 5.7 (0.3) 
 packed cells 8.5 (1.4) 6.0 (0.7) 9.9 (2.2) 
 serum 2.2 (0.3) 2.2 (0.3) 2.4 (0.3) 
     
volunteer 2 blood 1.9 (0.1) 1.8 (0.1) 1.7 (0.2) 
 packed cells 2.0 (0.2) 2.5 (0.1) 2.0 (0.1) 
 serum 0.8 (0.5) 1.1 (0.6) 2.0 (1.0) 
          
 
8.2.5. Fifth trial 
 
A fifth experiment was carried out in May 2003 with the same volunteers as in experiment 
three. Two male Belgians aged 27 y and 23 y ate a portion of 20 g Laminaria . The urine 
samples were collected in acid washed PE bottles. The bottles were stored at 4°C. Only 
selected urine samples were taken (range 0 to 48 hours after ingestion). Speciation 
analysis was done with a 3 mM ammonium oxalate buffer in 3% MeOH, pH 6 and detection 
was realised with ICP-MS. The objective was to get a better insight into the possible 
presence of reduced methylated species (MAIII and DMAIII). 
 
The results of the speciation analysis in urine again confirmed those from the previous 
experiments and a good agreement with the results of Francesconi et al.  [2002] was again 
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noticed. Efforts were made to confirm the presence of the reduced DMA, which was 
proposed by Francesconi et al.  [2002]. There is much debate about the real identity of the 
synthesised MAIII and DMAIII. An easy means of getting the reduced compounds is by the 
so-called ‘Reay and Asher’ method: reduction of DMA or MA with an acid solution of 
Na2S2O3 and Na2S2O5 leads to DMAIII and MAIII, respectively [Reay and Asher, 1977]. 
Reduction of MA leads to two product peaks MAIII1 and MAIII2 and a trace of unchanged MA. 
DMA leads to one product peak and a trace of unchanged DMA (figure 8.21). 
 
 
Figure 8.21. Chromatograms of solutions of DMA and MA and their reduced compounds 
upon reaction with Na 2S2O3  and Na2S2O5  in H2SO4 . Separation on PRP-X100 anion 
exchange column, detection with ICP-MS. 
 
The retention time of the first MAIII peak is consistent with that reported by others 
[Francesconi et al. , 2002; Gailer et al. , 1999] and this is most likely the real (CH3)As(OH)2. 
According to Feldmann et al.  [unpublished data], the reduction of DMA does not lead to 
DMAIII, but to a compound in which the arsenic-oxygen double bond is replaced by an 
arsenic-sulphur double bond. They also mention that reduction of MA also leads to one, 
possibly two sulphur-containing arsenicals. The peak of MAIII2 at tR 11.4 min and DMAIII at 
tR 17.4 min are due to these sulphur containing arsenic species. It is noteworthy to mention 
that both sulphur-containing compounds have a long retention time on the Hamilton PRP-
X100 column. Moreover, according to Gailer et al.  [1999] the retention time of DMAIII is 
invariable with varying buffer pH. 
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DMAIII is an intermediate in the methylation pathway suggested by Challenger [Challenger, 
1945]. Although DMA is the end metabolite of inorganic arsenic in humans, some mammals 
do further methylate DMA to TMAO, via DMAIII. I consider it justified to state that DMA is 
formed from arsenosugars by a mechanism in which TMAO is also involved, because in 
dimethylarsinoyl arsenosugars, the arsenic is bound to two methyl groups, oxygen and an 
alkyl substituent. Whether the real DMAIII has been detected by Francesconi et al.  [2002] 
or not, it makes sense to assume that this species can be present. DMA is the main 
metabolite of arsenosugars and TMAO has been detected in trace amounts [Francesconi et 
al., 2002]. This demethylation process goes via DMAIII. Because MA has been detected in 
many of our urine samples, a similar interpretation can be made about the presence of 
MAIII. MAIII and DMAIII are known to be very unstable and their detection should be realised 
within a very short time span. But even then speculations can be made whether oxidation 
should already have occurred in vivo, taking into account the residence time of the 
metabolites in urine in the bladder. On the other hand, the bladder is considered a reducing 
environment, preventing oxidation to the pentavalent state. 
 
Spiking a urine sample with a solution of reduced DMA shows that it does not co-elute with 
the unknown peak at the end of the chromatogram. The sulphur-containing DMAIII 
compound has a longer tR. The chromatogram of the same urine sample to which MAIII was 
added, shows that the peak at tR 11.4 min co-elutes with a very small but broad peak 
(figure not shown). However, it is not very clear whether this bump is due to MAIII2. The 
urine sample was analysed within a short time span that should allow the detection of MAIII 
according to the findings of Gong et al.  [2001]. But even if this bump co-elutes with the 
synthesised MAIII2, then we may be dealing with the sulphur-containing arsenical and not 
the real MAIII. As told before the issue of reduced methylated species is far from clear. At 
the moment there are still doubts about the proper method of synthesis. Add to this that 
convincing analytical methodology is yet lacking. Therefore it is premature to make any 
further assumptions about the possible presence of these reduced species in urine. 
 
8.2.6. Sixth trial 
 
Experiment six was done in August 2003. Only one volunteer participated (Belgian male, 
aged 27 y). He ate a portion of 20 g Laminaria . The urine samples were collected in acid 
washed PE bottles. The bottles were stored at 4°C. All urine within the interval of 3 prior to 
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100 hours after ingestion was collected. Speciation analysis was done with a 3 mM 
ammonium oxalate buffer in 3% MeOH, pH 6 on a Hamilton PRP-X100 anion exchange 
column and detection was realised with ICP-MS. The purpose of this experiment was to find 
out more about the unknown metabolite eluting at the end of the chromatogram and to 
confirm the presence of MA. 
 
A urine sample was chromatographed with 3 mM ammonium oxalate in 3% (v/v) MeOH 
(pH 6) on both an analytical and a preparative PRP-X100 column and spiked with MA. In 
both cases a perfect match was observed (figures not shown). 
 
 
Figure 8.21. Retention time of urinary arsenic metabolites in function of different buffer 
pH values. 
 
One of the urine samples was chromatographed on a Hamilton PRP-X100 anion exchange 
column using a 30 mM sodium phosphate with variable pH values (5, 6, 7, 8 and 9). The 
results are shown in figure 8.21. The retention behaviour of DMA and MA is completely in 
accordance with the findings of Gailer et al.  [1994; 1999]. At pH 7, DMA and MA co-elute. 
The unknown component shows no change in retention behaviour. This might be due to 
the fact that it is highly negatively charged or that it experiences other than purely ionic 
interactions. Francesconi et al.  [2002] have done a similar experiment on a urine sample. 
They chromatographed a urine sample on the same type of column (though shorter) with a 
20 mM NH4HCO3 buffer at pH values 8, 9.5, 10 and 10.7. For the strongly retarded 
unknown metabolite, they observed a great influence of the retention time in function of a 
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variable pH. They noticed that this behaviour was similar to that of arsenate. In conclusion 
they stated that both arsenate and the unknown form carbonate complexes in the mobile 
phase. The difference between both outcomes might be due to the fact that another buffer 
was used, or that we are dealing with a different compound. 
 
 
Figure 8.22. Chromatograms of isolated unknown peak in urine and solution of 
standards of AsIII, DMA, MA and AsV. Separation on PRP-X100 anion exchange column, 
detection with ICP-MS. 
 
Using a preparative Hamilton PRP-X100 column, this unknown metabolite was isolated, 
freeze-dried and analysed in Graz during a short stay at the research group of Prof. Dr. 
Francesconi. In total 16 preparative separations were done using 0.5 mL undiluted urine. 
The flow rate of 10 mL/min was split to enable 95% to be collected by a fraction collector. 
5% was sent to the ICP-MS for determination of the retention time. All fractions were 
combined and freeze-dried. A total of 45 ng As was isolated. This would allow analysis with 
infusion ES-MS/MS. First the freeze-dried fraction was reconstituted in a minimal amount of 
water and separated on a Hamilton PRP-X100 anion exchange column with 20 mM 
(NH4)2HPO4 in 3% (v/v) MeOH, pH 6. The result is shown in figure 8.22. The original 
fraction completely disappeared. Instead 5 peaks can be observed: two in the void volume, 
one co-eluting with DMA and two closely eluting near MA and AsV , respectively. The high 
salt content in the fraction can cause this shift in retention time. No further efforts were 
made to repeat this experiment. Only very recently Hansen et al.  [2004] reported on the 
presence of 2-dimethylarsinothioyl acetic acid (CH3)2As(S)CH2COOH in sheep urine. This 
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compound has a retention time, which is consistent with the one isolated in trial 6. The 
identity was confirmed by ES-MS, NMR and spiking. On the one hand it is likely that this 
arsenical is also the compound that appears in the human urine samples throughout all 
seven trials in this work. On the other hand, Hansen et al.  reported that when using a 
mobile phase pH of 5.3, the compound was permanently absorbed on the anion exchange 
chromatogram. They used an NH4HCO3 mobile phase. Also Francesconi et al.  [2002] used 
an NH4HCO3 mobile phase and observed a strong pH dependency of the strongly retarded 
component. We have found no pH dependency of the unknown compound, but we used a 
phosphate buffer. Upon oxidation 2-dimethylarsinothioyl acetic acid forms DMAA, so the 
peak closely eluting to MA (in figure 8.22) could be DMAA. 
 
8.2.7. Seventh trial 
 
 
Figure 8.23. Chromatograms of a urine sample and the same urine sample spiked with 
DMAE and TMAO. Separation on CS10 cation exchange column, detection with ICP-MS. 
 
A last experiment was conducted in November 2003. Again only one volunteer participated 
(Belgian male, aged 27 y). He ate a portion of 24 g Laminaria . The urine samples were 
collected in acid washed PE bottles. The bottles were stored at 4°C. All urine samples 
within the interval of 3 prior to 120 hours after ingestion, were collected. The main focus 
was on the use of cation exchange chromatography, investigation of the chromatographic 
recovery and of a mass balance of arsenic in urine. At that time, Hansen et al.  [2003b] had 
reported on the presence of DMAA and the fact that it closely elutes near MA. Therefore it 
was checked again whether MA was present in the urine samples. 
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Cation exchange chromatography was done on a Dionex CS10 column with 10 mM pyridine 
buffer, in 3% (v/v) MeOH, pH 2.7. Anion exchange chromatography was done using a 3mM 
ammonium oxalate buffer in 3% (v/v) MeOH, pH 5.2 and 8.2. In both cases, ICP-MS served 
as the element-selective detector. Total arsenic in urine was done via HG-AFS using the 
digestion procedure described in section 8.2.4. Figure 8.23 shows the chromatograms of 
urine taken 23.5 hours after ingestion of the Laminaria , and the same urine sample to 
which individual solutions of TMAO and DMAE, respectively, were added. In contrast to the 
findings in experiment three, no clear occurrence of DMAE could be stated this time. 
Instead TMAO could be identified. TMAO was also identified by Francesconi et al.  [2002] as 
a trace in the urine of a volunteer who had ingested a pure arsenosugar. Similar spiking 
with TETRA and AB shows that no TETRA is present in the urine samples and that some AB 
could be found, possibly because of ingestion of other seafood. 
 
 
Figure 8.24. Chromatogram of urine sample separated on PRP-X100 anion exchange 
column. In insert a detailed area of same chromatogram. Detection with ICP-MS. 
 
The anion exchange chromatogram of the urine sample collected 23.5 hours after ingestion 
is shown in figure 8.24. The oxalate buffer at pH 5.2 was used. Seven peaks and an 
interference of 75ArCl+ can be observed. The same urine sample was spiked with individual 
solutions of DMA (not shown), MA, AsV  and Laminaria extract, respectively. This is shown in 
figure 8.25. Peaks 3, 4 and 6 co-elute with MA, AsV  and arsenosugar SO3, respectively. This 
is the first time the presence of an arsenosugar is noticed. Arsenosugar SO3 is the most 
abundant of the three arsenosugars present in the Laminaria . 
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Figure 8.25. Chromatogram of urine sample and the same urine sample spiked with AsV, 
MA and Laminaria extract. Separation on PRP-X100 anion exchange column, detection 
with ICP-MS. 
 
Figure 8.26 shows the same urine sample, spiked with a solution of DMAA. A different and 
more diluted urine sample had to be used, because only a DMAA standard with low 
concentration was available. DMAA appears at the same retention time as MA when using 
the oxalate buffer at pH 5.2. Therefore the urine sample was again spiked with both 
solutions of MA and DMAA and chromatographed using a buffer at pH 8.2 (figure 8.27). 
Now, it can be clearly seen that DMAA is absent and MA is present. DMAA appears in the 
right shoulder of the DMA peak. Hansen et al.  [2003b] also evaluated the retention 
behaviour of DMAA and DMA on the same column, but with a 30 mM acetic acid buffer at 
pH 3, 4, 5.3, 6.4 and 8.5. They also observed a decrease in the tR of DMAA and an increase 
in the tR of DMA, respectively, in function of an increasing pH. At pH 8.5, DMA and DMAA 
eluted closely together. Although oxalate and acetate are not identical, both buffers contain 
a carboxyl group. 
 
All urine samples were analysed for their total arsenic content using HG-AFS. 2 mL urine 
was digested using the procedure described in section 8.5. The results are shown in table 
8.8. The data are not normalised according to the creatinine content. It can be seen that 
the maximum amount of arsenic is recovered from the urine sample collected 23.5 hours 
after ingestion. The arsenic content in the Laminaria was measured with NAA and found to 
be 43.4 mg/kg. The sample was irradia ted at a thermal neutron flux of 1.2x1012 n cm-2 s-1 
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during 7 h. Iron flux monitors were used to correct for the discrepancies in neutron flux 
between samples as a result of different positioning versus the reactor core. As2O3 was 
used as a standard. The 559 keV ?-rays emitted by the 76As (t½ 26.3 h) isotope were 
measured with a Ge(Li) detector coupled to a multi channel analyser. Taking into account 
an amount of 24 g Laminaria that was ingested, a total of 22.6% of all ingested arsenic is 
recovered from the urine. The remainder is still in the algae matrix and excreted via the 
faeces or is taken up and excreted via another route than renal. Hansen et al.  [2003a] have 
estimated the average urinary excretion of arsenic by sheep to be 86%. This assumption 
was based on the calculation of arsenic excreted in the faeces. However, a big difference 
might be expected between sheep whose diet is entirely based on algae and a human who 
does not normally consume seaweed. 
 
 
Figure 8.26 (left). Chromatograms of urine sample and the same urine sample spiked 
with DMAA. Separation on PRP-X100 anion exchange column, detection with ICP-MS. 
Mobile phase pH 5.2. 
 
Figure 8.27 (right). Chromatograms of urine sample and the same urine sample spiked 
with DMAA and MA. Separation on PRP-X100 anion exchange column, detection with 
ICP-MS. Mobile phase pH 8.2. 
 
Quantitative analysis of the urine sample (+ 23.5 h) by HPLC-ICPMS using a calibration 
curve obtained with standards of DMA shows that the arsenic content is 115.5 ng/mL. This 
means 65.5% of the arsenic is recovered from the anion exchange column. The remainder 
is still bound to the stationary phase. Feldmann and co-workers [unpublished data] have 
reported that recoveries could be extremely low and that flushing the column with 
ammonia slowly released a large amount of arsenic compounds from the column. 
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Table 8.8. Arsenic concentrations in urine samples. 
 
      
sample mass relative time As conc. As mass As cumulative 
 [g] [h] [ng/mL] [mg] [mg] 
      
     
blank urine - 0.75 11.5   
      
urine 1 410.9 + 0.75 2.0 0.8 0.8 
urine 2 479.0 + 2.25 5.3 2.6 3.4 
urine 3 211.4 + 3.25 13.5 2.8 6.2 
urine 4 243.5 + 7.00 82.2 20.0 26.2 
urine 5 161.1 + 9.75 83.2 13.4 39.6 
urine 6 204.9 + 15.25 144.0 29.5 69.1 
urine 7 223.1 + 23.50 176.3 39.3 108.5 
urine 8 177.4 + 27.00 118.1 21.0 129.4 
urine 9 164.6 + 30.75 107.8 17.7 147.2 
urine 10 167.4 + 35.00 88.5 14.8 162.0 
urine 11 138.9 + 39.25 64.7 9.0 171.0 
urine 12 249.4 + 48.00 75.4 18.8 189.8 
urine 13 195.3 + 52.00 42.0 8.2 198.0 
urine 14 245.1 + 54.00 13.0 3.2 201.2 
urine 15 167.0 + 56.25 22.9 3.8 205.0 
urine 16 141.7 + 59.00 24.0 3.4 208.4 
urine 17 197.8 + 61.50 2.0 0.4 208.8 
urine 18 426.4 + 72.00 1.7 0.7 209.5 
urine 19 228.3 + 76.50 29.1 6.6 216.1 
urine 20 218.8 + 82.00 38.5 8.4 224.6 
urine 21 194.6 + 87.00 20.0 3.9 228.5 
urine 22 329.8 + 96.25 19.5 6.4 234.9 
      
 
8.3 Stability of arsenosugars in SGF and SIF 
 
When algae are consumed, it takes a long pathway before the non-digestible residue is 
excreted. Mastication breaks down the algae as the salivary glands release enzymes that 
initiate the chemical digestion of carbohydrates. This mixture then enters the acid 
environment of the stomach. In the stomach the food is mixed into chyme and proteins are 
being digested. Afterwards the debris enters the small intestines in which most nutrients 
are digested and absorbed. At this stage, arsenic compounds in solutions are efficiently 
taken up by the bloodstream and quickly transported. The arsenic compounds are mostly 
excreted by the kidneys. A few preliminary in vitro incubation experiments were carried 
out. Algae were incubated in solutions of simulated gastric fluid (SGF) and simulated 
intestinal fluid (SIF). SGF and SIF were prepared according to the USP regulations [USP, 
2000]. The preparation of both SGF and SIF is described in section 6.3.2. 
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In a first experiment, Laminaria seaweed was boiled, chewed and afterwards incubated in 
SGF. At different time intervals between 1 minute and 4 hours a portion of the masticated 
algae were taken from the SGF, cleaned and dried. The dried products were cooled with 
liquid nitrogen before grinding in a dismembrator. The powdered Laminaria was analysed 
for its total arsenic content by NAA as described in section 8.2.7. The accuracy of the 
measurement was tested by the analysis of a certified reference material, NIST SRM 1571 
orchard leaves, which has a certified value of 10 ± 2 mg kg-1 As. The value obtained using 
our method was 12.4 ± 0.4 mg kg-1 As (n = 4). The results are shown in table 8.9. Boiling 
of the algae efficiently extracts a large amount (40%) of arsenic. Surprisingly however, 
incubation in SGF does not lead to further leaching of arsenicals from the algae matrix. 
 
Table 8.9. Arsenic concentrations in raw, boiled and processed Laminaria. 
 
    
sample As conc. sample As conc. 
 [mg/kg]  [mg/kg] 
 (n = 1)  (n = 1) 
    
    
unboiled Laminaria 23.9 Laminaria after 1 h in SGF 15.0 
boiled laminaria 14.3 Laminaria after 2 h in SGF 15.1 
Laminaria after 1 min in SGF 16.1 Laminaria after 3 h in SGF 15.4 
Laminaria after 30 min in SGF 15.1 Laminaria after 4 h in SGF 15.3 
    
 
The powdered Laminaria was extracted according to a method similar to that of Shibata 
and Morita [1992]. A 0.1 to 0.2 g portion was weighed into 12 ml centrifuge tubes. 10 mL 
of a 1+1 H2O/MeOH mixture was added. The suspension was vortex-mixed, ultrasonicated 
during 15 minutes and centrifuged at 5000 rpm during 15 minutes. The supernatant was 
transferred into a Petri dish. This procedure was repeated another two times. The collected 
supernatant fractions were left drying overnight in an oven at 40°C. The residue was 
diluted with 5 mL deionised water, weighed and stored at 4°C prior to analysis. Triplicate 
analysis was done using HPLC-ES-MS/MS. For each arsenosugar and DMA, one MRM 
transition was recorded. The results are shown in figure 8.28. Looking at the right side of 
figure 8.28, it can indeed be seen that the arsenosugars are efficiently extracted by the 3 
minute boiling step. However, incubation in SGF seems to further extract the arsenosugars 
and DMA from the seaweed matrix. On the other hand, the free arsinoyl riboside (denoted 
as AsSug-254 in the chromatograms, the molecular mass of this compound) is formed upon 
incubation in SGF. Gamble et al. [2002] have reported on the stability of arsenosugars in 
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an acid environment and in simulated gastric fluid (SGF). They reported that solutions of 
arsenosugars are slowly degraded (1.4% per h at 38°C) into a compound with mass 254 
Da. Their measurements were done using both HPLC-ICP-MS and HPLC-ES-MS/MS. 
 
 
Figure 8.28. Abundance (left) and relative abundance (right) of different arsenic species 
in Laminaria methanol extracts. 
 
The degradation involves an acid hydrolysis of the acetal group at C1 of the ribose and 
leads to the free arsenosugar, a compound that is identical to all arsenosugars. Taking into 
account the fact that the total amount of arsenic does not significantly change, it could be 
concluded that all arsenosugars are transformed into the free arsenosugar. Looking at 
absolute intensities (left side of figure 8.28), AsSug-254 accounts only for a minor amount, 
but this compound might have a very low ionisation efficiency in the ES source. 
Unfortunately no standard of the free arsenosugar is available. However, it seems 
unrealistic that this sugar analogue has an ionisation efficiency that low compared to those 
present in the Laminaria sample. Therefore it makes more sense to doubt about the 
extraction efficiency of boiled algae versus algae that have been incubated in SGF. Because 
extraction efficiencies were not determined, it is difficult to draw any conclusions about 
possible transformations of arsenosugars in SGF. The only fact that can be retained is that 
a certain amount of the free arsenosugar is formed in the acid environment of the stomach. 
 
This experiment was also carried out on raw Laminaria . In function of the incubation time 
in SGF a similar pattern could be observed compared to boiled Laminaria , with the 
exception that the amount of DMA did not significantly change. The same remark can be 
made as in the first experiment. The free arsenosugar was detected in the algae extracts 
after incubation in SGF, but quantitative aspects are missing. 
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Table 8.10. Arsenic concentrations in raw and processed Laminaria. 
 
    
sample As conc. sample As conc. 
 [mg/kg]  [mg/kg] 
 (n = 1)  (n = 1) 
    
    
raw Laminaria 29.7   
    
Laminaria in SGF  Laminaria 3 h in SGF & in SIF  
    
15 min in SGF 22.8 15 min in SIF 21.6 
30 min in SGF 21.0 30 min in SIF 21.2 
60 min in SGF 20.3 45 min in SIF 24.4 
120 min in SGF 18.9 60 min in SIF 22.0 
180 min in SGF 20.3 120 min in SIF 19.1 
    
 
The experiment was repeated on raw Laminaria , but now measurements were carried out 
with HPLC-ICP-MS. Again the seaweed was first chewed. The Laminaria was divided in two 
portions for incubation in SGF and in SGF and SIF, respectively. The procedure was exactly 
the same as described above. The results are shown in table 8.10. Because the algae were 
not boiled, incubation in SGF extracts about 23% after 15 minutes and 32% between 30 
and 180 minutes. This is more or less in agreement with the 22.6% of the total ingested 
arsenic that was recovered from the urine in the last ingestion experiment. However, it is 
difficult to compare an in vitro incubation experiment in SGF that only partly mimics the 
action of the stomach and an ingestion experiment in which the total GI tract is involved. 
 
The chromatograms of methanol extracts from algae incubated in SGF for different time 
periods, are shown in figure 8.29. The amount of AsSug-PO4 and AsSug-SO3 decreases and 
arsenosugar OH co-elutes with the free arsenosugar. The concentration of these arsenicals 
was determined using a calibration curve of DMA. Thus the efficiency of the methanol 
extraction can be calculated. In case of the raw Laminaria the methanol extraction 
efficiency is 32.9%. For the Laminaria incubated in SGF for different time periods, the 
mean methanol extraction efficiency is only 8.8% ± 1.1%. Unfortunately it was not possible 
to conclude about the methanol extraction efficiency of the individual arsenicals. When, 
however, the peak intensities are divided by the overall methanol extraction efficiencies for 
raw and SGF-processed Laminaria , around 83% of the sum of the peak intensities is 
recovered (mainly as compound 254) in the Laminaria methanol extract after 15 min 
incubation in SGF compared to raw Laminaria methanol extract. 
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Figure 8.29. Chromatograms of raw Laminaria methanol extract and Laminaria methanol 
extracts incubated in SGF. Separation on PRP-X100 anion exchange column, detection 
with ICP-MS. 
 
Because in anion exchange, free arsenosugar and arsenosugar OH co-elute, cation 
exchange HPLC-ICP-MS was also used. The same samples were separated on a Dionex 
CS10 column with 10 mM pyridine in 3% (v/v) MeOH (pH 2.7). Using cation exchange the 
free arsenosugar is retained by the stationary phase. The chromatograms of the methanol 
extracts of raw Laminaria and Laminaria after 180 minutes of incubation in SGF, are shown 
in figure 8.30. The peak of the free arsenosugar is clearly observed in the incubated 
Laminaria sample. An interesting feature is the presence of TMAO in the same sample. The 
identity was confirmed on the basis of spiking with a standard of TMAO (figure not shown). 
The presence of TMAO might indicate that a harsher breakdown than just acid hydrolysis of 
arsenosugars occurs in SGF. Moreover, it confirms the hypothesis that arsenosugars 
degrade to DMA via a pathway in which TMAO is involved. The retention time of the free 
arsenosugar was determined via monitoring of 2 MRM transitions (255>195 and 255>97) 
and via a product ion scan of the molecular ion with m/z 255 with HPLC-ES-MS/MS using 
the sample of Laminaria methanol extract that was incubated in SGF for 180 minutes. 
Based on anion and cation exchange it can be concluded that the free arsenosugar is 
formed although quantitative aspects are missing. 
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Figure 8.30. Chromatograms of Laminaria methanol extract and Laminaria methanol 
extract incubated in SGF for 180 min. Separation on CS10 cation exchange column, 
detection with ICP-MS. 
 
The SGF was also chromatographed using anion and cation exchange HPLC-ICP-MS. 
Arsenosugar PO4 and arsenosugar SO3 were found in equal relative amounts as in the 
Laminaria itself, meaning that they are extracted into the SGF to the same extent. 
Speciation analysis of methanol extracts of Laminaria that were incubated for 3 hours in 
SGF and transferred into SIF for further incubation up to two hours shows no significant 
additional extraction. Only minor amounts of the arsenosugars can be found in the SIF, 
again in the same ratio as in the raw Laminaria methanol extract, indicating that extraction 
proceeds, be it to a minor degree. Based on the findings of the methanol extracts of 
Laminaria incubated in SIF and the constant extraction efficiency, it is more likely that 
some residual SGF was mixed into the SIF. Because of the presence of AsSug-254, a larger 
peak is found in the void volume (AsSug-OH + AsSug-254) of the chromatogram of the 
SGF and SIF compared to the methanol extract of raw Laminaria . Figure 8.31 shows three 
chromatograms: the SGF after 3h incubation with Laminaria , a methanol extract of 
Laminaria after 3 h incubation, and a mixture of both solutions. They were separated using 
cation exchange chromatography on the Dionex CS10 column. The thick black line 
represents the SGF after 3 hours of incubation. It can be seen that the free arsenosugar is 
also extracted from the seaweed matrix and can thus be taken up by the blood. The peak 
shape of the free arsenosugar and arsenosugar OH are deformed compared to the sample 
of Laminaria after incubation in SGF (thin black line). This is most probably due to the high 
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acidity of the SGF sample. When Laminaria and SGF were mixed and chromatographed the 
resulting peaks of free arsenosugar and arsenosugar OH (thick grey line) appear in 
between the peaks of the separate samples. Besides free arsenosugar and TMAO, two 
other minor unknown arsenic species appear in the SGF-processed Laminaria methanol 
extract. They could, however, not be detected in the SGF itself. 
 
 
Figure 8.31. Chromatograms of Laminaria methanol extract incubated in SGF, SGF after 
incubation with Laminaria and a mixture of both samples. Separation on CS10 cation 
exchange column, detection with ICP-MS. 
 
Finally it was questioned whether the free arsenosugar is one of the unknown metabolites 
in the urine of people who had ingested algae. Because the last urine experiment (trial 7) 
was conducted at the same time, urine samples were compared with incubated algae 
samples. Figure 8.32 shows the chromatograms of a urine sample and sample of an extract 
of Laminaria after 3 hours incubation in SGF. It can be seen that the free arsenosugar does 
not appear in the urine but that one of the unknown peaks in the chromatogram of the 
Laminaria extract co-elutes with an unknown urinary arsenic metabolite. 
 
 
 
 
 
 
0
400
800
1200
1600
2000
0 1 2 3 4 5 6 7 8 9
retention time [minutes]
in
te
n
si
ty
 7
5
A
s 
[c
o
u
n
ts
]
SGF after 3h incubation (A)
Laminaria after 3h incubation in SGF (B)
A + B (4+1)
AsSug-OH
AsSug-254
U TMAOU
AsSug-PO4
AsSug-SO3
DMA
Chapter 8. Arsenic: measurement of arsenic metabolites from arsenosugars 
______________________________________________________________________________________________________ 
 210
 
Figure 8.32. Chromatograms of urine sample and Laminaria methanol extract incubated 
in SGF. Separation on PRP-X100 anion exchange column, detection with ICP-MS. 
 
8.4. Conclusion 
 
ICP-MS was optimised for analysis of arsenic in urine. RF power and methanol content are 
considered the most relevant factors to exert an influence on the sensitivity of the arsenic 
detection. Furthermore it was checked whether simple sample dilution would yield 
quantitative recovery of arsenic notwithstanding the high carbon and salt content in urine. 
Changing the RF power from 1100 W to 1300 W and adding 3% MeOH to the solution 
resulted in a six-fold increase in signal intensity. At a dilution factor of 1:40, the NaCl in 
urine does not give rise to a significant spectral interference of 40Ar35Cl+. Several studies 
were carried out in which a number of volunteers ingested a portion of the seaweed 
Laminaria . Urine and/or blood were collected and analysed for their total arsenic content 
and/or arsenic speciation. A maximum As/creatinine in urine appears between 15 and 25 h 
after ingestion. DMA, MA, TMAO, DMAE, As-Sug-SO3 and AsV  were identified as metabolites 
of arsenosugars by analysis with cation and anaion exchange HPLC-ICPMS. DMA and DMAE 
were also identified using HPLC-ES-MS/MS. In total 11 different arsenic metabolites were 
detected. With the exception of a few minor differences, the chromatograms of 5 
volunteers look very similar. The total amount of arsenic in the whole blood, serum and 
packed cell fraction of two volunteers who ate Laminaria were analysed. Blood was 
collected before and 4 and 7 h after ingestion. There seems to be no significant increase in 
arsenic level at the three intervals. The results for serum are confirmed by speciation 
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analysis. In one experiment a mass balance was determined showing that 23% of all 
ingested arsenic was recovered from urine. Chromatographic separation showed a recovery 
of 66%, indicating that the remainder of the arsenic species could not be eluted from the 
column. By altering the pH of the mobile phase it was again shown that MA was present 
and that its presence was not confused with DMAA. In a series of incubation experiments 
of Laminaria in SGF and SIF it was shown that incubation in SGF extracts the arsenicals 
form the seaweed matrix and that the arsenosugars are partially degraded into the free 
arsenosugar and into TMAO. This free arsenosugar is also extracted into the SGF. Further 
incubation into SIF does not lead to a significant extraction. It was investigated whether 
this free arsenosugar appears in urine. The answer was, however, negative. 
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Chapter 9. Summary, conclusion 
and future work 
 
 
 
 
9.1. Indium 
 
Indium is widely used in the micro-electronic industry as a component in III-V 
semiconductor materials. InAs, InP, CuInSe2 are used in photovoltaic cells, light emitting 
diodes, laser diodes, high frequency microwave devices, millimetre wave 
telecommunications and ultra fast supercomputers. The superior performance 
characteristics of III-V indium containing semiconductors will further increase the use and 
production of this element. Indium is also incorporated in several alloys, solders, 
thermometers, infrared detectors etc. Indium is considered to be toxic to mammals with, 
depending on the physicochemical form in which it is administered, the kidneys and the 
liver being the major target organs. In vivo experiments on animals have proved indium to 
cause teratogenic and embryopathic effects. The testicular toxicity of several indium-
containing compounds has been recognized. Indium is capable of altering the haem 
biosynthetic pathway in liver, kidney and erythrocytes. Indium induces apoptosis in rat 
thymocytes at low doses and causes necrosis at higher doses. Indium is also responsible 
for severe damage to the lungs of animals. For the reasons described above indium has 
become an element of interest in clinical, toxicological and analytical studies. These studies 
have focused mainly on pathological, morphological, kinetic and biochemical aspects, 
whereas fractionation and speciation techniques have only been used rarely. It is well 
known that toxicity, bioavailability and metabolism are highly dependent on the chemical 
form in which the metal is present. As a result speciation experiments are becoming 
increasingly important. Method development and optimisation of the separation techniques 
was done using radioisotopes of indium. 114mIn was chosen because of its favourable 
nuclear properties. 114mIn was produced by irradiation of a cadmium target with protons. 
Afterwards a suitable separation procedure was developed to isolate the indium from the 
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cadmium matrix. The separation method was done using solvent extraction (oxine in 
chloroform) and liquid chromatography (HBr and HCl on a Dowex 50wx4 cation exchange 
resin). The suitability of a chromatographic buffer for fractionation experiments was 
checked with batch ultrafiltration experiments. Ultrafiltration is a convenient means of 
studying the behaviour of trace elements in clinical samples and the influence of different 
parameters on this behaviour. Ultrafiltration experiments were conducted in which serum, 
packed cells and solutions of transferrin, albumin and haemoglobin were incubated with 
[114mIn]InCl3 and ultrafiltered on a 10 kDa cut-off filter. The activity in the ultrafiltrate was 
measured and compared with a reference sample of the same incubated mixture. Thus a 
value of the amount of radio indium bound to the high molecular mass (HMM) and low 
molecular mass (LMM) fraction could be determined. Compared to the amount of In3+ 
bound to the HMM fraction of the undiluted serum sample (93%), dilution in the hepes and 
tris:HCl buffer systems does not drastically alter the binding characteristics of indium. 
Moreover, hydrolysis of In3+ is not responsible for the high amount of indium in the HMM 
fraction. The binding of InCl3 to transferrin and albumin was also checked. In the case of 
transferrin, binding was quantitative in the presence of bicarbonate. When hepes and 
tris:HCl were used without bicarbonate, they themselves bind to the protein and inhibit 
binding between metal and protein. Also in the case of albumin, the binding was dependent 
on the ligands in solution. Similar to serum, the effect of different buffers on the binding 
between [114mIn]InCl3 and packed cell proteins was tested. There is no difference in % 
HMM bound 114mIn in case of 0.9% NaCl, tris:HCl and hepes buffer. A solution of 
haemoglobin was also incubated with [114mIn]InCl3 and ultrafiltered. However, only 40% of 
the 114mIn was found in the haemoglobin fraction. It can thus be expected that other 
proteins of the erythrocytes are capable of forming a complex with In3+. Different 
chromatographic columns were tested for their suitability for indium speciation. The 
suitability of the chromatographic procedure was tested with in vitro experiments. In vitro 
incubation experiments were carried out with human serum and packed cells. Separation 
on a gel filtration column showed that most of the activity is found within the elution 
volume that also contains transferrin. Some activity is spread out over the fraction 
containing albumin and a third peak containing 9.3% of all 114mIn is found within the low 
molecular mass (LMM) fraction. This was also confirmed by anion exchange 
chromatography. The outcome is, however, dependent on the pH. A higher pH leads to 
hydrolysis of the In3+ with a decrease in the transferrin-bound fraction. The LMM 
compound of indium is most probably a complex of InCl3 with the elution buffer as 
experiments with gel filtration and electrospray mass spectrometry do presume. 
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Fractionation of packed cell lysate shows that In3+ does not bind to haemoglobin. 40% of 
all [114mIn]InCl3 is found in the HMM fraction of a pure haemoglobin solution. In packed cell 
lysate the 114mIn activity peak comes slightly ahead of the haemoglobin peak. In cation 
exchange chromatography, only a small amount of 114mIn can be found in the haemoglobin 
fraction. 
 
During this work three in vivo experiments were carried out on male Wistar rats. In a first 
experiment five rats were given an intraperitoneal injection of [114mIn]InCl3 during four 
consecutive days. One hour after the last injection the rats were sacrificed. The in vivo 
distribution of 114mIn was studied in blood and in different organs. Differential centrifugation 
was used to study the distribution in liver, kidney and spleen homogenate. Rat serum, 
packed cell lysate, urine and the cytosol of liver, kidney and spleen homogenate were 
examined by size exclusion fast protein liquid chromatography. The results show that 
serum accounts for 90% of the indium activity in whole blood. Indium is preferentially 
accumulated within liver, spleen and kidney, the highest amount of 114mIn being localised in 
the cytosolic fraction followed by the mitochondria. Size exclusion experiments show that in 
rat serum In3+ is bound to transferrin and a minor fraction to albumin. The present 
experiments also showed that InCl3 is not bound to haemoglobin in packed cell lysate. 
Indium is associated to the high molecular mass fraction in liver, kidney and spleen cytosol; 
only in the case of kidney, small amounts of 114mIn can be found in the low molecular mass 
fraction. In a second experiment five rats were given two subcutaneous injections of 
[114mIn]InAs. Major target organs were again spleen, liver and kidney. The results were 
similar to those obtained after intraperitoneal injection of [114mIn]InCl3, indicating that in 
vivo dissociation has occurred. The intracellular distribution of indium was examined by 
differential centrifugation. The cytosolic fraction contained most of the indium activity 
followed by the mitochondrial fraction, in close agreement with the previous experiment. 
Chromatographic separations on a preparative size exclusion column were carried out. It 
was shown that indium was mostly bound to high molecular mass compounds in serum and 
in the cytosolic fraction of spleen, liver and kidney. In a third experiment five rats were 
given four oral doses of [114mIn]InAs over a short period. Prior to this experiment the in 
vitro solubility in simulated gastric fluid and simulated intestinal fluid was determined. In 
case of the SGF only 1.3% of an InAs suspension dissolved after 48 hours incubation at 
37ºC. InAs was not soluble in SIF. Uptake of InAs after oral administration was minimal 
(<1%). Due to incomplete removal of traces of [114mIn]InAs from the gastrointestinal tract, 
it was impossible to calculate accurately the in vivo distribution over the different organs. 
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As the uptake and consequently the radioactivity in the organs were very low, no further 
chromatographic separations could be carried out. Considering this very low uptake, the 
toxic impact of InAs after oral administration should not be overemphasized. 
 
9.2. Arsenic 
 
The study of the speciation of arsenic in the marine environment is very complex. In 
seawater arsenic occurs as inorganic arsenite and arsenate at about 2 ng/mL. Algae take 
up this arsenate, possibly because they cannot distinguish it from phosphate. They 
accumulate it and transform it into a series of arsenofuranoside derivatives, denoted as 
arsenosugars. Although a total of 16 different arsenosugars have been identified, 4 are 
predominant. Algae can reach levels of 200 mg As /kg (dry mass), a factor 100000 higher 
than in seawater, but the average concentration amounts around 30-40 mg/kg. 
Arsenosugars are also present in crustaceans and molluscs, as a consequence of the 
presence of symbiotic unicellular algae. Most probably arsenosugars are the precursors of 
arsenobetaine. Arsenobetaine is the main arsenic species in fish, crustaceans and molluscs 
and is considered as the end metabolite in the marine geocycle. Because of their 
omnipresence in marine foodstuffs, arsenosugars enter the human food chain. In contrast 
to the metabolism of inorganic arsenic and of arsenobetaine, little is known about the 
impact of arsenosugars on humans. As a consequence no toxicity data are available. 
Biological monitoring of acute arsenic exposure is done by urine analysis. However, total 
arsenic determination in urine is not relevant. Instead, speciation analysis should be carried 
out. By using a combination of a separation technique and powerful detection systems, 
better insight into the different arsenic species will be obtained. The problem was 
addressed from this point of view.  
 
Hydride generation atomic fluorescence spectrometry and electrospray mass spectrometry 
were primarily considered for elemental and molecular detection, respectively, of the 
arsenic species in extracts of algae, urine and serum. At first the instrumental parameters 
of both instruments were optimised in order to obtain a good sensitivity for both systems. 
Because it is well known that the sensitivity of ES-MS/MS is species dependent and strongly 
influenced by the sample matrix (salts, organic solvents, acids, bases…) a lot of 
optimisation work had to be done. In a first stage instrument parameters such as capillary 
voltage, sample cone voltage, extraction cone voltage, hexapole RF lens voltage and 
collision energy were investigated. These parameters are species dependent. The capillary 
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voltage for all species is within the range 2.7 to 3.5 kV. For speciation analysis a mean 
value of 3.0 was used. The sample cone voltages are within the range 30 to 45 V. The 
extraction cone voltage and the hexapole RF lens voltage did not differ much and were set 
to values of 2.0 and 0.2 V, respectively. When the sample cone voltage is increased, in 
source fragmentation of the analytes occurs, leading to the naked As+ ion at high values. 
This approach is valuable when searching for unknown compounds. For complete 
fragmentation to As+, a sample cone voltage of minimum 120-130 V is needed for the 
cationic trimethylated compounds. A higher sample cone voltage is needed for the 
compounds containing an arsenic-oxygen double bond (130-150 V). This indicates that 
cleavage of an As-C bond is more readily achieved than cleavage of an As=O bond. When 
conventional 4.6 mm i.d. columns are used with a flow rate of 1 mL/min, the best 
sensitivity is reached when the sample is split with 60% going to the waste. A desolvation 
temperature of 300°C proves to best. With microbore 2.1 mm columns, 200 mL /min flow 
rate directly to the source gives almost optimum sensitivity. Addition of formic acid to the 
sample up to 50% leads to a 10-fold (cationic species and DMA), 40-fold (MA) or 300-fold 
(AsV) increase in sensitivity for infusion experiments. Addition of MeOH to the mobile phase 
does not necessarily improve the sensitivity. In the case of cation exchange, the sensitivity 
is improved by addition of 20% MeOH, whereas in anion exchange chromatography the 
outcome is dependent on the identity of the arsenical. UV-HG-AFS was also optimised. 
Inner diameter and type of teflon tubing did not seem to have much influence on the 
photo-oxidation properties of the UV-cell. Segmentation of the flow by addition of a stream 
of air efficiently reduces post-column peak broadening. Despite the quantitative breakdown 
of the organoarsenicals in the UV-cell, this approach cannot be used for determining the 
total amount of arsenic in real-life samples. The complex urine matrix prevents complete 
breakdown to arsenate. Sodium phosphate proves to be the best buffer for HPLC-UV-HG-
AFS detection, whereas ammonium bicarbonate and ammonium oxalate are best for HPLC-
ES-MS/MS. For dual detection purposes, ammonium oxalate seems to be the best 
compromise. The capabilities of HPLC-ES-MS/MS were explored using extracts of kelp 
powder. AsSug-SO4 and AsSug-PO4 undergo in source fragmentation. HPLC-ES-MS/MS via 
MRM analysis mode allows unambiguous detection of known arsenic species. The 
approaches of dual detection and increased sample cone voltage work fine in case of algae 
samples, but it is questioned whether these approaches will be able to detect the low 
amounts of unknown arsenic species in urine samples. 
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Several studies were carried out in which a number of volunteers ingested a portion of the 
seaweed Laminaria . Urine and/or blood were collected and analysed for their total arsenic 
content and/or arsenic speciation. First ICP-MS was optimised for analysis of arsenic in 
urine. RF power and methanol content are considered the most relevant factors to exert an 
influence on the sensitivity of the arsenic detection. Furthermore it was checked whether 
simple sample dilution would yield quantitative recovery of arsenic notwithstanding the high 
carbon and salt content in urine. Changing the RF power from 1100 W to 1300 W and 
adding 3% MeOH to the solution resulted in a six-fold increase in signal intensity. At a 
dilution factor of 1:40, the NaCl in urine does not give rise to a significant spectral 
interference of 75ArCl+. In a first experiment four Chinese and one Belgian volunteer ate 20 
g of Laminaria . The total amount of arsenic was determined via ICP-MS. A maximum 
As/creatinine in urine appears between 15 and 25 h after ingestion. The urine samples 
were also analysed via HPLC-ICP-MS. DMA and MA were identified. In total 11 different 
arsenic metabolites were detected. With the exception of a few minor differences, the 
chromatograms of the 5 volunteers look very similar. In a second experiment the sensitivity 
of UV-HG-AFS was tested. This technique was, however, inappropriate to detect the very 
low amounts of arsenic species in urine. It was also observed that boiling of the Laminaria 
resulted in partial degradation of the arsenosugars. A third experiment was conducted in 
Belgium and in China. Two Belgian volunteers ate 20 g of Laminaria . Urine was collected 
before and up to 40 h after ingestion. Blood was taken before and 2, 4 en 7 h after 
ingestion. Via HPLC-ICP-MS a similar urinary arsenic profile was observed as in experiment 
1. DMA and MA were identified by spiking with standards. Via HPLC-ES-MS/MS in MRM 
mode the presence of DMA and DMAE could be proved. The presence of MA in urine 
cannot be explained. After analysis of a kelp powder extract, that was stored at 4°C during 
one and a half year, it appears that the arsenosugars are partially degraded into DMA and 
MA. The different serum samples were separated via anion exchange HPLC-ICP-MS. No 
differences can be observed in the chromatograms of the serum samples taken before and 
2, 4 and 7 h after ingestion. In a fourth experiment only the total amount of arsenic in the 
whole blood, serum and packed cell fraction of a Belgian and a Chinese volunteer who ate 
20 g Laminaria were analysed. Blood was collected before and 4 and 7 h after ingestion. 
The arsenic concentration was determined via HG-AFS after mineralisation. There seems to 
be no significant increase in arsenic level at the three intervals. A fifth experiment was 
carried out on two volunteers who ate 20 g of Laminaria . Attention was given to the 
possible presence of MAIII and DMAIII. Measurements with HPLC-ICP-MS again showed a 
good similarity with the previous experiments. MAIII and DMAIII were produced from MA 
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and DMA and spiked in the urine samples. DMAIII is not present in urine. It could not be 
unambiguously shown that MAIII was present. Because of the controversy around the real 
identity of the reduction products of MA and DMA, the instability of MAIII and DMAIII in 
urine and the difficulties by which these species are detected, no further attention was 
given. A sixth experiment was done on 1 volunteer. The purpose was to get more 
information about one of the unknown metabolites. This compound was purified by 
preparative chromatography. After freeze-drying, this compound appeared to be degraded 
into a mixture of DMA, MA, AsV  and possibly also AsIII. On the other hand, the behaviour of 
this compound showed to be independent on the pH of the mobile phase by which it is  
eluted from the anion exchange column. Possibly we are dealing with a polymeric 
compound that shows affinity to the stationary phase by hydrophobic interactions rather 
than ionic. A last experiment was conducted with one volunteer. A mass balance was 
determined showing that 23% of all ingested arsenic was recovered from urine. 
Chromatographic separation showed a recovery of 66%, indicating that the remainder of 
the arsenic species could not be eluted from the column. By altering the pH of the mobile 
phase it was again shown that MA was present and that its presence was not confused with 
DMAA. Via cation exchange HPLC-ICP-MS the presence of TMAO was shown, whereas the 
presence of DMAE could not be confirmed. In a series of incubation experiments of 
Laminaria in SGF and SIF it was shown that incubation in SGF extracts the arsenicals form 
the seaweed matrix and that the arsenosugars are partially degraded into the free 
arsenosugar and into TMAO. This free arsenosugar is also extracted into the SGF. Further 
incubation into SIF does not lead to a significant extraction. It was investigated whether 
this free arsenosugar appears in urine. The answer was, however, negative. 
 
9.3. Future work 
 
As has been shown throughout this work, the investigation of the metabolism of 
arsenosugars in humans is important from different points of view. First, the fact that 
arsenosugars are partly transformed into dimethylarsinic acid (DMA) raises questions about 
the possible toxicity of arsenosugars. The LD50 value of DMA, which is also the main 
metabolite in humans after being exposed to inorganic arsenic, is much higher than of 
inorganic arsenic, but presumably much lower than that of arsenosugars. Unfortunately, no 
LD50 values for arsenosugars are currently available. DMA has been said to be a potent co-
carcinogen. From a toxicological point of view it is thus important to know exactly what 
kind of metabolites are formed from these arsenosugars and what impact these compounds 
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pose on human health. Besides DMA, at least ten other metabolites have been registered 
about which hardly anything is known. Next and closely related to the first statement is the 
legislative aspect. In view of health standards it is important to know what kind of arsenic 
species are present in a foodstuff. Limits that are based on total arsenic values do not 
achieve their aim. In the case of marine foodstuffs more than 90% of the total amount of 
arsenic is considered innoxious. A revision of arsenic in food standards is highly 
recommended. In the case of algae, of which the arsenic burden is mainly due to 
arsenosugars, a similar reasoning prevails, the more so as crustaceans, molluscs and even 
algae gain popularity in the Western kitchen. Add to this that algae are more and more 
used in medication, as food additives and cosmetics and as fertilisers. The fundamental 
scientific aspects of arsenic speciation urgently need a better understanding. The geocylce 
of arsenic is a complex area in which numerous oxidation, reduction (de)methylation, 
(de)alkylation, glycosidation and other reactions occur, some of them mediated by 
microorganisms. Recent insights have shown that the lipid fraction of algae and mammalian 
tissue also contains high amounts of arsenic. The high affinity of arsenic for sulphur has 
lead to numerous speculations about the presence of arsenic -sulphur compounds. By 
getting better insights into these complex processes, other questions about arsenic 
transformation in other media or environmental compartments may be solved. For these 
reasons it is important that this research is to be continued. 
 
For the next years I have applied for a post-doc fellowship. The objectives of the project 
are two-fold. On the one hand research will focus on the analysis of blood and urine 
samples of a population of volunteers, which have ingested an amount of seaweed. On the 
one hand urine and blood samples will be analysed. Biological monitoring of acute arsenic 
exposure is best done using urine samples. Soluble arsenic species are efficiently taken up 
by the gastro-intestinal tract, quickly transported by the blood and excreted in the urine via 
the kidneys. Urine samples will be analysed with ion exchange and reversed phase 
chromatography coupled to both ICP-MS and to ES-MS/MS. Urine analysis must reveal how 
much metabolites are formed and what their identity is. The population study should also 
show whether or not the presence of these metabolites is true for a group of people or are 
more individually determined. Moreover quantitative data and kinetic aspects about the 
metabolites will be collected. It is necessary to calculate the recovery of a separation. This 
serves as a quality control for sample preparation and separation and guarantees that 
hidden species are not overlooked. The amount of absorbed arsenosugars is dependent on 
the amount of algae ingested. With the Laminaria seaweed, the total amount of 
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arsenosugars is limited to 1.2 mg. A population of 10 men and 10 women will ingest this 
alga. Besides this population study, it is the intention to carry out similar experiments on a 
number of volunteers who will ingest larger amounts of arsenosugars. These studies should 
increase the rate of success for identifying unknown compounds with ES-MS/MS. There are 
two possible routes for obtaining arsenosugars in large amounts: by organic synthesis or 
isolation form natural sources. Because of the fast transport of arsenic species by the 
blood, the analysis of serum and packed cells should focus on those samples taken within a 
few hours after ingestion. The analysis of serum and packed cells can reveal information 
about early transformations and how the arsenosugars or their metabolites are transported. 
The same methodology as for urine samples will be used, complemented with gel filtration 
chromatography in order to find out whether the arsenic species are protein bound. It is 
the objective to develop a full methodology in order to quantify all arsenosugar 
metabolites, identify as many as possible and examine the variability of these metabolites 
among a given population. A second aspect deals with in vitro incubation experiments in 
which the transformations of arsenosugars in simulated gastric fluid and simulated 
intestinal fluid will be further examined. Arsenosugars are known to undergo hydrolysis in 
acid environment and to be broken down by microorganisms. In vitro experiments will be 
carried out in which algae samples will be incubated in simulated gastric fluid and simulated 
intestinal fluid. The extraction efficiency of these media for the arsenosugars will be 
determined. It will also be studied whether the microorganisms can further transform the 
arsenosugars or their hydrolysis products. The experiments will be done in an incubator in 
which the conditions of stomach and gut (CO2, microbial activity) will be mimicked as 
closely as possible. 
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Chapter 10. Samenvatting, 
conclusie en toekomstig 
onderzoek 
 
 
 
 
10.1. Indium 
 
Indium wordt voornamelijk gebruikt in de micro-elektronica industrie, als component in III-
V halfgeleiders (InAs, InP...). Aangezien indium toxisch is, houdt blootstelling in de 
werkplaats gevaren in voor de gezondheid van de arbeider. De chemische speciatie van 
indium in het menselijk lichaam is tot op heden weinig bestudeerd. Het onderzoek in de 
jaren ‘60 en ‘70 beperkte zich voornamelijk tot toxiciteitstudies van de verschillende 
indiumverbindingen, studies betreffende de binding van deze elementen met transferrine 
en experimenten met betrekking tot hun toepassing in de medische diagnostiek en 
therapie. In de jaren ‘80 en ‘90 werden, samen met de snelle evolutie van de productie van 
de III-V halfgeleiders, eveneens toxiciteitstudies verricht naar de effecten van 
halfgeleidercomponenten zoals InAs bij proefdieren. Indium wordt beschouwd als een 
toxisch element, met de nieren of de lever het doelwitorgaan, dit afhankelijk van de 
chemische vorm van het element. In vivo experimenten op proefdieren hebben aangetoond 
dat indium teratogene en embryopatische eigenschappen heeft. De testiculaire toxiciteit 
van verschillende indium-bevattende verbindingen werd aangetoond. Indium is in staat de 
heembiosynthese in lever, nieren en rode bloedcellen te verstoren. Indium induceert 
apoptose in rat thymocyten bij lage doses en veroorzaakt necrose bij hogere dosissen. 
Indium is tevens verantwoordelijk voor ernstige schade aan de longen van proefdieren. In 
deze toxiciteitstudies zijn chromatografische scheidingen weinig of niet aan bod gekomen. 
Nochtans kan via deze techniek nuttige informatie bekomen worden omtrent de chemisch 
actieve species van indium in lichaamsvochten en weefsels. Deze techniek biedt de 
mogelijkheid om het gedrag van indium, zowel in vitro als in vivo, beter te doorgronden. 
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Vooreerst werden via in vitro experimenten de scheidingsmethoden ontwikkeld en 
geoptimaliseerd. Daarna werden een reeks in vivo experimenten uitgevoerd op ratten. 
 
Voor de in vitro en in vivo experimenten met indium werd gebruik gemaakt van radioactief 
114mIn. Deze nuclide werd dragervrij geproduceerd door bestraling van Cd met protonen in 
het cyclotron. Na een koelingperiode van 30 dagen, nodig voor het verval van kortlevende 
indiumisotopen diende de isotoop afgescheiden te worden van de oorspronkelijke 
cadmiummatrix. Hiervoor werd gebruik gemaakt van solvent extractie (oxine in chloroform) 
en vloeistof chromatografie (HBr en HCl op Dowex 50Wx4). De kwaliteit en het rendement 
van deze scheidingen werden geoptimaliseerd met behulp van “batch” experimenten met 
reactor geproduceerde isotopen: 116mIn, 115Cd. Om de binding tussen InCl3 en diverse 
serumproteïnen te onderzoeken, werd onverdund serum geïncubeerd met [114mIn]InCl3 (pH 
2,3) bij 37°C en na 2 uur ge-ultrafiltreerd (cut-off 10 kDa). De activiteit in het ultrafiltraat 
werd gemeten via NaI-scintillatietelling. De activiteit werd vergeleken met een standaard, 
om te corrigeren voor het verschil in doorlaatbaarheid van de filters. Uit de resultaten bleek 
dat In3+ voor 93% geassocieerd was met de HMM fractie. Vervolgens werd het effect van 
verschillende buffers op de bindingseigenschappen van In3+ in serum bestudeerd. Daartoe 
werd onverdund serum en serum 1 + 9 verdund in 5 verschillende buffers geïncubeerd met 
[114mIn]InCl3 en na 2 uur onderworpen aan ultrafiltratie uitgevoerd zoals hierboven 
beschreven. Uit de resultaten bleek dat verdunnen in tris:HCl + NaHCO3 en in hepes + 
NaHCO3 buffer geen weerslag heeft op de verdeling van In3+ in serum. De waarden komen 
nagenoeg overeen met de referentiewaarde van het onverdunde serum. De hydrolyse van 
indium [In(OH)n(H2O)6-n]3-n (n= 0-4) bij neutrale pH is niet de oorzaak voor de 
aanwezigheid van 114mIn in de HMM fractie. Analoge ultrafiltratie experimenten toonden aan 
dat de binding van InCl3 met transferrine sterk afhankelijk is van de liganden in oplossing. 
Fosfaat en hepes binden zelf op transferrine en inhiberen hierdoor de binding tussen 
metaal en eiwit. Waterstofcarbonaat is vereist als ligand voor efficiënte binding tussen In3+ 
en transferrine. Daarom dient NaHCO3 aan de buffers toegevoegd te worden. Analoog als 
bij transferrine werd onderzocht of indium geassocieerd is met albumine. In een 
fysiologische oplossing van NaHCO3, fosfaat, citroenzuur en NaCl werd 91% van het In3+ 
teruggevonden in de HMM fractie. In een oplossing van hepes of tris:HCl is de associatie 
metaal eiwit minder uitgesproken. InCl3 bindt efficiënt met de HMM eiwitten in rode 
bloedcellen al is hemoglobine waarschijnlijk hiervoor niet verantwoordelijk. In vitro 
incubatie experimenten van [114mIn]InCl3 in serum en scheiding op verschillende kolommen 
toonden aan dat In3+ voornamelijk geassocieerd is met transferrine, met een laag 
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moleculaire component en in geringe mate met albumine. Het resultaat is niettemin 
afhankelijk van de pH van de [114mIn]InCl3 tracer. Bij pH 4 is In3+ reeds partieel 
gehydrolyseerd tot In(OH)2+. Deze component bindt veel minder efficiënt met transferrine 
en komt gedeeltelijk voor als LMM component. Wanneer serum geïncubeerd wordt met 
indiumtracer die op pH 1 gebracht is, komt indium voor als In3+ en bindt het volledig op 
transferrine. Informatie over de LMM component van In3+ werd gevonden via gelfiltratie en 
electrospray massa spectrometrie. Citraat is niet verantwoordelijk voor binding van In3+. Er 
wordt vermoedt dat de buffers (hepes en tris:HCl) het InCl3 complexeren. Gelijkaardige 
patronen werden reeds gerapporteerd voor Fe3+ oplossingen in tris:HCl buffer. In vitro 
incubatie van [114mIn]InCl3 in het lysaat van rode bloedcellen toonde aan dat In3+ niet 
geassocieerd is met Hb. Geschikte kolommen met kwantitatieve opbrengst voor 114mIn zijn 
Asahipak GS-520 7G, Superose 12 HR, Bio-Gel P2, Sephacryl S-200 HR, Superdex Peptide 
voor gelfiltratie, en Mini Q, Mono Q, Hi Trap Q FF Sepharose voor anion uitwisselings-
chromatografie in serum. 
 
Drie in vivo experimenten werden uitgevoerd op 3 groepen van 5 mannelijke Wistar ratten: 
na intraperitoneale administratie van [114mIn]InCl3 en na onderhuidse en orale administratie 
van [114mIn]InAs. Bij het eerste experiment waren de resultaten de volgende. De grootste 
hoeveelheden 114mIn komen voor in nier, lever en milt. Voor elk van deze organen werd de 
belangrijkste hoeveelheid 114mIn teruggevonden in het cytosol, gevolgd door de 
mitochondriën. Zowat 90% van de totale hoeveelheid 114mIn in bloed werd teruggevonden 
in het serum 2 uur na de laatste injectie. In tegenstelling tot de in vitro speciatie van 
[114mIn]InCl3 in serum is InCl3 bijna uitsluitend op transferrine gebonden, met een minieme 
hoeveelheid op albumine. Chromatografische scheiding van rode bloedcellysaat toonde aan 
dat 114mIn net voor de hemoglobinepiek elueert. In urine is In3+ voornamelijk gebonden op 
een laagmoleculaire massacomponent. Lever, nier en milt werden gehomogeniseerd en het 
cytosol werd gescheiden via gelfiltratie. In alle gevallen bleek dat In3+ voornamelijk (nier) 
of uitsluitend (lever en milt) geassocieerd is met de HMM fractie. Niettegenstaande sporen 
transferrine hiervoor verantwoordelijk zijn, was de 114mIn piekvorm te breed en de 
concentratie van transferrine te laag. Verwacht wordt dat een andere component(en) InCl3 
bindt. 
 
In de tweede reeks werd een suspensie van [114mIn]InAs eenmalig onderhuids geïnjecteerd. 
De activiteit in de feces bereikte een maximum na 2 dagen en nam daarna steeds maar af. 
Het 114mIn in de urine bereikte eveneens een maximum na 2 dagen. In het geval van urine 
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was echter na 3 dagen geen significante hoeveelheid 114mIn meer te meten. Analoog als bij 
experiment 1 kon vastgesteld worden dat 114mIn zich voornamelijk opstapelt in milt, nier en 
lever. Wat betreft de subcellulaire verdeling in lever, nier en miltcellen waren de grootste 
hoeveelheden 114mIn terug te vinden in het cytosol, gevolgd door de mitochondriën. Dit was 
opnieuw analoog als bij de intraperitoneale injectie van [114mIn]InCl3. Fractionatie 
experimenten in serum en cytosol van nier, lever en milt werden eveneens uitgevoerd. De 
resultaten waren analoog als die bij experiment 1. Indium is voornamelijk geassocieerd met 
de HMM fractie. 
 
Voorafgaand aan de derde reeks werd de in vitro oplosbaarheid van InAs in gesimuleerd 
maagsap en gesimuleerd intestinaal sap bepaald. InAs bleek slechts beperkt oplosbaar in 
maagsap (pH 1) te zijn en was onoplosbaar in intestinaal sap (pH 7). 4 dosissen 
[114mIn]InAs werden oraal toegediend binnen een termijn van 11 dagen. Meer dan 99% van 
alle toegediende activiteit werd de volgende 72 uur teruggevonden in de feces. Slechts 
minieme hoeveelheden waren terug te vinden in de urine. Door de aanwezigheid van 114mIn 
in het darmstelsel was het moeilijk de in vivo verdeling over de organen accuraat te 
bestuderen. Enkele trends konden hoe dan ook vastgesteld worden. In tegenstelling tot 
intraperitoneale en onderhuidse administratie was de milt geen doelwitorgaan. Nieren en 
lever bevatten slechts weinig 114mIn. De long bevatte een hoge hoeveelheid 114mIn. De 
oorzaak is te wijten aan het feit dat ratten  aan hun eten ruiken en zo een deel van het 
[114mIn]InAs inhaleerden. Maag, pancreas, dunne en dikke darm, niet toevallig de gastro-
intestinale organen vertoonden de hoogste hoeveelheid activiteit. De conclusie is dat de 
toxiciteit van InAs na orale opname niet overschat mag worden. Niettegenstaande de 
morfologische en biochemische gevolgen van InAs intoxicatie gekend zijn, blijkt dat de 
opname via ingestie zeer beperkt is. 
 
10.2. Arseen 
 
De speciatie van arseen in de mariene omgeving is een complex gebeuren. De concentratie 
van arseen in zeewater bedraagt ongeveer 2 ng/mL. Het arseen in het zeewater komt voor 
als anorganisch arsenaat en arseniet. Algen nemen dit arsenaat op, waarschijnlijk omdat ze 
het niet kunnen onderscheiden van het isosterische fosfaat. Algen accumuleren dit 
anorganisch arseen en transformeren het tot een aantal arsenofuranoside (arseensuikers) 
derivaten. Het gehalte aan arseensuikers in algen kan tot 230 mg As /kg (droge massa) 
bedragen, een factor 100000 hoger dan in zeewater, maar bedraagt gemiddeld 30-40 
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mg/kg voor bruinwieren. Arseensuikers komen ook voor in schaal- en weekdieren, dit als 
gevolg van de aanwezigheid van de symbiotische unicellulaire algen. Men vermoedt dat 
deze arseensuikers de precursors zijn van arsenobetaïne. Arsenobetaïne is het belangrijkste 
arseen species in vissen en in schaal- en weekdieren en wordt beschouwd als het 
eindmetaboliet in de mariene geocyclus. Deze arseenspecies manifesteren zich uiteraard in 
de voedselketen. In tegenstelling tot het metabolisme van anorganisch arseen en dat van 
arsenobetaïne, is weinig bekend over de impact van arseensuikers op de mens. Men heeft 
dan ook geen informatie omtrent de toxiciteit van deze verbindingen. Normaliter wordt 
arseen in urine bepaald om een idee te verkrijgen over de blootstelling aan dit element. 
Het totale gehalte aan arseen is echter geen maatstaf voor acute toxiciteit. Men dient 
speciatie analyse uit te voeren. Met behulp van een scheidingsmethode gekoppeld aan een 
detector kan men een beter beeld verkrijgen omtrent de verschillende chemische species in 
een monster. Vanuit deze analytische benadering werd dan ook het onderzoek gevoerd. 
Anion en kation uitwisselingschromatografie werd aangewend voor de scheiding van de 
arseen species. HG-AFS en ICP-MS enerzijds en ES-MS/MS anderzijds werden gebruikt als 
elementselectieve en moleculair-structureel selectieve detectors, respectievelijk. Deze 
toestellen werden eerst geoptimaliseerd. 
 
ES-MS/MS is sterk afhankelijk van de matrix waarin het analiet is opgelost en de 
gevoeligheid is verschillend naargelang de aard van de arseenverbinding. Methanol 
toevoegen aan de mobiele fase heeft niet noodzakelijkerwijze een positieve invloed op de 
gevoeligheid van ES-MS/MS. Enkel bij kationuitwisseling blijkt een stijgende hoeveelheid 
MeOH (20%) een positieve invloed te hebben op de gevoeligheid. Daarna werd HG-AFS 
geoptimaliseerd. Omdat organische arseenverbindingen niet rechtstreeks hydriden vormen 
werd een foto-oxidatie stap ingevoerd. De parameters voor een kwantitatieve conversie 
van organo-arseenverbindingen naar arsenaat werden geoptimaliseerd. De invloed van 
verschillende buffers op de gevoeligheid van beide detectors werd bestudeerd. Natrium 
fosfaat is de beste buffer wanneer enkel HG-AFS detectie gebruikt wordt. In het geval van 
ES-MS/MS zijn ammonium waterstofcarbonaat en ammonium oxalaat de beste opties. 
Indien duale detectie met beide systemen dient te gebeuren, blijkt ammonium oxalaat het 
beste compromis te zijn. De verschillende analyse modes bij ES-MS/MS werden getest aan 
de hand van extracten van algen. Arseensuikers SO4 en PO4 ondergaan reeds fragmentatie 
in de ES bron. De benadering van verhoogde bronspanning kan gebruikt worden om de 
arseenverbindingen compleet te fragmenteren tot het arseen ion. Dit principe biedt een 
alternatief voor de element selectieve detectors, al is detectie van een signaal bij m/z 75 
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geen garantie voor de aanwezigheid van arseen. Andere analieten kunnen in de bron 
gefragmenteerd worden tot een component met m/z 75. Duale detectie (UV-HG-AFS en ES-
MS/MS) en verhoogde bronspanning bij ES-MS/MS kunnen gebruikt worden om onbekende 
arseenverbindingen te identificeren. De vraag dient echter gesteld te worden of beide 
toepassingen gevoelig genoeg zijn om de lage gehaltes van onbekende arseenverbindingen 
in urine op te sporen. 
 
Verschillende klinische studies werden uitgevoerd waarin Chinese en Belgische vrijwilligers 
een portie Laminaria opaten. Urine en/of bloed werden gecollecteerd en geanalyseerd op 
hun totale hoeveelheid arseen en/of de verschillende arseen species. Vooreerst werd echter 
ICP-MS geoptimaliseerd voor de bepaling van de zeer lage hoeveelheden arseen in bloed 
en urine. Voor de bepaling van totaal arseen in urine bleek een verdunningsfactor van 1:40 
voldoende om een spectrale interferentie met 40Ar35Cl+ te vermijden. Toevoegen van 3% 
methanol en verhogen van het RF vermogen tot 1300 W leidde tot optimale gevoeligheid. 
Een eerste experiment gebeurde in China. Vier mannelijke Chinezen en een Belg namen 
hieraan deel. Het verloop van de concentratie van arseen in de urine werd onderzocht en 
speciatie experimenten werden uitgevoerd. 20 g (droge massa) Laminaria wordt gegeten. 
Arseenbevattende voeding werd vermeden tijdens en drie dagen voor het experiment. 
Urine wordt gecollecteerd voor en tot 100 uur na de start van het experiment. De totale 
hoeveelheid arseen in de urinestalen werd bepaald via ICP-MS. Een maximum As/creatinine 
in de urine treedt op tussen 15 en 25 uur na opname. De urinestalen worden tevens 
gescheiden via anion- en kationuitwisselingschromatografie en detectie via ICP-MS. In de 
chromatogrammen is een duidelijke toename te zien in de hoeveelheid DMA en MA. In 
totaal werden 11 verschillende arseenverbindingen gedetecteerd. Op een paar kleine 
verschillen na, waren de chromatogrammen van de 5 vrijwilligers zeer analoog. In een 
tweede experiment werd de gevoeligheid van UV-HG-AFS getest. Deze bleek echter 
onvoldoende voor de detectie van de arseen species in urine. Er werd tevens vastgesteld 
dat koken van het zeewier gedurende enkele minuten een invloed heeft op de stabiliteit 
van enkele arseensuikers. De hoeveelheid arseensuiker PO4 neemt af en arseensuiker OH 
en DMA nemen toe. Er werd besloten het zeewier niet meer te koken. Een derde 
experiment werd uitgevoerd in België en China. Twee Belgische vrijwilligers aten Laminaria 
(20 g). Urine werd gecollecteerd voor en tot 40 uur na opname. Bloed werd afgenomen 
voor en 2, 4 en 7 uur na opname. Via HPLC-ICP-MS werden opnieuw een groot aantal 
onbekende arseenverbindingen vastgesteld. DMA en MA konden geïdentificeerd worden via 
spiking met standaarden. Via HPLC-ES-MS/MS in MRM mode kon de aanwezigheid van DMA 
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en DMAE aangetoond worden. De aanwezigheid van MA in urine kan voorlopig niet 
verklaard worden. Na analyse van een extract van zeewier dat anderhalf jaar in de koelkast 
werd bewaard, bleek echter dat de arseensuikers partieel degradeerden met vorming van 
DMA en MA. De verschillende serummonsters werd gescheiden via anionuitwisseling HPLC-
ICP-MS. Zowel voor als 2, 4 en 7 uur na eten van zeewier is geen verandering in het 
arseenprofiel te zien. In een vierde experiment werd enkel de totale hoeveelheid arseen in 
bloed geanalyseerd. Twee vrijwilligers aten een portie Laminaria . Bloed werd gecollecteerd 
voor en 4 en 7 uur na opname. Arseen in bloed, gepakte cellen en serum werd bepaald via 
HG-AFS na mineralisatie. Ook hier bleek geen significante stijging van de arseengehalten 
op te treden. Een vijfde experiment werd uitgevoerd met twee vrijwilligers. De aandacht 
ging voornamelijk uit naar de mogelijke aanwezigheid van MAIII en DMAIII. HPLC-ICP-MS 
metingen toonden opnieuw aan dat de resultaten analoog zijn aan die van voorgaande 
experimenten. MAIII en DMAIII werden bereid uit MA en DMA en gespiket in de 
urinemonsters. DMAIII is niet in urine aanwezig. Er kon ook niet met zekerheid gezegd 
worden dat MAIII aanwezig is. Omwille van de controverse omtrent de ware identiteit van 
de reductieproducten van MA en DMA, hun onstabiel karakter in urine en de moeilijkheid 
waarmee ze kunnen gedetecteerd worden, werd niet verder ingegaan op dit onderwerp. 
Een zesde experiment werd uitgevoerd met 1 vrijwilliger en had als doel meer informatie te 
verkrijgen over 1 bepaalde onbekende arseenverbinding die telkens voorkomt in de urine. 
Deze component werd via preparatieve chromatografie gecollecteerd en opgezuiverd. Na 
vriesdrogen bleek echter dat deze component volledig omgezet werd in een mengsel van 
DMA, MA, arsenaat en mogelijks ook arseniet. Scheiding van de urine waarin deze 
component voorkomt met een fosfaat buffer bij verschillende pH, toonde echter aan dat de 
retentietijd onveranderd bleef. Mogelijks gaat het om een polymere component die via 
hydrofobe, en niet via ionaire, interacties interageert met de stationaire fase. Een laatste 
experiment werd uitgevoerd met 1 vrijwilliger. Er werd een massabalans opgesteld waaruit 
bleek dat 23% van alle opgenomen arseen teruggevonden werd in de urinemonsters van 
de vrijwilliger. Verder werd berekend dat het rendement van een scheiding op de kolom 
66% bedraagt. Dit betekent dat de resterende hoeveelheid niet geëlueerd kan worden op 
de kolom. Er werd nagegaan bij verschillende pH waarden van de mobiele fase of de 
aanwezigheid van MA niet verward werd met die van DMAA. Doch de aanwezigheid van MA 
bleek gerechtvaardigd. Via kationuitwisseling HPLC-ICP-MS werd de aanwezigheid van 
TMAO aangetoond. De aanwezigheid van DMAE kon niet bevestigd worden. 
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Via een reeks incubatie experimenten van Laminaria in SGF en SIF werd aangetoond dat 
SGF de arseenverbindingen uit de algen extraheert en dat ze omgezet worden in de vrije 
arseensuiker en in TMAO. Deze vrije arseensuiker wordt tevens mee geëxtraheerd in het 
SGF. SIF zorgt niet voor een significante extractie. Er werd nagegaan of deze vrije 
arseensuiker tevens in de urine voorkomt, doch het antwoord was negatief. 
 
10.3. Toekomstig onderzoek 
 
Verder onderzoek naar het metabolisme van arseensuikers in de mens is belangrijk vanuit 
verschillende standpunten. Ten eerste is reeds vastgesteld dat arseensuikers hoofdzakelijk 
omgezet worden in dimethylarseenzuur (DMA). Dimethylarseenzuur wordt eveneens 
gevormd als detoxificatiemetaboliet van anorganisch arseen in zoogdieren. Het vermoeden 
rijst dat DMA co-carcinogene eigenschappen heeft. Vanuit toxicologisch standpunt is het 
dus belangrijk te weten welke metabolieten gevormd worden uit deze arseensuikers en 
welke impact ze hebben op de gezondheid. Naast DMA komen nog een tiental verbindingen 
in urine voor, waarover niets bekend is. Vervolgens en hiermee geassocieerd is er het 
wetgevende aspect. Naar voedingsnormen toe is het heel belangrijk te weten welke 
arseenspecies schadelijk zijn en welke niet. Normen voor maximaal toelaatbare waarden 
die gebaseerd zijn op totale arseengehalten missen hun effect volledig. In het geval 
voedingsproducten van mariene oorsprong zijn, blijkt meer dan 90% van de arseenspecies 
in vissen niet toxisch. Een herinterpretatie van deze normen op basis van chemische 
speciatie dringt zich op. Voor algen, waarvan het arseengehalte nagenoeg uitsluitend uit 
arseensuikers bestaat, geldt een analoge redenering. Schaal- en weekdieren en zelfs 
zeewieren winnen veld in de Westerse keuken. Bovendien worden algen steeds meer 
gebruikt in geneesmiddelen, voedseladditieven en cosmetische producten en als meststof. 
Het fundamenteel wetenschappelijk aspect van de arseenspeciatie dient dringend 
aangepast. De geocyclus van arseen is een complex gebeuren van oxidaties, reducties, 
(de)methylaties, (de)alkylaties, glycosidaties en andere reacties, al of niet microbieel 
gemedieerd. Het ontrafelen van het mechanisme van het arseensuikermetabolisme in de 
mens kan meer inzicht bieden in dit complex gebeuren en antwoorden geven op de vele 
vragen die nog rijzen over arseen transformaties in andere compartimenten.  
 
Voor de komende jaren heb ik een voorstel voor verder onderzoek aangevraagd. De 
aanpak van dit onderzoek is tweeledig. Enerzijds zal het onderzoek zich toespitsen op het 
analyseren van bloed- en urinestalen van een populatie vrijwilligers die een hoeveelheid 
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zeewier hebben gegeten. Urinestalen zullen geanalyseerd worden met behulp van 
ionuitwisselings- en omkeerfasechromatografie gekoppeld aan zowel ICP-MS als aan ES-
MS/MS. Het doel van het analyseren van de urinestalen is nagaan welke en hoeveel 
metabolieten gevormd worden. De vraag stelt zich eveneens of dezelfde verbindingen 
voorkomen in een ganse populatie of eerder individueel bepaald zijn, en welke de gehalten 
en de kinetische aspecten van deze verbindingen zijn. Het opstellen van een massabalans 
vermijdt dat sommige verbindingen over het hoofd gezien worden. De hoeveelheid 
ingenomen arseensuikers is afhankelijk van hun gehalten in zeewieren. Een portie van 30 g 
gedroogd Laminaria komt overeen met een hoeveelheid van 1,2 mg As. Voor deze studies 
wordt gedacht aan een populatie van 10 mannen en 10 vrouwen. Naast deze 
populatiestudies zullen experimenten uitgevoerd worden waarbij vrijwilligers een grotere 
hoeveelheid eten, dit om de analyses met behulp van ES-MS/MS meer kans op slagen te 
bieden. Voor de isolatie van deze grotere hoeveelheden arseensuikers zijn er twee opties: 
organische synthese en isolatie uit natuurlijke bronnen. Omwille van het snelle transport 
van arseen door het bloed, zal bloedonderzoek zich toespitsen op de eerste uren na 
blootstelling. Het analyseren van serum en gepakte cellen laat toe na te gaan in welk 
stadium de arseensuikers reeds afgebroken worden. Dit zal tevens gebeuren met de 
hierboven vermelde technieken alsook met gelfiltratie chromatografie om na te gaan in 
welke mate de arseenverbindingen eiwitgebonden zijn. Via een systematische, 
interdisciplinaire aanpak, gericht op internationale samenwerking, is het de bedoeling een 
volledige methodologie ontwikkeld te hebben om kwantitatief alle metabolieten van 
arseensuikers in kaart te brengen, ze te identificeren en na te gaan in welke mate het 
metabolisme van arseensuikers systematisch voorkomt of individueel bepaald is. Anderzijds 
zal met behulp van in vitro incubatie experimenten getracht worden de transformaties in 
gesimuleerd maag- en darmsap te onderzoeken. Het is bekend dat arseensuikers hydrolyse 
ondergaan in zuur milieu en dat ze door micro-organismen afgebroken kunnen worden. In 
vitro experimenten zullen verder uitgevoerd worden waarbij algen geïncubeerd worden in 
gesimuleerd maag- en darmsap. Er zal nagegaan worden hoe efficiënt de arseensuikers uit 
de algen geëxtraheerd. Verder zal onderzocht worden in welke mate maagsap een efficiënt 
extractant is en of de micro-organismen in staat zijn de arseensuikers of derivaten hiervan 
verder af te breken. De experimenten zullen uitgevoerd worden in een broedstoof om de 
condities (CO2 gehalte, microbiële activiteit) in beide media zo goed mogelijk te imiteren. 
